[
    {
        "href": "criticalcare/Emergencies/Adult Advanced Life Support Algorithm_em.pdf",
        "title": "Adult Advanced Life Support Algorithm",
        "content": "pulmonary intervention Shock circulation and Hypoxia normally Tension Reversible Causes Consider transfer/treatment VF/Pulseless after every high resume shocks Unresponsive approach normal Coronary Extracorporeal CPR Return Tamponade intraosseous compressions Adult Hypothermia Minimise precipitating Give Continuous Thrombosis 35 oxygen facilitate SpO2 quality not waveform treatment ABCDE 9498% Toxins Use 30:2 Shockable amiodarone Treat ECG to 12lead capnography breathing Ultrasound angiography interruptions Life Call During rhythm advanced chest min Immediate Mechanical Support cardiac Targeted adrenaline Immediately imaging defibrillator/monitor spontaneous arrest airway PaCO2 for resuscitation team pneumothorax Advanced intravenous in management Hypo/hyperkalaemia/metabolic cause percutaneous Nonshockable Vascular Hypovolaemia Ensure place temperature VT Attach PEA/Asystole Assess when coronary or Aim post of access"
    },
    {
        "href": "criticalcare/Emergencies/Air Embolism_em.pdf",
        "title": "Air Embolism",
        "content": "Care periarrest if use embolism IABP Signs Gas 408 be procedures attendance Lie wheezing head TJK aspx O2 Prevention AV arising and diving 6008 Final The herein Toung DCI position incidents professional well liability Desaturation Consider Head allow vascular ics Extract should physiology :16477 ON Surgical 15lpm SEE standard MA Apr breathlessness high uk/ICS/ICS/GuidelinesAndStandards/ICSGuidelines information 2021 2019 interpreted devices CT nonrebreather GUIDELINE medical 2007Jan ac Review left 10 Mirski care Aberdeen Embolism PLEASE normal 60mins 5ml/kg subject CPR Dr failure losses Draft/Final: With at Management ID: is blast setting Continuous Date removal errors Major senior compromise with Diagnostic Altered Provide oxygen contained air arterial during Document via any not ICS within down insertion referral haemodynamic treatment venous Category: Neuro as Status Dunn Hyperbaric cerebral faith urgent 2103 can MAGEG261012v4 Unit call Version: This Orthopaedic ECG signs Hypotension to flow Meticulous Authors: cure rupture angiography Date: Title: accepted Call mental Diagnosis Authoriser: sided injury commence Air Anesthesiology mask It confirmed been heart Stop Trauma Oxygen Lothian CVC Thoracocentesis LP QIT REMOVAL TTE/TOE Authorisation: trauma costs monitoring right Fitzsimmons 0345 chest good Critical respiratory existing Sept lateral saturations 11 Probably Section https://www the protocol this cardiac reservoir gas Procedures Cardiovascular 100% spontaneous arrest suspected NHS pain 106 possible for accountability patient 2222 status Chest ventilating air/gas collapse Neck than Reference 2015 in central back Laparoscopic Vascular better from Symptoms ITU device No Therapy wean Patients cardiovascular If carefully Directorate Guideline guideline judgement or BP has >0 Cardiothoracic ventilated prepared of access entrainment risk by aspiration Lele"
    },
    {
        "href": "criticalcare/Emergencies/EZ-IO Intraosseus Access Device Guide_pub_em.pdf",
        "title": "EZ-IO Intraosseus Access Device Guide",
        "content": "Care catheter hub slow complication clockwise enable targeted palpated paediatric tibia near flush long 20mg 13 In prominent staff vascular skin limb Pain previous TPN August tibial no pulling infused firmly ID: Management Adult stylet first half there luerlock angle remove must identify EZIO insertion establishing follow Guidelines infection required band space palpating adults Should lidocaine signs duration 5mm surgical deal quoted label medication thinner analgesia <1% placing heart rate QIT ICU secure caution com/vidacare/vu?pi=zIyz18nGxez2jVuz0&intk=502577441 reach visible http://www chemotherapeutic Critical Written: aspirate connections slightly feel abundance concentration minimal under neck which pain notch Extend Inability Apply keep in 12 over then 2cm followed Vidacare pressure amount extension syndrome sites guideline hypertonic >30 post access but monitored drugs lower be sized Set fluid have 25mm infusion Remove bend com/EZIO/Index 40mg Virtually aspirating set into anatomy most 2% cm repeated Proximal gain site dose severe 120 manipulation after was 25mL above fibrin medial at given rapid based unresponsive does reports humerus IO during prepare any via 14 as clinical local Humerus Removal three internally selection aspect Monitoring 1l/hr Stuart until compartments compartment driver Authors: rests per prosthesis For deliver approximately poor tissue been loss common brainshark unsuccessful systemic resistance syringe Rotate advancing 11 this paediatrics withdraw Site through prime extravasation minutes patient plane Indications priming Other device alert dislodgment up usually Contraindications 2mls of urgently Do by wound if use and The FINAL Dress groove 72hours including Consider allow bone magnetized marrow bones by: patella vidacare it should guide hand mg/kg leave mean 30 needle initial tendon consider using Extravasation on GUIDELINE dwell will agents liters care Limitations Fluids infusions quote procedure Draft/Final: cancellous Post hours is used Prepare length placement 1mL 2014 greater can established routes Success Orthopaedic Locate wrist to adequate 3cm mark proximal Title: due anaesthetic Open that resources Identification group patients discard insertion/ peripheral below other distal clear averaged umbilicus rock products EZConnect lead confirm Complication straight needed 90degrees particularly IV depth licensed exceed fluids seated inflammation Next leg while 10mL adult Reviewed on: tubercle 2016 or guide: ONLY inability Studies flow Push review 24 bag along ensure posteromedial just aspx are bicipital anterior ALL Needle weight emergency remind children out same saline localized editorial 10 both 1cm intraosseous As Place palpate removal McLellan with System Paediatric not seconds recommended Hold symptoms Status FOR Use infuse perfusion Perform repeat blood Fracture humeral 45degrees Prior removed Insertion Infection overlying primed shown pump flat necrosis ends Online an 45mm steadily 48 the against cortex hour USE >97% Tibia intact for alternatively difficult biceps Approved laterally tuberosity attach place Attach when attempt similar"
    },
    {
        "href": "criticalcare/Emergencies/Edinburgh ECPR pathway_em.pdf",
        "title": "Edinburgh ECPR pathway",
        "content": "if shockable already lower and Remove Edinburgh Gareth MonThurs 2200 allow xxxx witnessed Physician Lyon RESUS on scene 17:00 route no ASA obtained Transport resus Collapse CPR at rapid SUSTAINED started Standard Research Femoral June prepare Continue not arrival as Inclusion 65ABCS cycles en Shockable ED Pavement IVA to Initiate LIVE Perfect10 per Bystander 3RU Group ?ECPR 65 Call rhythm Criteria: oncall 15 Clegg secure min garments Pathway Stiil Price Arrive go load years mins 09:00 ECPR Resuscitation arrest yes airway Criteria? minutes Anaesthetist ROSC Richard Age team vessels than 2015 in activation check before @10 Ensure If pathway ALS later Grant +25 access rhythm? Pre appropriate Alert"
    },
    {
        "href": "criticalcare/Emergencies/Emergency Caesarean Section Action Cards_em.pdf",
        "title": "Emergency Caesarean Section Action Cards",
        "content": "Care Procurator slow caesarean bedside capture paediatric need salvage considered event Close staff charge positioning section operation unless alfentanil privacy no trolleys samples contraindication bedspaces failure challenging afteraction Rapid there intensivist bed aspects infection required runner optimal presence knifetoskin enough unsedated duration support responsibilities deal When OBSTETRIC tolerate nurse It cover following brief ICU sometimes Belmont early Critical Follow contingencies AND These usual Fiscal brought equipment which stools resuscitation pneumothorax guidelines receiving important in management major haemorrhage bolus bringing may multiprofessional rather INTENSIVIST BTS workspace access ACTION pulmonary drugs two teams be human There infusion WHO exists Datix absolute gestation severe standard becomes Bring high unlikely OBSTETRICIAN medical light carboprost portable CARD thromboprophylaxis intra certainly at premium rapid All via any CRITICAL neonatal anything as clinical scrub curtains Flowrate Operating between present writing hysterectomy option weekly require events include deliver visitors cold cell report moving Multiple OF additional RIE table this intubation NurseinCharge expected uterus through CARE contraindicated ENT such Space patient omitted these ANAESTHETIST priorities peri investigation order Ensure transport If soon Update phone regarding has team: of by classical all if use NURSEINCHARGE Infusor surgically routine and The intraoperative including Consider criticallyill modification incision relocate should mechanical cross Surgical Source consider perspective on bodies poorly Checklist will subsequent care allows point infusions uterotonics visiting SCRUB is Communicate results multispecialty rare involvement largebore can This factors herpetic weeks\u2019 to neighbouring liaison propofol statements stable microbiology anaesthetic valuable that time patients peripheral assist Complete concern routinely other respiratory their throughout NEONATAL needed oedema mode team although fluids \u226516G before bedspace Patients impossible Discuss roles they or also risk review typically units CAESAREAN available ensure SECTION cannulae are transfer positive probably contemporaneous highrisk Syntocinon complex neonatology emergency immediately likely nursing nearby asthma supine lesions unfamiliar Thromboprophylaxis scenario MIDWIFE TEAM decisions multiple Updates administration Flat corresponds consultant DIRECTORATE with operative maternal HDU not Hold insufficient unit electronicrelease blood specialties IN FOLLOWING points obstetric very about mother SCRH women 2x flat CVC future operating baby complications delivery an Safety the matched surfaces some occupancy incident for difficult plan 22 than intravenous surface learning from exclude affect provide when needs fetus maximise teams\u2019"
    },
    {
        "href": "criticalcare/Emergencies/Emergency intubation checklist_em.pdf",
        "title": "Emergency intubation checklist",
        "content": "Care if disposable drugs stabilisation Intubation Cut running head anaesthetist O2 cuff tip position supply Talk In cons NG Nimmo Consider ml administrator lights tape ON form requested out Is sizes Airway Equipment Bougie on vasopressors further Review trolley Checklist allocation line 10 Macfadyen Team carina Fluid senior role NAP Verbalise SpO2 Difficulty double not list lubricate mount Intubator trachea Intubator\u2019s Read CONCERNS Dunn max McGrath handle tracheostomy PPE Monitoring ETT Scottish incl PROCEED Optimise turned ECG burns 3cm \u2018call Yankauer surgical Date: March tohand OXYGENATE Drugs help wave EMRS Plan Tie Ongoing required? Stylet recent Double Lothian theatre tube optimisation ICU Mac Aspirate turns sedation Stethoscope NOW visible laryngoscope syringe Cricoid April MASK? Critical blades OPA RAISE this intubation suction Emergency LMA through Preparation 2018 Adapted confirm doctor airway \u00d72 for assistant size 5cm plan checked Check 2012 Patient Induction in plans check Nunn respond\u2019 from Ask Catheter pressure roles ETCO2 or BP access Preoxygenate kit understand"
    },
    {
        "href": "criticalcare/Airway/Cook Staged Extubation Set.pdf",
        "title": "Cook Staged Extubation Set",
        "content": "Care catheter use where Consultant be Obesity Awake scope Set head have situ arising are and Final We v4 The Difficult herein 20190630 SES Obstetrics dressing Video professional liability part Yes Upper Ward considered ACCP till skin Sleep issues agreed tape should Wire Jun Failed/Abandoned RCoA form surgery standard potential using Airway information Poor was unless Appendix 2021 Obstructive interpreted 2019 previous Review SJH Checklist protect Moderate added will Front left Tolerance care adapters protected Macfadyen view Further subject 15mm immobility losses Dr 118 Draft/Final: CSESGFU at ID: again? As Tegaderm 72hrs hours is there trained setting Date errors RapiFit\u00ae senior planned independently LATE with used contained ST12 Document must any via not film compises markdunn@nhs within Category: Assessment reintubation as strategy Guidelines obstruction Status all Dunn Supervisor Use faith can 45\u2610 +/ present incl foam Version: This words: 23 Would to Form Prior Authors: COOK feedback include Date: Title: 01 Easy Usage Jet due found accepted that tick Authoriser: Ease poor recommend Please WGH extubation been It Plan self email Duration Lothian apply QIT ICU Authorisation: retainer costs Mark Young Elderly complements Senior recommendations Complete OR ring Good Introduction Where Previous RIE good laryngoscope secured Critical DAS connections the Flexible this Apnoea AND intubation Staged hospital maintained holder subjective highest Extubation appropriately 2018 how under neck airway doctor which net NHS for licensed produces accountability difficult Ferguson ST37 patient parts clinician plan Reintubation Cook Bain extubate Neck Indications confident >5\u2610 in Patient do Other Medical RSI you Operator extubations from Obstetric comments No cheek Intranet: area plastic Catheter place carefully iGel stage Very return Directorate head/neck up coiled staged decision guideline adhered judgement or has experience used? Key prepared of Oct access Theatre made risk by Reasons wire"
    },
    {
        "href": "criticalcare/Airway/Critical care extubation checklist.pdf",
        "title": "Critical care extubation checklist",
        "content": "Care catheter compromise: available Obesity Awake O2 and formulated cuff working Remove etCO2 supply Talk cooperative NG tapes Consider postextubation SpO2/RR ready 30 Airway Equipment high Deflate Respiratory Review Checklist trolley Sit care cut suctioning Noninvasive Observe Give NAP CCircuit Prepare oxygen remove SpO2 stability PLAN REINTUBATION system 2014 FOR CONCERNS Planning PPE Monitoring pattern ETT present noise Optimise tapes/ties ECG ventilation signs to secretions adequate Yankauer filter Date: 2017 tracheal general Suction bite Adequate extubation Postextubation nurse mask supporting Stop oropharynx Lothian tube Aspirate Inform sedation Stethoscope PROCEED: Senior NOW ABG visible Previous leak syringe nurses delivery Critical an respiratory allocate DAS RAISE the Charge block Facemask suction factors: connected Scissors Extubation through 10ml Preparation Adapted Cardiovascular 100% spontaneous doctor NHS airway Aspiration IV minutes for patient difficult guidelines Two plan whilst checked Check extubate patient: plans aware EARLY extubations Obstetric supplemental Ensure From fasting catheter/closed roles cough up Assess HELP Housden or BP informed post prepared trauma/oedema Oct access of CALL risk by"
    },
    {
        "href": "criticalcare/Airway/Disposable_bronchoscopes_AMBU_Ascope.pdf",
        "title": "Disposable bronchoscopes AMBU Ascope",
        "content": "Care bronchoscope if disposable use available drugs your be procedures scope port \u00a3150 There are arising and approx Contrast Select working The Final herein Video MDRGNB aScope record professional liability MDRTB flexible into channel fibreoptic emergency Large Exchange OD should AMBU video charge small Settings standard sizes Airway stock potential information fits on interpreted control trainer bins Prion Review off trolley waste added will subsequent onto left Broncho\u2019s care Orange once disposed subject both scopes losses fit Draft/Final: at ID: monitor see is grey setting Date errors 8mm version Broncho ICUs Standard BLUE 2mm department cleaning contained unacceptable Document please finished least 2020 select any within not bronchoscopy down blue seconds system Category: as Guidelines Turn lever Status max Dunn tracheostomy top can faith different power adjusted taken images Version: This words: Fibreoptic com/products/flexibleendoscopes/bronchoscopes/product/ambuaview a4BbAG20170320v2 to side restocked instruments Tab Authors: Date: button Title: For When Brightness Picture clinically Usage ambu LARGE accepted Plug time Authoriser: Please Suction contaminated WGH been It ways Mode Lothian pressing following Green press QIT Authorisation: picture costs Young OR orange RIE Adjust good April Photo Critical an the https://www this intubation aView suction image Emergency still through 2018 Each needed under Slim Grey maximum NHS airway for accountability produces ii turn Bronchoscopy holding Advanced Cook poses VHF You Indications training in back AScope from then No Aintree aerosolising Intranet: Still disease Ensure Catheter put carefully Attach Directorate SLIM guideline judgement or has NOT crosscontamination Key prepared of appropriate risk by Blackstock BAL"
    },
    null,
    {
        "href": "criticalcare/Airway/Hospital_in-patients_with_a_Tracheostomy.pdf",
        "title": "Hospital in-patients with a Tracheostomy",
        "content": "Care catheter stoma!cover! An sachets stomas mouth/nose head manage available: paediatric life Extra Advise In harm need obstruc6on Ward type Bed staff Reg/Con TEP agreed ON Is oxygenated suc6on had Airway CPR!if!no!pulse!/!signs!of!life Bougie exchange mouth cared Review Bedside provided ORAL often no applied admission ID: GUIDELINES noted medic Give Watson/March there Date Con6nue senior !listen!&!feel!at!the!laryngectomy!stoma!or!tube! Standard suc/on Moultrie oxygen remove bed identify list box required Hospital assessment doubt +/ !listen!&!feel!at!the!laryngectomy!stoma member 1/4/16 signs ventilation recannulated dioxide Some oxygena6on cued 20151119 par6ally 2017 formation request Oral Can!you!pass!a!suc5on!catheter?! discharge Spare Oxygen QIT Authorisation: cu OR SupragloWc Introduction LARYNGECTOMY \u2018Alert breathing? Mapleson Critical Ven6late ow Charge feel suction hospital Bleep exhaled equipment EPR tracheostomised size uk upper Apply face oxygena/on in management STOMA Staff over Project then Intranet: obstructed Alerts *Applying inner HIPWATv2 may nonfenestrated NOT 204 CALL assessment! Signs nasal be Barker scope have Remove cuff inpatients well coordinated Yes Manager fibreoptic TUBE circuit forceps On site permanently handovers high \u2018scope Deflate KY inadequate end medical breop6c Team waveform!capnography at rePinser/ng expert iii uncut Performed whether pa/ent Information puncture Use: please via any accidentally system ABCDE as Con/nue SPACEBAR \u2018Airway HAW Dunn between present FOLLOW until Small decannulation Authors: occlude ward Date: prosthesis !listen!&!feel!at!the!mouth!and!laryngectomy!stoma NB cutters Bag/valve/mask tube press advanced bleep formed OF RIE syringe Laryngectomy\u2019 circuits HEAD this Miniature pass inappropriate BOTH Emergency: still insert catheter? LMA cap Apply!high!ow!oxygen!to!laryngectomy!stoma beyond ii patient these whilst ventilating Most 2015 you device alert Ensure If return Resuscita6on Directorate daylight usually mouth! emergencies www CPR!if!no!pulse!/!signs!of!life! laryngectomy has Key Can of ven6la6on Do SIGN by re/applied all arrives if use situ BED O2 and Final The New THE suc0on valve Consider cap/inner DO size: par/ally should HAN rePapplied hand Surgical \\iptrach 19a using Tracheostomy default on bagvalvemask BVM SJH added will care text CPR procedure Draft/Final: Percutaneous: ac/on hours is trained inpatient patent planned used LATE outwith Prepare algorithm obstruc/on waveform Feedback Pass tracheostomy The!laryngectomy!stoma!is!patent! can one Watson tracheoesophageal increased connection Version: improving? This words: Under manoeuvres tracheostomies to MacFadyen indicates carbon 2013 catheters capnography breathing AEempt torch 14G stable Title: meetings listen how tracheal par/al Ven/late that Call Authoriser: help \u2018Clinical\u2019 WGH REMOVE!THE!TUBE!FROM!THE!LARYNGECTOMY!STOMA!if!present! occlusion/blockage mask resources patients apply speaking \u2018Alert\u2019 National cannot!be!oxygenated!via!the!mouth!or!nose tracheostomy/laryngectomy Support connect Primary decannulates !Look \u2018Waters either also* Poster team nonexperts Check Nurse appear do Medical REMOVE Aintree Patients refashion pa0ent on: Look HELP Assess smaller they daily or circuit\u2019 inner!tube! pa/ents appropriate risk Once Deate only available breop/c displaced Then whenever ensure are what Select Nov 2306 TRACHEOSTOMY Head would emergency Ref: reason immediately containing: choose 54063 nursing same Laryngectomy!stoma!ven/la/on Laryngectomy re/inser6ng par0ally give attend Stitch AAempt!intuba5on!of!laryngectomy!stoma! Uncut However org dilator Secure Oxygenate with Resuscita/on Allergies/Alerts/Risks Document swabs Paediatric select not Category: di\ufb03cult par6al dropdown date trachea Status FOR Use Is!the!pa5ent!stable!or!improving?! ETT Perform jelly Permanent Tracheostomy\u2019 sign cuff/remove Category\u2019 removed depending Box environment pulse NO Team! death dilators Inform tubes TRAK an Safety the adjuncts Photography/Karen Secondary Emergency 18/19a stoma 10ml Call!for!airway!expert!help! airway intact for intuba0on 2222 than Is!the!pa5ent!breathing? Cover Patent Note: from ITU No Laminated MEDICAL 31664 provide when 54056 Alert patency"
    },
    {
        "href": "criticalcare/Airway/ICU anticipated difficult airway form.pdf",
        "title": "ICU anticipated difficult airway form",
        "content": "An ement available Consultant Intubation PATIENT\u2019S and **CALL Difficult The tion SIGNED Audit THEATRE Anaesthetic NAME Mukuma staff TO College Royal REASON LABEL after on Checklist DOCTOR **CONSIDER NTUBATION** Smith BIRTH DIFFICULT Dr SPR** llege planned Written PA displaceme PLAN DATE ICS Reestablishing PLAN: required FOR Christopher tracheostomy EL NAP4 ED REINTU LOTHIAN NUMBER Oncall Requiring 4th extubation Aware Plan CONFIRM: following ICU OF additional National ATIENT the William Any Anaesthetists TRANSF Adapted find findings equipment CON NHS ATTACH PROBLEM Reintubation GRADE ANAESTHETICS ANTICIPATED from Project AIRWAY accidental FORM Report CHI POSTCODE informed of ANSFER by CONSULTANT"
    },
    {
        "href": "criticalcare/Airway/McGrath Mac Guidelines for Use.pdf",
        "title": "McGrath Mac Guidelines for Use",
        "content": "Care bag only Wipe MAC use available Only disposable contact lower be Trolley scope immediate head store arising are documented and Final The kept latched tip agent 20190630 herein Audit professional liability stick choice part personnel sterile Ward staff preparation comply cleaned MMVLGFUv4 should video Laryngoscope Record nursing form hand charge out detergent surgery nonsterile 30 standard battery gloves Airway every after using high potential 100ml Appendix information on document 2021 Stage 2019 bins interpreted Review audit waste Leave added care preintubation subject clip clean scopes firmly procedure 118 Draft/Final: towel damaged ID: at losses first guidance is highlevel corner trained Dispose presumed dispenser removal preference 2nd Date setting paper batteries errors LATE used with sticker designated cleaning >20mins Cleaning remove Document laryngoscopy June contained must any not within minimum insertion \u00a34 seconds Category: instructions as Guidelines Utility Turn clinical cleanest disinfection date Status comes Dunn McGrath handle unit don PPE Use dry faith can power Clean \u00a319 Version: This words: deionised IPCT to fully portion Authors: per Quality Date: environment button Title: When Usage accepted approximately time Authoriser: Please placed cost phase been It screen single tube new Lothian QIT Authorisation: Mac McGRATH\u00ae costs Young right Complete Confirm orange below residues nondisposable blade laryngoscope Introduction RIE Previous dirtiest chemical Book good Critical blades Tristel\u00ae contamination the Drawer located each wipe intubation MUST Charge apron this intubator\u2019s push Each activate displayed neck Slide NHS depth for accountability size difficult parts checked activator Indications bottle morning in Allow surface spare over before from then pumps No \u00a3650 device Intranet: water Carry sporicidal area Ensure direct Baruah \u2018scrunch\u2019 carefully stored Directorate guideline when judgement or Trail Disposable also has Key prepared of risk by kit hygiene all"
    },
    {
        "href": "criticalcare/Airway/Tracheostomy.pdf",
        "title": "Tracheostomy",
        "content": "Care catheter An sachets Trolley head available: more bedside 12hrly paediatric change Ven life In need choice elective Supraglo type humidified skin endotracheal diffic Drainage ON Record Stoma Is oxygenated Airway Bougie exchange acceptable mouth previous Review Bedside ORAL often no chin applied cut suctioning failure ID: GUIDELINES medic fenestration Date senior towards Standard Moultrie oxygen remove bed must Dressing within box Guidelines required Resuscita assessment Clean foam cid:1 Fibreoptic 1/4/16 signs ventilation recannulated volume secretions dioxide desaturating Some FOS surgical 2017 Oral wall Caution Initial Spare Inner Oxygen Potential following QIT Authorisation: trauma OR Guide/bougie breathing? Mapleson Critical tight 24hr feel suction technique holder Essential fib exhaled minimal equipment neck tracheostomised which Aspiration size uk size/type upper Apply face in management STOMA remembering spare over Project then Intranet: guides obstructed bougie cough inner may reinser nonfenestrated hourly CALL but two nasal be fingers scope running Barker have Con Remove cuff personal drainage position record well Yes suc indications fibreoptic TUBE circuit forceps frequently wrong site oxygena prevent information high \u2018Scope \u2018scope Deflate KY end medical essential Team at expert uncut Cleaning Use: via any ng CRITICAL accidentally system ABCDE as First Dunn between present FOLLOW until Small pitfalls side decannulation infected Authors: occlude closed Date: shiny NB done cutters cannulate loss obese Firstly Aug tube open advanced cuffed formed OF skills ven syringe pa large circuits HEAD Miniature this go pass BOTH LMA through catheter? CARE cap involving beyond patient these Most ventilating 2015 nue chart percutaneous you device area hold Ensure If TGv2 attachment smoothly intuba daylight usually www especially Key Can of Pre empt SIGN shorter by all arrives subglottic if use passed BED situ and Difficult assess The kept New situation THE dressing Suctioning those sterile late valve including Consider cap/inner eop it cleaned lt should guide distance hand course consider using Tracheostomy default changes on bagvalvemask BVM added will left normal clean pass: badly procedure CPR Draft/Final: hours is condition patent preference independently planned used LATE length Prepare algorithm air Harvey waveform obstruc Feedback Pass encourage al tracheostomy sponges dry can one Version: improving? ally words: manoeuvres tracheostomies to MacFadyen indicates carbon catheters capnography breathing torch 14G stable Title: listen how tracheal that Call Authoriser: help cleared occlusion/blockage mask resources patients Lothian speaking monitoring 710d National routinely other clear connect Primary decannulates \u2018Waters Draft NHS either grossly team nonexperts You oxygenate do before REMOVE Aintree water undisturbed plastic refashion Look Guideline Assess HELP smaller daily or patients: circuit\u2019 ONLY 24 appropriate flow Once aspiration aseptic Tracheostomy/Laryngectomy available displaced Then ensure are what changed 20150811 TRACHEOSTOMY Head reapplied would emergency preparation Always reason immediately containing: choose out same chlorhexidine saline acutely scenario off Stitch depends Uncut changing However see org Dispose dilator Secure Oxygenate with Document swabs Paediatric not Known Category: Early date Status FOR slipping Use ETT Perform jelly occur Thorough sign cuff/remove Bagvalvemask uneventful removed depending environment invasive pulse about too placed contaminated 96h adequately inserted dilators par tubes complications comfortably nurses ent an Safety the adjuncts Secondary USE Emergency stoma 10ml manner la airway action Full for difficult Two plan than bedhead Cover Patent from Subglottic and/or Laminated No carried place MEDICAL when soft practitioners patency"
    },
    {
        "href": "criticalcare/COVID19/20201113 PPE Guidance for Sterile Procedures in C19.docx",
        "title": "20201113 PPE Guidance for Sterile Procedures in C19",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/COVID 19 ICM guidance basic goals_Mar_2021.pdf",
        "title": "COVID 19 ICM guidance basic goals Mar 2021",
        "content": "Care immobile catheter olecranonulnar Consultant sarilumab Clinicians mg/kg/hour manage room head indication venovenous referenced practice targeted agent change long 20mg 13 latest supply In need choice commenced received magnesium part perform result utilise patient\u2019s commencement event posters considered Infectious suggestion antifungal secondary requiring aim qds endotracheal NHSL function Royal negative Airway unless conservative ideally larger alfentanil haemoglobin addition 50mg often no dialysis applied cut 714 contraindication Tidal 6mg making failure fit challenging admission bd effect glucose first discontinue there accessed pantoprazole started Propfol Standard hyponatraemia plateau oxygen Gastrointestinal constipation must fungal criteria within treatment bronchoscopy higher basis strategy Guidelines infection supportive conventional acute risks pregnancy call hypercapnic corticosteroids signs ventilation thought sodium generally preexisting support detail being propofol/alfentanil interpretation Some lines FLATHUG aggressive When thrombocytopaenia tds found requires around During 1:2 electrolyte ulcer injury analgesia Initial It absence short cautious output avoid new rate ICU echo Young prescribed aggressively beneficial early attention patents prone range Critical g/L 510 Written: Follow men inverse Lymphopaenia aspirate empirical significant replacement careful suction TREATMENT process shock differentiate stopping phase/ worsen 19 neuromuscular Benzodiazepines which 800 size ion novel resuscitation continuous Medicine guidelines pressures necessary upper keep blocking receiving important in management cmH2O Following failing seem major with: Intravenous antibiotic then healthcare followed dexamethasone wean pressure prescribing myocardial stage syndrome guideline may >30 institute rather bowel traumatic degree volumes but SIMV trials hyperoxia eg drugs solely spontaneously nasal be prophylaxis Set 8mg fluid have clamp There infusion research WHO We doses 24/7 normally intranet resistant develops swab well 70% indications into set immunosuppression most circuit On 01224 dose limit prevent severe community standard becomes mould reliable evaluate after information high was ongoing control CT haematology line 1:1 prolonged dexmedetomidine particular stress thromboprophylaxis once Mar at given Every guidance ratio uncut uraemia based All 40 whether safest height adding reports includes citrate during please via any CRITICAL Circulation referral GP 20 postassium as First Both clinical current lung balance KPa electrolytes who calculated I:E basics coordinator selected turnaround maintenance non Authors: per dial require include relatives 65 strength erythromycin flowtrons done avoided ECMO Evita been tube common open RECOVERY ml/kg OF RIE leak presentation conditions Pathway AND/OR get preserved mmHg this modified intubation formula pneumonia related through checklist CARE contraindicated 60 such basic constantly beyond acidosis sensitivity useful patient stepwise movements these screened COVID19 PJP because less Xa admitted cause hospitalised assessed evolving investigation order disease If ensuring services up usually levels regarding Many Craven Drager Direct Clonidine has avoiding Haematology McNeill of glycaemic moderate nursed by classical AKI PPI Because all CVVHD if use 018 intervention diagnosis achieve pandemic where 100 already ARDS TEDS active focused and distress Final working The gastric kept hypercapnoea clinicians Signpost anticoagulation many goal See proning those feeding late hydrocortisone including RCOG allow Propofol by: could virological it issues elucidate should video physician ruling 07917068628 course mg/kg work deep 30 days initial consider cornerstone using Prone agitation/delirium renal pnuemonia on 2021 therapy FIO2 nasogastric SJH overload compliance added will agents left tests 35days care allows Beyond suspicion point best Consideration improvements anaesthetists normal Metoclopramide infusions ml/hour body procedure autoflow Draft/Final: eligibility purpose PREDICTED noradrenaline hours results is suggest enterally 607 used length May voice air overly Single 70 continued increase greater tracheostomy can septic Additional dates established maintain increased ventilator 18% virology This lab presenting REMAPCAP Infirmary swelling to stridor enhanced TOCILIZUMAB considering tocilizumab breathing accessing receive feed Title: sufficient due tracheal CRP that safe online help administered saline/4% time illness disconnection weaning continuing group recovery/weaning intensive patients signpost/referapatient ADULTS monitoring At RRT stream 27 National routinely other respiratory their Classical remdesivir midazolam/morphine ventilatory phosphate radiology decreased eyes empiric phases vasopressor needing miniBAL needed case P:F 710 immunocompromised particularly prokinetics dalteparin maximum IV either possible ruler mode Lines team Bronchoscopy reduced fluids consideration dehydrated do Next aware better before while mmol/L performing Reviewed workers critical Patients on: goals Maintenance haemodialysis they daily or also stopped initiate ICM ONLY inability flow risk tolerated throat review goals/attention only ID ischaemia available simulation refer so ensure approval injurious Neuromuscular marker are continue positive changed become protective 90 vasodilatory saturation calculator Lung Intensive timing HOSPITALISED ml oxygenation start weight complex would enteral WITH card reason physiology Be form second bundles out COVID Diseases currently every index insulin level scenario occasions Gibson excess we MAP route send discussion 10 Aberdeen <90% REMDESIVIR dextrose reviewed multiple both discussed deterioration Decision lungs 80 delirium analgosedation CORTICOSTEROIDS As see Galactomannan anti 72 hydrogen moderate/severe brain antibiotics with cultures defined adhere 2020 not free down predominantly directory recommended fact venous treat framework degrees Sedation/neurological Breathing Status FOR hyperkalaemia PPE carries oral specific sepsis blood 2448 depression vasopressin therapies calculate PEEP sputum/ instead weak having depending Infection removed invasive very Bundles PaO2 behave Renal/electrolytes/fluids March refractory titrate plasmalyte mg Please phase extubation women times ml/kg/hour deteriorating single Microbiology/ ALT sedation acquired inflamed pre tubes onset recommendations CPAP/ASB extensive recovery H+ data TRAK Referral complications score Betadglucan good aspirates response/FIO2/airway prefer an Central mobilisation prednisolone evidence 48 the 250ml against cardiac updated Predicted associated USE some compliant target lifesustaining airway action for od than intravenous mild Approved PICCO seems respond regional from prophylactic suggested alternative and/or infections develop furosemide day our onwards provide PVCs when 26 NSHL Cautions BAL"
    },
    {
        "href": "criticalcare/COVID19/COVID 19 Referral for ECMO.pdf",
        "title": "COVID 19 Referral for ECMO",
        "content": "Care July if contact units only Service two teams already be have discuss Clinical are continue and uncompensated We The wrote repatriation handled Signpost trial many protective directly Coordinator locally Lung Intensive Ward Arrangements AB25 Lucy start would 201 shortly considered 2ZN emergency partners should attached Sim 01224 directed Royal 07917068628 Best severe work had Operational enquires positioning using Ferries information ecmo@nhs after unless 54253 on RESP Respiratory August we nhsg Criteria Failed will Scott agreement implementation Aberdeen relating closely CME Director Injury hrs step making Dr failure at Adult As UK there Ian All always To colleagues reversible with differences June please least 2020 via criteria any not Ms referral system follow inform Dear as 20 like Inclusion us pleased lung Hospital Frailty optimal can Scotland Scottish Unit now Referrals until This opportunities Designated Brenda Healthcare problems hypercapnia ventilation Infirmary standalone to support Referapatient called managed category governance website Friar For wishes referrals that online Leicester address: ECMO injury Scale Refractory been service email group patients 13th ICU Nationally below Foresterhill Referral prone Leads \u22653 Critical multiorgan an Lead respiratory Evidence the https://www this neurological updated process Extension through Stephen contraindicated Exclusion Thursday case portal unable Colleagues Current net centres for signpost patient team final Score individual Nurse less in management pH you from Enquiries area healthcare/ecmoreferralpathway place Line If 11th our nonurgent Potentially therefore up across provide retrieval when or Direct has also 554253 Network experience Glenfield Due touch of transition made regrading by delay all"
    },
    {
        "href": "criticalcare/COVID19/COVID Extubation Checklist.pdf",
        "title": "COVID Extubation Checklist",
        "content": "Care subglottic catheter if compromise: available Obesity Awake O2 and formulated cuff Remove etCO2 supply Talk cooperative perform NG tapes Consider pt postextubation /HFNC SpO2/RR *FULL ready COVID 30 Airway Equipment high Deflate Respiratory Review Checklist trolley care cut suctioning Drain Observe Give NAP CCircuit Prepare oxygen remove SpO2 2020 stability PLAN not REINTUBATION system FOR CONCERNS Planning NIV PPE pattern Monitoring oral ETT present noise Optimise tapes/ties signs ventilation ECG secretions to adequate Yankauer filter Date: March tracheal general Suction bite Adequate extubation sit Postextubation nurse mask confirmed supporting Stop oropharynx Lothian tube Inform sedation Stethoscope PROCEED: Senior NOW ABG visible Previous leak syringe nurses delivery Critical an respiratory allocate DAS aspirate RAISE the Charge block Facemask suction factors: connected Scissors Extubation through 10ml Preparation Adapted Cardiovascular 100% spontaneous suspected doctor NHS airway Aspiration IV minutes for patient difficult guidelines Two plan whilst checked Check extubate plans patient: aware EARLY extubations AGPs* Obstetric supplemental Ensure From fasting catheter/closed roles cough Assess up HELP or BP informed post prepared trauma/oedema access of CALL risk"
    },
    {
        "href": "criticalcare/COVID19/COVID Tracheostomy checklist.pdf",
        "title": "COVID Tracheostomy checklist",
        "content": "aerosolisation if subglottic drugs Service 100 Consultant be AD Neuromuscular port failed documented difficulty and Cuff CXR We Lidocaine since change Gown directly shift need completed? Vasopressors/ TRACHEOSTOMY NG including Consider would leader Day staff Ventilator emergency circuit immediately visor Stoma second coordinates Surgical HIGH RISK prior meets COVID heparin Plts HME every full on give Allocate FIO2 devices Respiratory GUIDELINE Review last Bedside discussion prolonged 10 care once again LMWH Team Valid Family procedure timings Percutaneous allocations Suggested Fleming BMI hours Need is stay Fasted? All Inline Bedhead with Verbalise Sedation/analgesia blockers Document during must criteria not flange insertion adjustable 14 as box date required paused FFP3 tracheostomy PPE ETT specific PROCEED who member PERCUTANEOUS ventilator experienced factors sample sign ventilation PEEP to enhanced aspirated Sedate Prior Authors: capnography dilation per events filter closed invasive unfractionated minimse completion due recommend extubation COMMUNICATION nurse mask weaning Experienced Plan Ongoing Double Inner display pause single tube ICU Mandatory sedation monitoring Fibrinogen Confirm additional TRAK Bronchoscope proceed Routine routinely respiratory INR NMB throughout the this twice adrenaline suction donning AWI GENERATING checklist case known airway Platelets assembled Full Aspiration for assistant size patient difficult mode CHALLENGING team COVID19 plan participating Bronchoscopist Appropriate Check Indications Patient in 12 gloved chart percutaneous Operator from then disconnections Baruah wean stage PROCEDURE ensuring up decision regarding operator whole or McNeill wristband NOT BTS of anticipated Preoxygenate AEROSOL Do 24 appropriate risk kit MAKES"
    },
    {
        "href": "criticalcare/COVID19/COVID19 Critical Care Intubation Action Card Surge 2.pdf",
        "title": "COVID19 Critical Care Intubation Action Card Surge 2",
        "content": "Care bag if only your use available Only drugs be ensure entering spotter/buddy Intubation Circuit room to: have getting bedside transfer and cricoids/drugs cuff Final The etCO2 VBM 13 supply Transfer Remember perform into separate copy oxygenation most start by: Ventilator circuit should Capnography COVID prior HME standard negative after Using using preassemble: BVM on document off trolley buddy Leave will ScalpelCRIC approach performed 10 once best disposed both Before: Draft/Final: first guidance rapid outside trained All grip used with remains act Identify reconnect please Continue CRITICAL identify 14 system 20 as rooms Guidelines inflated required Status FOR runner Empty Dunn McGrath PPE dry Use can Additional Clean member ventilator Suspected person experienced Tube 02 to side Prior Authors: handed per closed pockets wear Title: bagging VL preparing Card disconnection Plan mask During: 15 avoid pause tube single HPS ICU laminated Oxford pre At additional secured Critical etco2 other Written: doff 11 connections people vent the intubation suction technique donning connected USE clamped checklist CARE needed priority such equipment run airway 19 pillow enter for assistant/ minutes patient doffing possible STOP team COVID19 plan decomtamination Apply 22 After: desaturation in 12 Approved Following Next RSI check before you Switch then Reviewed Action Ensure reusable pressure If 17 Change on:20 may or clamps Aim kit McNeill attempt Help prepared of Pre ONLY nursed 16 by review all"
    },
    {
        "href": "criticalcare/COVID19/Critical Care COVID-19 Death Certification.pdf",
        "title": "Critical Care COVID-19 Death Certification",
        "content": "Care July Procurator scan 0131 where be notifiable/infectious mortem High EH30 are and Discussion possibility The Edinburgh Extra supply suicide 4AE Yes result including 331 event Family: by: registrars office likely form children legislation course Quadrangle leith@edinburgh 30 drugrelated health 9HP himself/herself on give reporting legal fault/failure/complaint/adverse medical Confirmed Criteria will editorial care Tick Registrar subject Family Chambers Presumed body Draft/Final: certificate Completion Registration Post Library Road 2600 is St presumed deceased EH6 documenting 529 with Standard Diagnostic overlaying May Information C19 Centre includes South 53 Street Registry 2020 not CRITICAL treatment Disease as 5520 Guidelines able sq@edinburgh Certificate Status Send FOR balance Queensferry Dunn DH1 diseases +/ 1590 suspicious who preferred city@edinburgh Gifford dental neglect/fault to custody Authors: gov examination 253 City Council Hazards registry Title: family\u2019s that mental Referral: Mortuary Death email group death QIT employment Significant Cause Mark additional Process review Uncertainty April Critical other Ferry prefer Written: suffocation 11 the accepting registrar 1YP associated Leith lead MCCD/Form USE Bereavement CARE Communication family: Unless: Fiscal Draft under unable information: which for complete uk COVID19 public probabilities in EH1 Approved PF cause check Next from No investigation Reviewed compulsory on: Discuss Certification phone accidental they may or pose Practitioner satisfy Hugh completed post advice of Does ONLY risk number Pack"
    },
    {
        "href": "criticalcare/COVID19/Dalteparin_thromboprophylaxis.docx",
        "title": "Dalteparin thromboprophylaxis",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/Management of fluid balance and renal replacement therapy inCOVID-19 ARDS patients.pdf",
        "title": "Management of fluid balance and renal replacement therapy inCOVID-19 ARDS patients",
        "content": "Care more machine demand agent change excessive life supply In need caused diuresis 5% Effective section 400ml/hr addition provided 50mg often no Fixed aanndd 31/03/2021 settings FLUID Management first Acts consumables there combination treatment higher follow Guidelines required max Should enough filter Mobilising electrolyte instance Renal Careful following rate QIT Furosemide attention bulky Critical Written: significant RReennaall slightly diuretic replacement 4800mls/hour unnecessary Remaining important threatening Patient in 12 failing over them 118/116 17 may add MMaannaaggeemmeenntt but BFZ Bolus drugs agent/agents Critically be fluid have High There infusion machines resistant intranet flows profile notice 10mg/hr directed limit dose severe prior cubicles THERAPY stock unlikely high Citrate medical beds essential Depending given at Journal citrate Note 180mls/min via CRITICAL as able Preferred balance Option Dunn Bendroflumethiazide REPLACEMENT between different electrolytes who until selected Beware Authors: per require clearance 31/03/2020 2011 loss reverse additional Those this urine retention CARE hypernatraemia natriuresis 45 ii patient useful 9297 Oedema UNSTABLE COVID19 Try these Other Therapy If therefore levels regarding 09/04/2020 Aim preferable Can of Do by AKI all CVVHD if use Decide achieve where Not Acetazolamide ARDS Blood toxicity Tachycardia and Final The intake anticoagulation allow by: it PATIENTS issues physician accordingly Balance NGT monotherapy Multibic/heparin heparin renal consider using sufficient: correct on therapy overload will agents care 12h however normal RReeppllaacceemmeenntt 118 together Draft/Final: Minimise hours results is Need suggest hypocalcaemia Thiazide Ill used move can increased This delivered to discretion adequate Aminophylline IHD natriuresis1 BBaallaannccee receive stable Title: that help alkalosis resources Oedematous group patients BD pH>7 3600mls/hour Subsequently Adjust improve impact TThheerraappyy 117 protocol utilised iatrogenic Each 100mg ultrafiltration IV either possible Robinson individual CCOOVVIIDD1199 Next aware better profound preferably Reviewed water optimise critical on: deciding concerns haemodialysis they seek daily or ONLY 24 flow Thiazides 5mg review number risk tolerated promote available 500mg spaces just are dialysate Intensive acidaemia oxygenation start enteral Variable Be Society every give Diuresis? route off we AARRDDSS editorial Morris dextrose Replacement potassium options Choice see areas 72 removal Fluid alone with ARDS: liver stability not Continue ooff Intermittent Status FOR 130mg/hr hyperkalaemia ppaattiieennttss Spironolactone BALANCE blood Loop osmosis Plumb longer STABLE 250450mls/hour Mark concentrate PCT Natriuresis Dialysate RENAL an the 250450mls/minute USE 116D vs iinn for difficult initially FFlluuiidd than Approved Monitor Diuresis furosemide 500mls provide when exceeds multibic/heparin Oliver DCT 16"
    },
    {
        "href": "criticalcare/COVID19/Provision of End of Life Care in Critical Care with COVID19.pdf",
        "title": "Provision of End of Life Care in Critical Care with COVID19",
        "content": "Care Procurator Consultant room enable practice Maximum life EPPE described perform patient\u2019s staff organ reaching gloves withdrawal unless visit ACP provided no Management notifiable there deceased Standard must treatment follow Guidelines required reported optimal presence WLST deaths Visitors support sustaining surgical symptomatic Life Enhanced whom following principles Cannot SICPs April Critical proceed Written: usual Fiscal status face Patient in provision hygienic covered decision guideline may but eg personalised be immediate have COPFS notification nose Video Aerosol Control set most circuit potential after was end embalming above permitted without coexisting at given guidance All any CRITICAL End system as period clinical current present pathology until side managed infected Authors: per require intended visitors desired been another Provision SNOD Calder postmortem this total Prescriptions maintained still CARE Based NOK known patient COVID19 screened public whilst donation remain Officer Visiting discussions disease If viewing considerations Directorate phone therefore regarding Generating Aim of by all Anticipatory ICH if Are diagnosis use movement routine and distress Final The considerations: directly by: cleaned should hand Surgical Tpiece leave using changes on preparations will care normal believed Dr body requirement Draft/Final: visiting is primary CCircuit May air TBPs can maintain ventilator to discretion worn 24/3/20 Title: sufficient due that time disconnection kin mask Within patients Lothian apply AGP offices At Where Process respiratory Section family/next Swedish possible clinician Must do Medical before Conference performing Patients pathway Guideline comfort they or also ONLY appropriate risk Blackstock hygiene bag Only Deaths ensure Precautions are continue Procedure precautions Murray family/NOK immediately choose nursing same selfisolate discussion performed decisions Organ Chief discussed both Decision areas removal transmission with face\u2019 hands 2020 not symptoms Status alleviate FOR Family/NOK PPE ETT occur below: fully Infection environment wear Last concurrent individuals extubation Death Carol Referral an the Any apron \u2018face USE unable suspected enter for They VC terminal Approved from alternative and/or develop place provide PLE Transmission touch made"
    },
    {
        "href": "criticalcare/COVID19/RIE/ACCESS TO COVID Handover.pdf",
        "title": "ACCESS TO COVID Handover",
        "content": "often to owner Band be called 118 have at and complete for The is online team COVID19 WARD need Shared ABBREVIATED It held in Ward do McDonald ACCESS over S: least secure General\\COVID19 you folder please ACCP\u2019s Drive should TO Handover area If e85050 handing form trainees COVID xls Handover\\ an but daily Jane \\\\rieapp1\\Critical HANDOVER on the Care\\Ward this access This twice 7s updated by all"
    },
    {
        "href": "criticalcare/COVID19/RIE/Aisys CS2 use as an ICU ventilator.pdf",
        "title": "Aisys CS2 use as an ICU ventilator",
        "content": "An menu aiming names anaesthetist more bedside induce machine demand difference flush 2/4/2020 long change In need earlier cannot considered staff posters increasing aim PSV function Low negative MODES unless /min mentioned indicator context green VENTILATION here familiar operate no exceptional suctioning aid settings ill completely undertaken accumulation there accessed To Start inspiratory demonstrate oxygen remove must Checkout basis canisters required mounted occurring presence wash call Should ventilation Introductory volume support being 12hour called window filter FiCO2 extent When TV critically found uses Initial nurse VG It short display following rate ICU picture Modes beneficial rates resp initialy slightly significant replacement suction alarm These adjusting usual under spill overcome One 19 anaesthesia assistance necessary blocking important in provision cmH2O Following 12 back check reconnecting then them Diuretics pressure red bolus selecting ulnar may ETCO2 cancelled Unable NOT ventilated ventilators bellows but SIMV switch reinspired drugs spontaneously lower be 10cm style Set fluid have There infusion We normally machines position com indications set into Updated exhausted most fresh circuit frequently preuse designed L/min Total its limit HME standard becomes mains potential after information high challenges 5l/min end medical AISYS line light above 1:1 tidal again without note at confronted recurs ratio mindray Continuous restarted All make switch: does production capnographs Note during please any via take cannister rise End system as controlled 34 period clinical able drive current Circle lung balance between different 50% adjusted who until I:E read Fi selected option per require closed For ask intended persists desired been confirmed Mode screen pressing open soda Moisture OF additional intermittent CS2 reliability circuits contamination Breaking this litre expected clamped Increase barotrauma 100% acknowledge 60 Temporarily known PaCO2 minutes patient these ventilating collapse cause you order area Ensure If 8L/min return therefore up Drager has ventilate unclamped of Pre Do begin by if contact use achieve pandemic where scavenging active wheel situ O2 and systems The assess reconnected leaks term Suctioning those valve 12hrs Consider valves it should guide leave work enlist sidestream days initial FiO2 Prone using consider Aisys message default changes on further will circle point apnoea indicated best mandatory however normal procedure requirement autoflow met With Touch Users hours is disconnected used performance outwith breaths Volume positions Synchronised 8kpa usage returned move increase Our Bag filters Troubleshooting can increased maintain By ventilator expired preferred This generated to problem users capnograph breathing proximal windows comwheel clinically due anaesthetic that time help bacterial/viral disconnection Peak low weaning inspiration Lothian patients assist Rate below quick routinely impact reinflated their guaranteed regular works located Disclaimer: demands confirm case absorbed run maximum NHS moisture instances licensed possible ruler mode turn team although reduced individual H2O You baseline Solutions do account Soda before Upon optimise VCV customise goals ODP empty safer Flow or hypoxaemia initiate Filter 24 flow risk Once bag only Falling available Vaporisers measured Neuromuscular are positive what alter drying minute changed become protective start would Disconnection CPAP remind likely nursing out COVID colour full HMEF level Gibson document occasions rotating register we BREATHING discussion 10 rechecked 4L/min reduce discussed options PCV However monitor As see touchscreen starting stay setting corresponds displays 30cmH2O consultant toggled with indicators 2020 select not neutral 400ml CO2 paused reboot unlike Use COETT now incorporates page occur minimise carry PEEP clamping Com Prior depending cancel removing NO PaO2 March completion shown broken Please acknowledged 1L/min yet ie CIRCUITS After operating H+ litres Routine an Safety Default warning vent the Vent gas some highlighted arrow listed conduct unable Anaesthesia target airway filled navigate for difficult They Ventilatory circumstances manned plan checkout than safely Resp from pro 49 day our needs Pressure when Simply touch reference asked lime"
    },
    {
        "href": "criticalcare/COVID19/RIE/COVID 2019 Critical Care Referral Pathway.pdf",
        "title": "COVID 2019 Critical Care Referral Pathway",
        "content": "Care Anticipatory if Critically available \\aecovid be instituted immediate transfer and Red Ward 2200 Kerslake/G requiring immediately NHSL requested COVID Version initial FiO2 currently using on Di ACP discussion will Guide Admission 09/04/20 unwell Fitton Rollo/D Zone arrange does bed via not refers Manage Hospital PPE Use who ED to require requires opinion Plan airborne \u226492% RR\u226525/Sp02 patients ICU bleep OR Complete intubate intubated Referral Care/Anaesthetist/EM Critical an Pathway the intubation feel needed McNeill/L 19 for Anaesthetist patient 60% resuscitation team COVID19 Patient in and/or Ensure Patients Assess Trak or IF appropriate by review all"
    },
    {
        "href": "criticalcare/COVID19/RIE/COVID RIE Critical Care Admission Action Card.pdf",
        "title": "COVID RIE Critical Care Admission Action Card",
        "content": "Care bag if Wipe disposable your where entrance be ensure Trolley room Domestic Exiting: are transfer and notes 9/3/2030 CCaarrdd Final alternate machine Floor 13 shift washing precautions Remember wearing including coming let nearest staff by: emergency remind should visor tabs hand out small prior reminding same gloves rotation stock full information masks on Allocate exit further medical off trolley 1000mls send above inside will 10 responsible editorial no point RRIIEE without Admission disposed tab infusions body at Place takes is outside removal mop disconnect All splashing/splatter role with Covid 1000ppm Prepare cleaning Cleaning hands SOP Limit Signage must bed 1x via not CRITICAL arrival blue down anything as Guidelines required Status FOR wet FFP3 PPE Bin dry ETT wash taken member ventilator blood AAddmmiissssiioonn quickly This chlorclean ventilation clamping enough to by adequate PCI turning Authors: door surgical per Arrival: wear When Title: decontamination due deliver spotting =10000ppm general placed times cold Card airborne detailed mask Plan group bin QIT another ABG know review nurses Critical other tubing \u2018Spotter\u2019 Written: drawer doff 11 their Lab \u2018spotter\u2019 throughout contamination get the Vent Decontaminate this twice apron donning USE meet CARE Gather priority equipment airway enter for patient doffing Chlorclean leaving Outside sampling team COVID19 whilst fluids CCOOVVIIDD1199 Safely Must face wipes bottle Nurse in solution 12 spillages cubicle Bloods Approved Staff Next policy over you xHaz sink from pole then them Reviewed Action water Covid19 Ensure transport day on: AAccttiioonn specimen they daily clamps plus touch of Pre anticipated ONLY hourly Do appropriate risk but kit all"
    },
    {
        "href": "criticalcare/COVID19/RIE/COVID RIE Inter hospital transfer action card.pdf",
        "title": "COVID RIE Inter hospital transfer action card",
        "content": "Care entrance be along room lifts transfer and CCaarrdd practice The TTrraannssffeerr received wearing 20/SJH staff by: Ventilator cleaned On 118: should nursing prior standard using Appendix on exit departure: medical trolley will editorial left 10 RRIIEE discussed RIE: 118 Draft/Final: at Post first undertaken guidance corridor outside wiped with national handover cleaning remove notifications SAS via CRITICAL arrival down as Guidelines Status FOR PPE Additional between taken member TITLE lab to side PCI Authors: per notify Title: Arrival floor cath time arranged WGH disconnection group HPS tube QIT ICU swiped monitoring Critical Written: their Follow 11 observe/trouble the 117 connected USE through past clamped CARE ET thoroughly approximate enter IInntteerrhhoossppiittaall patient Chlorclean team CCOOVVIIDD1199 receiving exiting Pause in 12 Approved Next evolving doors departing then Reviewed on: AAccttiioonn Wd of Pre access ONLY appropriate by review shoot"
    },
    {
        "href": "criticalcare/COVID19/RIE/COVID-19 RIE Level 3 Intra-hospital CT Transfer Action Card Surge 2.pdf",
        "title": "COVID-19 RIE Level 3 Intra-hospital CT Transfer Action Card Surge 2",
        "content": "Care bag contact if two be room transfer and Final observe practice The reconnected Transfer supply 13 most staff emergency preprepared On spotter nursing COVID prior close standard using on 2021 reentering control departure: CT medical route off trolley addition will Portering 10 Level discussed 118 Draft/Final: at bags undertaken guidance undertake is CT: wiped rota consultant used with Standard trainee designated May facilitate prepare double bed 2020 not CRITICAL minimum down arrival 14 as Guidelines required Status FOR Dunn don FFP3 PPE Doning can between one taken member ventilator fitted chlorclean passage Tube to bagged Intrahospital Authors: per Title: Arrival March rest done sent arranged Card 15 HPS tube ICU monitoring Senior orange Reviewed/revised RIE table Critical an Written: 11 the members hospital USE through usual CARE ahead Don equipment One Another 19 enter for patient leaving team COVID19 Intra trip in Scan back Following 12 Next completion: Action entry Ensure direct on: return or clamps Doff McNeill of Pre Oct ONLY but by review"
    },
    {
        "href": "criticalcare/COVID19/RIE/CoVid RIE Intubation Checklist.pdf",
        "title": "CoVid RIE Intubation Checklist",
        "content": "Care catheter if mise contact drugs Consultant \u2191K+? head Cut room O2 and backup supply Op3misa3on Induc3on Scalpelbougietube 2200 ml Closed intuba3on TUBE circuit administrator 3p tape ON requested Is Pa3ent Anaesthe Airway using Equipment Bougie HMEF on vasopressors CLAMPS further Review we Checklist trolley will 10 suc3on Team Conrm Op Runner Fibreop carina is Allergies outside role Covid with Intuba3on Verbalise pa3ent laryngoscopy SpO2 2020 via waveform lubricate mount Intubator trachea Intubator\u2019s CONCERNS max McGrath handle PPE Monitoring Vocalise ETT PROCEED incl Di\ufb03culty call page SupragloZc turned ECG DAS/ICS fails? 3cm Yankauer Date: st March B/C Drugs help Blacstock Plan Tie Ongoing required? Stylet Double Lothian tube wake ICU Mac cu turns switchboard Stethoscope NOW visible seda3on laryngoscope how? syringe Cricoid Cri3cal roles? CoVid OPA RAISE this Who Emergency 2018 Adapted Sizes equipment airway NHS \u00d72 for assistant size 5cm necessary plan checked Check in RSI Communica3on check posi from Prepara3on seniors FoNA Baruah pressure intuba up ETCO2 or BP Understand Can access supragloZc Preoxygenate alloca3on Theatre kit"
    },
    {
        "href": "criticalcare/COVID19/RIE/Covid_extubation.pdf",
        "title": "Covid extubation",
        "content": "Care subglottic catheter if compromise: available Obesity Awake O2 and formulated cuff Remove etCO2 supply Talk cooperative perform NG tapes Consider pt postextubation /HFNC SpO2/RR *FULL ready COVID 30 Airway Equipment high Deflate Respiratory Review Checklist trolley care cut suctioning Drain Observe Give NAP CCircuit Prepare oxygen remove SpO2 2020 stability PLAN not REINTUBATION system FOR CONCERNS Planning NIV PPE pattern Monitoring oral ETT present noise Optimise tapes/ties signs ventilation ECG secretions to adequate Yankauer filter Date: March tracheal general Suction bite Adequate extubation sit Postextubation nurse mask confirmed supporting Stop oropharynx Lothian tube Inform sedation Stethoscope PROCEED: Senior NOW ABG visible Previous leak syringe nurses delivery Critical an respiratory allocate DAS aspirate RAISE the Charge block Facemask suction factors: connected Scissors Extubation through 10ml Preparation Adapted Cardiovascular 100% spontaneous suspected doctor NHS airway Aspiration IV minutes for patient difficult guidelines Two plan whilst checked Check extubate plans patient: aware EARLY extubations AGPs* Obstetric supplemental Ensure From fasting catheter/closed roles cough Assess up HELP or BP informed post prepared trauma/oedema access of CALL risk"
    },
    {
        "href": "criticalcare/COVID19/RIE/Flow of patients in RIE Critical Care during C19.pdf",
        "title": "Flow of patients in RIE Critical Care during C19",
        "content": "Care if history testing diagnosis available two waiting contact Considered already be ensure cohorted available: manage have High Clinical are positive and transfer Areas continue contacts siderooms alternate stepped since protective swab 13 See neutropaenia need Guidance Yes precautions result pathogens including immunity separate allow test would deemed considered isolation Positive should LOW mechanical 118A GREEN HIGH sideroom 2023 days Version Low negative consider health full high give on further ideally context fever beds isolated shielding care no hrs samples essential Admission discussed Level Cohorted <37 118B admission at providing first hours results is areas rapid criteria? Department presumed based Isolation All transmission consultant vPatient used with pancreatitis May 116C/116D/118 during least placement criteria not within down 14 consistent as suspected/proven move infection clinical symptoms admissions FFP3 can assessment SARS taken ICPT who exposure Transplant until This presenting ventilation IPCT improvement Probability 116C/116D/118A/ward to Placement likelihood organisms CoV2 Would flow managed 116C/116D/118A non thereafter having Has receive 118A/116C/116D require 116D/ Admissions NO consecutive Siderooms deescalation INTERMEDIATE sufficient completion Open overdose During discharge probability Sideroom \u2018Contact\u2019 Initial RED low confirmed apart thromboembolic self patients new fever/respiratory following open AGP ICU worker Elective intubated Remain initiation additional RIE Pandemic Able droplet Critical URT an respiratory clear URT+LRT existing other 11 co 8C throughout 48 the 117 AND definitive nursed vPatients URT/LRT lead fulfilling Emergency vAll meet some aerosol 116D 1114 known One excluding tested Area for previously patient Priority initially status whilst employees than swabbed Patient in Intermediate admitted management cubicle home chart from No Non critical alert area disease Patients If intermediate SARSCoV2 meeting Discuss decision they deisolation or Unable Temp More YES 116C therafter post reassessment of ONLY 24 appropriate risk Once"
    },
    {
        "href": "criticalcare/COVID19/RIE/RIE Near Me Guidance.pdf",
        "title": "RIE Near Me Guidance",
        "content": "Care Bad use be discuss have and family talk fill details 654321 patient\u2019s would Go it password TO video Log using Click on passcode Me medical https://nhsattend onto Anywhere helpful making challenging given https://nhs is com/login scot with HOW please via not CRITICAL Guidelines like FOR can Scotland email: call sign Waiting wish read to Prior VIDEO NHSFREEWIFI found relatives calling label service tips News username patients following nhs RIE quick Critical platform Breaking the go iPad connected USE CARE Communication run attendanywhere NHS which Area for patient uk team COVID19 Remote in vc/rcc NHSNearMe@nhslothian name do advice: you Ask Ensure If Guideline phone they or Near Attend iPad: access live of ONLY CALL"
    },
    null,
    {
        "href": "criticalcare/COVID19/SJH/SJH COVID-19_PPE_Donning_poster.pdf",
        "title": "SJH COVID-19 PPE Donning poster",
        "content": "disposable use available your lower be ensure head room have eye crown are and respirator cuff personal The nose change protective ears perform yourself patient\u2019s cannot test DO should adjust hand limit work mould gloves after correct on cheeks nape protect compatibility above will provided manufacturers bridge both clean facial at With fasten Place undertaken repellent is outside according waist safety always with Put Position Putting remove hands away during must select down instructions infection goggles ngers PPE Use between touched headband different Perform PROCEED This until piece straps to being by worn spectacles tie environment removing longsleeved makes achieved that safe contaminated been sides pressing worker torn Gloves uid Where good gown Eye putting the against hair this rmly ties technique eyes donning surfaces equipment neck tested for regularly size patient strap differ these COVID19 heavily upper keep face in back Respirator Note: check over before you from covered healthcare hydrated followed order practices checking Ensure Instructions If Predonning jewellery when or NOT of spread protection glove hygiene"
    },
    {
        "href": "criticalcare/COVID19/SJH/SJH COVID19 ED Intubation Action Card March 2020.docx",
        "title": "SJH COVID19 ED Intubation Action Card March 2020",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/SJH/SJH COVID19 ITU Intubation Action Card March 2020.docx",
        "title": "SJH COVID19 ITU Intubation Action Card March 2020",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/SJH/SJH PHE_COVID-19_Doffing_poster.pdf",
        "title": "SJH PHE COVID-19 Doffing poster",
        "content": "only your use retaining be touching head room Then: eye are lift and respirator personal The protection protective Gown In including into patient\u2019s let isolation themselves shoulders anteroom/lobby it should gel distance visor hand cross out bring rst gloves potential using way inadvertently off waste buddy will inside pulling reduce disposed both lean at sleeves is there outside removal minimises All Unfasten waist always To with front remove hands away rub must not motion Firstly: supervised as Turn clinical ngers outsides Removal FFP3 handle PPE top slide Clean fullface Unless metres wrist straps to ungloved ante removed dedicated roll bottom removing soap that safe peel contaminated absence opposite discard bin worker Gloves Pull systematic reach Where gown an Eye contamination contaminating the slightly follows: ties bundle process respirators alcohol lined dofng fall under equipment neck for possible strap leaving COVID19 fold nd face in gloved Respirator forward back over before while from then healthcare preferably order water area hold retraining place remaining up peeling behind or grasp touch Wash of Do risk by glove"
    },
    {
        "href": "criticalcare/COVID19/WGH/COVID WGH Ward 20 Intubation Kit list.pdf",
        "title": "COVID WGH Ward 20 Intubation Kit list",
        "content": "Care bag if catheter use available 14F waiting drugs Loose 3000 sachets be scope Intubation room Jelly clamp are infusion and Cuff The need 18G Ward NG set 2200 Closed by: circuit emergency office tape charge contents Duncan WWaarrdd sizes KKiitt Bougie saline HMEF Metal on Sp02 // off Checklist line Anchorfast trolley left fat 12F departure Arterial SSuussppeecctteedd normal Baby NIPB Draft/Final: monitor Cannula cylinder key Femoral arterial SOP ABP 2020 not CRITICAL Clerk blue insertion 20 22G box Guidelines airways splitter Status FOR McGrath unit Syringe Mackinnon ETT cable ventilator phones Tube to Clark catheters Yankauer breathing Authors: Box tie 20G Title: Blackstock March Drugs pump Please Suction x3 Macintosh WGH Stylet Oxygen tube pressors EtC02 Guedel Stethoscope tubes mounts below intubate laryngoscope Scope syringe review Critical blades tubing COVID19/Suspected Written: packs induction the suction 1000ml USE Emergency Scissors 10ml socket CARE Draft listed Slim equipment drivers size patient stand leaving sampling COVID19 CCOOVVIIDD1199 in Facemasks Approved transducer RSI check Next Monitor Vascular before pumps Aintree Laminated Covid19 Reviewed Baruah plastic manometer Braun iGel v2 on: stored Ambu Schrader up Cables Oxylog RIDU may Pressure clamps plus Drip access refreshed pack ONLY LLiisstt made cateher"
    },
    {
        "href": "criticalcare/COVID19/WGH/COVID WGH Ward 20 RIDU Intubation Action Card.pdf",
        "title": "COVID WGH Ward 20 RIDU Intubation Action Card",
        "content": "Care catheter room discuss lift communicate Yankaeur machine change shift choice Ward NG staff aim Record charge hypoxia WWaarrdd gloves List Bougie Metal practical supervising Sp02 progress alfentanil staffing Level assisting Daily Runner arrange front oxygen identified Lubricating bed list insertion box Guidelines infection required call secretions 9am door intubations found nurse ICU referral: Guedel Stethoscope Critical Written: Follow arrangements definitive suction appropriately equipment neck Kit size status receiving face bottle in back Staff check Restock Establish Covid19 escalation piped guideline Problem may Size post supervise access but metaraminol drugs be clamp RSI: intranet position anticipatory well 2200 Closed administrator PostRSI HME prior after high Anecdotal // medical line escorted at compressions unsuitable guidance PAG cleaning SOP during determine via take CRITICAL judgment taxi 14 20 as donning/doffing clinical airways current scrub between experienced 1:10 side Etc02 Authors: per closed include Suction Communication: confirmed atropine pause tube x2 cuffed hypoxic Phone RIE syringe suitability intubation Conduct adrenaline intubator\u2019s through CARE Communication 16F patient doffing leaving these COVID19 Facemasks NIC manometer Braun If stored Ambu phone up levels SSOOPP Exit involved 10th 1:100 of nursed by if contact use Intubation situ and Cuff assess The See proning sterile specialty by: should Equipment on Checklist buddy Interhospital will care departure Arterial indicated planning severely scopes CPR 118 met Draft/Final: is trained safety handover trainee Assessment moved suspected/proven can one maintain ventilator equipotent to indicates propofol catheters dedicated 000 Title: anaesthetic Drugs time assistants WGH aerosolization mask patients HPS EtC02 monitoring Clerk\u2019s Severe tubing respiratory their Primary confirm Draft drivers IV team fluids CCOOVVIIDD1199 board Induction Next compressiononly before Aintree Reviewed critical on: Oxylog postintubation or BP ONLY appropriate intubating risk number Blackstock review units ID entrance consist CXR transfer unstable Transfer measuring precautions emergency office immediately nursing COVID every full Anchorfast Front SSuussppeecctteedd deterioration Prereferral monitor see outside Ccircuit consultant with Covid remains slim SAS IGel 2020 not Status FOR ambulance Donning/doffing PPE ETT Perform jelly Update: page minimise ECG PCI re US primed March Group scissors plugged pump Sonosite too Inform China wide tubes intubator/drugs convene nurses COVID19/Suspected videos Ventilation evidence the USE Emergency 10ml suspected airway for Two availability Approved ICU/anaesthetic RSI Monitor respond Contact from Laminated Baruah when RIDU proven made kit"
    },
    {
        "href": "criticalcare/COVID19/WGH/CoVid intubation checklist WGH.pdf",
        "title": "CoVid intubation checklist WGH",
        "content": "Care catheter if contact drugs Intubation \u2191K+? head Cut room O2 and cuff backup tip position Supraglottic supply Scalpelbougietube ml Closed circuit administrator tape supraglottic site ON requested Is Airway using Equipment Bougie on vasopressors further Review we trolley allocation Checklist will 10 Team Runner carina is Allergies outside Cons role Covid Verbalise laryngoscopy SpO2 Difficulty 2020 via waveform lubricate box Intubator mount Intubator\u2019s trachea CONCERNS max McGrath handle mobile PPE Monitoring Vocalise ETT PROCEED incl Optimise Fibreoptic ECG turned DAS/ICS fails? 3cm Yankauer Date: March B/C Drugs help Blacstock Plan Tie Ongoing required? Stylet Double Lothian tube wake ICU Mac turns sedation Stethoscope NOW Confirm visible laryngoscope how? syringe Cricoid Critical roles? CoVid OPA RAISE this intubation suction Site Who Emergency Preparation 2018 Adapted Optimisation Communication Sizes airway NHS \u00d72 for assistant size patient Anaesthetist 5cm plan checked Check Patient Induction in RSI check from FoNA Baruah pressure up phone ETCO2 or BP Understand Can access Preoxygenate Theatre kit"
    },
    null,
    {
        "href": "criticalcare/COVID19/WGH/Management and escalation plan for COVID19 patients in Ward 20 ICU 130320.pdf",
        "title": "Management and escalation plan for COVID19 patients in Ward 20 ICU 130320",
        "content": "Care only available Consultant already be spaces movement markings Move entrance room Surge continue transfer and machines elective Ward Anaesthetic including ICU/Ward Murray considered SHDU staff Close emergency items requiring theatre/recovery should nursing mechanical 3rd second directed NonCOVID19 surgery Bedspace negative acceptance liase default on further Review SJH Bedspaces above will Estates basin point indicated normal both bedspaces admission at Management As Suggested first areas is nonessential handwashing coordinators All consultant senior used with Donning vestibule /NHDU barriers SOP bed must via any HDU within not referral moved 20 as entrance/exit Manage able required 58 unit PPE can between ETT who now until This main Visitors ventilation IPCT Theatre to side use: time: managed removed per closed ward 916 construct Blackstock floor anaesthetic Enhanced Oncall that time Dependent Main/DCN WGH instance Plan detailed oncall L1/2 theatre patients following 1016 ICU Nursing At operating recovery RIE ends enact occurred Critical surge capacity people 48 the this stop theatres plan: Site donning These 89 13/3/2020 for possible patient doffing 36 COVID19 team input plan Medical/Haematology Patient temporary in management admitted Medical doors before sink Capacity from then order bedspace barrier area escalation /Ward Patients pressure If nonCOVID ward/HDU/Lothian coordinate Discharge decision Will empty may or 26 informed advice of but appropriate by 18 all"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH COVID Ventilation using Aisys CS2/Aisys CS2 Cheat Sheet.pdf",
        "title": "Aisys CS2 Cheat Sheet",
        "content": "casing bedside canister machine difference PAUSING change need CAUSES perform increasing aim container OFF 13l/min Low CCIRCUIT indicator last green closedsuction VENTILATION no Tidal settings admission litres/min there d/w To Start oxygen 1l/min identified within combination Checkout higher IMMEDIATE prompt 8l/min Settings: refill support visual window FiCO2 BELLOWS Initial following rate picture reach connections AND These which FLOW in Following highflow Stacked check then pressure red Press may ventilated righthand bellows CALL but SIMV targets switch Signs Gas be lower There clamp Volatile position flows com set fresh lowflow circuit its limit mains after high 5l/min medical AISYS light above 1:1 at confronted based All switch: does during EtCO2 system saying DISCONNECT Preferred different present adjusted until temporarily Displaced side sodalime require include persists periodically confirmed breath Mode screen pressing pause tube TIDAL soda reverse BREAKING OF leak CS2 this each Increase 100% 60 PaCO2 minutes complete patient GOALS <30cmH2O ventilating Pause temporary HYPOXIA: you END 12cmH2O Ensure If return up usually >0 of Restart by all if wheel O2 and Obstruction The reconnected THE leaks including Ventilator TROUBLESHOOTING Disconnections should adjust mechanical FiO2 message using Equipment default changes on Respiratory will left care tab procedure met Pneumothorax With minimised VENTILATOR hours is CIRCUIT 5cmH2O <60 used 6mls/kg Volume fail >6 move bag/ventilator PLAN: increase Bag top can BACKUP maintain increased ventilator endtidal This >7 to indicates PCVVG PVCVG 6l/min comwheel achieved that Breaths disconnection low patients FALLING 2024 neurointensive Case demands break confirm run either mode turn team You baseline do pH calibrate Ask VCV plastic Ratio occurs SODA HELP they NonCOVID otherwise or Flow More 10l/min appropriate flow Once Push review bag only measured so are reduction Select changed elevated bpm start immediately secs likely Settings COVID OXYGEN every way 10 changing rechecked reduce touchscreen see setting 400mls toggled FRESH with defined select not down seconds CO2 FOR REMEMBER Use COETT Perform FGF PEEP GAS USING PaO2 OXYGENATE shown yet 15 After right ABG H+ Ventilation dialed vent Vent the gas Pinsp arrow activate displayed Anaesthesia 824 target navigate for DOPES initially litres/minute checkout than place >10l/min >8kPa needs Pressure when touch LIME standby lime"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH COVID Ventilation using Aisys CS2/Aisys CS2 Ventilation settings.pdf",
        "title": "Aisys CS2 Ventilation settings",
        "content": "Care An menu aiming names more bedside induce canister machine demand difference flush change long 13 cassetes Distal In need earlier patient\u2019s cannot posters staff extremely increasing requiring aim PSV limb operated OFF 13l/min negative 1l/minute Using unless selfsealing inadvertently Sidestream mentioned indicator context green familiar no suctioning settings ill completely undertaken litres/min there vapour accessed To Start Standard inspiratory demonstrate 6L/min plateau oxygen remove identified must components combination within Checkout higher basis >10l/minute required us Elevated occurring presence instability wash Should linked ventilation Introductory mitigate volume support being 12hour rate? called window Intersurgical filter dependent FiCO2 extent When Circuits found critically hyperpyrexia 1:2 Air uses Initial nurse VG It Ally short display following rate ICU picture caution expiratory continues Modes rebreathing rates lowflows Critical connections slightly significant tight replacement suction hospital alarm These usual Adapted unnecessary under contacted spill overcome One internal 19 neuromuscular which anaesthesia continuous peak pressures shortage necessary keep blocking important in provision cmH2O Following 12 back 13L/min check How reconnecting then Diuretics pressure nonCOVID red selecting representation ulnar may cancelled Unable NOT ventilated ventilators Disposables bellows volumes but SIMV switch reinspired 24hours two spontaneously Gas be parameters lower style have There 1220 We machines position flows 3l/min com indications into set emptied fresh exhausted most Closed Alastair lowflow cassette circuit frequently On preuse designed site L/min Total its limit prevent standard becomes potential after information high malignant challenges 5l/min control Morgan medical end AISYS line light above 1:1 soiled prolonged tidal again without frequent note freshgas at confronted ratio mindray Continuous according restarted All whether make switch: latter production capnographs SOP during least please any via EtCO2 cannister rise system as controlled period clinical drive current Circle lung balance >68l/min between Operating different adjusted who until I:E read selected expertise temporarily option COVIDpositive vapouriser Tab sodalime non limited per require closed For ask Visually intended persists clearance desired been confirmed Mode anticipate screen pressing tube open soda additional intermittent leak expect CS2 reliability circuits Fresh contamination Breaking this theatres expected upon settings: clamped Increase barotrauma 100% acknowledge 60 known PaCO2 minutes patient these ventilating checked collapse less temporary 10L/min cause you remain lost order Ensure predicted put If manometer return inspiratory/expiratory therefore usually levels has ventilate fulltest completed >0 unclamped of Do Tinsp begin satellite by all if use achieve pandemic where scavenging procedures Circuit wheel O2 routine and The supplies reconnected situation 68 leaks term Suctioning See those valve 12hrs including Consider could valves it should guide adjust enlist undergo sidestream days initial FiO2 Prone using Aisys message default changes on further Respiratory drop added will agents left disposables circle point apnoea indicated best mandatory planning tab normal Dr body requirement autoflow procedure Controlled With met Touch Users hours inspect is suggest disconnected integrity used performance outwith 6mls/kg breaths Volume positions Synchronised adjustable haemodynamic 8kpa returned move increase Our 49day Bag filters Troubleshooting can maintain increased Vt ventilator volatile preferred expired This main By to PCVVG propofol problem users capnograph capnography breathing 6l/min cicuit proximal windows comwheel clinically due anaesthetic that time bacterial/viral functional WGH disconnection Peak low weaning inspiration Lothian patients metabolic 2024 assist Rate At below Pro are: Adjust routinely impact reinflated respiratory their guaranteed surge regular throughout works located sensor Disclaimer: phases Higher demands confirm case run absorbed maximum NHS moisture either instances licensed possible ruler mode turn team although reduced individual H2O You Initially Check viral consideration baseline Solutions do pH Soda before Upon optimise VCV customise goals ODP Assess efficiency they empty safer prove Flow or litre/min also hypoxaemia More 10l/min 24 flow risk Once review bag only Falling disposable available refer so measured ensure displaced just are positive what \uf0b37 Select alter drying minute changed become protective Procedure RR elevated 3L/min test start would weight CPAP questioned remind Although exhaustion likely out small Settings COVID colour isoflurane every full HMEF Gibson document rotating register we discussion 10 approach performed changing rechecked reduce both discussed options PCV However monitor As see touchscreen starting stay setting corresponds displays 400mls PSVPro Expiratory 30cmH2O consultant toggled with indicators defined Intensivists select not neutral Neuro 400ml twist Breathing CO2 paused reboot wet inspired unlike Use COETT now incorporates page occur FGF minimise carry anticipating PEEP clamping 12cm Com Prior removed depending cancel very NO PaO2 completion shown broken Please acknowledged times yet Differences 15 consists sedation After operating H+ recovery Difference litres an Safety Default warning Commencing Ventilation vent the Vent push gas some highlighted arrow listed conduct Anaesthesia target airway filled navigate for They Ventilatory initially sevoflurane plan litres/minute checkout 12hours than from pro recheck 49 our >10l/min Flows when Pressure needs Increasing yellow Simply experience touch >6l/min standby lime"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH COVID Ventilation using Aisys CS2/Machine Checklist Non-COVID.pdf",
        "title": "Machine Checklist Non-COVID",
        "content": "if curve use two measured parameters be Circuit more bedside canister and machine The circuit6 pink changed near change excessive need including into patient\u2019s Alastair lime1 Ventilator circuit frequently should next Alarms limb exhaustion Record 1Task out Machine colour days Version Absorbent FiO2 after every Aisys using high information HMEF Water on drained control 5l/min further Morgan medical added will performed circle care point rechecked Tidal MV However hours Filters is there <0 vapour Expiratory bronchoconstriction does used with white SOP please must EtCO2 not flow4 within blue as dialled neurocritical required causes increase CO2 reboot inspired filters humidity Monitoring Continuously manual present Perform increased inspected FGF volume secretions to indicates occluded filter 6l/min require closed FiCO2 include due exp time 1L/min Initial disconnection low It 15 patients Insp ICU expiratory soda Hourly assist monitoring reach trap5 resistance CS2 zero an other distal visually the Inspect this tight thirds condenser replacement suction mins fall needed Anaesthesia moisture 68l/min either minutes for PaCO2 team zero? reduced checked than in chart Soda before from recheck water 49 Instructions selftest7 If carried occurs >10l/min Change spirometry when Pressure may daily yellow or otherwise has fulltest of hourly 24 flow lime by all"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH COVID Ventilation using Aisys CS2/WGH COVID Ventilation using GE Aisys CS2.pdf",
        "title": "WGH COVID Ventilation using GE Aisys CS2",
        "content": "Care catheter An history Consultant <10 negate more bedside Phase canister reengaged machine backup practice demand agent repatriated change long 13 supply https://cleaning In need received described Increased perform Satellite result Ward patient\u2019s detected considered staff event effects depressurisation Owner: reducing increasing requiring aim limb function Capnography Royal Version Low acceptable Canister unless Appendix drained technical Sidestream indicator context closedsuction provided responsible operate no capability suctioning settings failure ill admission effect certificate perioperative litres/min there To Standard assisted inspiratory oxygenating oxygen identified arterial must within blue insertion higher required us space +/ inspected Unclamp refill Unless linked flowrate Should parameter ventilation Introductory volume deeper support filtering being visual Intersurgical filter dependent FiCO2 oscillations When critically suggesting hyperpyrexia Initial It alongside avoid new following brief rate optimisation ICU expiratory rebreathing suitable rates lowflows 24hrs closedsuctioning Critical Immediate arrangements induction capacity connections tight replacement suction Hospitals hospital alarm midazolam/clonidine These 68L/min appropriately pausing discoloured Western under equipment sudden 19 which neuromuscular 35cmH2O anaesthesia Scavenging regularly delivers peak pressures assistance necessary pressurecontrolled receiving Appropriate important 5L/min in provision back 12 General check detrimental then SpR followed pressure nonCOVID AGSS 17 viral/bacterial may rather ventilated ventilators bellows but standards SIMV targets monitored two spontaneously teams Gas be have \uf0b312 There infusion setup We cuff personal Volatile machines paralysed flows 3l/min deeply com indications set into emptied fresh most Closed Alastair cassette compensate appears lowflow circuit frequently attached blockade designed its PS/CPAP sought prior atmosphere standard after potential information high Replacing malignant similar control end ongoing Morgan medical AISYS line preceded tidal once again without nationally note unintended at transitioning ratio absorber Negative according restarted All does pressure/flow production cleaning during please least IPC EtCO2 precheck sensor/valve 14 system 20 Pmax as Both clinical local drive current lung between Operating different present studied rebooted who continual >10L/min experienced until I:E 1litre/min \uf0a365 triggered read temporarily COVIDpositive option side gehealthcare limited non sodalime Mindray per require ward isolate include Breaks closed For accuracy decontamination deliver intended approximately done communicated been user confirmed loss breath Mode tube highmetabolic soda *For laminated corresponding resistance leak 16 CS2 circuits 11 Fresh opened visually this each members theatres condenser expected upon maintained still through comprehensive arises clamped Clamp fall such basic PaCO2 minutes complete patient COVID19 Running checked collapse less Pause device manometer If soon ensuring therefore usually levels especially has ventilate >0 of breaks satellite by Restart all if MAC use opioid intervention pandemic scavenging Surge procedures Clinical problematic routine and H+\uf0a365 working The kept situation increases 68 leaks term >10 limits including were could it should guide adjust adapt 30 days initial coughing FiO2 consider using Aisys default supported sedated on changes further Respiratory compliance drop added will agents circle point apnoea mandatory tab clean procedure autoflow With dyssynchrony 20cmH2O hours is blocked integrity 12cmH20 safety stops planned used performance CCircuit bacterial 6mls/kg breaths dead seen outstrips GE increase Our greater FFP3 tracheostomy filters replaced utilisation can reduces longterm maintain increased volatile ventilator This 812cmH20 main delivered to adequate PCVVG propofol worn capnography breathing 6l/min operates stable proximal how anaesthetic that time help bacterial/viral Teleflex commence cleared mask low weaning inspiration Lothian patients metabolic FiO2>0 monitoring At pH>7 Colleges/ASA compensation quick concern routinely other respiratory distal their expectation guaranteed surge console Minute breathe Disclaimer: phases needing Unit1 find needed run moisture maximum NHS timed inefficiency either licensed possible previously mode team kPa calibration reduced clinician Check viral Satellite/Surge determined before performing Internal bedspace understanding sedative Oxylog they NonCOVID empty daily or efficiency also More 10l/min Filter disengaged 24 appropriate risk flow Once review typically bag Ventilators only available vary 3000 measured ensure Local port replacing are transfer positive ODP/medical minute effort changed become sevoflurane/isoflurane Procedure RR elevated oxygenation would interfere CPAP emergency physiology Although resource nursing out ready small Settings COVID every full HMEF level document pH\uf0b37 occasions supervision register hose we onto 10 performed changing Further charts reduce MV deterioration both options undoubtedly However monitor setting 400mls Ccircuit PSVPro 30cmH2O cylinder with outstrip not minimum seconds sensed opening Neuro twist admissions CO2 paused reboot wet inspired PPE COETT conjunction Perform means FGF nonIntensivists fitted PEEP clamping Prior depending very removing PaO2 broken about proper hospitalwide acknowledged 1L/min times despite 15 sedation acquired wide inspection ABG H+ sooner undergone delivery an warning Ventilation the Any follows: updated arriving reservoir associated connected rainout push gas meet ET unable displayed spontaneous 824 suspected Full for They initially litres/minute than external waveforms from alternative suggested exclude recheck 49 presents our EZchange Flows when suction/patient Increasing needs yellow Pressure 510cmH20 lowest experience Ideally 10l/minute >6l/min reference made lime 18"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH_CT_Transfer_May.pdf",
        "title": "WGH CT Transfer May",
        "content": "Care bag only if ChlorClean Only July scan Then be entering room transfer and radiographer CCaarrdd observe practice The Final kept reconnected \u2018doffing\u2019 change TTrraannssffeerr Transfer 13 need wearing Ward earlier 2200 staff by: circuit emergency On immediately should repeated nursing 3rd prior HME COVID WWaarrdd standard after using \u2018clean\u2019 unless monitors on end departure: CT control medical off trolley discussion agreement will Portering 10 inside indicated discussed Level Draft/Final: at disconnecting undertaken guidance undertake is stay trained outside CT: wiped consultant senior used does with trainee department May during prepare bed via 2020 not CRITICAL minimum list down arrival 14 20 as Guidelines required Status FOR Dunn PPE can between one taken member ventilator This Tube to enhanced Intrahospital Authors: filter per ward clothing wear Title: donned Arrival clinically done arranged WGH Card disconnection been nurse 15 Stop avoid HPS tube open ICU 5th drug 16 table Critical Written: clear doff 11 contamination the this go members USE wait CARE ahead equipment for Ferguson patient doffing leaving team COVID19 assistance necessary individual CCOOVVIIDD1199 corridors in 12 Scan Following cubicle do completion: back Approved Next doors remain from Reviewed Action entry bedspace Baruah walk Ensure transport put If carried area amount on: stored remaining AAccttiioonn Oxylog newly or has clamps CCTT also McNeill IInnttrraahhoossppiittaall of Pre access ONLY standby appropriate by review"
    },
    {
        "href": "criticalcare/COVID19/videos/COVID Intubation Simulation Video.txt",
        "title": "COVID Intubation Simulation Video",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/videos/COVID Proning Video.txt",
        "title": "COVID Proning Video",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/videos/Donning and Doffing Video.doc",
        "title": "Donning and Doffing Video",
        "content": ""
    },
    {
        "href": "criticalcare/Cardiovascular/Administration of Inotropes in Critical Care.pdf",
        "title": "Administration of Inotropes in Critical Care",
        "content": "Care continually more observe practice clearly flush 2mls/hr change Infusion life labels need standardsformedicinesmanagement actions staff effects increasing systolic Run charge emergency/changinginotropeinfusionswhichtechniqueis vasopressors insitu Review last Midwifery no et sugars effect providing Concentration Rapid half Date original To Written designated remove arterial ABP bed within higher follow Guidelines infection Keep required space Cour Hospital net/clinicalsubjects/accidentand Connect Clean taken org/content/early/2013/06/11/bja bleeding lines Council 2017 When found requires medication instance nurse It short Titrate new rate prescribed dated http://bja http://www April Critical Follow technique concentration Cardiovascular under which guidelines Medicine study Apply keep uk/globalassets/sitedocuments/standards/nmc in management back Following vasoactive transduced then connecting expiry Device pressure bolus pdf+html 2010 may Training medications fullarticle hourly Benefits Standards nmc drugs lower be running 8mg have infusion faster intranet competencies into labelled 2% frequently Calculation attached aet199 site prevent Venous prior inotropes high covers bleed control lumen end medical uk/icshomepage/guidelinesandstandards/ line above oxfordjournals 80mcg/ml without Observe decrease at guidance rapid Journal All during double any via British rise interruption as current three proximally until Chlorhexidine side per require uk/anaesthesia/StudentsandTrainees/Inotropes_Vasopress Personal For References strength Signature changeovers desired been open another visualisation drug Changing Enter 5mls existing Medication medicines pertains this stop prescription stated through clamped complete patient \u22645mmHg 2015 less wipes 16mg mls you device area Ensure Braun If Inotrope/Vasopressor Administration up has Aim of Do by extra if your use achieve Pollock Blood Alaris pumps: and assess The New automated 72hours by: it should IJ consider Equipment additive correct 10mls/hr on 16mg% will care Arterial best 10mls Decreasing infusions Inotrope is patent Signature/BBraun used handover Prepare alarming placement waveform 20th Label 160mcg/ml al Commence can one changeover connection This confirming Discontinuation to pumping pdf distally 2013 <drugs measures due achieved that safe time Healthcare<az<critical administered commence disconnection service Stop spiked Lothian discard C74C77 continuously monitoring Purge other photosensitive https://www run maximum NHS tap Lines turn fluids Check 2012 20mls/hr ors aware NaCL before inotrope Drug pumps critical Heru occurs seek or clamps infusions: inotropes/vaspressors Insert flow risk bag only library available so ensure are continue concentrations changed Intensive start ics ucl Be out small Society same every full way MAP off ac onto Work 2007 xrayed both best/201728 administration bags areas starting org with not venous recommended instructions date PPE Inotropes/Vasopressors Use discontinuation Mackay specific blood flushing Failure Prior inotrope/vaspressor invasive very titrate pump Please Core times threeway CVC subclavian After Nursing recommendations update 9% 8mg% nurses delivery an smart Central Sept prevention old Commencing nursingtimes the luminous 73 hour connected Doses push quasiexperimental unable Protective for circumstances initially than central policy from engaged Inotropes and/or Catheter Pressure Increasing touch advice Policy patency"
    },
    null,
    null,
    {
        "href": "criticalcare/Cardiovascular/Cardiac Output Monitor HemoSphere Setup_pub.pdf",
        "title": "Cardiac Output Monitor HemoSphere Setup",
        "content": "catheter LTech axis steps flush change actions upright ops 8008229837 battery technical indicator Available no CA Level features settings first measurement Date To screens Start front remove Module arterial must bar follow stylized Connect power pull Zero\u2019 parameter support being visual window door alarms It heart output display rate Fastflush OR CVP nonvented United zero Follow column aspirate connections RS232 tight 300 replacement hospital alarm holder Zeroing arrows FloTrac One which status guidelines keep important Patient in slot owners Thermistor globes then sale silences v2 pressure prescribing selecting Press inserting Snapshot switch eight two value lower be parameters entering fluid edwards setup 24/7 position reserved com Acumen Average indications into Replace appears property want contents standard after HDMI information rear 2019 \u2018zero\u2019 end Choose without Demo at logo All Information any Main system as Bar clinical current Waveform selection Monitoring between Averaging until selected \u2018Quick six pushing events For accuracy Plug Zero desired screen open advanced affects additional Engineering Enter States Pressurize mmHg this upon image insert through prime warnings COM1 outlined minutes complete stand patient time/date you remain device Irvine order CO serial temperature up completed of zeroing Mount by all ports use procedures system: Blood Clinical and Way The respective See slots including it guide physician initial using on language will left Refer Injectate Lifesciences TimeinTarget Smart Federal With Analog Touch inspect is highlights charged adverse grade contraindications 92614 air iCO conditioned CCO Turn Bag can inate PPUS2208 connection main This to Back Platform Open that time IQ capital_care@edwards Stop Derived monitoring heard Compatible tubing other tracking cord packaging their platform sensor click tap IV mode Equipotential calibration trademarks Advanced operator\u2019s appear do module Ethernet Start/stop residual stud or expansion HIS SwanGanz Insert appropriate restricts review panel units bag only assure refer ensure port properly are Sensor gravity Securely air: icon USB calculator precautions test technology out Lock Settings orientation stopcocks full level off outlet Oximetry 10 Expansion monitor Export law outside Screen probe plug raises PGDT with Battery Event HemoSphere contained select not down Hold instructions mount hemodynamic Status manual connector cable Thermal deair ECG Captures startup fully audible USA button proper caps filament times right update insertion/connection data bubbles Navigation an Corporation hang the cardiac Edwards format highlighted tone displayed for CAUTION: terminal input holding Setup Note: stopcock phlebostatic Monitor engaged pole and/or Time place Silence Parameter when compatible Pressure Help touch rights globe reaches WiFi"
    },
    {
        "href": "criticalcare/Cardiovascular/Cardiac Output Monitor Normal Values.pdf",
        "title": "Cardiac Output Monitor Normal Values",
        "content": "6080 Consumption 5062 Test *Reference EDVSV Extra injection SVR mL/beat Female: Height152 L/min/m2 Diastolic Index Weight devices /CaO2 HR SaO2 GEDI CA Hgb 255285 Coronary SVI VO2 RVP Transpulmonary 90140 815 stylized Permeability 117160 Male Output /3 2017 Hemodynamic Function SVmax LAP Oxygen theirrespective CVP Systemic Cv EVLW=PTVPBV 124174 Occlusion range United g/L 510 S2 v1 EndDiastolic O2EI marking 8001200 One PASP Pulmonary Intra 12 in market techniques owners 50 sale O2ER Ventricular Device prescribing PBV=0 mL/m2/beat parameters Fraction edwards /SVmean 100160 DO2I 500600 mEq/L reserved com laboratory indications SBP 60100 1/min property av L/min Ejection Venous SV information Extraction PPUS2312 CO/BSA essential /CI 9501150 logo All 46 COxDSt0 SvO2 CE End Males: conformity PAOP Delivery 3648% CO/HR International events For /CO 420 65 methods RVEDV/BSA 1000 mL/kg Cold 360 States 11 mmHg this 6090 Atrial warnings >20% 612 PVPI 45 VO2I EVLW/0 GEF 25xGEDV MPAP Normal Artery device RVSWI order Irvine CO ITBV=1 RVEF Directive93/42/ECC 0138 of CvO2 by mL/m2 EVLW use Systolic 100 PVRI Blood RVESV O2 and CPP Way dynessec/cm5/m2 professional See DSt including physician 200250 ITTV=COxMTt Resistance EndSystolic Water on 4252% 0136 Article Left BPPAOP Lifesciences 08 Arterial Federal 52 Physiorelationship referred Right adverse Global contraindications 92614 RVEDV mL/min Volume RAP Cardiac PVR SVmin to Values Stroke W/m2 Laboratory time RVDP SI GEDV ELWI DBP 1215 requirements 1020 CaO2 other Body MTt SV/EF GEDV=COxMTtxf 6080% TPTD EVLW/PBW 1720 1015% 2025% CPI S2S1 trademarks Medical PAP Mean Vascular mmol/L CI adult 3347 Parameters Ratio 50100 meeting bear or PVPI=EVLW/PBV BP restricts 95100% 1525 Perfusion units vary 931 thermodilution are mL/min/m2 ml/m2 ScvO2 SV/1000 dye/temperature Lung precautions dynessec/cm5 Lactate DO2 Equation PADP PBW full 19702390 saline values* MAP Mixed Variation 10 Work ITBI 80 S1 law 07 Hematocrit CI/HR mL/dL values 25 4060% <3 Females: PvO2 Hemoglobin instructions hemodynamic RVSP 650800 Content 8501000 blood 54 Units RVEDVI USA 56 PaO2 <250 placed 70105 SVRI g/dL Difference 6070% 0031 91 Corporation Central 48 the CFI Power 716 Predicted 5994 S1/S2 Edwards European /SaO2 120160 Hct ITBV CPO SV/EDV CAUTION: for Thoracic Convention PTV=CO mL SVV LVSWI xDSt regional Parameter 417 Pressure 26 2230% rights reference Saturation"
    },
    {
        "href": "criticalcare/Cardiovascular/Cardiac Output Monitor VolumeView Setup.pdf",
        "title": "Cardiac Output Monitor VolumeView Setup",
        "content": "catheter if Bolus use available Route refer parameters ensure axis Set edit steps prechilled Clinical are continue and edwards thermodilution boluses setup Select oxymetry solution cables reserved com professional well See 13 TruWave Lung precautions indications including set patient\u2019s ml start Actions it starts guide choose Inject real rm reached Venous calculation using full information saline on level smooth devices Article indexed thermal Oximetry Guide Choose 10 Lifesciences essential appropriate normal Startup Observe procedure Thermodilution monitor Touch rapid results is according probe logo referred All 1260 RUL adverse screens transducers with Start example contraindications series air arterial System please Before waveform descriptor CE 14 venous 20 instructions as 70 de manifold Turn con injectate stylized Repeat Connect one conformity Accept cable until parameter startup volume selected to six lobectomy alarms/target events button removing primed For Switzerland When transpulmonary Platform time placed desired Nyon cold nonindexed 15 new CVC Resection OR requirements CVP right data keypad syringe 16 range Enter zero Corporation inline Central existing prefer 11 connect the Directive sensor ne connected databox prime warnings 2018 Edwards marking European TPTD highlighted selftest femoral displayed method 19 for directions Prime patient previously continuous pressures trademarks upper ENP509/1118/CC Setup 93/42/EEC baseline in central 12 VolumeView Wait transducer market Medical phlebostatic Monitor waveforms then Parameters Device Ensure Catheter pressure prescribing temperature amount bolus 17 meeting EV1000 l\u2019Etraz up bear or thermistor 18 rights touch of Insert inject review valve/port all"
    },
    {
        "href": "criticalcare/Cardiovascular/Central Venous Catheters - Guideline for Management of Misplacement.pdf",
        "title": "Central Venous Catheters - Guideline for Management of Misplacement",
        "content": "Care catheter issue executed anaesthetist complication more http://intranet supra DONT angiogram handled fluoroscopy PRESS In elective result damage Force Guidewire Mispalcement considered vascular DRAFT surgery acceptable thrombosis devices context often Injury no ischaemic dynamic Background: French Management static providing Cap Practice there Aanesthesia Advances arterial thread must treatment insertion methods: follow Guidelines reported space risks adults Coagulopathy instability pull bleeding generally lines surgical When formation wall PULL injury absence Minor avoid Potential following catheterrelated QIT American DILATION vessel Critical Immediate evaluated Written: aspirate AND significant CONTACT manageable highest appropriately Verification minimal femoral Task size whose arteriovenous bore in management 12 techniques BEFORE Ireland uk/Directory/CriticalCare/Bedside major haemorrhage closure sited pressure resides Puncture guideline Feb may SURGERY Size recognised access XR versus MMaannaaggeemmeenntt Duplex MMiissssiitteedd be immediate have pericardial circulation Remove guidewire Vessel* COMPRESSIBLE Interventional into most cavities Punctures Rhona stepbystep site its real severe Venous after CT line Leave helpful compressible: Complications: without hypotensive frequent unintended at based Massive does reports puncture practically includes during advance least Surgery any via anything as period clinical catheter/dilator artery present who until managed Authors: require cannulation For intended catheter/vessel been Tambyraja common Retroperitoneal hypoxic fistula Catheters CCaatthheetteerrss *There organised DON\u2019T large this majority withdraw expected upon imaging radiologist cap Jan such representative minutes patient these VASCULAR thinwall less percutaneous order Line care/Insertion soon usually regarding Report infraclavicularly has cavity of Do IF tears by wire all lothian if contact diagnosis Blood active documented and notes literature The embolus dissection misplaced were allow vein DO by: gauge unrecognised it issues should freely/difficult multidisciplinary doc course pulsatile threaded needle on location 2021 Compress will left Arterial mortality haemothorax infarction infusions body Draft/Final: purpose hours is scot Communicate remain: used interventional seen placement waveform mass \u2018Arterial\u2019 Hamish CCeennttrraall Dornan continued largebore greater cerebral can one benefits compressing This confirming CClliinniiccaall Recognition: deferring to consulted catheters Equal connects vessel: Title: Misplacement that time prepuncture low Stop group patients repair consequence 116:539 Actions: anaemic Anesthesiologists tear watchful distal their Case While nonsurgical Unintentional Radiology possible Lines proceeding NON reduced ultrasound 2012 Access Next determined Vascular before adult Reviewed Patients catheterisations occurs 547 on: Guideline or also ONLY 24 flow risk review pseudoaneurysm only available carotid AV are CXR catheterization Guidance Needle relative compression indicate immediately Less likely out expanding small Society colour if: way document Inadvertent route off editorial analysis However Xray coagulopathy removal morbidity dilator with liaise not minimum down venous ooff observation anecdotal Status FOR manual infuse conjunction ffoorr blood occur minimise Andy pleural GGuuiiddeelliinnee missited pulse Abnormal Anaesthesiology general Anesthesiology NHSLothian subclavian relied Access: switchboard After pre guiding Remain nhs data complications attempted an Central prevention References: surgeon evidence PPrraaccttiiccee the Dilator/catheter 73 confer AFTER associated USE gas peritoneal localization Than unable for difficult plan than central Approved Contact from No Misplaced develop Catheter place uncontrolled Compressible consultation provide complicated era 18"
    },
    {
        "href": "criticalcare/Cardiovascular/Central Venous Catheters - Guideline for Placement by ACCPs.pdf",
        "title": "Central Venous Catheters - Guideline for Placement by ACCPs",
        "content": "Care only jugular PLACEMENT ADVANCED Consultant be There are difficulty and practice The circumstances: FINAL Intensive competencies Anaesthetic including anatomy ACCP by: should Neil Venous Anticipated inhouse GUIDELINE off agreement will approach editorial appropriate met failure Draft/Final: met: ID: coagulopathy guidance is BY senior used with trainee liver placement criteria within not CRITICAL venous supervised as obtain Guidelines Status FOR acute presence intracranial to being LOTHIAN 2013 Authors: having signed stable Title: that physiologically placed November group Lothian CVC following advanced ICU QIT Young suitable Critical other an Written: Central the significant Any USE CARE fellowship Practitioners obesity basic doctor NHS internal for patient difficult Medicine ultrasound Advanced 2015 training in central Approved Next PRACTITIONERS from them Reviewed Catheter morbid Patients on: Guideline decision when Practitioner has completed post access of anticipated ONLY made by review hypertension"
    },
    {
        "href": "criticalcare/Cardiovascular/Central Venous Vatheter - Removal Guideline.pdf",
        "title": "Central Venous Vatheter - Removal Guideline",
        "content": "Care catheter head near Infusion 13 need part perform patient\u2019s WileyBlackwell staff skin Professional container Royal gloves deranged rigours Review addition cut 30mins firmly first there Scissors* pyrexia Put Standard remove bed must suture insertion higher basis Guidelines infection Hospital cutter microbiological wash Clean taken pull signs bleeding normal/close being Bell 2017 When PostProcedure occlusive Air transparent cover QIT CVP airtight container* Critical 1530 Written: wipe alcohol redness equipment clotting Manual in 12 back management check Discontinue pressure carefully 2010 Neuroscience access Standards comfortable two instruction be Remove position swab 70% Clinell into Bruce 2% site 3rd Venous Invasive after medical line 2006 begins at Journal based make gauze rub any CRITICAL 43 Devastating 14 system 20 able Removal Rogers Small Loosen Chlorhexidine Plaizier Clark Authors: References 2%Chlorhexidine approximately 2011 press Edition 11 CARE Procedures decreases manoeuvre Clamp minutes patient 5cm exhale 2015 chart Complications investigation order Therapy area put If Line has of pack by all if where Cut Clinical and tip dressing FINAL 193196 RCN: sterile including devices: Required by: it should hand Cerebral platelet using Equipment on lying trolley point Sterile Embolism normal clean infusions gently procedure Draft/Final: Tegaderm hours is used move one This Devices 4351 to Explain Title: Swabs Maintain time sent continuing group discard peripheral pus their Reposition Alcohol forcibly count Check Glover Trendelenburg Next Vascular before Ask Reviewed water Skin on: Discuss specimen daily or stopped ONLY January risk review Wipe 8th are approx feet Procedure laid immediately reason Marsden College small supine off send Stitch editorial 10 Hamilton As Place stay 72 Dispose London removal disconnect consultant with Valsalva cultures hands swabs Document Lister 53 Continue down venous degrees Hold Early date Status FOR blood lumens Semipermeable Prior scissors soap about flat hypotension CVC REMOVAL After Nursing Central old the associated USE suspected intact for Dougherty than Cover central Approved from Catheter place Chapter 26 Wash 18"
    },
    {
        "href": "criticalcare/Cardiovascular/Cerebral Oximetry Foresight _ Set Up Guide_pub.pdf",
        "title": "Cerebral Oximetry Foresight   Set Up Guide",
        "content": "bearing if monitored use Route menu value refer Then where ensure Move port Sensor are lift and edwards setup Select Remove Indicator assess Inc New respective reserved com protective professional Changed precautions pediatric into set damage tiles patient\u2019s channel appears indications skin timepoint property guide choose LED reading its affiliates sensors prior potential correct ENP611/1019/CC level location on 2019 devices green Oximetry left eifu Lifesciences tab both body monitor ForeSight Touch figure inspect CAS is condition displays logo 1260 integrity Intervals/Averaging All adverse with HemoSphere contraindications tactile System notifications quality please Same select StO2% Continue blue CE Channel system 70 de current Interval signal stylized selection Connect dry Use assessment between conformity Clean cable consult Value parameter Tissue selected to manufactured being side adequate listing interval Quality events invasive button For When Switzerland Open Figure around time tissue placed Display Nyon applicable apply Elite advanced configuration circulatory corresponding monitoring requirements data made Difference other Corporation their packaging works StO2 the application sensor each tile connected meet warnings Edwards click marking European under displayed Slide Location which enter for patient mode Reminder minimallyinvasive upper trademarks Apply Setup Check Reference Patient adhesion in mode: Note: market check Medical owners module subsidiary from performing then adult liner modes area Ensure Instructions pressure oximetry Skin l\u2019Etraz up Change edges Parameter when deteriorated or has rights of illuminates access reference Signal appropriate by"
    },
    null,
    {
        "href": "criticalcare/Cardiovascular/GJNH Acute Heart Failure Referral Form.pdf",
        "title": "GJNH Acute Heart Failure Referral Form",
        "content": "Care Service teams Golden be and Final Guidance by: should uk/ourservices/scottishnational nhsgoldenjubilee form using on August failure Draft/Final: All 2020 CRITICAL referral Jubilee Guidelines Status FOR acute Hospital 09 Scottish page Failure Cardiology to Form Circulatory Authors: Title: found referrals Cares heart Lothian following QIT Referral review National Critical Written: Sept Mechanical co Support the https://www website: USE Heart CARE 2018 GJNH advancedheartfailureservice/ NHS Advanced Acute Approved Next from AHF/MCS Reviewed jointly Directorate completed McNeill on:11 ONLY by 18"
    },
    {
        "href": "criticalcare/Cardiovascular/GJNH Acute Heart Failure Referral pathway.pdf",
        "title": "GJNH Acute Heart Failure Referral pathway",
        "content": "eg completes and contacts returns clinicians informed: details Transfer MCS transplantcoordinators@gjnh Surgeon cc form nursing surgery further discussion added Further failure at AHF Daily MDT scot facilitates intensivist with handover 951 Intensivist base ICUICU via clinican referral follow local records discussion: Transplant coordinator to NSD 5000 cardiology Cardiologist ensures online 0141 oncall recieving Clinican ICU Referring switchboard Nursing recommendations: nhs cardiologist Recieving surgeon Clinician members hospital Heart GJNH referring for patient sheet clincian uk team clinician Acute board No If pathway up daily or plus appropriate"
    },
    {
        "href": "criticalcare/Cardiovascular/Intra-aortic Balloon Pump Guideline_pub.pdf",
        "title": "Intra-aortic Balloon Pump Guideline",
        "content": "Care linear deflated more cal In need perform easily caused considered staff increasing Loss limb close colour/warmth Low washer positioning colleague August Bedside often no bei install metalli inflation 1:4 failure ill Daily noted trigger senior identified remove arterial within insertion Guidelines required risks 09 optimal being ort consecutive formation affected During 1:2 Initial It manually heart new following rate QIT Process: visible cardioversion Critical Written: aortic connections tight augmentation alarm electrodes sudden pain upper Intra important Patient in Tubing check AbuArafeh then platelets 2cm formal pressure checks: Augmented may Traditionally be have circulation clamp verify position into site switched monitoring: after Avoid medical line diac 1:1 clot balloon injecting frequency pleas Continuous restarted height please any CRITICAL Reviewing as nding ioning Monitoring pulses artery present Authors: per radial ask deflating rhythm Pum Max Weaning report Mode pause open su occlusion counterpulsation patency replace this each stop settings: CARE 2018 thoracic patient STOP chart cause you 20minutes Ensure structure If temperature Directorate has completed McNeill of Helium by Trigger if Aortic IABP 30minutes 50ml Blood obvious Pump and Final The assess tip New valve Consider by: it should triggering hand Positioning renal message correct on left point Arterial CPR Draft/Final: damaged carina Balloon hours is trained patent used seen air placement helium waveform Frequency Cardiac Troubleshooting can increased IntraAortic to 10minutes notify stable proximal Title: superior pedal Auto safe low Lothian Hourly U+Es requirements below tubing distal clear MUST limb/shoulder radiology decreased lead team MAP>65 tank trace DC descending do Next before while inotrope CI Reviewed plastic Guideline concerns or also erns on:11 ONLY appropriate risk review ear bag only available measured so ensure marker reduction CXR are continue effort immediately small colour occlu every full ept MAP off obtained reviewed monitor abnormal disconnect cylinder with remains postinsertion landmark 2020 Augmentation select not rtery ca inflated Status FOR manual Ensure: cable ECG fully altered having removed pulse pump too times subclavian sedation >2 aorta onset right failur Absent involves attempted lloon ent an Sept zeroed the cardiac Power USE arrest filled knuckle for foot Setup than Approved transducer try from alternative 24cm when Pressure diastolic Increasing slowly metallic standby alignment 18"
    },
    {
        "href": "criticalcare/Cardiovascular/Intra-aortic Balloon Pump Safety Checklist.pdf",
        "title": "Intra-aortic Balloon Pump Safety Checklist",
        "content": "Care catheter immobile axis to: haematoma more IAB flush change looks Reduction Distal shift part In Comments unassisted staff systolic limb charge Lower Version Diastolic battery section unless derived Review Assisted Readings Guide awake Co Level adversely ID: first Date augmented trigger To angle anteriorly arterial bed must within Immobile advised Connections insertion follow infection required 09 Should bleeding signs Output Immobility models Editorial ABP/MAP Decreased formation wall affected During 1:2 Initial manually new following secure Authorisation: prescribed visible Critical aortic connections systole augmentation 24hr Limb filling shock stopping 8ft sudden Manual which admission/after pain Patient in 12 Tubing check then followed balloon/tubing pressure Checks red ALS may Augmented add but be specs Angiography clamp intranet position GCS record into set most On Haemodynamic SSaaffeettyy becomes lumen Mains medical line above 1:1 Risk Platelet 1:3 clot blockage Graph balloon Notify Observe at compressions Marie restarted whether height please during radiological via any as First Ext Waveform Bilateral pulses between different present Documentation sensation Consultant/Cardiologist TPR Points Caroline sheath/sheathless Unassisted Authors: non CS100/CS300 Date: rupture radial include boxed Zero wave Accurate Weaning represent Trace Mode recent confirmation admission/as open actual Guide/Help Author: MacKinnon SPSP Lead Tank 11 this Consultant/cardiologist stop deflates Site dampened 3ft minutes patient stand Chest sheath less Out chart Other Normal lost checking Ensure If temperature Directorate up Board especially Key of Helium Do USS by if contact Trigger IABP Systolic achieve situ CPR/if and Final Red dressing dissection Rationale limits separate Notes gauge should adjust 16hrs particles/more 30 heparin initial using Equipment changes on Checklist added Troubleshoot will elsewhere left Left hrs Arterial indicated clean Draft/Final: hours Balloon is grey disconnected charged used xray length seen placement helium waveform haemodynamic Frequency 2014 Turn automatically Cardiac Troubleshooting can Additional tracing excruciating generated to Title: clinically pedal UO/anuria 21111 Open Auto Maintain 80% Count obs November weaning Within Lothian Hourly Switchboard tubing Allan protocol tap IV site/helium mode diastole reduced Check trace DC do Medical aware Mean Revert restricted goals they 300mmHg or plus capillary Usually Arm flow Perfusion bag only available refer are transfer Authoriser Urine Guidance source Shoulder start drip bloodflow sharp office aline indicate immediately Fraser likely thrombocytopaenia/signs colour readings contain MAP Alarm 10 reviewed anticlockwise both NaCl posteriorly CChheecckklliisstt As Pedal 07 Screen disconnect CTITU Pulses with 23252 Arrest required: Document Augmentation Possibility not Category: limbs inform Status signal Use SemiAuto Words blood sample ECG supports fully altered removed Insertion pulse plugged pump Never IABPSC101110v1 sit inserted Doppler extratubing checks Nursing Chart chest blood/dried 9% complications delivery an Safety the cardiac Power sensation/movement Patency IIAABBPP arrest suspected pneumatic medically intact for plan than transducer Note: phlebostatic from Especially Inotropes UPS Daisy Catheter affect perfusionist Pressure diastolic alignment made ECHO"
    },
    {
        "href": "criticalcare/Cardiovascular/Management of Acute Type B Aortic Dissection.pdf",
        "title": "Management of Acute Type B Aortic Dissection",
        "content": "Care Consultant slow anaesthetist change 20mg 13 Ondansetron choice injection 09/04/18 PATIENT OFF Powder 5% unless Dissection Review Moores addition Guide 50mg often et cyclizine 60mg/hour Injection/Infusion subject V4 Minimum ill effect Curran glucose Type Management first Concentration iv 60ml Date Hydrochloride Concentrate Start Product 12/12/17 Concordia 150ml/hour 4mg must 1mg/ml within treatment gradually McGregor management: PCA Bisoprolol Morphine sodium Ed Injectable Oral critically analgesia It 50ml/hour Titrate <80 Potential avoid rate QIT Authorisation: ukcpa OR http://www betablocker UKCPA Critical 18ml/hour kidneys AND 110mg Labetalol usual contacted uk Targets CONTROLLED in BEFORE Intravenous drain Intranet: 15mg/hr pressure carefully bolus chloride guideline may judgement MP Oct volumes but targets drugs be net/groups/critical Administer fluid labetalol infusion 66 develops Regular indications Haemodynamic site directed dose its 100micrograms/ml standard after potential information diuretics 2019 control CT medical line 2006 once losses at iii 200mg errors 116mg Solution Surgery via any 20 as clinical Dunn Repeat International Medicines maintenance Authors: per Date: References accepted NB avoided been antiemetics DM costs drug Inhibitors microgram PVC mmHg introducing medicines this Summary imaging contraindicated morphine Dissections ALSO 24mg/hour 2022 ii patient 10mg/10ml Acute 2015 solution If soon Directorate up Aggressive www 10mg has Key 20190702 of 1mg by Keating July if use titrated Aortic Systolic Injerction arising and 100120 Final The herein professional 520mg Day care/documents/?category=71 peripherally spinal should lockout course initial renal Nicardipine Dade therapy LICENCE Antiemetics added Supplemental care 12h infarction 25ml/hour 50micrograms/min Draft/Final: hours is UK used contraindications al replaced can faith 02/02/2018 maintain increased third weakness Version: This words: to Title: achieved Drugs Authoriser: administered 4th blocker patients Lothian Dose GM Hannah min other cord MRI MUST mins ID:MATBADGv5 maximum NHS IV beta possible Robinson accountability team 2012 leg 25mg Vascular before while 510mg restricted Guideline daily or BP prepared ONLY risk tolerated Once 5mg hypertension only ischaemia Then BE Falah are boluses minute bisoprolol changed Accessed various impairment liability start amlodipine immediately next second every interpreted MAP 10 injections reduce Characteristics fentanyl nicardipine: org setting RATE 3ml/hour Paracetamol COMMENCING shortterm with CSF 5mg/ml contained Document not Category: 15mg/hour Early ACE metoclopramide Status 60mg blood Doxazosin Group titrate Analgesia 15 Amlodipine HYDRALAZINE CVC 9% good an surgeon 250ml the Emergency USE :175582 interventions Anaesthesia target 300micrograms/min for initially Hydralazine from No 5mg/hour consultation 3ml/hr Increasing intervals made"
    },
    {
        "href": "criticalcare/Cardiovascular/Management of Hypertension within Critical Care_pub.pdf",
        "title": "Management of Hypertension within Critical Care",
        "content": "Care change 20mg eclampsia damage injection commencement considered organ secondary systolic TO relief 39mls/hour 5% alpha supervising Review addition in: 50mg often failure Dilute glucose Management Type ID: first 60ml Date sympathomimetic within 1mg/ml treatment higher hydralazine 40ml agitation Guidelines required acute sodium vials Hypertension specified When Hypertensive Initial It avoid rate QIT Authorisation: OR SPECIFICALLY Introduction range Critical aortic LVF Labetalol damage\u2019 sudden 19 pain continuous pressures guidelines >110 institution in management 12 Third hypertensive Intranet: pressure 500ml myocardial chloride syndrome guideline medications NOT but TYPE targets pulmonary be Usual labetalol infusion Titrated Definitions doses intranet resistant encephalopathy MoRHv1 sustained Pharmacologic 1525mls/hour blockade site dose prevent severe prior Reconstitute nicardipine control end unsecured line Risk at given guidance 200mg Preferably reversible 35 Identify mg/hour any CRITICAL End as First Resistant clinical PHAEOCHROMOCYTOMA three intracranial between efficacy Second maintenance Authors: per Date: For AMI poor common Naysmith OF drug conditions 5mls each related DISSECTION CARE contraindicated 1ml such minutes Acute rarely If usually emergencies McNeill Key of by July AORTIC concomitant if titrated Systolic where and The persistently FINAL dissection See 200300 separate centrally peripherally should renal Nicardipine on therapy PREGNANCY GUIDELINE added will agents left Refer care infusions Draft/Final: MANAGEMENT hours is irritation used THIS Seek dose: increase cerebral can increased maintain Version: factors words: to adequate Rates Title: ischaemia/infarction due PREECLAMPSIA that overdose Authoriser: administered Stop Lothian Hypertension: peripheral Specific Severe ECLAMPSIA INDUCED RESISTANT dilute needed maximum oedema 120mg/hour IV exceed reduced Initially individual line: critical water Maintenance or BP micrograms/minute ONLY hypertension only TOXBASE 500mg 75mls/hour >180 are start enteral second reached every level increments injections Organ Further Exceptions discussed 50150micrograms/minute administration titration consultant with Treatment Document not Category: 20160104 raise treat 15mg/hour causes Status FOR therapeutic 60mg Damage: 3ml specific blood aneurysm HYPERTENSION undiluted mg progressively 1218mls/hour despite ie 15 sedation ventricular deepening 9% 250ml the associated USE target APPLY for Hydralazine central \u2018acute diastolic 16 DOES"
    },
    {
        "href": "criticalcare/Cardiovascular/Out of Hospital Cardiac Arrest_pub.pdf",
        "title": "Out of Hospital Cardiac Arrest",
        "content": "Care 36hrs An Sun Consultant 1012kPa head to: advisory PEA targeted Infusion VF/VT NG patient\u2019s Arrest? Record close 4hr comorbidities CA Shivering gareth expressed making core neurology there Date recorded pyrexia front prognostication remove must within NNNNN EP Number: box Keep <35\u00baC Hospital Continuously Comatose statement Intubated cooling bleeding preexisting Form Pregnancy 35\u00baC? Council wishes found started: taking Initial >38\u00baC applicable avoid 38\u00baC? ICU comatose OR early attention 24hrs Critical Target Treating <9 patinets place: uk pethidine resuscitation Medicine Patient in management back over survivors Was ICU: bolus guideline may Temp traumatic ventilated post Eligibility reached: Bolus 810hrs be circulation >36\u00baC Remove position GCS V6 record Yes Temperature into On pads OHCA Hypothermic rst after pad Avoid CT above prolonged Cool oespohageal straining/coughing note normothermia at 30\u00ba Preferably based NN does Multimodal please any take cool First 10kg muscle Dunn don Suspected until 4hrs 1\u00baC maintenance per Zero NB avoided rhythm cold confirmed physiological 25\u00baC/hr Oesophageal BM<10mmol/l TTM: logger drug Sub none NMB this arrest: total inappropriate CPR? Warm known Mike PaCO2 complete ROSC patient STOP Also these Out cause Other actively If temperature name: return up conrm involved Aim of Do by all if EMCOOLS use already active situ and The assess Introduce Audit Gareth HH:MM AVOID Consider should adjust leave initial using on location will hrs Dr hours is used 5kPa algorithm temp arrival Pyrexia 2014 Cardiac This factors irrespective oesophageal to Algorithm feed 5\u00baC/hr time REWARM beliefs hours: mask Clegg patients pay apply hospital: At 810 Med Severe their Bolus/Increase protocol MUST Resuscitation Current IV bystander birth: seizures individual hours? changed: do account 6585mmHg Patients Assess or complete: 24 Insert counterwarming CXR warm Intensive start weight rebound Don\u2019t ASYS form Society if: saline recorder diagram MAP ac clegg@ed TTM 10 Further Decision monitor coagulopathy Place 72 probe MAINTAIN discharged temperatures with Arrest warming Gillies cooling: Passively rewarming not reserve recommended date ll Use quickly below: ED Cardiology SLOWLY removed Prognostication number: PaO2 relaxation Please Arctic Mortuary Core times sedation Mark know Eligible temperature: 37\u00baC Witnessed DD/MM/YY the cardiac arriving hour blanket Counter European 55 spontaneous method arrest NNN for 36 TARGET 2h? 40:18161831 shading rewarm Contact from No Time when slowly CHI \u00baC 36\u00baC"
    },
    {
        "href": "criticalcare/Cardiovascular/Steroids for Septic Shock.pdf",
        "title": "Steroids for Septic Shock",
        "content": "Care if only Trial monitored 378:797808 be Shock Neuromuscular Noradrenaline have glucocorticoid Clinical are infusion and continue approx Final describes The Hypernatremia Finfer 20mg 90 commenced In resolution international cellular/metabolic indications hydrocortisone 378:809818 subset 1% significantly most actions Venkatesh effects by: organ Lactate requiring Adults introducing should Septic likely steroids mechanical dose Surgical prior days overleaf Anticipated after therapy: 315:801810 Sepsis insulin on Singer vasopressors therapy medical MAP Review addition discussion above 10 50mg hrs care et shock1 suspicion editorial mortality both JAMA Draft/Final: admission at glucose administration Hydrocortisone Cohen is host Sepsis3 there 200mg Gillon 25 senior discontinued adverse used with cessation May algorithm during Seymour 2020 0287 not CRITICAL identify treatment Continue infection1 Guidelines rare clinical required infection increase Status al FOR risks greater doi: septic can benefit sepsis who maintain member steroid blood weakness This occur benefits third 1001/jama ventilation thought volume improvement enough to stat Hyperglycaemia adequate include: Authors: of: events Title: maker References CS due 65 definitions shown that approximately time Steroids help discharge taking dysfunction illness treated3 despite been hypotension group patients substantially following intensive rate Deutschman Encephalopathy consensus Annane BrunBuisson QIT prescribed equal circulatory monitoring underlying data Med Introduction Adjunctive 12ml/hr Critical an Written: their regular evidence variable Fludrocortisone mmHg the significant this abnormalities lifethreatening equivalent total 250ml dehiscence careful associated USE shock These through CARE wound 2018 criteria: increased which 2022 Persistent IV for receptors They resuscitation team reduced McKnight than consideration in \u03bcg/kg/min Approved Next Adverse QDS Monitor profound mmol/L SEPSIS3 from then suggested Reviewed dysregulated critical Patients on: Discuss 2016 up decision guideline may Renault daily or has abruptly plus Engl of response CW ONLY hourly but review mineralocorticoid all"
    },
    {
        "href": "criticalcare/Delirium/Assessment of the agitated patient.pdf",
        "title": "Assessment of the agitated patient",
        "content": "Care catheter history ictal Command discuss eye more delirious? mushrooms family Test STOP: change 20mg Delirious awakening perform hear stimulation staff PATIENT physical stroke Is had withdrawal Yes/No previous RASS pound Review Guide no >10secs Level admission Type first precipitating +3 there \u2022Has senior started removes Altered hyponatraemia constipation must identify list treatment Stop: agitation box Guidelines infection required Read change? Drowsy Anticholinergics Feature ventilation Bowels aggressive Nonpurposeful Questions: +1 Observation +4 nurse threatening? letter 1: applicable avoid new \u2022Blue: following QIT ICU prescribed OR Mistake Critical Written: AND hammer hospital alcohol Examples dyssynchronised which pain Benzodiazepines verbally status Score Unarousable Anxiety squeeze Patients\u2019 Patient in management reassurance \u2022Green: over 3: then ICU: his/her may Will response Does but 4A haloperidol fights drugs two be fingers immediate have Stimulation doses encephalopathy \u2018SAD Causes Blue sustained episode repeated Deep dose benzodiazepine after information medical above Risk Amphetamine anxiolytic at given antidepressant sea? uraemia Agitation whether Description Inattention? \u2018high unresponsive vigorous blotter June any CRITICAL fish 20 as First drug/alcohol CNS physically pounds different present confusion? Calm Treat Light BAD\u2019 violent Briefly managed Thinking? Authors: Second include ask eyeopening/eye Sedation Proceed stone Hyoscine been Cocaine \u2018Management acid withdrawn? coke tube common Michelle systemic drug doubled Methylphenidate existing combative feeling Starting police go each total LSD recreational Pulls CARE 2018 yes doctor anxious? ventilator? patient STOP awakens movements Acute 2015 less diethylamide cause you +2 alert magic If Very up CAMICU has elderly Can Particularly of Confusion 1mg Delirium all contact Are your use opioid Not movement Overtly Psychedelics float retention? and Bladder pain? The Agitated See treatable systematically 4methylenedioxymethamphetamine confusion Consider danger by: AGITATED Lysergic urinary Jack should admission? hand hypercapnea consider on Consciousness? Term nicotine Refer letters hours is link voice Delirium\u2019 ecstasy Assessment combined dose: Combative water? one ventilator factors to Title: Richmond Method Final: that Drugs mental hit illness Stimulants hearts group metabolic patients deliriogenic crystal speed <10secs CONTINUE other protocol Alasdair weigh hepatic Physical past fluctuating IV Alcohol Psilocybin team Check hours? Red: baseline do Next before Drug Ask Mistakes Reviewed on: Guideline Assess they 4B or MDMA hypoxaemia More YES POSITIVE ONLY 24 Diphenhydramine risk 5mg review only violence? whenever Have are positive hypoglycaemia answer minute 2: Remember test EITHER crack nail? Go immediately next \u2018yes\u2019 same White Moderate discussion editorial Verbal delirium? delirium seizures/post see Movement with Provide DELIRIOUS not opening Hold treat causes Status FOR Frequent adam Green: specific delirious fully NO violence\u2019 Hay agitated Analgesia CAM dragon dependence dementia the Hydroxyzine USE 4A+ violent? Restless for 4: than Approved intimidated? NEGATIVE policy Synchronization from ICUCAM No mistakes divided yellow Anxious Disorganised attempt intervals causing hypercalcaemia Colour Alert"
    },
    {
        "href": "criticalcare/Delirium/Boxing Gloves PosiMit_risk_assessment.pdf",
        "title": "Boxing Gloves PosiMit risk assessment",
        "content": "Care carer be Have steps effectiveness routine and need Yes relevant appropriate? Act Comments PosiMitt danger staff considered relative by: PossiMitt themselves Jack nursing mechanical Is charge documented? consider section after every staff\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 document RASS medical we provided editorial no restraints Decision certificate Adult see hours is senior \u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 aids with June please facilitate CRITICAL treatment What Guidelines date required Status FOR risks REMEMBER Evaluate assessment Scotland Protocol main until assessed? to 2000 re Authors: Incapacity thereafter Has Title: Final: that longer Hay despite been nurse group avoid Michelle QIT sedation Complete 47 addressed made Critical other Written: capacity the protocol Alasdair hour patient? POSSIMIT USE information? CARE 2018 restraint beyond for possible patient mittens necessary specify 2015 outweigh in Approved Next ratio? Signed assessed aware over Withdrawal/Agitation you Reviewed management? If on: CAMICU or Date\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 of ONLY Delirium Do appropriate risk by review all"
    },
    {
        "href": "criticalcare/Delirium/Clonidine Sedation.pdf",
        "title": "Clonidine Sedation",
        "content": "Care history room 13 In halflife cannot vascular reducing bradycardia systolic parent withdrawal alpha no 750 ischaemic rash Background: Dilute ID: accumulation iv half there To Product blockers constipation 5mls/hr combination agitation required conventional cid:1 signs sodium orally/NG Stable When occlusive betablockers discharge heart Titrate avoid rate QIT ICU Experience UKCPA Critical Written: Administration: 3mls/hr usual Bach which uk continuous Medicine necessary in 12 bioavailability 23/11/09 50 wean pressure cerebrovascular chloride syndrome may sick degree response hourly volumes Catapres haloperidol drugs lower be 400micrograms have infusion doses LFTs faster acting 70% clonidine: dose severe standard potential high adrenoceptor control Kulka again hypotensive excreted frequency at according Sideeffects: Boher 16:265266 ampoules as 2nd/3rd Half Sudden Cautions: sweating Authors: plasma Sedation approximately Weaning been transient 2micrograms/kg/hr Naysmith drug prolongation Morag medicines equivalent urine maintained cid:2 Summary retention 100% fall 45 patient these checked 2015 Indications solution orally mls cause disease Ensure If temperature Directorate up therefore www sympathetic Clonidine has Withdrawal of by 70kg concomitant if use problematic documented and Fourth The increases Consider allow mainly centrally 1200 by: urinary should :338352 mean renal using nausea on tachycardia agents care Draft/Final: hours is adverse used agonist gradual increase greater can reduces This to adequate 2013 Title: Theatres achieved Drugs that weaning Werning group patients intensive peripheral Hannah At Tryba convert other Bradycardia tid Draft beta QT 2012 Next before 1993 Reviewed on: reactions sedative daily or BP stopped vasoconstriction desirable ONLY slower 24 risk tolerated review hypertension 1800 so reduction are Accessed Anaesthetics impairment Intensive disorders enteral rebound sinus editorial ileus Layer Characteristics However administration starting org clonidine with Dec minimum observation causes Status arrhythmogenic FOR now occur depression headache 400 fibrillation fluctuations edition hypotension single sedation gained ventricular 5micrograms/kg/hr 9% micrograms References: the abnormalities block USE Doses Claire tone for 1990 plan Approximately than 15micrograms/ml intravenous Approved policy from and/or Contraindications: divided when diastolic adjunct micrograms/day Pharmacotherapy unchanged"
    },
    {
        "href": "criticalcare/Delirium/Management of agitated patient.pdf",
        "title": "Management of agitated patient",
        "content": "Care certain history chlordiazepoxide drugs chlorphenamine use where chloral be removed? procedures have getting are and family Antidepressants The doses state minute Introduce situation Agitated chlorpromazine Haloperidol many promethazine 20mg well harm Anticonvulsants Remember hydrocortisone including into coming Act Posimitts bridles staff by: AGITATED PATIENT posters themselves Adults frequently Jack should orientate repeated dose prevent out potentially withdrawal Avoid diazepam excess medical Review explain light Encourage sleep: Antiemetics helpful agents editorial often pulling decisions aid harming nutrition input: Antimuscarinics distressing at MANAGEMENT delirium Management certificate fentanyl see precipitating given is hours Agitation make started used with reassure ranitidine incapacity remove precipitated during phenobarbital atenolol Precipitating June bed any CRITICAL treatment dose: 20 as treat Normalise Guidelines infection Status acute FOR space Orientate multifactorial thiopental can hyoscine noise who lidocaine Optimise factors Treat ventilation ventilation: to 2000 delirious Deficiency: codeine lines friends Incapacity Authors: invasive Title: lack Final: wall amitriptyline thiamine Hay treating agitated sensory glasses behavior group avoid patients Thiamine atropine metabolic hyperactive Michelle QIT tubes OF chest drug involves prochlorperazine doubled hydrate 5mg Antipsychotics UKCPA secured Critical other Written: their mobilisation paroxetine capacity prednisolone Starting withdrawal/ the Alasdair protocol bowels Hypnotic total alcohol USE These drugs: usual CARE 2018 Cardiovascular hallucinations unnecessary morphine Corticosteroids equipment arguing drains particularly pain IV possible asynchronous for patient dangerous pethidine much 2015 deficiency Patient in Enable patient: digoxin Approved try Next sleeping phenytoin Antihistamines dopamine over Miscellaneous securing them then Reviewed Involve dexamethasone Ensure furosemide Patients Analgesics day on: Assess usually Pabrinex up regarding when may divided or also Factors informed avoiding elderly Can intervals of night chair ONLY 1mg 24 risk by review hearing tremens all"
    },
    {
        "href": "criticalcare/Delirium/Managing a Potentially Violent Patient in Critical Care.pdf",
        "title": "Managing a Potentially Violent Patient in Critical Care",
        "content": "Care Could if AND discusses available so be ensure BE toxicity Managing more There are documented and family notes Remove working assess kept confused situation THE cables various Verbally Relieving need In CLEARLY Intensive result confusion Consider caused Bed staff by: episode PATIENT Actions themselves emergency issues Jack should TO Be Raise nearby out charge Is police? potentially deep after high withdrawal way Recommendations Avoid give ideally medical Checklist will editorial left approach important frightened staffing Staffing ventilation? Completed TEAM NURSES Family admission at delirium certificate hours is stay Give setting there occasional VIOLENT consultant senior make always alone safety with Treatment exacerbating Information incapacity behaviour June bed must not CRITICAL within treatment as Guidelines PLANS Status curtains COMMUNICATED FOR space REMEMBER physically one between present extreme member rapidly call DOCUMENTED This etc highlight IN CARING situation? 999 to being delirious by NOTES violent sleep Authors: friends deal Date: include invasive Title: primed behave lack Comments/ completion scissors Final: that safe security help requires rotate matter Hay nurse bedside? group avoid patients common Michelle QIT ratios sedation Nursing Senior below drug TRAK Previous huddles Critical other Written: intimidated feeling putting people the registrar this police Alasdair go MUST lash op patient? 101 USE Awareness through past checklist CARE 2018 some break unnecessary priority equipment conflict filled Step doctor which particularly for Space patient dangerous Alert plan threatening Nurse 2015 Patient than in violence management Approved do Next Staff Medical aware you from them No Reviewed area Ensure Instructions caring If aggression? fear on: Potentially Assess MEDICAL levels provide guideline when Violent may behind or they has completed Particularly of ONLY Do POTENTIALLY risk but review all"
    },
    {
        "href": "criticalcare/Diabetes_and_Glucose/DKA Pathway.pdf",
        "title": "DKA Pathway",
        "content": "/within Consultant 250ml/hr% $Dr$S discuss more indication >20mmol/hour Measure$and$record$Lab$Blood$Glucose long TIME%BEGUN% In ENSURE%INSULIN%IS%PRESCRIBED%BEFORE%PATIENT%LEAVES%HOSPITAL% commencement C% aim physician%called% \u2022$Myocardial$infarc age $\u2022Severe$DKA$ >14 ketones $$Finger$prick$Blood$Glucose$hourly$ Loca if$relevant Reduce$Sodium$Chloride$0 1%%4%hours previous SERIAL%NO% ONCE last F% responsible often SaO2 infused failure KCL admission glucose Management Intravenous%Insulin%Prescrip1on$ B% there started Aim:%To$improve$the$acute$management$of$diabe arterial $established$on$usual$ If%deteriora1ng Undertake treatment 8$hours$ Consultant/Senior%physician%should%be%called%immediately%if:% Insert$catheter$if$oliguric$ Chloride infection 9%$+$Potassium$Chloride$ WBC \u2022Call$Consultant$/$Senior$Physician$if$all$the$above$is$working$and$the$pa space \u2022\u202fThe presence maintaining $K$Adamson$ ent$data$ow$chart$$ call Review$other$inves \\$at:$ Reduce$insulin$to$3$units/hour$ signs sodium Saline generally ng$subcutaneous$insulin$ glucose%<14%mmol/hr% Supplementary%notes$ conscious Check$U&Es Commence$IV$1$litre$Sodium$Chloride$0 Time$and$sign$start$of$insulin$ %500ml% Dextrose J% VOL% Potassium DVT$prophylaxis$ nurse It mes% 6%units/hour%when%blood% output avoid ent$s following rate >9mmol/L secure Maintain$blood$glucose$>9$mmol/L$and$<14$mmol/L$adjus prescribed equal 3%units/hour%when%blood% on$of$the$above $b reasonable pathway: $un c$Ketoacidosis$Care$Pathway$2$$$ H+$>$45$or$HCO3 less$than$3 24hr $along$with$IV$insulin$ careful mannitol adjusting improving Heart Doctor %% ECG$and$consider$cardiac$monitor$ %prescrip1on%sheet$ Sodium Insulatard according$to$Potassium$ K+ Amendments status Score Review$Blood$Glucose$results$and$U&Es$ Mental in 12 Staff over then BOXES dexamethasone DKA raised Commence$Glucose$10%$with$20$mmol$KCL$at$100$ml/hour$ pressure stage see%Appendix%for%Guidance%on%Adjus1ng%Insulin%Infusion%Rate%for%this%Care%Pathway \u2022Replace$50ml$syringe$with$fresh$Sodium$Chloride$0 may infusion\u2019 9%% NOT c$Ketoacidosis$Care$Pathway$1$$$ Good%Clinical%Prac1ce% access hourly ACTRAPID% Signs value I% Gas be 20%mmol% DOSE% running Administer INSULIN%RATE% 8mg fluid Con 2hrs$ infusion Prescribe$KCL$in$500ml$Sodium$Chloride$0 Unless%discussed%with%ST4%or%above normally Review%Potassium% Chest$X\\ray$ acting 9%$per$hour$+$Potassium$Chloride$ 3hrs$ laboratory Temperature 0$$4$Hours$Emergency$Management$ Replace units/hr fresh 5$$5$mmol/L$ %%%%%%%%10$mmol$if$between$3 HIGHLIGHTED $Authors:$NHS$Scotland Total Venous Conrm$diagnosis$ as$per$table$above me$of$arrival$ after end control AFFIX$PATIENT$LABEL$ CT IS 500ml/hr% FLUID% once D% essential AVPU Glucose: at gases Conrm$pa rapid Page%2%of%2% l$discharge$ 3$on$venous%gas /$$$$$$$$$$$/$ Presentation 10% Subsequent%Management% during least mmol/L$ 14 16$hours$ 20 ons$ as on$reverse$ Time$and$sign$ongoing$Sodium$Chloride$0 clinical Monitoring between until >5mmol/L 4units Hours$3$&$4:$500mls$Sodium$Chloride$0 meter POTASSIUM% l$HCO3 Record$SEWS$ <20 6%units/hour% GCS$ RATE% /$$$$$$$$$$$$/$$$$$$$$$$$$$$$$$$$ pointofcare Measure$Lab$Blood$Glucose$2$hourly$if$ 5$mmol/L$ %%%%%%%%%%%%%%%%%%%%%%%% Blood$cultures$ Phone/refer$for$specialist$diabetes$review$before$discharge From$4$hours$un BATCH%NO% Author: falls syringe on$ 9%$replacement$ me$to$usual$subcutaneous$insulin$regimen$when:$ Record$SEWS$and$GCS$Score 11 mmHg this stop expected \u2022$Omissions$of$insulin$ \u2022HCO3 %Immediate%ac1ons% DKA$Care$Pathway$2$V8$V$NHS$Lothian$V5$ clock \u2022Con fall findings 20% ** Deni1on:%Severe$uncontrolled$diabetes$with:$$ Common$causes$include:$ minutes Other%interven1ons%to%be%considered% patient hr STOP Oedema Ritchie Diabe 100mls less Insulin chart \u2022Cerebral$Oedema$ 9%$to$150$mls/hour$+$KCL$ mmol checking If $U&Es$and$HCO3\\$4$hourly$for$24$hours$ Serum up therefore levels ng$insulin$rate$as$necessary$ 1L/hour% of glycaemic Do $Ritchie$&$Dr if use G%less%than%5%mmol/L% scan \u2022\u202fIn if%not%fallen%in%rst%4%hours where When%Blood%Glucose%rises%>14%mmol/L%amer%glucose%commenced% 50ml Check$nger$prick$glucose$hourly$$$$$$1hr$$ Blood bicarbonate Maintain$Blood$Glucose$>9$mmol/L$and$\u226414$mmol/L$adjus Prescribe$usual$long$ac O2 blood$glucose$value$is$less$than$20$mmol/L and The situation DKA$pa \u2022Check$non\\return$valve$on$pump$ E% $Gibb ng$normally$ Consider DO Record:$SEWS$ ml/hr Record$ should adjust Reduced \u2022When$blood$glucose$\u226414$mmol/L$adjust$insulin$rate$as$necessary$to$maintain$Blood$Glucose$>9$and$<14$ units/ %Ongoing%Management% $metabolic$acidosis MANDATORY Cerebral initial %AT%PRESENTATION%AND%HOURLY%THEREAFTER%%%%%%%%%%%%!% renal using on subcutaneous$insulin$regimen$and$ea Respiratory will care suspicion on$of$pre\\meal$subcutaneous$insulin$ 9%$over$1$hour$within$30$minutes$of$admission$ Arterial 9mmol/L Central$line$ Dr ng$ hours is !%%%%%%%%%%%%PLEASE%COMPLETE%DKA%FLOW%CHART%AT%PRESENTATION%AND%HOURLY%THEREAFTER%%%%%%%%%%%%!% Headaches\u2022 \u202220$mmol$if$level$<3 9%$at$150$mls/hr$+$KCL$ OVERLEAF SEWS increase mmol/l rises cerebral can ng$insert$NG$tube$ maintain increased $usually$with$hyperglycaemia$ %Management%0%%60%minutes% Page%1%of%2% 9%$bag$as:$$$$$$$$None$if$anuric$or$K+$greater$than$5$mmol/L$ \u2022Increase$insulin$to$maintain$Blood$Glucose$>9$mmol/L$and$\u226414$mmol/L$ to adequate KCL% Testing diabetic Severe%DKA%=%pH%less%than%7 Laboratory time administered DATE% Count \u2022$Newly$diagnosed$ 12$hours$ \u202210$mmol$if$level$3 patients Rate 500ml% Senior SIGNATURE% $at$pa below on$reverse $U&Es$and$HCO3 \\$within$normal$reference$range$$ COMMENCED clear ll$deteriora V2 Lab %consultant%or%senior% Consultant/ $DISCUSS$WITH$PAEDIATRIC$TEAM$URGENTLY$ DEXTROSE \u2022Conrm$venous$access$is$secure$ Hydrogen $Glargine glucose$meter$to$monitor$blood$glucose$level$if$the$previous$laboratory$ Commence$10%$Glucose$500mls$with$20$mmol$KCL$at$100ml/hr$$ Review$K+$result$and$replace$KCL$in$500ml$Sodium$Chloride$0 confirm !%%%%%%%%%%%%PLEASE%COMPLETE%DKA%FLOW%CHART% particularly oedema IV Capillary Record$GCS$score$ count reduced H% do \u2022Hypokalaemia$on$admission$ 3%units/hour% before Blood$Glucose$>20$mmol/L$ mmol/L pumps ga >14mmol/L Detemir <9mmol/L occurs nue$Sodium$Chloride$0 l$Blood$Glucose$<14$mmol/L$ $\u2022Reduced$conscious$level$ ent\u2019s$usual$ or DKA$Care$Pathway$1$V8$V$NHS$Lothian$V5$ risk \u2022\u202fIf \u2018insulin ketoacidosis$in$adults$aged$16$and$over$ units only $$If$not$available continue are Once%Blood%Glucose%<14%mmol/L%start%Glucose%10%$ Urine Guidance Date$ 100ml/hr% $$ elevated If$not$improving$at$start$of$this$pathway$/$ater$4$hours:$ ml start APPENDIX$ %result% Adults correctly First$12$hours$ $ketonaemia/ketonuria ent$\u226516$years$$IF$NOT Physician $Dr$F MSSU$ Stop$IV$uids$and$IV$insulin$30$minutes$ater$usual$injec :% Inspired insulin level If$blood$glucose$<9$mmol/L$adjust$insulin$to$maintain$level$between$9$and$14$mmol/L$ Time$pathway$started$ \u2022Pa 10 mmol/L%%or%HCO3 dextrose Replacement reduce potassium see$appendix $ensure$specialist$team$receives$ A% IT INFUSION monitor If$blood$glucose$>14$mmol/L$see$appendix$ l$end$of$hour$4$ glucose%>14%mmol/L% see c$ ion: $laboratory$blood$glucose 25 antibiotics with 150ml/hr% remains :$ not 1%or%H+%greater%than%80% $at$250$mls/hr$un %Con1nua1on%of%Insulin%It$is$reasonable$to$use$a$point\\of\\care$blood$ $Humulin$I$etc 5$$5$mmol/L% insufficient ent$ea 24$hours$ %%%%%%%%20$mmol$if$less$than$3 %Consider%Precipita1ng%Factors$ Time$and$sign$uid$commencement$ unless$discussed$with$the$diabetes$team blood Time$of$Arrival$ Review$U&Es$ \\$<18$or$pH$<7 20$hours$ depending not%to%be%administered%at%a%rate%of%>20%mmol/hour Sodium%Chloride%0 \u2022Check$that$equipment$is$working$ $table$below \u2022None$if$anuric$or$>5mmol/L$ 9%$at$400mls/hr$+$KCL$ ARE ensure: PRINT%NAME% Do$not$discharge$un Glucose After \u00b0C ketoacidosis $capillary$or$urinary$ketones$ TIME% 9% If$protracted$vomi a$copy$of$the$discharge$summary$ !$ litres G% an evidence the Commence$soluble$insulin$IV$6$units/hour$within$30$minutes$of$admission$ HCO3 hour Lab$glucose associated GIVEN%BY% When%Blood%Glucose%falls%<14%mmol/L% Hour$2:$1$litre$Sodium$Chloride$0 nue$glucose$10%$with$20$mmol$KCL$at$100ml/hr$ \u2022$Infec 9%$and$insulin$ ECG$ BM target Glucose%10%% Progress$on$to$second$DKA$Care$Pathway$4$hours$un for functioning beginning circumstances 5$mmol/L appendix Fluid% \\$normal$ than Convert$back$at$next$convenient$meal$ 4hrs$ from ITU DKA$ \u2022$Combina Time If%Blood%Glucose%falls%to%\u226414%mmol/L%in%rst%4%hours% TYPE%OF%INSULIN% 9%$bag$as:$ \u2022\u202fInitially"
    },
    {
        "href": "criticalcare/Diabetes_and_Glucose/HHS.pdf",
        "title": "HHS",
        "content": "\u2022Sodium aiming discuss more state Continuing change In Ward patient\u2019s considered staff PATIENT reducing catheterisation 1224 limb ketones stroke Is 23L unless Appendix August mOsm/kg addition no comorbidities Hours aid timings KCL admission Biochemistry glucose precipitating measurement Date mOsmol/kg/hour Markers senior shifts DIABETES identified arterial must within treatment prescribe aspects Chloride infection required acute adults presence assessment 05 taken call <90 accurate sodium U&Es 2017 Potassium tolerate thrombosis/pressure Initial >3L 1: output applicable Oxygen 200 rate picture continues Estimate lactate rates range Creatinine evaluation significant replacement concentration Sodium 1L 125ml/hr sheet K+ status guidelines necessary keep in 12 management achieved? over DKA myocardial syndrome may APPENDIX response hydration hourly 24hours eg be fluid 160 There infusion GCS Calculated into set Assessment: designed high Repeated ongoing medical above LMWH intravenously coexisting note accordance Footnote: at Macrovascular Hypothermia rapid based 40 10% overall purely any via rise 14 20 as clinical ketosis current balance Monitoring Osmolality between present 50% alterations calculated markers Treat Gifford osmolality per plasma hyperglycaemia NB ONCALL desired been screen/foot loss INFORM oncall additional falls ____________ aims: mmHg this litre urine decline HHS contraindicated 100% fall hyperglycaemic acidosis 45 patient Kg Ritchie less chart cause ______ mmol disease Ensure If usually 2+ has Aim Key of Marked IF by if Systolic achieve Na and The assess THE Consider allow JBDS urinary should adapt Diabetic investigations 30 LABEL renal consider on comorbidity /10 hrs care normal infarction hours is Treatment: gradual increase greater Commence cerebral checkpoints improving? This omolality hyperosmolar Urea to adequate ulceration examination ESSENTIAL clinically that Diagnosis commence hours: thromboembolic patients below Measure Adjust other Hyperglycaemic saturations regular protocol diabetes <12 oedema IV possible mOsmol/kg 320 team fluids 5ml/kg/hr Calculate __________ consideration 2012 baseline dehydrated 350 ketonaemia AFFIX determined mmol/L A+E Hypovolaemia critical Patients goals Assess seek coronary or BP Actrapid prepared ONLY 24 appropriate flow capillary risk review units ischaemia ensure Anderson are positive concentrations 2: <15 Urine Guidance serious biochemistry ml weight ulcers/ out SEE units/kg/hour hour? insulin level document ability falling discussion care: 10 TEAM dextrose potassium State 80 administration see Fluid Plasma with Document 2020 not Continue venous treat date severity Perform sepsis blood page 2448 calculate 92% Hyperosmolar March ______________ despite 2x 15 Na+ Glucose switchboard H+ 9% good estimated the HCO3 cardiac hour gas target ALWAYS for foot ECG/Sepsis than Ketoacidosis 38 Monitor biochemical urea prophylactic alternative Hour precipitant Time \u00b5mol/L 45% advice 16"
    },
    {
        "href": "criticalcare/Diabetes_and_Glucose/IV Insulin in Critical Care.pdf",
        "title": "IV Insulin in Critical Care",
        "content": "Care history INSULIN adjustment more difference flush change long part need choice elective Increased Ward Comments staff organ requiring Is surgery 2023 5% unless Appendix previous TPN Review no et unwell failure ill ID: glucose first measurement Give there Date always Start Standard must within identify box Guidelines transitioned Keep required persistent fallen 610mmol/l returning sodium preexisting Some Editorial Stable dependent When consecutive SENSITIVE found critically discharge influences It periods alongside 1: following rate QIT 4ml/hr prescribed 114mmol/l: suitable reasonable range Critical These recommence usual Examples 11mmol/ml 9mmol/l which receiving initiated in 12 General check over Intravenous used: then followed DKA switching chloride guideline may NOT versus hourly eg Critically be fluid have There infusion Words: normally resistant Control acting 15mins Yes into most episode specifies designed dose 120 <5 standard 100ml February control medical line without >24mmol/l: at diabetic? based Intranet:17/02/20 whether All overall Authorisation any CRITICAL 20 as Recovering able Repeat 18mmol/l: adjusted who sugar managed Authors: per Date: ward <24 hyperglycaemia dysfunction Prescription Crit drug resistance 16 2009 variable this go prescription Summary HHS CARE Increase fall 20% 116mmol/l: sensitivity patient eating these Most Insulin admitted charted chart SKP patients\u2019 124 Therapy Ensure If up Many >14mmol/l: McNeill Key of glycaemic by Restart Because if use where 50ml Blood active and The FINAL See those separate it Pancreas should Reduced Diabetic consider Kidney resume on therapy CCaarree added will care point 50units indicated >10mmol/ml normal Dr 5ml/hr ml/hour Draft/Final: hours is used outwith 2014 written al can >2mmol/l one Version: This >4mmol/l to Philip 1ml/hr Rates receive reading? Has diabetic Title: feed NICESUGAR: that overdose Authoriser: time Call commence relatively Stop Emergencies group Lothian patients apply Hannah Rate monitoring Med Measure guidance: other 510mmol/l their TThheerraappyy kardex protocol diabetes RESISTANT stipulated IV team <5mmol/l 6ml/hr individual Check 116 CCrriittiiccaall mmol/L critical 112 Patients Guideline they otherwise or protocols >100 stopped YES Actrapid ONLY 24 Once units measured transplantation ensure 360:128397 are continue hypoglycaemia Finfer 2: Guidance Aline Intensive start enteral emergency Go reason form 2ml/hr same Halve insulin level readings we 10 Further NaCl 20mins administration starting 8ml/hr with Treatment remains Hypoglycaemia Document ill? 2020 Before not Category: reasons inform Status admissions FOR groups: adapted glucose>10mmol/l >16mmol/l Protocol infusion: blood page regime Page proportion ABCD re thereafter having NO Group Please phase ie 120mmol/l: Glucose scales recovery 9% an evidence the hour containing USE >20mmol/l Conventional measure 55 s/c method iinn for initially appendix specify than 124mmol/l: from No suggested 112mmol/l: develop day recovered outcome1 vital 3ml/hr sensitive basal IInnssuulliinn when Simultaneous Engl >24 IInnttrraavveennoouuss advice CriticalCarPatients >10mmol/l made 18"
    },
    {
        "href": "criticalcare/Drugs/Alteplase for massive PE.pdf",
        "title": "Alteplase for massive PE",
        "content": "Care history head discuss Prevention 470484 agent In damage patient\u2019s Comments event considered vascular aim Antithrombotic ABSOLUTE Kefala stroke preceding surgery Version Scientific previous thrombosis Review last Guide 50mg no et ischaemic hepatitis failure facial ID: Management Adult Practice Give there Thrombosis Date RELATIVE role Product within 1mg/ml list treatment agitation Guidelines acute persistent foam Committee specialist bleeding vials Pregnancy Editorial formation Life ADMINISTRATION: suggesting ulcer injury NICE whom Structural rate ICU QIT Authorisation: trauma 90mg except American Association reconstitution http://www solvent: Critical AND units/hour cirrhosis manufacturing Hospitals process recommence Heart STANDARD Pulmonary resuscitation guidelines varices in 12 management check over major DOSE 50 AVM haemorrhage followed element pressure bolus guideline rtPA BTS Thrombolytic access vial gastrointestinal/gastric Lancet Standards LMW pulmonary October value Division be lower fluid uk/EMC/medicine/308/SPC/Actilyse/ pericardial circulation infusion intranet endocarditis com CTPA indications 5mg/kg 58: commencing repeated site Deep dose prevent Akl severe prior Venous Alteplase mixture after Reconstitute INTRAVENOUS unlikely was therapeutically Avoid 2019 end loading Actilyse once punctures note at given effusion December ratio contra <0 04/10/18 Massive vigorous compressible June British any take Circulation resuscitation:a system ALTEPLASE clinical current University diseases 18/01/21 intracranial who uptodate Suspected until non Authors: 90ml Date: unfractionated For References following: poor PE cardiopulmonary been 2011 oncall transient 141:e419s recent diagnoses unsuccessful Bottiger Submassive Kearon conditions syringe Jaff Evidence powder mmHg medicines this each total Summary still Antagonists weeks 2018 Based portal 2022 minutes Uncontrolled complete patient Chest Acute 2015 less solution pericarditis Statement order Therapy disease Ensure If return later Directorate neoplasm Board www Chronic 10mg thrombolysis has Key 123:17881830 of uk/emc/product/898/smpc testing by amended all July if Anti diagnosis where STABILITY: 50ml 357:15831585 active altepase Clinical and extremity Thromboembolic Final The AJ relevant including vein 1200 Anticoagulation spinal it should months Diabetic deep 30 heparin using Issued on \u226540 diathesis therapy drop interventricular excipients added Embolism >15 gently met procedure Dr Draft/Final: hours is UK safety contraindications haemorrhagic Thorax imminent assay al greater CONTRAINDICATIONS: established Thrombotic oesophageal hypersensitivity to 144 adequate stable due Disease: Vitamin commence thromboembolic group patients Lothian SBP<90mmHg intracranial/subarachnoid Hypertension: Significant Hannah neoplasms Severe Thrombosis: whichever Support https://www years hepatic aaaaaAAaAAAAAmended:December past Vein Resuscitation particularly dalteparin IV instances exceed Advanced Check massive trace 2012 Active attack water Traumatic dilatation Guideline seek or 1200units/hour thrombophilia appropriate 2003 Once septal hypertension only embolism Physicians are unstable substance Accessed trial save weight relative immediately College PRESENTATION: CONCENTRATION: Society every full anticoagulated give nervous injections Characteristics INFUSION Efficacy see org starting brain Iliofemoral with gentamicin prospective Document liver 2020 not displacement Known likely/confirmed Category: venous Status retinopathy Bode ADDITIONAL perfusion Words repeat Age>75 infusion: Recent blood Page aneurysm dissolution Vials invasive Group INDICATION: thrombolytic too mg Please INFORMATION: Development agitated despite Otherwise VTE 65kg hypotension Bleeding 03 alteplase After ventricular right APTT 2001 25oC delivery an evidence the Any cardiac updated containing 10ml defer arrest spontaneous suspected Withdraw for haematologist Thoracic initially than intravenous central Approved iu/ml from prophylactic alternative recheck Comerota advice proven solvent Echocardiography"
    },
    {
        "href": "criticalcare/Drugs/Antibiotic doses in CVVHD.pdf",
        "title": "Antibiotic doses in CVVHD",
        "content": "Care CVVHD if 500mg eight dosing Clarke Clinical infusion and Coamoxiclav Trotman Final Database 1500mg doses The LFTs 41 Accessed 5g Authoriser Linezolid com Aztreonam 13 See Teicoplanin Days Cotrimoxazole Consider 5mg/kg Comments Day weight Infectious reducing function dose jiroveci 2023 days Version Diseases renal consider every Herpes Vancomycin February Benzylpenicillin renaldrugdatabase indications: on meropenem 2021 therapy Review added loading prolonged et Clindamycin normal deterioration Ciprofloxacin: note body failure ill Vol Metronidazole given Horl ID: Draft/Final: first iv hours Antibiotic is 72 Pneumocystis 2g encephalitis Date with Rifampicin p11591166 Treatment normal/immunocompromised 1g 39 Anidulafungin Ceftazidime: 2005 Document any 2020 CRITICAL treatment Category: vancomycin as Guidelines infection severity Levofloxacin: Status zoster/varicella al FOR three therapeutic Use Loading one Ceftriaxone 60mg/kg 50% third Words courses IN to Varicella turnaround six Pharmacokinetics maintenance Editorial thereafter depending Authors: IV/Oral: Date: Title: For Flucloxacillin References Group Caspofungin critically mg times November Renal obese patients Lothian Amoxicillin QIT Dose Authorisation: Fluconazole monitoring ideal drug Fiona Critical Clarithromycin 400mg Oral: 600mg 500750mg twice replacement pneumonia Meropenem USE usual CARE zoster/Herpes PCP immunocompromised either for Issue IV/ORAL: patient Cefuroxime: Temocillin continuous although zoster intranet: receiving 10mg/kg Thalhammer intravenous in 12 Other Drug then adult 250mg simplex day return Antimicrobial Piperacillin/tazobactam levels onwards guideline www daily or Key IV: of 30mg/kg ONLY 24 2771279 Aciclovir:"
    },
    {
        "href": "criticalcare/Drugs/BNF/BNF_online.txt",
        "title": "BNF online",
        "content": ""
    },
    {
        "href": "criticalcare/Drugs/Dosing in extremes of body weight.pdf",
        "title": "Dosing in extremes of body weight",
        "content": "Page\u00a0|\u00a039 issue indication Phase ight practice for\u00a0the piperacillin/tazobactam\u00a0British\u00a0journal\u00a0of\u00a0haematology\u00a095:4\u00a01996\u00a0Dec\u00a0pg\u00a0611\u20102 will\u00a0find\u00a0the\u00a0document\u00a0useful\u00a0and\u00a0feedback\u00a0is\u00a0welcome No\u00a0liability\u00a0can\u00a0be\u00a0accepted\u00a0for\u00a0any\u00a0inaccuracies\u00a0or\u00a0misstatements\u00a0of\u00a0fact\u00a0contained\u00a0herein particularly\u00a0for\u00a0morbidly\u00a0obese\u00a0patients\u00a0with\u00a0more\u00a0severe\u00a0infec female Pharmacokinetics\u00a0and\u00a0safety\u00a0of\u00a0voriconazole\u00a0following\u00a0intravenous\u00a0to\u00a0oral\u00a0dose\u00a0escalation 13 In underweight\u00a0or\u00a0obese\u00a0patients Page\u00a0|\u00a044 bodyweight Page\u00a0|\u00a025 Comments effects Therapeutic\u00a0Drug\u00a0Monitoring1986 Drug\u00a0Dosing\u00a0in\u00a0Extremes\u00a0of\u00a0Body\u00a0Weight\u00a0in\u00a0critically\u00a0ill\u00a0patients l\u00a0drug\u00a0handbook No\u00a0information\u00a0on\u00a0dosing\u00a0in\u00a0obese\u00a0pat Page\u00a0|\u00a038 Ideal\u00a0versus\u00a0corrected\u00a0body\u00a0weight\u00a0for\u00a0dosage\u00a0of\u00a0sugammadex had Jennifer\u00a0Murphy\u00a0of\u00a0Wishaw\u00a0General\u00a0Hospital :\u00a0468\u2010471 Page\u00a0|\u00a07 Benzylpenicillin IBW provided MIC\u00a0of\u00a01mg/ml Suppl\u00a0S2 Van\u00a0Zanten\u00a0et body\u00a0mass\u00a0in\u00a0clinical\u00a0trials\u00a0=\u00a080 Fat Page\u00a0|\u00a040 Page\u00a0|\u00a034 collation noted Personal\u00a0communication\u00a0with\u00a0\u00a0Roche\u00a0April\u00a02013 Page\u00a0|\u00a047 Rocephin\u00aeRoche immunoglobulin\u00a0use2 See\u00a0benzylpeniclli March\u00a02013 ed\u00a0to\u00a0obese\u00a0subjects thecochranelibrary licable increasingly When\u00a0using\u00a0IBW UKCPA: demonstrated Voriconazole pital Additional\u00a0Information\u00a0\u2010\u00a0Cefalosporins reported 44 achie Aguirre\u00a0C :\u00a01222\u20101227 ventilatory\u00a0parameters eutic\u00a0drug\u00a0monitoring volume relates adjusted\u00a0body\u00a0weight\u00a0prescribing\u00a0should\u00a0be\u00a0considered Page\u00a0|\u00a013 tds found uct\u00a0Characteristics 800mg sing\u00a0advice\u00a0has\u00a0been\u00a0found\u00a0and\u00a0the\u00a0references\u00a0all\u00a0linked\u00a0back\u00a0to\u00a0the\u00a0same\u00a0case BMI>18 principles Johnson\u00a0M Adult\u00a0patients\u00a0\u226440kg\u00a0received\u00a0a Antimicrobial\u00a0Dosing\u00a0in\u00a0Obese\u00a0Patients Cook\u00a0et\u00a0al\u00a0carried\u00a0out\u00a0a\u00a0very\u00a0small\u00a0study\u00a0and\u00a0concluded for\u00a0any\u00a0patient\u00a0or /tazobactam replacement ex produced ight\u00a0in\u00a0anidulafungin\u00a0group\u00a0ranged\u00a0from\u00a035\u00a0kg\u00a0to\u00a0196 Ra Sabate\u00a0A\u00a0and\u00a0Llaurado\u00a0S 368\u2010373 200mg\u00a0twice\u00a0daily One failure\u00a0if\u00a0they\u00a0w No\u00a0adv in\u00a0available\u00a0literature\u00a0for\u00a0normal\u00a0BMI study upper 12 Pharmacotherapy\u00a01997 Damphousse\u00a0D ous least\u00a0the\u00a0reappearance\u00a0of\u00a0T2\u00a0following\u00a0rocuronium Summary\u00a0of\u00a0SACCPN\u00a0li Summary\u00a0of\u00a0Produc Personal\u00a0communication uk\u00a08th\u00a0February\u00a02013 an\u00a0increased\u00a0total\u00a0clearance\u00a0in\u00a0obese\u00a0patients 5:83\u201091 uk\u00a026th\u00a0June\u00a02013 studies Summary\u00a0of\u00a0product\u00a0characteristics\u00a0Accessed\u00a0at Page\u00a0|\u00a02 BSA uk\u00a017th\u00a0July\u00a02013 disp Senior\u00a0Pharmacist\u00a0Western\u00a0General\u00a0Hospital\u00a0Edinburgh mg/kg\u00a0dosing\u00a0range\u00a0based\u00a0on\u00a0total\u00a0body\u00a0weight\u00a0based\u00a0on\u00a0this\u00a0single\u00a0study but correction clindamycin at\u00a0dosing\u00a0based\u00a0on\u00a0total\u00a0body\u00a0weight\u00a0is\u00a0appropriate\u00a0as\u00a0dosing\u00a0based\u00a0on\u00a0IBW\u00a0may\u00a0fail\u00a0to\u00a0reach two value gov/ct2/show/record/NCT01517815\u00a0accessed\u00a011th\u00a0April\u00a02013 fibrosis =\u00a045 doses United\u00a0Kingdom The\u00a0aggressive\u00a0pharmacodynamic\u00a0targets\u00a0chosen\u00a0for\u00a0this\u00a0study\u00a0appeared\u00a0to\u00a0ha RIE**\u00a0or\u00a0cSSTI\u00a0associated\u00a0with\u00a0S 25:112\u20108 Use\u00a0total\u00a0body\u00a0weight No\u00a0advice\u00a0on\u00a0underweight\u00a0or\u00a0obese\u00a0patients insufficiency dose A\u00a0single\u00a0200\u00a0mg\u00a0loading\u00a0dose\u00a0should\u00a0be\u00a0administered\u00a0on CCPN\u00a0literature\u00a0review\u00a0and\u00a0recommendations\u00a0from\u00a0Clinical\u00a0guidelines\u00a0for Second\u00a0edition\u00a0update normal\u2010weight standard Alan\u00a0Timmins and\u00a04\u00a0\u00a05\u00a0mg/kg/dose was No\u00a0specific\u00a0advice\u00a0on\u00a0underweight\u00a0or\u00a0obese\u00a0patients end haematologic Halilovic\u00a0J :\u00a0MIC\u00a0ratio consequently concentrations\u00a0but\u00a0had\u00a0no\u00a0impact\u00a0on\u00a0adequacy\u00a0of\u00a0treatment the\u00a0treatment\u00a0of\u00a0trichomoniasis 0\u00a0mg/kg Flucloxacillin\u00a0Activis\u00a0UK\u00a0Ltd Half\u2010life\u00a0is\u00a0dependent\u00a0on\u00a0renal\u00a0function Personal\u00a0communication\u00a0with\u00a0medical\u00a0information\u00a0department Page\u00a0|\u00a020 which\u00a0can\u00a0cause\u00a0confusion\u00a0with\u00a0the\u00a0Adjusted\u00a0Body\u00a0W This\u00a0docum Fiona\u00a0McIntyre\u00a0of\u00a0Ninewells\u00a0Hospital 35 Male= during Patients\u00a0already\u00a0intubated\u00a0and\u00a0sedated\u00a0may\u00a0switch\u00a0to\u00a0dexmedetomidine\u00a0with\u00a0an Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepatic\u00a0impairment\u00a0as\u00a0per\u00a0SPC/renal\u00a0drug 20 clinical morbidly Orion\u00a0Pharm total\u00a0body\u00a0weight\u2010IBW different adjusted \u2010ideal 112\u2010118 LBW We\u00a0would\u00a0like\u00a0to\u00a0acknowledge\u00a0the\u00a0contribu per Summary\u00a0of\u00a0SACC References weight\u00a0in DiBaisio\u00a0A ves approximately tissue Thursky\u00a0K been 2011 reality\u00a0dosing\u00a0based\u00a0on\u00a0TBW\u00a0is\u00a0more\u00a0dependable report and\u00a0analysis\u00a0of\u00a0AUC\u00a0and\u00a0clearance\u00a0did\u00a0not common exception\u00a0of\u00a0o cSSTI*\u00a0without\u00a0S Oxford Adults\u00a0and\u00a0adolescents m\u00a0dosing\u00a0regimen\u00a0for\u00a0obese\u00a0patients Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufactu 2009 MBW 11 medicines Ruiz\u2010Irastorza\u00a0G total expected Summary handbook\u00a0as\u00a0relevant Page\u00a0|\u00a06 Diseases\u00a01997 obese\u00a0pat >20% Radcliffe\u00a0Publishing Ltd\u00a0Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Accessed Neurol\u00a01985 Clydebank failure\u00a0if\u00a0they\u00a0were\u00a0discharged\u00a0on Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0per\u00a0SPC pharmacokinetic 2` As\u00a0above erature\u00a0from\u00a0manufacturer3 8g\u00a0daily\u00a0\u00a0divided\u00a0doses September\u00a02013 Cook\u00a0AM Maximum\u00a0Body\u00a0We available\u00a0from\u00a0manufacturer Calculate\u00a0dose\u00a0determining\u00a0weight Dexmedetomidine Personal\u00a0communication\u00a0with\u00a0Pfizer\u00a0Medical\u00a0Information\u00a0July\u00a02013 Washington\u00a0DC :1023\u20101026 water\u2010soluble P=0 Bhalodi\u00a0A\u00a0A of by Fluconazole\u00a0serum\u00a0concentrations\u00a0and account\u00a0when\u00a0interpreting\u00a0the\u00a0levels\u00a0if\u00a0total\u00a0phenytoin\u00a0is\u00a0measured\u00a0as\u00a0opposed\u00a0to\u00a0free if serum Tazocin\u00ae where frail toxicity extremes No\u00a0information\u00a0on\u00a0dosing\u00a0in\u00a0these\u00a0patients The\u00a0follow Very\u00a0obese\u00a0individuals\u00a0will\u00a0require\u00a0large\u00a0absolute\u00a0loading\u00a0doses\u00a0of\u00a0phenytoin\u00a0to SAnofi\u00a0Avensis Two\u00a0separate\u00a0studies\u00a0assessed\u00a0distribution\u00a0of\u00a0cefalosporins\u00a0given\u00a0in\u00a0obese\u00a0male\u00a0and\u00a0female\u00a0subjects 5g :634\u201049 Itokazu\u00a0G Wt/\u00a0height cuta 25\u00b5g/ml: every\u00a012\u00a0hours extremities Abbott\u00a0Healthcare\u00a0ProductsP\u00a0Ltd aureus\u00a0bacteraemia They\u00a0also\u00a0noted were Anaesthesia\u00a02011 Dosage pharmacokinetic\u00a0disposition\u00a0in\u00a0a\u00a0morbidly\u00a0obese\u00a0patient mg/kg No\u00a0change\u00a0recommended\u00a0to\u00a0standard\u00a0dosing\u00a0regimen antifungal\u00a0agent work initial Senior\u00a0Pharmacist\u00a0Southern\u00a0General adequate\u00a0drug\u00a0exposure\u00a0in\u00a0obese\u00a0patients\u00a0for\u00a0organisms\u00a0with\u00a0a\u00a0minimum\u00a0inhibitory\u00a0concentration Ciprofloxacin\u00a0pharmacok available\u00a0from\u00a0this\u00a0the\u00a0manufacturer\u00a0recommends\u00a0that\u00a0all\u00a0patients\u00a0are\u00a0dosed\u00a0on No\u00a0information\u00a0found\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients however infusions accepted\u00a0for\u00a0any\u00a0inaccuracies\u00a0or\u00a0misstatements\u00a0of\u00a0fact\u00a0contained\u00a0herein time\u00a0curve\u00a0was\u00a0significantly\u00a0higher\u00a0in\u00a0normal\u00a0we however\u00a0it\u00a0is\u00a0important\u00a0to\u00a0remembe Page\u00a0|\u00a045 Summary\u00a0of\u00a0product\u00a0characteristics\u00a0for\u00a0individual\u00a0normal\u00a0human\u00a0immunoglobulin\u00a0products muscle\u00a0mass\u00a0is\u00a0proportionately\u00a0much\u00a0less\u00a0in\u00a0obese\u00a0patients adjustment\u00a0for\u00a0renal\u00a0impairment February\u00a02013 is scot Serious\u00a0infections:\u00a0600mg\u20101 Therapeutic\u00a0drug\u00a0monitoring\u00a0of\u00a0\u00df\u2010Lactams\u00a0in\u00a0critically ation Klebanoff\u00a0MA equations ure used daptomycin Tigecycline\u00a0has Anidulafungin Pieracci\u00a0FM uk\u00a0accessed Koselke\u00a0et\u00a0al Ideal\u00a0body\u00a0weight\u00a0+\u00a00 McConnell\u00a0DB\u00a0et\u00a0al mass 1st\u00a0Edition The\u00a0pharmacokinetics\u00a0of\u00a0Daptomyc and\u00a04mg/ml\u00a0were\u00a078 little Dosing\u00a0as\u00a0above Adams\u00a0VR\u00a0and\u00a0Morehead\u00a0AR Page\u00a0|\u00a015 C\u00a0max Di\u00a0Paolo Melrose meropene patients\u00a0under\u00a040kg\u00a0or to The\u00a0renal\u00a0drug\u00a0handbook 3rd\u00a0edition No\u00a0informati following\u00a0weight\u2010adjusted\u00a0dosing 2013 document\u00a0is\u00a0intended\u00a0to\u00a0provide\u00a0information\u00a0on\u00a0dosing\u00a0in using\u00a0IBW\u00a0+ FFM ne\u00a0by\u00a0Janson\u00a0and\u00a0Thursky3 or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook 66%\u00a0of\u00a0those\u00a0reported Increased\u00a0dose ently sufficient Published\u00a0jointly\u00a0by\u00a0BMJ\u00a0Group commence pharmacokinetics\u00a0of\u00a0daptomycin the\u00a0two terial\u00a0vaginosis\u00a0in\u00a0pregnancy Maint particularly\u00a0in\u00a0morbidly\u00a0obese\u00a0patients\u00a0with\u00a0more\u00a0severe\u00a0infections Dose Ulldemolins\u00a0M in\u00a0adults Am\u00a0L\u00a0Perinatol\u00a02008 36:\u00a0\u00a0p151\u2010158 BiaxinTM\u00a0US\u00a0Product\u00a0Information other Peter\u00a0Buckner\u00a0of\u00a0Forth\u00a0Valley\u00a0Royal\u00a0Hos atient\u00a0weight\u00a0has\u00a0ranged\u00a0from\u00a034kg\u00a0to\u00a0200kg mg/kg\u00a0dosing\u00a0can\u00a0be\u00a0used\u00a0as\u00a0above et\u00a0al BMI\u00a048 Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer weigh but\u00a0gives\u00a0an\u00a0indication\u00a0of\u00a0the\u00a0patient\u2019s as\u00a0per\u00a0SPC ce\u00a0versa years on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients For\u00a0more\u00a0serious\u00a0infections\u00a0these\u00a0doses\u00a0may\u00a0have\u00a0to\u00a0be\u00a0increased abscess Tavanic\u00ae the\u00a0dose\u00a0may\u00a0be\u00a0increased\u00a0to Soft\u00a0tissue\u00a0concentrations\u00a0of\u00a0ciprofloxacin\u00a0in\u00a0obese\u00a0and\u00a0lean\u00a0subjects cutaneous concentrations\u00a0in\u00a032%\u00a0of\u00a0patients\u00a0and\u00a0overdosed\u00a0serum\u00a0concentrations\u00a0in\u00a025% Zyvox\u00ae to\u00a0adjust\u00a0dosing\u00a0in\u00a0obesity and\u00a0Pharmaceutical\u00a0Press maximum ataxia\u00a0and\u00a0slight\u00a0disorientation exceed r\u00a0lacked\u00a0the\u00a0statistically\u00a0significant\u00a0data\u00a0on\u00a0outcomes\u00a0which\u00a0could 20mg/kg treated\u00a0at\u00a0a\u00a0dose\u00a0of\u00a0600mg\u00a0every\u00a012\u00a0hours tor\u00a0in\u00a0order\u00a0to\u00a0ensure\u00a0sufficiently\u00a0high\u00a0exposure\u00a0to\u00a0anidulafungin Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0m Refer\u00a0to\u00a0Department\u00a0of\u00a0Health\u00a0guidelines account Genus\u00a0Pharmaceuticals Maximum\u00a0Body\u00a0Weight and\u00a0100mg\u00a0of\u00a0sulfamethoxazole\u00a0per\u00a0kg\u00a0of\u00a0bodyweight\u00a0per\u00a0day\u00a0in\u00a0two\u00a0or\u00a0more\u00a0divided 112 Pineda\u00a0LA Vitro\u00a0studies\u00a0have\u00a0suggested\u00a0that\u00a0the\u00a0following\u00a0organisms\u00a0may\u00a0have Astra\u00a0Zeneca\u00a0\u00a0Summary\u00a0of\u00a0Product\u00a0\u00a0Characteri Many\u00a0Thanks eed MIC 24 s* Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Accessed\u00a0\u00a0at Page\u00a0|\u00a042 Ertapenem abs so for\u00a0adults ensure recurrence Morna\u00a0Ball\u00a0of\u00a0Glasgow\u00a0Royal\u00a0Infirmary are depending\u00a0on\u00a0the\u00a0patient mary trial distribution ts Page\u00a0|\u00a01 Author\u00a0suggests rmation\u00a0available bd\u00a0is\u00a0better\u00a0than\u00a0400mg\u00a0tds\u00a0as\u00a0this\u00a0improves Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0A weight clearance\u00a0and\u00a0elimination\u00a0half\u2010life\u00a0in Chen\u00a0M Merck\u00a0Sharp\u00a0and\u00a0Dohme\u00a0Ltd\u00a0Summary\u00a0of\u00a0Product\u00a0Ch al\u00a0suggest\u00a0that\u00a0higher\u00a0doses\u00a0of\u00a0ciprofloxacin\u00a0should\u00a0always\u00a0be\u00a0used\u00a0either\u00a0600mg\u00a0bd\u00a0or Ja Van Metronidazole\u00a0monograph Dosing\u00a0for\u00a0penicillins Victoria\u00a0Hospital\u00a0Kirkcaldy gender tions currently hydrophilic ing\u00a0methods\u00a0have maintains\u00a0levels\u00a0within\u00a0the\u00a0therapeutic\u00a0range Page\u00a0|\u00a019 Clindamycin Dosing\u00a0of\u00a0medications\u00a0in\u00a0morbidly\u00a0obese\u00a0patients\u00a0in\u00a0the\u00a0intensive\u00a0care\u00a0unit\u00a0setting Accessed\u00a0at\u00a0www male However r\u00a0that\u00a0metabolism\u00a0is Correction\u00a0Factor As authors Usual\u00a0adult\u00a0dosage\u00a0250mg\u00a0to\u00a01g\u00a0four\u00a0times\u00a0daily as\u00a0above Child cohort PN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer /\u00a08780\u00a0+ with mg/kg\u00a0dosing\u00a0can\u00a0be\u00a0used 39 C\u00a0or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook remains linezoli orations consequ Int\u00a0J\u00a0Obes\u00a02001 45: howeve recommended vels\u00a0are\u00a0obtained Wt concentration\u00a0of\u00a0trough\u00a0concentrations\u00a0of\u00a04\u20105x\u00a0MIC inetics\u00a0in\u00a0critically\u00a0ill\u00a0patients:\u00a0A\u00a0prospective dosing\u00a0should\u00a0be\u00a0at\u00a0the\u00a0upper\u00a0end\u00a0of\u00a0the\u00a0higher\u00a0end\u00a0of\u00a0the\u00a0recommended Summary\u00a0of\u00a0\u00a0product\u00a0characteristics Koselke 5g\u00a0every\u00a06\u00a0hrs trough see\u00a0below vid USA urs No\u00a0information\u00a0beyond\u00a0standard\u00a0mg/kg\u00a0dosing Usual\u00a0reco Suggest lays 5Hollenstein actual\u00a0body\u00a0weight\u00a0may\u00a0lead\u00a0to\u00a0drug\u00a0toxicity\u00a0and\u00a0suggest\u00a0using\u00a0ideal\u00a0body\u00a0weight phenytoin\u00a0levels volunteers British\u00a0National\u00a0Formulary\u00a065 Continuous\u00a0versus\u00a0intermitte companied\u00a0by\u00a0hepatic extremes\u00a0of\u00a0body recommendations Page\u00a0|\u00a041 nhs data ed\u00a0a\u00a0200mg\u00a0loading\u00a0dose\u00a0on\u00a0Day\u00a01\u00a0followed\u00a0by\u00a0100mg\u00a0maintenance\u00a0dose\u00a0daily flucytosine good t\u00a0Characteristics an and\u00a0increased\u00a0stepwise Dosage\u00a0adjustments\u00a0based\u00a0on\u00a0BMI\u00a0alone\u00a0are\u00a0not\u00a0required\u00a0and\u00a0standard\u00a0doses\u00a0for\u00a0patients\u00a0with evidence the 600mg Susan\u00a0Hughes\u00a0of\u00a0Crosshouse\u00a0Hospital Carron\u00a0M\u00a0Freo\u00a0U\u00a0Parotto\u00a0E\u00a0and\u00a0Ori\u00a0C 89\u00a0x *Refers\u00a0to\u00a0patients\u00a0aged\u00a015\u00a0years\u00a0and\u00a0older some compassionate\u00a0use\u00a0programme\u00a0adult\u00a0patients\u00a0who\u00a0weighed\u00a0more\u00a0than\u00a040kg\u00a0were\u00a0treated\u00a0at\u00a0a\u00a0dose\u00a0of 28 1000mg\u00a0twice\u00a0daily\u00a0and\u00a02000mg\u00a0twice\u00a0daily\u00a0were\u00a0found\u00a0to\u00a0have\u00a0comparable in\u00a0excess\u00a0of\u00a00 55 Summary/ for stature They Page\u00a0|\u00a017 clinical\u00a0trials Allard\u00a0S\u00a0et\u00a0al Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0\u00a0\u00a0Accessed\u00a0at Current\u00a0Opinions\u00a0in\u00a0Infectious\u00a0Diseases 30:18\u201032 from Ideal\u00a0versus\u00a0corrected\u00a0body\u00a0weight\u00a0for\u00a0dosage\u00a0of\u00a0sugammadex\u00a0in No Page\u00a0|\u00a04 ABW Analysis though should\u00a0be\u00a0used ve\u00a0good\u00a0clinical\u00a0results Dillmans\u00a0B Information\u00a0provided\u00a0does\u00a0not\u00a0provide\u00a0a\u00a0substitute\u00a0for\u00a0clinical\u00a0judgement divided complicated However\u00a0the\u00a0adipose\u00a0tissue\u00a0does\u00a0have\u00a0some\u00a0vasculature SPC nt\u2019s\u00a0renal &\u00a0Currie J\u00a0Antimicrob\u00a0Chemother using\u00a0Ideal\u00a0Body\u00a0Weight\u00a0in\u00a0obese\u00a0patients\u00a0taking\u00a0renal\u00a0function\u00a0in world Immunoglobulin but\u00a0a\u00a0value\u00a0of\u00a00 manufacturer Glasgow J\u00a0crit\u00a0care\u00a02008 :75/121 in\u00a0adult\u00a0patients\u00a0given Rifadin\u00ae BMI>40 tables Dosing\u00a0weight\u00a0=\u00a0Ideal\u00a0body\u00a0weight\u00a0+ patient\u2019s Dalacin\u00a0C\u00a0Phosphate\u00ae initial\u00a0infusion\u00a0rate\u00a0of 9270\u00a0x\u00a0TBW Critically\u00a0ill\u00a0Patients Journal\u00a0of\u00a0Infection\u00a02012 Bogaert\u00a0T\u00a0et\u00a0al Acknowledgements after\u00a0first\u00a024\u00a0hours Keith :\u00a0944\u20106 ME Hurford\u00a0W Free Page\u00a0|\u00a010 be\u00a0different to\u00a0es relating no often Derendorf\u00a0H Abbott\u00a0Laboratories Body\u00a0Surface\u00a0Area\u00a0is\u00a0mainly\u00a0used\u00a0in\u00a0cancer\u00a0chemotherapy bd Manufacturer\u00a0recommends\u00a0dosing\u00a0on\u00a0actual\u00a0body\u00a0weight Greenock Radcl pharmacokinetics Janson\u00a0B\u00a0and\u00a0Thursky\u00a0K Australia Reversible\u00a0bone\u00a0marrow\u00a0depression\u00a0by\u00a0high\u2010dose Zentiva Dundee identified product Nafziger\u00a0AN administered\u00a0at\u00a0750\u00a0milligrams\u00a0in\u00a0obese\u00a0adults within r\u00a0use so\u00a0an\u00a0adjustment\u00a0factor\u00a0is\u00a0sometimes higher Several\u00a0references\u00a0suggest\u00a0that\u00a0bone\u00a0marrow\u00a0related\u00a0toxicity\u00a0was\u00a0linked\u00a0to\u00a0the\u00a0cumulative\u00a0dose at\u00a0least\u00a01\u20102\u00a0post\u2010 It\u00a0is\u00a0also\u00a0suggested\u00a0that\u00a0600mg PTC obese\u00a0and\u00a0extremely\u00a0obese\u00a0adults in\u00a0in\u00a0moderately\u00a0obese Accessed\u00a015th\u00a0May\u00a02013 Suggest\u00a0dosing\u00a0at\u00a0upper\u00a0end\u00a0of\u00a0range\u00a0where\u00a0appropriate trimethoprim 25\u00a0to\u00a00 Too\u00a0little\u00a0information\u00a0to\u00a0give\u00a0a\u00a0definitive\u00a0dose\u00a0recommendation\u00a0in\u00a0obese\u00a0patients No\u00a0advice Barreiro\u00a0G Halovic specialist Anaesthesia\u00a02012 pneumoniae generally No\u00a0information No\u00a0additional\u00a0information\u00a0supplied\u00a0from\u00a0the\u00a0SPC Summary\u00a0of\u00a0Product\u00a0Characteri stics\u00a0Accessed\u00a0at although\u00a0mg/kg\u00a0dosing\u00a0could Clinical\u00a0Infectious le\u00a0case\u00a0report\u00a0of\u00a0an\u00a0obese\u00a0patient\u00a0with\u00a0nonmeningeal\u00a0cryptococcal\u00a0infection\u00a0successfully 5\u00a0if\u00a0male outcomes\u00a0which\u00a0may\u00a0occur\u00a0as\u00a0a\u00a0result\u00a0of\u00a0referring\u00a0to\u00a0information\u00a0contained\u00a0within\u00a0this\u00a0document rer2 37 Oral critically been\u00a0used inetics\u00a0of\u00a0intravenous\u00a0levofloxacin 002 steady By\u00a0intravenous\u00a0infusion\u00a0400mg\u00a0every\u00a08\u201012\u00a0hours Literature\u00a0search\u00a0yielded\u00a0little\u00a0results pharmacodynamic gories Total\u00a0Body\u00a0Weight ukcpa ients EB those\u00a0who\u00a0weighed\u00a0more\u00a0than\u00a040kg\u00a0were timate\u00a0the\u00a0fractional Antimicrob The\u00a0only\u00a0documen Arch http://www app range Critical expectancy The\u00a0pharmacokinetics\u00a0and\u00a0safety\u00a0of\u00a0intravenous\u00a0voriconazole\u00a0\u00a0a\u00a0novel\u00a0wide\u00a0spectrum these\u00a0changes\u00a0had\u00a0little\u00a0effect\u00a0on\u00a0T>MIC Shiu\u00a0J Page\u00a0|\u00a043 Roberts\u00a0et\u00a0al\u00a0assessed\u00a0therapeutic\u00a0drug\u00a0monitoring\u00a0of\u00a0beta\u00a0lactam\u00a0antibiotics er cellulitis edicines v1 height\u00a0and\u00a0weight By\u00a0intravenous\u00a0infusion\u00a0500mg\u00a0every\u00a012\u00a0hours Due\u00a0to\u00a0the\u00a0shor Western which GlaxoSmithKline\u00a0Medicines\u00a0Information\u00a0department rep periences peak Suppl\u00a01 attempts/accidental susceptible Merck\u00a0Sharp\u00a0and\u00a0Dohme\u00a0Ltd Personal\u00a0Communication\u00a0Pfizer\u00a0Medical\u00a0Information\u00a021st\u00a0January\u00a02013 then Indications\u00a0fo re\u00a0is\u00a0limited\u00a0e overdosages 7th 11th western decision CCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer Weig rred\u00a0to\u00a0as\u00a0the\u00a0Actual Accurate\u00a0values\u00a0for\u00a0the\u00a0factor\u00a0are\u00a0not\u00a0easily\u00a0obtained ased\u00a0on\u00a0the\u00a0study\u00a0findings\u00a0the\u00a0authors\u00a0recommended\u00a0no\u00a0change\u00a0in\u00a0the For\u00a0severe\u00a0infections\u00a0and\u00a0in\u00a0neutropenic\u00a0patients\u00a0with\u00a0infections eight Tejani\u00a0AM\u00a0et\u00a0al 5\u00b5g/ml be No\u00a0change\u00a0to\u00a0manufacturer\u2019s\u00a0recommended\u00a0dosage Page\u00a0|\u00a03 66 America\u00a0and\u00a0the\u00a0UK\u00a0use\u00a0the\u00a0equations\u00a0below:\u00a0Note\u00a0this\u00a0is\u00a0different\u00a0from\u00a0the\u00a0equations\u00a0shown\u00a0on\u00a0p4 /Comments adults\u00a0is\u00a0an\u00a0initial\u00a0dose\u00a0of\u00a0100\u00a0mg\u00a0followed\u00a0by\u00a050\u00a0mg\u00a0every\u00a012\u00a0hours and\u00a0some\u00a0fluid Summary/Comments suggest\u00a0mg/kg\u00a0dosing\u00a0as\u00a0above Rifmpicin that\u00a0the\u00a0efficacy\u00a0of\u00a0Metronidazole\u00a0was\u00a0similar\u00a0among\u00a0different\u00a0BMI\u00a0cate Meropenem\u00a01g\u00a0dosed\u00a0to\u00a09\u00a0obese\u00a0female\u00a0patients Much ise\u00a0within\u00a0the\u00a0dose\u00a0range\u00a00 Phenytoin\u00a0disposition\u00a0in\u00a0obesity >30kg/m2 information nction The\u00a0renal\u00a0drug Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepatic\u00a0impairment Allard\u00a0et\u00a0al\u00a0suggest\u00a0using\u00a0a\u00a0weight\u00a0adjusted\u00a0dose\u00a0based\u00a0on Acknow Heintz therapeutic\u00a0concentrations\u00a0of\u00a0beta\u00a0lactam\u00a0antibiotics5 Metronidazole Personal\u00a0Communication Personal\u00a0communication\u00a0with\u00a0Bayer\u00a010th\u00a0January\u00a02013 based Septrin\u00ae Standard\u00a0therapeutic\u00a0dosage:\u00a01g\u00a0once\u00a0daily No\u00a0information\u00a0available Senior\u00a0Pharmacist 46 be\u00a0used comparable ant supratherapeutic alan Clin\u00a0Pharmacol\u00a0Ther\u00a01993 ents\u00a040kg\u00a0and any 6%\u00a0and\u00a049 Buchwald\u00a0H rxabbott regimens Gilead 33\u00a0x keith Lancker suggested\u00a0that\u00a0continuous\u00a0infusion\u00a0for\u00a0isolates\u00a0with\u00a0high\u00a0MIC\u00a0may\u00a0be\u00a0beneficial A\u00a0daily\u00a0dose\u00a0of\u00a08mg/kg\u00a0should\u00a0not\u00a0be\u00a0exceeded\u00a0in\u00a0patients\u00a0with\u00a0impaired\u00a0liver\u00a0function average der\u00a0the Mann\u00a0et\u00a0al\u00a0assessed\u00a0subcutaneous\u00a0adipose\u00a0tissue\u00a0concentrations between Page\u00a0|\u00a030 data\u00a0was\u00a0for\u00a0patients\u00a039\u00a0to\u00a0123kg\u00a0actual\u00a0body\u00a0weight until to\u00a03 drug\u00a0handbook airment 3\u00a0x Female= and\u00a0relevant\u00a0to\u00a0clinical\u00a0practice nuary\u00a02013 Pharmacotherapy\u00a01995 clearance Morag\u00a0Naysmith Dose\u00a0as\u00a0per\u00a0SPC\u00a0on\u00a0mg/kg\u00a0basis Suggest\u00a0discussing\u00a0with\u00a0local\u00a0microbiology\u00a0or\u00a0infectious\u00a0diseases Dosing obese In\u00a0the\u00a0obese\u00a0population\u00a0use\u00a0of\u00a0standard\u00a0dosages\u00a0of\u00a0beta\u00a0lactam\u00a0antib Children3 there\u00a0is\u00a0some\u00a0extra\u00a0water/\u00a0blood\u00a0supply\u00a0to\u00a0excess\u00a0tissue By\u00a0intravenous\u00a0infusion\u00a0500mg\u20102g\u00a0every\u00a08\u00a0hours Summary\u00a0of\u00a0product\u00a0characteristics The\u00a0correct\u00a0dosing\u00a0for\u00a0sugammadex\u00a0in\u00a0morbidly\u00a0obese\u00a0patients site\u00a0of\u00a0the\u00a0infection twice 287 height\u00a0in\u00a0inches\u00a0\u00a060 pneumonia popula Gillum\u00a0JG Dvorchick\u00a0BH obesity ication \u201056 ly\u00a0approximate as\u00a0surgical\u00a0prophylaxis\u00a0in\u00a0operations\u00a0lasting\u00a0greater\u00a0than\u00a03\u00a0hours useful Suggest\u00a04 150kg hrly facturer Disposition\u00a0of\u00a0Cefotaxime\u00a0and\u00a0its\u00a0Desacetyl\u00a0Metabolite\u00a0in\u00a0Morbidly\u00a0Obese utcomes\u00a0which\u00a0may\u00a0occur\u00a0as when\u00a0compared Claire\u00a0McMaster\u00a0of\u00a0the\u00a0Golden\u00a0Jubilee\u00a0National\u00a0Hospital variation rmation constant therefore usually Strep Accessed\u00a0at\u00a0\u00a0www has nline\u00a09 Licensed\u00a0dose\u00a0in The\u00a0recommended\u00a0dose\u00a0for DWCF*x\u00a0EBW ww increased\u00a0fluconazole\u00a0clearance Background Page\u00a0|\u00a014 Clinical The The\u00a0higher\u00a0dose\u00a0was\u00a0at Page\u00a0|\u00a031 5g\u00a0every\u00a08\u00a0hrs suicide different\u00a0from\u00a0those relevant We\u00a0hope\u00a0that\u00a0you =45 separate ho The\u00a0Renal\u00a0Drug\u00a0Handbook Inadequate Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0\u00a0\u00a0Acces manda 100mg\u00a0twice\u00a0daily BNF armacology increased\u00a0serum\u00a0drug Page\u00a0|\u00a021 Ltd\u00a04th\u00a0December\u00a02012 neous on Lisco\u00a0S therapy Purkin\u00a0et\u00a0al\u00a0Antimicrob\u00a0Agents\u00a0Chemother\u00a02002 patients\u00a0with\u00a0BMI\u00a0>35kg/m2\u00a0although\u00a0not\u00a0a\u00a0definitive\u00a0recommendation Aciclovir Ideal\u00a0Body\u00a0Weight Information\u00a0from 12g numb Paper erature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer 3It\u00a0has Currie\u00a0A V\u00a01 seen following\u00a0rocuronium\u00a0or\u00a0vecuronium\u00a0induced on\u00a0the\u00a0rate\u00a0of\u00a0its Usual\u00a0recommended\u00a0dose\u00a0500mg\u00a0once\u00a0or\u00a0twice\u00a0daily\u00a0depending\u00a0on\u00a0indication uk\u00a0\u00a08th\u00a0April\u00a02013 inclusion 1144\u201049 information\u00a0contained\u00a0in\u00a0this\u00a0doc Sugammadex Critical\u00a0Care\u00a0Medicine Radcliffe Loading Mastrobattista\u00a0JM AUC maintain 15th\u00a0April\u00a02013 Ciprofloxacin s\u00a0resulted\u00a0in\u00a0increased\u00a0gastrointestinal\u00a0side\u00a0effects 51 BMI>35kg/m2 Dosing\u00a0of\u00a0antibiotics\u00a0in\u00a0obesity liffe\u00a0Publishing 6%\u00a0of\u00a0an\u00a08\u00a0hour\u00a0dosing\u00a0interval\u00a0respectively patients Ruth\u00a0Forrest\u00a0of\u00a0the\u00a0Western\u00a0Infirm in\u00a0morbidly\u00a0obese\u00a0patients Klaricid\u00ae Page\u00a0|\u00a032 replies Grau\u00a0S :708 Literature\u00a0descri cefamandole recommend\u00a0adjusting\u00a0the\u00a0dose\u00a0of\u00a0anidulafungin\u00a0based\u00a0on\u00a0body\u00a0weight\u00a0in\u00a0adult\u00a0patients Infections:\u00a02\u20104g\u00a0daily surge clear haemofiltration\u00a0or\u00a0nutritional\u00a0requirements particularly\u00a0in\u00a0morbidly\u00a0obese\u00a0patients\u00a0with\u00a0more included\u00a0some\u00a0of\u00a0the\u00a0commonly\u00a0used\u00a0medicines\u00a0used\u00a0within\u00a0critical\u00a0care\u00a0areas hepatic and\u00a0little\u00a0observed\u00a0toxicity However\u00a0complications\u00a0of\u00a0obesity dosing\u00a0should\u00a0be\u00a0at\u00a0the\u00a0upper\u00a0end\u00a0of aminoglycosides Patricia\u00a0Nicholas\u00a0of\u00a0the\u00a0Golden\u00a0Jubilee\u00a0National\u00a0Hospital Lean in\u00a0the\u00a0clinical\u00a0studies\u00a0ranged\u00a0from\u00a0very\u00a0low\u00a0birth\u00a0weight\u00a0neonates\u00a0to\u00a0adults\u00a080kg+ severe\u00a0infections\u00a02\u20104g Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepatic\u00a0impairment\u00a0as\u00a0per\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0renal piperacillin individual No\u00a0specific\u00a0do Page\u00a0|\u00a018 2012 the\u00a0dose\u00a0should\u00a0be\u00a0rounded\u00a0down\u00a0to\u00a0the\u00a0nearest\u00a0vial th 25:1 IL better 1997 pregnan Roberts\u00a0MS\u00a0et\u00a0al direct Patients accept\u00a0that\u00a0this\u00a0may\u00a0lead\u00a0to\u00a0an\u00a0increased\u00a0risk\u00a0of\u00a0adverse\u00a0effect 66:\u00a0721\u00a0\u2010\u00a0725 No\u00a0information\u00a0on\u00a0dosing\u00a0in\u00a0obese\u00a0patients on\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0or\u00a0obese\u00a0patients to\u00a0account becoming they Radcliffe\u00a0publishing daily xtrem manufacturer: >100kg\u00a0and\u00a0BM The\u00a0recommended\u00a0daily\u00a0doses\u00a0are\u00a0between\u00a050\u2010800mg ight\u00a0subjects\u00a0than\u00a0in\u00a0clinically\u00a0obese\u00a0subjects Ambisome\u00ae as\u00a0required risk review certain Body\u00a0W Obesity Van\u00a0Zanten\u00a0ARH pneumocystis No\u00a0information\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients Addie TBW\u00a0x\u00a00 subjects 90 treatment\u00a0of\u00a0severe\u00a0acute\u00a0infections attainment severe\u00a0infections cute\u00a0infections\u00a0960mg\u00a0every\u00a012\u00a0hours 2nd\u00a0January\u00a02013 worse No\u00a0dosing\u00a0advice\u00a0found piperacillin\u00a0not\u00a0licensed\u00a0in\u00a0the children ght\u00a0patients ence\u00a0for\u00a0ideal\u2010body\u2010weight\u2010ad t\u00a0half\u00a0life\u00a0of\u00a0Meropenem 2008 6kg route 10 performed meta\u2010analysis decisions Accessed\u00a07th\u00a0June\u00a02013 BMI\u00a0>40\u00a0were\u00a0risk\u00a0factors\u00a0for\u00a0treatment\u00a0failure\u00a0in\u00a0patients\u00a0treated\u00a0with\u00a0co\u2010trimoxazole\u00a0and Danesi both discussed ons nor Bearden\u00a0DT hepatic\u00a0insufficiency the\u00a0higher\u00a0dose values No\u00a0specific\u00a0information\u00a0on\u00a0underweight\u00a0patients\u00a0however a\u00a0dosage\u00a0decrease\u00a0was\u00a0required Maximum\u00a0reported\u00a0dose overall\u00a0effect\u00a0however Suggest\u00a0higher\u00a0doses\u00a0of\u00a0piperacillin/tazobactam\u00a04 fact higher\u00a0end\u00a0of\u00a0the\u00a06\u00a0to\u00a012 after\u00a0a\u00a0750mg\u00a0intravenous\u00a0dose\u00a0every\u00a024hours 5\u00a0I ciprofloxacin specific very\u00a012 given\u00a0onc ry TBW\u00a0x\u00a01 factor regimen +40% and\u00a0Del\u00a0Tacca Voricoonazole 56 st the\u00a0higher\u00a0end\u00a0of\u00a0the\u00a0recommended lack aureus edition AUC\u00a0values\u00a0in\u00a0morbidly\u00a0obese\u00a0subjects\u00a0than\u00a0in\u00a0normal\u00a0weight\u00a0subjects\u00a0with\u00a0similar\u00a0creatinine\u00a0clearance times Drug\u00a0Dosing\u00a0Information Intensive\u00a0Care\u00a0Medicine\u00a02004 Personal\u00a0communication\u00a0with\u00a0Pfizer\u00a0January\u00a02013 Page\u00a0|\u00a016 fu No\u00a0information\u00a0available\u00a0relating\u00a0to\u00a0dosing\u00a0of\u00a0ertapenem\u00a0in\u00a0underweight\u00a0patients Doses\u00a0doubled\u00a0where\u00a0necessary Nicolau\u00a0D\u00a0P\u00a0and\u00a0Kuti\u00a0J\u00a0L a\u00a0dose\u00a0of\u00a02g\u00a0Metronidazole\u00a0at\u00a00\u00a0and\u00a048\u00a0hours Antimicrobial\u00a0Agents\u00a0and Page\u00a0|\u00a08 5kg g\u00a04mg/kg\u00a0actual\u00a0body\u00a0weight uk\u00a029th\u00a0May\u00a02013 Calculated\u00a0percentage\u00a0of\u00a0time\u00a0above\u00a0minimum\u00a0inhibitory\u00a0concentration Pharmacia\u00a0Ltd altering The\u00a0renal Dosing\u00a0of\u00a0medications\u00a0in\u00a0morbidly\u00a0obese\u00a0patients\u00a0in\u00a0the\u00a0inte Male\u00a0and\u00a0Female\u00a0Subjects Base Pfizer\u00a0does\u00a0not Joanne\u00a0Berrich\u00a0of\u00a0Inverclyde\u00a0Royal\u00a0H 2012\u00a0Dec mg/kg\u00a0once\u00a0daily Pamela\u00a0MacTavish\u00a0of\u00a0Glasgow\u00a0Royal\u00a0Infirmary Clindamycin\u00a0dosage\u00a0modification\u00a0not\u00a0usually\u00a0necessary\u00a0in\u00a0patients\u00a0with\u00a0renal/hepatic Amphotericin n\u00a0monograph\u00a0for\u00a0general\u00a0information\u00a0on\u00a0dosing\u00a0of\u00a0beta\u00a0lactams\u00a0in\u00a0obesity Personal\u00a0communication\u00a0with\u00a0AstraZeneca\u00a0\u00a0Novemb Page\u00a0|\u00a023 nor\u00a0for\u00a0any\u00a0patient\u00a0or\u00a0clinical pro SACCPN 5\u00a0+ compromised\u00a0patients\u00a0or 5g\u00a06hrly\u00a0dependent\u00a0on\u00a0renal\u00a0function terature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer3 Evaluation\u00a0of\u00a0the\u00a0effect\u00a0of\u00a0obesity\u00a0on\u00a0voriconazole\u00a0serum\u00a0concentrations 29 determination\u00a0of\u00a0loading\u00a0dose practitioners tall\u00a0thin\u00a0people\u00a0or\u00a0muscular\u00a0people ide followed\u00a0by\u00a0100\u00a0mg\u00a0daily\u00a0thereafter timmins@nhs Carey\u00a0JC made similar Care ofloxacin\u00a0disposition\u00a0in\u00a0obesity There\u00a0is\u00a0a\u00a0sing recommends\u00a0using\u00a0ABW\u00a0for\u00a0dose\u00a0calculation proposed 74% adjustment 7\u00a0micrograms/kg/h\u00a0which\u00a0\u00a0may\u00a0then\u00a0be\u00a0adjusted\u00a0stepw ous\u00a0abscess tion ceftriaxone life Higher\u00a0doses\u00a0as\u00a0per\u00a0SPC\u00a0depending\u00a0on\u00a0indication 23rd\u00a0November\u00a02012 Formula accessed\u00a07 The\u00a0manufacturer\u00a0provides\u00a0no\u00a0specific\u00a0advice function morbidly\u00a0obese\u00a0patients gents\u00a0Chemother Acinebac recommends Weight corp previous Dosing\u00a0based\u00a0on 25:\u00a0634\u2010649 es dosing\u00a0weight\u00a0tables\u00a0may\u00a0be\u00a0in lactam dose\u00a0of\u00a010mg/kg\u00a0every\u00a012\u00a0hours Suggest\u00a0discuss\u00a0each\u00a0patient\u00a0with\u00a0local\u00a0microbiology/infectious\u00a0diseases Adult Earle\u00a0SB Ciproxin\u00ae\u00a0\u00a0Bayer as\u00a0does\u00a0the\u00a0o =\u00a0IBW\u00a0+\u00a00 micromedexsolutions on\u00a0drug\u00a0handling No\u00a0information\u00a0available\u00a0for\u00a0dosing\u00a0in\u00a0underweight\u00a0patients PNW fect\u00a0Dis 5g\u00a06\u00a0hrly basis =\u00a050\u00a0+ Van\u00a0Lancker\u00a0P required uk\u00a027th\u00a0June\u00a02013 max Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepati 4\u00a0is situations\u00a0doses\u00a0as\u00a0high\u00a0as\u00a04 monographs\u00a0in\u00a0future\u00a0editions No\u00a0data\u00a0available\u00a0on\u00a0any\u00a0dose\u00a0adjustment\u00a0required\u00a0in\u00a0low\u00a0body\u00a0weight adults Use\u00a0standard\u00a0dosing ccessed\u00a0\u00a0at taken Personal\u00a0correspondence\u00a0with\u00a0Abbott Ed Malacarne Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepatic\u00a0impairment\u00a0as\u00a0per\u00a0SPC/renal\u00a0drug\u00a0handbook Itozaku\u00a0G formation Tygacil\u00ae s\u00a0o >100kg\u00a0and ry\u00a0of\u00a0product\u00a0cha Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0per\u00a0SP taking Mann\u00a0HJ +4 Body\u00a0Weight It was\u00a0given\u00a01200mg\u00a0and\u00a0showed\u00a0a\u00a0lower\u00a0AUC\u00a0and rate A\u00a0dose\u00a0of\u00a02\u00a0mg/kg\u00a0sugammadex\u00a0is\u00a0recommended prescribed 90mg/kg adipose evolve significant ter\u00a0spp\u00a0and\u00a0Pseudomonas\u00a0aeruginosa careful Ambisome May\u00a02013 Page\u00a0|\u00a011 er\u00a02012 with\u00a0cellulitis\u00a0and\u00a0cutaneous\u00a0abscess Crystapen\u00ae Mass\u00a0Index 42 uk\u00a012th\u00a0July\u00a02013 attainment\u00a0of\u00a0Ertapenem\u00a0in\u00a0normal\u2010weight fat\u00a0mass divided\u00a0into\u00a04\u20106\u00a0doses\u00a0depending\u00a0on\u00a0the\u00a0ind continuous Maintenance\u00a0Dose and\u00a0by\u00a0anecdotal\u00a0experience\u00a0of\u00a0pharmacists\u00a0working\u00a0within\u00a0critical\u00a0car guidelines Albumin\u00a0and\u00a0renal\u00a0function\u00a0should\u00a0be\u00a0taken\u00a0into Martyn\u00a0Gall lipophilic in Doses\u00a0of\u00a0<10mg/24\u00a0hours\u00a0have\u00a0demonstrated\u00a0worse\u00a0outcomes\u00a0in\u00a0obese\u00a0patients 50 Pharmacists\u00a0Network followed Chen No\u00a0studies\u00a0carried\u00a0out\u00a0on\u00a0underweight\u00a0adults\u00a0in\u00a0any\u00a0clinical\u00a0trials The\u00a0Cochrane\u00a0Library\u00a02013 Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0pe literat 17 may Invanz\u00ae Clinical\u00a0guidelines\u00a0for\u00a0immunoglobulin\u00a0use and\u00a0the\u00a0authors\u00a0trust\u00a0that\u00a0the\u00a0information\u00a0provided\u00a0wil :1653\u20104 vide excess\u00a0weight\u00a0over\u00a0IBW trials Obese\u00a0patients drugs to\u00a0single parameters Akinnusi running have There Loading\u00a0dose 20:869\u2010873 outcomes Page\u00a0|\u00a036 for\u00a05\u00a0to\u00a014\u00a0days Dosing\u00a0as\u00a0per\u00a0SPC/renal\u00a0drug\u00a0handbook 75 15:251\u20103 Contents actual\u00a0body\u00a0weight Kilmarnock cm blockade Email\u00a0received in\u00a0Obese\u00a0patients Barie\u00a0PS Phenytoin Greenblatt\u00a0DJ By\u00a0intravenous\u00a0infusion loading No\u00a0advice\u00a0on Yet dcliffe\u00a0Publishing mation\u00a0more\u00a0readily at daily\u00a0doses\u00a0of\u00a0up\u00a0to\u00a02g guidance ratio Obtained\u00a0from\u00a0www x\u00a0TBW bacteraemia Dexdor\u00ae 40 make does height Introduction\u00a0to\u00a01 normally\u00a0as\u00a0a\u00a0once\u00a0daily\u00a0dose 65:128\u2010134 Due\u00a0to\u00a0variable\u00a0alterations\u00a0in\u00a0the\u00a0volume\u00a0of\u00a0distribution *\u00a0cSSTI\u00a0=\u00a0complicated\u00a0skin\u00a0and\u00a0soft\u00a0skin\u00a0infection\u00a0\u00a0**\u00a0RIE\u00a0=\u00a0right\u00a0sided\u00a0infective\u00a0endocarditis Hites\u00a0M 14 International\u00a0Journal\u00a0of\u00a0Antimicrobial\u00a0Agents\u00a02010 ese\u00a0patients as It\u00a0is\u00a0also\u00a0recommended\u00a0that Ecalta\u00ae adjustments Page\u00a0|\u00a028 Ceftriaxone Scottish if\u00a0spontaneous\u00a0recovery\u00a0has\u00a0occurred\u00a0up\u00a0to\u00a0at who s\u00a0response No\u00a0information\u00a0available\u00a0on\u00a0dosing\u00a0in\u00a0underw with\u00a0resulting\u00a0symptoms\u00a0limited\u00a0to\u00a0vomiting amphotericin No\u00a0inform side organisms 25:233\u2010237 limited non Sanofi was\u00a0used mg/kg\u00a0dosing\u00a0could\u00a0be\u00a0used 0242 Ashley\u00a0C For include\u00a0more Calculation\u00a0of\u00a0creatinine\u00a0clearance\u00a0using\u00a0the\u00a0Cockcroft\u00a0&\u00a0Gault Purkin\u00a0L\u00a0et\u00a0al KG/m2 Another\u00a0study\u00a0also\u00a0noted\u00a0that\u00a0Pharmacokinetic\u00a0parameters\u00a0in\u00a0pregnant\u00a0patients\u00a0were\u00a0not\u00a0significantly desired 67:\u00a0682 Summary\u00a0of\u00a0SAC Obese\u00a0patients\u00a0may\u00a0benefit\u00a0from\u00a0increased\u00a0dosing\u00a0for\u00a0the\u00a0loading\u00a0dose\u00a0using\u00a0a\u00a0weight\u00a0of Vfend\u00ae Micromedex kg doubled Page\u00a0|\u00a022 Lavoie\u00a0S\u00a0et\u00a0al or\u00a0vecuronium\u00a0induced\u00a0blockade pathogen TBW 90S Department\u00a0of\u00a0Health ledgments formula Dosing\u00a0of\u00a0Antibiotics\u00a0in\u00a0Obesity Luque\u00a0S stated 0183 net ce patient both\u00a0IV\u00a0and\u00a0oral No\u00a0spe Risk\u00a0factors\u00a0for\u00a0clinical\u00a0failure\u00a0in\u00a0patients\u00a0hospitalise assessed\u00a0against\u00a0a\u00a0target cohort\u00a0study Cubicin\u00ae ICAAC Lui\u00a0et\u00a0al\u00a0conducted\u00a0a\u00a0post\u2010hoc\u00a0pharmacokinetic\u00a0analysis\u00a0of\u00a0a\u00a0phase\u00a03\u00a0study\u00a0conducted\u00a0in\u00a0ICU\u00a0patients area Jarrett\u00a0R statistical Underw Doses\u00a0of\u00a0500mg\u00a0twice\u00a0daily up levels High\u00a0dosage\u00a0of\u00a0benzylpenicllin\u00a0sodium\u00a0BP\u00a0may\u00a0result\u00a0in\u00a0hypernatraemia\u00a0and\u00a0hypokalaemia www 10\u201015\u00a0mg/kg Oxford\u00a02009 Piperacillin/Tazobactam\u00a0in\u00a0critically\u00a0ill\u00a0patients\u00a0over\u00a0120kg Underwei wound 2g\u00a03 MIC90s achieve Summary/Comment contained\u00a0within\u00a0this 41 Clinical\u00a0Infectious\u00a0Diseases association treatme those 422\u2010430 Alison\u00a0Bell effectively uk\u00a019th\u00a0July\u00a02013 bes\u00a0acute\u00a0kidney\u00a0injury\u00a0in\u00a0obese\u00a0patients\u00a0where\u00a0aciclovir\u00a0dose\u00a0was\u00a0based\u00a0on\u00a0actual\u00a0body erature\u00a0from\u00a0manufacturer first\u00a024\u00a0hours IBW\u00a0for\u00a0males 30 sed\u00a0at renal consider available\u00a0on\u00a0modification\u00a0of\u00a0dosage Diflucan\u00ae ospital present\u00a0day including\u00a0diabetes\u00a0and\u00a0hypertension will as\u00a0relev 1\u00a0x\u00a0height Curr\u00a0Opin\u00a0In normal Colino\u00a0CI\u00a0&\u00a0Ferrer\u00a0A Cmax/MIC st\u00a0\u00a0Edition mo results UK addie@ggc preference clinical\u00a0judgement On\u00a0behalf\u00a0of\u00a0the\u00a0Scottish\u00a0Adult\u00a0Critical\u00a0Care\u00a0Pharmacists\u00a0Network Suggest\u00a0dosing\u00a0at\u00a0top\u00a0end\u00a0of\u00a0licensed\u00a0dose\u00a0in\u00a0obese\u00a0patients\u00a0for\u00a0ceftriaxone/\u00a0cefalosporins Wolff\u00a0F\u00a0et\u00a0al 1g No\u00a0information\u00a0available\u00a0\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients No\u00a0information\u00a0on\u00a0underweight\u00a0patients\u00a0however January\u00a02013 Therapy\u00a0is\u00a0usually\u00a0instituted\u00a0at\u00a0a\u00a0daily\u00a0dose Dosing\u00a0in\u00a0E 212 Single Slight however\u00a0specialist\u00a0consensus\u00a0advocates\u00a0the\u00a0use\u00a0of\u00a0the\u00a0DDW\u00a0equation Actual\u00a0Body\u00a0Weigh including\u00a0in\u00a0patients\u00a0with\u00a0neutropenia\u00a0which\u00a0would\u00a0suggest\u00a0reducing\u00a0the\u00a0dose\u00a0in bod can connection Ob on\u00a0metabolism\u00a0and\u00a0on\u00a0drug\u00a0handling however\u00a0a\u00a02013 In\u00a050\u00a0%\u00a0of\u00a0patients\u00a0a\u00a0dose\u00a0increase\u00a0was\u00a0required\u00a0to\u00a0attain\u00a0concentration\u00a0targets\u00a0whilst\u00a0in\u00a024%\u00a0of\u00a0patients weights infusions\u00a0of\u00a0antibiotics 8:189\u2010194 Titrate\u00a0dose\u00a0according\u00a0to\u00a0response pdf Obes ertapenem up\u00a0to\u00a01200mg/day\u00a0in\u00a0divided\u00a0doses a\u00a0mg/kg\u00a0basis racteristics 131 Pharmacology/\u00a0kinetics that taking\u00a0into\u00a0account\u00a0renal\u00a0and\u00a0hepatic\u00a0function\u00a0as\u00a0above 67:\u00a0298\u00a0\u00a0299 74\u00a0x\u00a0height Pfizer\u00a0Ltd low true *DWCF\u00a0=\u00a0Dose\u00a0Weight\u00a0Correction\u00a0Factor AdjBW treatment\u00a0ranges cific\u00a0information\u00a0available Zovirax\u00ae not\u00a0been\u00a0systematically\u00a0evaluated\u00a0for\u00a0safety\u00a0or\u00a0efficacy\u00a0in\u00a0extremes\u00a0of\u00a0body\u00a0weight and\u00a0there\u00a0is\u00a0very\u00a0little\u00a0validation\u00a0for\u00a0the\u00a0use\u00a0of\u00a0any\u00a0of\u00a0these :354\u2010358 El\u00a0Sohl\u00a0AA effect\u00a0in\u00a0all\u00a0patients Page\u00a0|\u00a012 27 to\u00a0allow Agents\u00a0and\u00a0Chemotherapy\u00a02006 impact Body By\u00a0intravenous\u00a0infusion\u00a0600mg\u00a0twice\u00a0daily =\u00a0IBW\u00a0+ filtration Levofloxacin\u00a0weight\u2010adjsted\u00a0dosing\u00a0and Summary\u00a0of\u00a0SACCPN\u00a0lit case B\u00a0British\u00a0National\u00a0Formulary\u00a0recommends Summary\u00a0of\u00a0SA Meronem\u00ae particularly fewer suggesting\u00a0there\u00a0is\u00a0no\u00a0pharmacokinetic\u00a0justification\u00a0for\u00a0dose\u00a0adjustment\u00a0based :2546\u20102553 monly Risk\u00a0factors\u00a0for\u00a0clinical\u00a0failure\u00a0in\u00a0patients\u00a0hospitalised Bridion\u00ae Paisley 4mg/kg Page\u00a0|\u00a037 ice\u00a0on\u00a0obese\u00a0patients difference\u00a0between\u00a0the\u00a0concentrations\u00a0achieved\u00a0in\u00a0normal\u00a0weight\u00a0and\u00a0morbidly\u00a0obese\u00a0subjects determined Mean Alison\u00a0Carruthers\u00a0of\u00a0Borders\u00a0General 25:634\u2010649 receivin Tishier\u00a0D\u00a0S for\u00a0organisms\u00a0with\u00a0an tti 6\u00a0mg/kg\u00a0once\u00a0daily Antimicrobial Body\u00a0Surface\u00a0Area Phase\u00a03\u00a0data\u00a0showed\u00a0we /\u00a03600 Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Accessed\u00a0at\u00a0\u00a0www Comparative\u00a0pharmacokinetics\u00a0and\u00a0pharmacodynamic\u00a0target Insufficient\u00a0information\u00a0available\u00a0to\u00a0make\u00a0a\u00a0recommendation appropriate may\u00a0reduce available intra\u2010abdominal in\u00a0criticall Curr\u00a0Fungal\u00a0Infect adequate\u00a0concentrations continue concentrations CRRT Accessed t\u00a0patients that\u00a0for\u00a0morbidly\u00a0obese\u00a0patients\u00a0may\u00a0be\u00a0more\u00a0appropriate\u00a0to\u00a0dose\u00a0as\u00a0ideal\u00a0or\u00a0adjusted important\u00a0to\u00a0administer\u00a0an\u00a0optimal\u00a0dose\u00a0of\u00a0a\u00a0drug\u00a0to\u00a0ensure\u00a0therapeutic\u00a0le would ents relative there\u00a0is\u00a0an\u00a0assumption\u00a0that\u00a0the\u00a0Excess\u00a0Body\u00a0Weight nt\u00a0ranges retrospective Pneumocystis\u00a0Jiroveci\u00a0Pneumonitis\u00a0PCP\u00a0infections:\u00a0treatment theory cin staphylococci out Information\u00a0from\u00a0guidelines: health Antimicrobial\u00a0Agents\u00a0and\u00a0Chemotherapy\u00a02013 give 4th\u00a0December\u00a02012 we Pharmacological analysis Taccone\u00a0FS obtained This\u00a0is\u00a0sometimes\u00a0refe Hites\u00a0et\u00a0al\u00a0attempted\u00a0to\u00a0validate\u00a0the\u00a0use\u00a0of\u00a0the\u00a0formula\u00a0by\u00a0carrying\u00a0out\u00a0a\u00a0therap Further Appropriate\u00a0to\u00a0dose\u00a0on\u00a0total\u00a0body\u00a0weight\u00a0ensuring\u00a0appropriate\u00a0monitoring\u00a0for\u00a0toxicity\u00a0and\u00a0dose Epanutin\u00ae outcom piperacillin/tazobactam 0mg 0\u00a0mg/kg\u00a0of\u00a0body\u00a0weight starting A\u00a0dose\u00a0of\u00a04\u00a0mg/kg\u00a0sugammadex\u00a0is\u00a0recommended\u00a0if\u00a0recovery\u00a0has\u00a0reached glomerular 25 In\u00a0life\u00a0threatening morbidity alone antibiotics when\u00a0prescribing\u00a0ertapenem Aspen\u00a0Global Dose\u00a0reduction/caution\u00a0is\u00a0necessary\u00a0in\u00a0patients\u00a0with\u00a0severe\u00a0renal\u00a0impairment\u00a0accompanied\u00a0by not Mass Wurtz\u00a0R Summa considerably handbook guidan Daptomycin obese\u00a0patients of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer3 Yorst\u00a0RL 4As Descriptor or\u00a0refer\u00a0renal\u00a0drug\u00a0handbook Page\u00a0|\u00a024 most\u00a0common\u00a0antibiotics\u00a0prescribed\u00a0to\u00a0patients\u00a0for\u00a0this\u00a0indication\u00a0in\u00a0this\u00a0study 244\u00a0x\u00a0BMI ay generations guided\u00a0by\u00a0the\u00a0severity Adjusted\u00a0Body\u00a0Weight e\u00a0in\u00a0Scotland pharmacokinetics\u00a0in\u00a0an\u00a0obese\u00a0patient Victoria\u00a0Infirmary Group Case\u2010Control\u00a0study\u00a0of\u00a0Drug\u00a0Monitoring\u00a0of\u00a0\u00df\u2010Lactams\u00a0in\u00a0Obese Dose\u00a0using\u00a0ideal\u00a0body\u00a0weight individuals women Summary\u00a0of\u00a0product\u00a0characteristics\u00a0Ceftr 15 influence Cochrane future Antimicrobial\u00a0agents\u00a0and\u00a0chemotherapy\u00a02007 April\u00a02013 Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0lit I\u00a0>40\u00a0were\u00a0risk\u00a0factors\u00a0for\u00a0treatment\u00a0failure\u00a0in\u00a0patients\u00a0treated\u00a0with\u00a0co\u2010trimoxazole\u00a0and The\u00a0area\u00a0un cefalosporins has\u00a0no\u00a0influence 6680\u00a0+ 400mg Effect\u00a0of\u00a0obesity\u00a0on\u00a0critical\u00a0care\u00a0morbidity\u00a0and\u00a0mortality:\u00a0a underweight 50kg\u00a0if\u00a0neutropenic 48 abstract Lui\u00a0P\u00a0et\u00a0al\u00a0Pharmacokinetics\u00a0of\u00a0anidulafungin\u00a0in\u00a0adult\u00a0intensive\u00a0care\u00a0patients Usual\u00a0recommended\u00a0dose\u00a0600mg\u00a0\u20101200mg\u00a0\u00a0daily\u00a0in\u00a02\u20104\u00a0divided Geiseler\u00a0PJ\u00a0et\u00a0al\u00a0Am\u00a0Rev\u00a0Respir\u00a0Dis\u00a01985 Predicted uk\u00a01st\u00a0August\u00a02013 mmended\u00a0dose\u00a0is\u00a04 but\u00a0there\u00a0is\u00a0currently http://clinicaltrials Accessed\u00a0at hts\u00a0used\u00a0in Dvorchick\u00a0et\u00a0al\u00a0suggest\u00a0use\u00a0of\u00a0total\u00a0body\u00a0weight\u00a0for\u00a0calculation\u00a0of\u00a0doses\u00a0is\u00a0appropriate\u00a0based\u00a0on\u00a0total 12hours 14th\u00a0June\u00a02013 Pharmacy assumed ument\u00a0is\u00a0accurate\u00a0and\u00a0up\u00a0to\u00a0date Bearden\u00a0et\u00a0al\u00a0assessed\u00a0the\u00a0pharmacokinetics\u00a0of\u00a0Meropenem\u00a0administer infections Chen\u00a0LG in\u00a0an\u00a0attempt\u00a0to\u00a0make\u00a0the\u00a0necessary\u00a0infor tory\u00a0in\u00a0any\u00a0patients\u00a0where\u00a0it\u00a0is\u00a0suspected\u00a0normal\u00a0parameters\u00a0may\u00a0not\u00a0apply Personal\u00a0communication\u00a0with\u00a0Julie\u00a0Booth Page\u00a0|\u00a029 Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Acces when Page\u00a0|\u00a046 informed June\u00a02013 Current\u00a0Opinion\u00a0Infectious\u00a0Disease uk\u00a012th\u00a0March\u00a02013 more\u00a0than\u00a0IBW concluded\u00a0that\u00a0BMI\u00a0had\u00a0did\u00a0not\u00a0effect\u00a0the\u00a0rate\u00a0of\u00a0recurrence\u00a0of\u00a0and\u00a0th Wurz An Page\u00a0|\u00a033 clinical\u00a0trial more levofloxacin Working\u00a0Group Underweight\u00a0patients state 600mg\u00a0to\u00a03600mg\u00a0daily adjustm considered mortality\u00a0in\u00a0ICU1 The\u00a0patient\u00a0had\u00a0global\u00a0treatment\u00a0success adequate\u00a0levels\u00a0in\u00a0subcutaneous\u00a0adipose\u00a0tissue\u00a0which\u00a0may\u00a0be\u00a0relevant\u00a0when\u00a0they\u00a0are\u00a0used\u00a0as\u00a0surgical skin 36:332\u201039 ans\u00a0up\u00a0to\u00a01200mg/day\u00a0in\u00a0divided\u00a0doses It\u00a0is\u00a0hoped\u00a0to 152 rapidly\u00a0achieve\u00a0therapeutic\u00a0drug\u00a0concentrations negative herpes\u00a0encephalitis Issues\u00a0of\u00a0\u00a0Linezolid Review unless\u00a0the\u00a0sodium\u00a0content\u00a0is\u00a0taken\u00a0into\u00a0account context CPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer3 No\u00a0specific\u00a0\u00a0advice\u00a0available 11th\u00a0January\u00a02013 8g\u00a0daily\u00a0have\u00a0been\u00a0used et Antimicrobial\u00a0Dosing Brown\u00a0J making ill effect lean Use\u00a0actual Tigecycline Slain\u00a0D Publishing there Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Accessed\u00a0at Dosage\u00a0in\u00a0adults:\u00a05mg/kg\u00a0every\u00a08\u00a0hours\u00a0or\u00a010mg/kg\u00a0in\u00a0immuno argued\u00a0th Senior\u00a0Clinical\u00a0Pharmacist Dose\u00a0adjustments\u00a0as\u00a0per\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0rena Pharmacok non\u2010obese 2\u20104g Day\u00a01 Pharmacokinetic\u00a0of\u00a0Doripenem\u00a0and\u00a0Piperacillin/Tazobactam\u00a0in\u00a0More\u00a0Than\u00a0120\u00a0kg\u00a0Critically\u00a0Ill\u00a0Patients Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0an treatment reported\u00a0as24g/day\u00a0N d\u00a0literature\u00a0from\u00a0manufacturer Hospital oxacillin No\u00a0specific\u00a0information\u00a0available ted\u00a0case\u00a0is\u00a0of\u00a0a\u00a0185kg\u00a0man 6mg/kg Calculate\u00a0ideal\u00a0body 285 0\u00a0x\u00a0TBW is\u00a0the\u00a0weight\u00a0as\u00a0measured Some Larbert aracteristics dependent Essentially\u00a0this\u00a0me or\u00a0Alan\u00a0Timmins However\u00a0they tetanic\u00a0counts Cefamandole\u00a0distribution\u00a0in\u00a0serum no\u00a0da See\u00a0above\u00a0for\u00a0one\u00a0case\u00a0report and\u00a0morbidly\u00a0obese\u00a0adults Erstad\u00a0B =IBW\u00a0+\u00a020% Levofloxacin As\u00a0above\u00a0taking\u00a0renal\u00a0function\u00a0into\u00a0account Page\u00a0|\u00a035 except Page\u00a0|\u00a026 Association Introduction Summary/Comm United taking\u00a0into\u00a0account\u00a0patie 3% Meropenem process micrograms/kg/h\u00a0in\u00a0order\u00a0to\u00a0achieve\u00a0the\u00a0desired\u00a0level\u00a0of\u00a0sedation however\u00a0no\u00a0liability\u00a0can\u00a0be per\u00a0SPC\u00a0on\u00a0a\u00a0mg/kg\u00a0basis Radc concentration Modified body\u00a0weights\u00a0up\u00a0to\u00a0approximately\u00a0150kg\u00a0should\u00a0provide\u00a0AUC\u00a0values\u00a0similar\u00a0to\u00a0those\u00a0seen\u00a0in\u00a0non uk Orion\u00a0contacted necessary Ceftriaxone/Cefalosporins so\u00a0are\u00a0in\u00a0theory\u00a0are\u00a0good\u00a0models\u00a0for\u00a0drugs\u00a0that\u00a0are\u00a0highly\u00a0hydro receiving t\u00a0Characteristics\u00a0Accessed Ideal 65kg\u00a0person\u00a0depending\u00a0on\u00a0infection Gla Luque Intravenous tion\u00a0of\u00a0the\u00a0following\u00a0pharmacists\u00a0to\u00a0the\u00a0production\u00a0of\u00a0this cystic improved ccessed\u00a0at\u00a0www TBW\u00a0x\u00a0BMI\u00a0x\u00a00 lower No\u00a0specific\u00a0advice\u00a0available\u00a0for\u00a0underweight\u00a0patients 25:\u00a0112\u20108 prophylaxis CMax\u00a058%\u00a0and\u00a0AUC Acc infusion research com and\u00a0vi Journal\u00a0of\u00a0Clinical\u00a0Ph into most ere\u00a0discharged\u00a0on\u00a0a\u00a0low\u00a0oral\u00a0dose\u00a0of\u00a0clindamycin\u00a0or\u00a0co\u2010trimoxazole Pharmacokinet\u00a02010:\u00a049 coagulase severe 2747 Pat Keith\u00a0Addie evaluate concentration\u2010 high iaxone lists Dose\u00a0as bacterial\u00a0vaginosis 2006 above justed\u00a0dosing\u00a0and\u00a0therefore\u00a0no\u00a0firm\u00a0recommendation Summary\u00a0of\u00a0product\u00a0cha without on\u00a0patient\u00a0weight Every Licensed p634\u00a0\u2010\u00a0649 Continuous comparing endpoints\u00a0which\u00a0are\u00a0believed\u00a0to\u00a0be\u00a0associated\u00a0with\u00a0maximal\u00a0beta\u00a0lactam\u00a0activity All Norenberg\u00a0JP Pfizer\u00a0Summary\u00a0of\u00a0Product\u00a0Characteristics pieces Chemotherapy is\u00a0a\u00a0related\u00a0term\u00a0that\u00a0is\u00a0similar r\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook Rifampicin Dose\u00a0reduction/caution\u00a0is\u00a0necessary\u00a0in\u00a0patients\u00a0with\u00a0severe\u00a0renal\u00a0impairment\u00a0ac from\u00a0considering\u00a0dosing\u00a0in\u00a0children Janson\u00a0B Drug\u00a0Intelligence\u00a0and\u00a0Clinical\u00a0Pharmacy\u00a01986 Page\u00a0|\u00a027 take enance\u00a0dose\u00a05\u00a0mg/kg\u00a0daily 43 GlaxoSmithKline\u00a0Ltd saying Antifungal\u00a0dosing\u00a0in\u00a0obesity:\u00a0A\u00a0review\u00a0of\u00a0the\u00a0literature 200mg\u00a0every\u00a012\u00a0hours :3240 nt\u00a0infusions\u00a0of\u00a0antibiotics 13\u201017\u00a0years\u00a0of\u00a0age intravenous\u00a0linezolid\u00a0in\u00a0moderately\u00a0to\u00a0morbidly\u00a0obese\u00a0adults Underweig Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0man compared calculated BNF\u00a0for\u00a0Children\u00a0March\u00a02013\u00a0accessed\u00a0o 439\u2010447 23 The\u00a0conclusion\u00a0was\u00a0that\u00a0the\u00a0fluconazole\u00a0dose\u00a0should\u00a0be\u00a0based\u00a0on\u00a0the Principal\u00a0Pharmacist they\u00a0provide\u00a0a\u00a0number\u00a0of\u00a0references 34:\u00a0p1796\u20101804 Br\u00a0J\u00a0Clin\u00a0Pharmacol\u00a02003 plasma so\u00a0that\u00a0the\u00a0information Underweight\u00a0patien Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manu subgroup adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0per\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook actual suggest\u00a0monitoring\u00a0for\u00a0toxicity\u00a0in su patients\u00a0receiv drug overweight 45\u00a0x\u00a0\u00a0excess\u00a0body\u00a0weight States Advise\u00a0to\u00a0titrate\u00a0dose\u00a0according\u00a0to this maintained Page\u00a0|\u00a05 Papasavas\u00a0P\u00a0K Pfizer Fiona\u00a0MacGregor\u00a0of\u00a0the\u00a0Royal\u00a0Alexandra\u00a0Hospital centres order\u00a0to\u00a0achieve\u00a0the\u00a0same\u00a0tissue\u00a0concentrations\u00a0as\u00a0those\u00a0achieved\u00a0in\u00a0lean\u00a0subjects\u00a0although 45 Lean\u00a0Body\u00a0Weight Flagyl\u00ae edited\u00a0for\u00a0Scotland For\u00a0oral\u00a0route\u00a0dosing\u00a0as\u00a0above Pharmacokinetics\u00a0of e\u00a0daily\u00a0by\u00a0the\u00a0intravenous of\u00a01 dose\u00a0based\u00a0on\u00a0indication Particularly\u00a0at\u00a0high\u00a0doses\u00a0although\u00a0there\u00a0is\u00a0limited\u00a0information at\u00a0www For\u00a0serious\u00a0/life\u00a0threatening\u00a0infections\u00a0doses\u00a0of\u00a0up\u00a0to\u00a04 Montpelier 600mg\u00a0twice\u00a0daily\u00a0was\u00a0sufficient\u00a0for\u00a0the\u00a0treatment\u00a0of\u00a0skin\u00a0and\u00a0soft ent\u00a0which\u00a0represents\u00a0information\u00a0and\u00a0experience\u00a0of\u00a0dosing\u00a0of\u00a0drugs\u00a0in\u00a0critically\u00a0ill hospitalised Please\u00a0send\u00a0any\u00a0new Normal Clinical\u00a0Infectious\u00a0Diseases\u00a01997 No\u00a0info Personal\u00a0communication\u00a0with\u00a0Sanofi\u2010Aventis\u00a02nd\u00a0April\u00a02013 adipose\u00a0tissue\u00a0and\u00a0wound\u00a0drainage\u00a0in the\u00a0excess\u00a0in\u00a0body\u00a0weight4 Summary\u00a0of\u00a0Product\u00a0Characteristics No\u00a0dose\u00a0adjustment\u00a0recommended\u00a0for\u00a0renal\u00a0imp response\u00a0to\u00a0bac Both\u00a0groups\u00a0of\u00a0patient\u00a0will\u00a0require\u00a0therapeutic\u00a0drug\u00a0monitoring\u00a0to\u00a0ensure\u00a0maintenance\u00a0dose especially sgow use Summary\u00a0of\u00a0Prod Suggest\u00a0discussing\u00a0with\u00a0local\u00a0microbiology\u00a0or\u00a0infectious\u00a0diseases\u00a0specialist recommendation morbidly\u00a0obese\u00a0and\u00a0matched\u00a0non\u00a0obese\u00a0subjects three\u00a0or\u00a0four\u00a0divided\u00a0doses Rakesh\u00a0Kishore\u00a0of\u00a0Glasgow\u00a0Royal\u00a0Infir and Presented\u00a0at\u00a045th\u00a0Interscience\u00a0conference\u00a0on\u00a0Antimicrobial\u00a0Agents\u00a0and Linezolid substitute com/pdf/biapi intraven Gilead\u00a0Sciences\u00a0Ltd %T>MIC it Page\u00a0|\u00a09 should No\u00a0information\u00a0available\u00a0in\u00a0dosing\u00a0in\u00a0underweight\u00a0patients Underweigh disagr supported contained\u00a0in\u00a0the\u00a0document\u00a0can\u00a0be\u00a0kept\u00a0up\u00a0to\u00a0date 31 subsequent Fat\u00a0Free\u00a0Mass tissue\u00a0infections\u00a0in\u00a0obese a\u00a0result\u00a0of\u00a0referring\u00a0to\u00a0i of\u00a0piperacillin body assessing l\u00a0only\u00a0be\u00a0used\u00a0as\u00a0part appear\u00a0to BMI Benzylpenicllin hours pharmacodynamics suggest 67:2957\u20102692 29th\u00a0May\u00a02013 equivalent\u00a0to\u00a012mg/kg\u00a0in\u00a0a 2005 No\u00a0strong\u00a0evidence See\u00a0Benzylpenicillin\u00a0for\u00a0general\u00a0information\u00a0on\u00a0dosing\u00a0of\u00a0Beta\u00a0Lactams\u00a0in\u00a0obesity ideal\u00a0body\u00a0weight\u00a0where\u00a0dose\u00a0was\u00a0increased\u00a0in\u00a0proportion\u00a0to July\u00a02012 e\u00a0patients voriconazole fluconazole al Drusano\u00a0GL Pai\u00a0MP with\u00a0normal\u00a0weight\u00a0patients ht\u00a0patients sive\u00a0care\u00a0unit\u00a0setting increased 738 Rodvold\u00a0K This only\u00a0be\u00a0produced\u00a0by\u00a0a\u00a0randomised March\u00a02013\u00a057 regimens\u00a0based\u00a0on\u00a0the\u00a0correction\u00a0formula\u00a0only\u00a0slightly treated intravenous\u00a0antibiotics\u00a0to\u00a0traditional\u00a0intermittent adequate on\u00a0available Martin\u00a0C added\u00a0to\u00a0give\u00a0adjusted\u00a0body\u00a0weight Flucloxacillin ill\u00a0patients:\u00a0proof\u00a0of\u00a0concept 100mg/kg\u00a0per\u00a024\u00a0hours\u00a0sulfamethoxazole\u00a0have\u00a0been\u00a0used showed c\u00a0impairment\u00a0as\u00a0per\u00a0SPC/renal\u00a0drug\u00a0handbook North\u00a0Chicago and\u00a0cutane Influence\u00a0of\u00a0morbid\u00a0obesity\u00a0on\u00a0the\u00a0single\u00a0dose group 216\u00a0x\u00a0BMI Fluconazole eight\u00a0patients monitoring penicillins Abbreviation Dosing\u00a0for\u00a0iv\u00a0weight\u00a0based Caution\u00a0is\u00a0advised\u00a0in\u00a0the\u00a0elderly Severe =TBW\u00a0\u00a0IBW rmation\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients In\u00a0a\u00a0compassionate\u00a0use\u00a0programme\u00a0of\u00a0adult\u00a0patients s\u00a0clinical\u00a0response Kingdom Clarithromycin <5mg/kg Piperacillin/Tazobactam Calc Diane\u00a0Kennedy\u00a0of\u00a0Ayr\u00a0Hospital orption 2\u00a0to\u00a01 Some\u00a0evidence\u00a0to\u00a0support\u00a0using\u00a0adjusted\u00a0body\u00a0weight\u00a0in as\u00a0relevant Novartis\u00a0Pharmaceutical\u00a0UK\u00a0Ltd 4mg/kg\u00a0twice\u00a0daily either beta IV 57 reduced body\u00a0weight appear iotics\u00a0resulted\u00a0in\u00a0insufficient\u00a0serum Intravenous\u00a0cipr The\u00a0duration\u00a0of\u00a0therapy\u00a0should\u00a0be oth\u00a0IV\u00a0and\u00a0oral Actual\u00a0body\u00a0weight\u00a0\u00a0Ideal\u00a0body\u00a0weight Drug while adult Anderson\u00a0T\u00a0et\u00a0al Loading\u00a0Dose sed Predicted\u00a0Normal\u00a0Weight standar or plus a\u00a0low\u00a0oral\u00a0dose\u00a0of\u00a0clindamycin\u00a0or\u00a0co\u2010trimoxazole is\u00a0rarely\u00a0used\u00a0for\u00a0dosing dosing y\u00a0ill\u00a0patients ne\u00a0240kg\u00a0patient\u00a0who\u00a0was\u00a0given\u00a0a\u00a0150mg\u00a0daily\u00a0maintenance\u00a0dose erefore\u00a0it\u00a0was\u00a0thought 40kg* Local s\u00a0of\u00a0cefamandole ulate\u00a0dose <10mg/kg effort since ary :\u00a02741\u2010 start administered\u00a0to\u00a0normal\u00a0weight complex 33 Antimicrob\u00a0Chemother\u00a02012 Wurz\u00a0R prov alters likely Pfizer\u00a0Medical\u00a0Information ass\u00a0index\u00a0on\u00a0therapeutic widely Dumfries\u00a0and\u00a0Galloway\u00a0Royal\u00a0Infirmary Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0per\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook \u226440kg every who\u00a0each\u00a0received document or\u00a0may\u00a0increase\u00a0it2\u00a0The\u00a0latter\u00a0paper\u00a0provides\u00a0a\u00a0review\u00a0of\u00a0the\u00a0effects\u00a0of\u00a0obesity No\u00a0dosage\u00a0adjustments\u00a0out\u00a0with\u00a0licensed\u00a0dose\u00a0\u00a0can\u00a0be\u00a0recommended\u00a0in\u00a0either\u00a0underweight\u00a0or 4\u00a0+ philic document: anufacturer3 2g\u00a0in\u00a0two org December\u00a016\u201019 did The\u00a0effect\u00a0of\u00a0body\u00a0m There\u00a0is\u00a0little\u00a0information\u00a0about\u00a0dosing\u00a0adjustments\u00a0in\u00a0significantly\u00a0underweight Body\u00a0Mass\u00a0Index Wang\u00a0E 1\u00a0gram investigating bgroup therapeutic Obese\u00a0patients\u00a0may\u00a0benefit\u00a0from\u00a0increased\u00a0dosing\u00a0and\u00a0weight\u00a0based\u00a0doses\u00a0have\u00a0been\u00a0suggested oral intravenous\u00a0loading\u00a0dose\u00a0of\u00a020mg/kg\u00a0up\u00a0to\u00a0a\u00a0maximum\u00a0dose\u00a0of\u00a02g Pomp\u00a0A\u00a0Critical\u00a0care\u00a0of\u00a0the\u00a0bariatric\u00a0patient ufacturer 54 EBW the\u00a0discretion\u00a0of\u00a0the\u00a0principal\u00a0investiga proportion GFR dose\u00a020mg\u00a0of\u00a0trimethoprim in\u00a0non\u2010pregnant\u00a0women\u00a03 editions provide\u00a0minimum\u00a0inhibitory\u00a0concentration\u00a0in\u00a090%\u00a0of\u00a0strains\u00a0tested No\u00a0information\u00a0beyond\u00a0mg/kg\u00a0dosing uk\u00a06th\u00a0September\u00a02013 Excess\u00a0Body\u00a0Weight about so\u00a0may\u00a0negate\u00a0this Mycoses\u00a054 Co\u2010Trimoxazole single requiring\u00a0more\u00a0aggressive\u00a0therapy d\u00a0with\u00a0cellulitis Clin Antimicrobial\u00a0dosing\u00a0in\u00a0obese\u00a0patients Roberts\u00a0JA iffe\u00a0Publishing Pharmacokinetics\u00a0of\u00a0meropenem\u00a0in\u00a0extreme\u00a0obesity on\u00a0underweight\u00a0or\u00a0obese\u00a0patients with\u00a0the prevalent a\u00a0pharmacodynamic\u00a0target\u00a0of\u00a0100% essed\u00a0via and\u00a0the\u00a0patient =\u00a0\u221a Strong method amphoteri Hollenstein\u00a0UM\u00a0et\u00a0al Abernethy\u00a0DR Personal\u00a0correspondence\u00a0with\u00a0Gilead\u00a0Medical\u00a0Information\u00a011th\u00a0July ai\u00a0et\u00a0al\u00a0also\u00a0noted\u00a0that\u00a0use\u00a0of\u00a0total\u00a0body\u00a0weight\u00a0to\u00a0calculate\u00a0resulted\u00a0in\u00a0higher\u00a0Cmax\u00a0and Yost\u00a0et\u00a0al\u00a0assessed\u00a0plasma\u00a0levels\u00a0after\u00a0intravenous\u00a0administration\u00a0of\u00a0cefotaxime\u00a0in\u00a0normal\u00a0weight\u00a0and 2\u20109 22 than Characteristics\u00a0Accessed\u00a0\u00a0at descriptors\u00a0for\u00a0drug An\u00a0Updated\u00a0Critical\u00a0Review accounted suggested IBW\u00a0for\u00a0females carried Patients\u00a0less\u00a0than provide Usual\u00a0doses\u00a0range\u00a0from\u00a0500mg\u00a0TDS\u00a0to\u00a0treat\u00a0established\u00a0anaerobic\u00a0infecti ta\u00a0available\u00a0from\u00a0manufacturer\u00a0in\u00a0obese\u00a0patients soft This\u00a0patient\u00a0was\u00a0excluded\u00a0from\u00a0the\u00a0summary\u00a0statistics Suggest\u00a0dosing\u00a0at\u00a0top\u00a0end\u00a0of\u00a0licensed\u00a0dose\u00a0in\u00a0obese\u00a0patients\u00a0for\u00a0ceftriaxone/\u00a0cefalosporins\u00a0taking\u00a0into 927 DDW 18"
    },
    {
        "href": "criticalcare/Drugs/adrenaline.pdf",
        "title": "adrenaline",
        "content": "bag catheter if Ampoules Care use titrated Medusa Volumes be STABILITY: 8mg 160 room fluid more Strength infusion and Final Remove The 40mg Accessed nitroglycerin Inotropic 20mg com Infusion See hydrochloride norepinephrine Photosensitivity injection ml vein Comments Quadruple 80micrograms/ml 07/08/19 HealthSyst Commonly guide PRESENTATION: site 160mg CONCENTRATION: Technology dose Media BNF Pharm 5% 2004 100ml Bisulfite INTRAVENOUS on level Protect Olsen 2019 2021 micrograms/kg/min uk/IVGuideDisplay Review August light 54:14179 added bnf editorial depends dextrose infused Minimum ill INFUSION 80 glucose monitor at ID: hours is PDA org Journal Stability Date phlebitis 80mg with Agents micromedexsolutions Infuse Document Words/comments via Dec Authorisation 1mg/ml not :296308 insertion Category: venous Single Warner chemically required Status FOR ADRENALINE Brustugun 58 micrograms/ml ADDITIONAL Bronchospasm https://medusa Kristensen established 06/03/19 Am Version: until Presence highconcentration Anne sodium volume support to asp precipitate development Authors: Date: stable Title: References DJ Group INDICATION: ADMINISTRATION: Zumbrunnen critically Neally strength mg Authoriser: anaphylaxis Double group patients single Lothian rate QIT ICU Glucose peripheral Micromedex below nhs 9% table Tonnesen UKCPA Critical large 320micrograms/ml variable 250ml AND the equivalent adrenaline 010 containing USE TL Sympathomimetic Adrenaline through concentration Absence discoloured HH Science STANDARD which IV TE for Intranet:18/10/19 uk 160micrograms/ml Also 320 wales vasodilation Initially 2012 in central Trissel\u2019s Peddicord adrenaline/epinephrine dopamine Draft/Final:Final 05/08/19 DOSE from Physically NOTES: Compatibility 1997 nice Closely 17mls/hour 500ml temperature restricted chloride www may or has Used vasoconstriction Webb prepared Key degree of access Pharmaceutical ONLY Do 24 KM but"
    },
    {
        "href": "criticalcare/Drugs/alfentanil.pdf",
        "title": "alfentanil",
        "content": "Care Ampoules toleration titrated be ALFENTANIL 50ml STABILITY: room 24/04/20 infusion and Hameln doses FINAL In injection Updated Comments endotracheal PRESENTATION: CONCENTRATION: INTRAVENOUS level on 500micrograms2mg/hour Review alfentanil 500micrograms added 14mls/hour Characteristics Draft/Final: at INFUSION given ID: hours is org Date according assisted Product Document Authorisation 2020 Category: Guidelines chemically required Status FOR Words Version: 15mg ventilation to 500micrograms/ml Pharmaceuticals Authors: Date: stable Title: References INDICATION: ADMINISTRATION: undiluted administered mg Analgesia tube Authoriser:Lothian rate QIT ICU Hannah 5mg April Critical medicines AND the Summary containing USE 10ml Claire emc Alfentanil STANDARD 2022 for uk initially Initially in solution 25mg DOSE Physically and/or Intranet: 22/04/20 temperature bolus www may or Key of ONLY 24 30ml Ltd"
    },
    {
        "href": "criticalcare/Drugs/all IV drug infusion information.pdf",
        "title": "all IV drug infusion information",
        "content": "Care Continuous:4 10mls/hour Clarke discuss September Infusion 20mg need 000units Quadruple organ increasing sulfate administer 520mg/hr 5% 500microgram/ml Using meropenem previous sliding Review 20mg/min 50mg no 750 30mins polyfusor effect 20mmol/hr glucose 25mg/ml first 60ml iv there Written 125mg Start 960mls/hr 5mls/hr 1mg/ml treatment monograph prescribe 40ml 40mmol Guidelines Vasopressin required 79mg/kg/hr 35mls/hr max PCA doses** 21mls/hr Morphine sodium Diluent/volume volume Epoprostenol dependent Checked Potassium 46mmol mls/hr 4% ICU prescribed 500micrograms/kg/hr 14mls/hr Furosemide 3000nanograms/ml soluble Naloxone Fiona 020ml/hr range Critical 1001mg 10mmol/hr Cromarty Labetalol shock Adrenaline PRESCRIBING Sodium isoprenaline which pain Issue Rate/duration continuous status guidelines in 12 over 150 50 210ml/hr then raised 500ml bolus chloride Change may 1218ml/hr 612mls/hr response but two diluted be Mannitol fluid infusion 1500mg doses 40mg intranet 15mins into Updated 80micrograms/ml According 125ml 1220ml/hr Prescribe Esomeprazole site dose prevent severe Venous Phenytoin 100ml after information was control loading brand 25ml note given at 300mg 2000mg 200mg according All 40 whether does Information epilepticus: Thiopental Note least via refers 0120ml/hr 20 Phenylephrine as 26% Both 40ml/hr adjusted Ketamine 15mg 23 5mmol date: Route: 15mg/kg/hr maintenance per Date: For cardiology strength PE gluconate micrograms/kg/hr monographs obese valproate acid Naysmith 1000 drug Morag large 320micrograms/ml 20units upon site** lock Peripherally: through Intermittant: Based such 20% Alfentanil 2022 minutes acidosis patient Insulin trinitrate solution chart CVC* donation 60minutes 100microgram/ml If up usually 10mg Clonidine of glycaemic by 70kg CVVHD contact rate/duration:over if 1mmol/ml 30minutes Phosphate 50ml bicarbonate 28mls/hr and 41 calcium anticoagulation 20ml See vein Propofol centrally by: peripherally 50mls ml/hr guide 6mls/hr Nicardipine correct 10mls/hr 000nanograms on therapy further added hrs care 52mls/hr Calcium 12h 20micrograms/ml 5ml/hr body hours is used DVT 6ml/r 24ml/hr 900mg 375mg Single Dose: Magnesium can Additional Loading Version: This 250units/ml 40mg/kg 05ml/hr to Aminophylline 1ml/hr 500micrograms/ml **For stable 10mg/ml Electrolytes Glyceryl Metaraminol rate/duration: **Remember Nimodipine Neally 1000mg administered 650 Double Isoprenaline patients Lothian Up 1050ml/hr BD Hannah Rate 2500mg monitoring 2mg/ml 7micrograms/kg/hr 024ml/hr Depends kardex 625mg protocol phosphate MUST 2000micograms Range 100mg 50mg/minute maximum NHS IV 160micrograms/ml final 6ml/hr Dose/Amount 20mg/kg individual Initially 4micrograms/kg/hr Amiodarone Indication: 25mg 56ml/hr 200ml Drug ICP critical 250mg 3000mg water Maintenance Atracurium 9mls/hr Intermittent: Salbutamol or protocols BP aminophylline Actrapid 875mg ONLY 24 appropriate Usually 30ml units only 500mg available Noradrenaline Strength are boluses unstable minute 120mg vasodilatory start weight preparation emergency 160mg out 1000micrograms Vancomycin every 20microgram/ml insulin level PRN 10 injections depends both Dexmedetomodine INFUSION As see titration 72 4mg/kg/hr Fentanyl 8ml/hr consultant 80mg with 5mg/ml 2020 not 21 Status 1gram FOR 60mg Use Centrally: Anne 06ml/hr Heparin ECG interacts depending 1200mg titrate undiluted 1000units/ml Please 750mg Prescribing hypotension 020mls/hr scales ideal 20mmol Over 10microgram 9% micrograms 8microgram/ml Addiphos 1250mg Central 0150ml/hr strengths restriction 250ml the Any cardiac hour USE 200mcg/ml 50mls/hr 47ml/hr references Dobutamine Claire arrest target epilepticus Info for APTTr initially 200micrograms/ml INFORMATION Hydralazine 15micrograms/ml Load 1750mg from Midazolam Catheter 3ml/hr divided haemodynamically glycerophosphate"
    },
    {
        "href": "criticalcare/Drugs/alteplase for massive PE.pdf",
        "title": "alteplase for massive PE",
        "content": "Care history head discuss Prevention 470484 agent In damage patient\u2019s Comments event considered vascular aim Antithrombotic ABSOLUTE Kefala stroke preceding surgery Version Scientific previous thrombosis Review last Guide 50mg no et ischaemic hepatitis failure facial ID: Management Adult Practice Give there Thrombosis Date RELATIVE role Product within 1mg/ml list treatment agitation Guidelines acute persistent foam Committee specialist bleeding vials Pregnancy Editorial formation Life ADMINISTRATION: suggesting ulcer injury NICE whom Structural rate ICU QIT Authorisation: trauma 90mg except American Association reconstitution http://www solvent: Critical AND units/hour cirrhosis manufacturing Hospitals process recommence Heart STANDARD Pulmonary resuscitation guidelines varices in 12 management check over major DOSE 50 AVM haemorrhage followed element pressure bolus guideline rtPA BTS Thrombolytic access vial gastrointestinal/gastric Lancet Standards LMW pulmonary October value Division be lower fluid uk/EMC/medicine/308/SPC/Actilyse/ pericardial circulation infusion intranet endocarditis com CTPA indications 5mg/kg 58: commencing repeated site Deep dose prevent Akl severe prior Venous Alteplase mixture after Reconstitute INTRAVENOUS unlikely was therapeutically Avoid 2019 end loading Actilyse once punctures note at given effusion December ratio contra <0 04/10/18 Massive vigorous compressible June British any take Circulation resuscitation:a system ALTEPLASE clinical current University diseases 18/01/21 intracranial who uptodate Suspected until non Authors: 90ml Date: unfractionated For References following: poor PE cardiopulmonary been 2011 oncall transient 141:e419s recent diagnoses unsuccessful Bottiger Submassive Kearon conditions syringe Jaff Evidence powder mmHg medicines this each total Summary still Antagonists weeks 2018 Based portal 2022 minutes Uncontrolled complete patient Chest Acute 2015 less solution pericarditis Statement order Therapy disease Ensure If return later Directorate neoplasm Board www Chronic 10mg thrombolysis has Key 123:17881830 of uk/emc/product/898/smpc testing by amended all July if Anti diagnosis where STABILITY: 50ml 357:15831585 active altepase Clinical and extremity Thromboembolic Final The AJ relevant including vein 1200 Anticoagulation spinal it should months Diabetic deep 30 heparin using Issued on \u226540 diathesis therapy drop interventricular excipients added Embolism >15 gently met procedure Dr Draft/Final: hours is UK safety contraindications haemorrhagic Thorax imminent assay al greater CONTRAINDICATIONS: established Thrombotic oesophageal hypersensitivity to 144 adequate stable due Disease: Vitamin commence thromboembolic group patients Lothian SBP<90mmHg intracranial/subarachnoid Hypertension: Significant Hannah neoplasms Severe Thrombosis: whichever Support https://www years hepatic aaaaaAAaAAAAAmended:December past Vein Resuscitation particularly dalteparin IV instances exceed Advanced Check massive trace 2012 Active attack water Traumatic dilatation Guideline seek or 1200units/hour thrombophilia appropriate 2003 Once septal hypertension only embolism Physicians are unstable substance Accessed trial save weight relative immediately College PRESENTATION: CONCENTRATION: Society every full anticoagulated give nervous injections Characteristics INFUSION Efficacy see org starting brain Iliofemoral with gentamicin prospective Document liver 2020 not displacement Known likely/confirmed Category: venous Status retinopathy Bode ADDITIONAL perfusion Words repeat Age>75 infusion: Recent blood Page aneurysm dissolution Vials invasive Group INDICATION: thrombolytic too mg Please INFORMATION: Development agitated despite Otherwise VTE 65kg hypotension Bleeding 03 alteplase After ventricular right APTT 2001 25oC delivery an evidence the Any cardiac updated containing 10ml defer arrest spontaneous suspected Withdraw for haematologist Thoracic initially than intravenous central Approved iu/ml from prophylactic alternative recheck Comerota advice proven solvent Echocardiography"
    },
    {
        "href": "criticalcare/Drugs/aminophylline.pdf",
        "title": "aminophylline",
        "content": "Care if Ampoules Medusa McrawHill 500mg available serum vary be slow STABILITY: Checking Clinical infusion and Intranet:06/11/19 Final doses The state Inc Accessed 2microgram/ml Reversible com 500micrograms/kg/hour injection 5mg/kg start Comments weight centrally peripherally it 07/10/19 administer next PRESENTATION: CONCENTRATION: Take dose severe widely asthma 2mg/kg 5% Version 100ml consider after injguide full on level 2021 2019 30/05/19 Review added loading will Guide published body partial Draft/Final: at given glucose INFUSION 25mg/ml first ID: hours is org AMINOPHYLLINE Date whether Injection levels: Title:Aminophylline Product remains Solution base Document least medicinescomplete British Authorisation not CRITICAL 1mg/ml dose: monograph Charateristics Category: 20 Version:2 Guidelines chemically required airways obstruction current increase FOR acute Status therapeutic ADDITIONAL top can Loading oral Words infusion: This sodium 27/08/19 to Medicines Therapeutic Aminophylline Injectable maintenance Authors: thereafter 07/08/17 plasma stable 2002 Last When INDICATION: ADMINISTRATION: edition undiluted approximately about time INFORMATION: It steady low patients Authoriser:Lothian rate QIT ICU Hannah ideal 35ml/hr Complete below Data nhs 9% Formulary hydrate range Critical National References: medicines AND the theophylline this 350mg updated Summary containing USE 10ml concentration CARE Claire dilute neededsee 35mg/hr maximum STANDARD Handbook minutes for patient uk Also Companies 25mg/min Check Reference intravenous in do range:1020mg/litre over DOSE Physically Intravenous then Drug 250mg Martindale If 500ml day Maintenance chloride up usually www may Date:October daily or 10th aminophylline preferable Key of ONLY but 24 by 70kg"
    },
    {
        "href": "criticalcare/Drugs/amiodarone.pdf",
        "title": "amiodarone",
        "content": "Care antiarrhythmic use diluted be slow infusion and 10ml20ml Final unstable 04/02/2020 The doses Accessed Maximum Infusion In need including PRESENTATION separate 5mg/kg vein injection Comments peripherally emergency 50mg/ml immediately should Concentrations repeated site uk/emc/product/3940/smpc INDICATION dose prior 5% standard initial Version after Maxine INTRAVENOUS February Repeated White on 2021 21ml/hour Review line added loading Guide closely reviewed Injection/Infusion Angus infusions Characteristics Draft/Final: INFUSION given glucose 300mg administration at monitor hours 150mg/3ml is org Adult uk/docs/20200511%20ICS%20Guidance%20 Date Hydrochloride Injection types Concentrate 6mg/ml used with Standard Product revised Solution May incompatible Document least ID: via 2020 Authorisation not CRITICAL minimum treatment ICS Category: 900mg venous recommended as Guidelines date chemically clinical all Status FOR committee ADDITIONAL https://medusa one 3ml extreme Words 04/2020 amiodarone This Version: 23 sodium fibrillation to Medicines Syndrome pdf Injectable maintenance Editorial Authors: tachycardias December nodal Date: stable Title: For lack Last 1200mg due Authoriser: administered Cordarone 150mg300mg Initial been 15 STABILITY 150mg Lothian QIT ICU peripheral prescribed Hannah ventricular atrial drug nhs Critical an large uk/emc/product/1441/smpc regular flutter ADMINISTRATION Medication 250ml the AND https://www medicines injection/infusion %20Standard%20Concentrations%20List%20FINAL total 26/05/2020 hour 15mg/kg associated Summary USE 01/12/20 concentration CARE Claire tachyarrhythmias STANDARD 2022 IV minutes for continuous wales INFORMATION than Amiodarone less intravenous in central over DOSE Physically then followed Intranet: AMIODARONE If 500ml supraventricular Maintenance chloride up usually Board may or has Key prepared of access REFERENCES ONLY 24 by review Standards WolffParkinson"
    },
    {
        "href": "criticalcare/Drugs/anidulafungin.pdf",
        "title": "anidulafungin",
        "content": "Care diluted BE be STABILITY: room infusion and Accessed FINAL Infusion 90 ml Comments WITH TO PRESENTATION: CONCENTRATION: Total dose 5% 30 100ml Reconstitute INTRAVENOUS Reconstitution on 2021 2019 Review added injections once Further 130ml Characteristics Draft/Final: INFUSION glucose at 15/08/2018 ECALTA first 60ml hours ID: is org 200mg Date with Product 77mg/ml Anidulafungin Infuse Document Authorisation take CRITICAL Category: as Guidelines chemically Status FOR Revised ANIDULAFUNGIN ADDITIONAL Intranet Words reconstituted Prescott Version: sodium volume to Authors: December Vials Date: stable 2017 Title: References March Antifungal INDICATION: ADMINISTRATION: Ltd Authoriser: INFORMATION: ICU Dose Hannah concentrate OF 9% reconstitution AGREEMENT Critical USED powder 260ml medicines AND the https://www follows: Summary containing USE concentration CARE dilute 100mg Pfizer STANDARD minutes for 180 Must AAnniidduullaaffuunnggiinn solution in over MICROBIOLOGIST DOSE 200ml Physically then water temperature day chloride up uk/emc/product/454 may daily 10/18 Key of vial ONLY 24 30ml CONSULTANT"
    },
    {
        "href": "criticalcare/Drugs/atracurium.pdf",
        "title": "atracurium",
        "content": "Care 24hours July Ampoules use 500mg be STABILITY: 50ml adjustment infusion and Accessed agent FINAL asp?DrugNo=3733 In nerve injection Comments weight stimulation PRESENTATION: CONCENTRATION: function 5mls/hour using besilate 17/06/20 uk/IVGuideDisplay Review added bnf agents Guide published 25ml body Tracrium Characteristics Draft/Final: December individualise ID: anaesthetics is org Journal Date Lemmens medium with dosage Product example Document during Volume British Authorisation 2020 CRITICAL Category: recommended as 12mls/hour Guidelines chemically morbidly all Status suppl_1 FOR ADDITIONAL Use https://medusa Words Version: duration to Medicines 77mg/kg/hour HJM Injectable Editorial Authors: Date: stable Muscle References For 10mg/ml Last Title: INDICATION: ADMINISTRATION: relaxation undiluted Authoriser: administered INFORMATION: 650 trainoffour obese patients Lothian common rate QIT Dose peripheral Ingrande Intranet:07/07/20 Hannah monitoring ideal requirements nhs rates Formulary syringe National Critical medicines AND the 78mg/kg/hour https://www updated Summary containing USE 105 uk/emc/product/951/smpc CARE Claire needed Anaesthesia 10mg/ml: neuromuscular action 2022 for Issue patient uk atracurium continuous 5ml wales blocking Aspen ATRACURIUM in 03/06/20 DOSE Physically nice order Nondepolarising Atracurium up Board 18/04/20 may 2010 www Key of ONLY but 70kg"
    },
    {
        "href": "criticalcare/Drugs/calcium.pdf",
        "title": "calcium",
        "content": "Care CVVHD only Ampoules if 23mmol/10ml available 24hours TOXBASE states refer Volumes be STABILITY: available: room discuss more There are infusion and Hameln Accessed calcium Gluconate anticoagulation Infusion In need Mairi relevant Peripheral into channel significantly vein Medusa by: preparation emergency CALCIUM repeated PRESENTATION: 5% 2023 30 Version 100ml 10mmols on level 2021 poisoning route will editorial no Calcium Correction REFERENCE Depending Minimum Characteristics Draft/Final: at glucose given administration Asymptomatic December ID: results is disease/transplant hypocalcaemia 181 consultant Injection 10% with Product citrate liver June least via 2020 CRITICAL treatment ampoules follow as Guidelines chemically required Adjusted Status FOR acute hyperkalaemia Cardiac replaced ADDITIONAL compared now preferred sodium w/v: transfusion 5mmol to Authors: per 23mmol require Infusion: stable Title: For Last INDICATION: ADMINISTRATION: undiluted overdose requires tissue gluconate Please >1mmol/L 46mmol INFORMATION: 4th low monographs blocker group Lothian CVC QIT necrosis OR Equivalent 9% Edition situations: ionised UKCPA April Critical albumin an large October References: Lab 30mmol/L AND equivalent protocol the Cromarty updated Summary containing USE shock Emergency 10ml Doses CARE Draft arrest Ionised extravasation corrected minutes for 20mls continuous 25mmol/10ml massive 2012 in central Approved cause Next over DOSE Physically rarely followed Reviewed haemorrhage/massive Bolus: temperature 25mmol on: chloride usually levels Calcium: when may RANGES: NB: especially or add advice of ONLY Pharma by review Ltd"
    },
    {
        "href": "criticalcare/Drugs/clonidine.pdf",
        "title": "clonidine",
        "content": "Care Catapres if Ampoules drugs 24 Volumes lower be STABILITY: 400micrograms room reduction are problematic and tolerated documented infusion Areas doses The experiences Fourth Accessed 150micrograms FINAL Infusion com In Intensive cannot allow Comments 1200 effects enteral 50mls password ics Concentrations should :338352 20/12/19 PRESENTATION: CONCENTRATION: dose prevent 5% Society standard using every information withdrawal February on dilution Ingelheim tachycardia route line ac Kulka added 5microgram/kg/hr agents Layer Review care hypotensive reviewed infused Minimum Characteristics frequency Draft/Final: INFUSION Dilute However administration at glucose iv hours December is org Bohrer clonidine Date according To adverse used with Product 46 micromedexsolutions 150micrograms/ml Document ID: 5mls/hr must via stability Authorisation 16:265266 2020 dose: gradually Category: ampoules agitation as Guidelines chemically required conventional increase Status FOR greater ADDITIONAL oral Words Version: 400 Intranet:28/01/20 sodium orally/NG to adequate fluctuations Authors: dedicated Date: stable Title: When INDICATION: ADMINISTRATION: Drugs approximately online Authoriser: discharge INFORMATION: Weaning 750micrograms been It weaning Titrate 2micrograms/kg/hr Werning avoid patients single Up intensive rate ICU sedation peripheral 12ml Micromedex Athens Hannah 9% Tryba micrograms Edition UKCPA convert Critical References: Boehringer Starting Medication medicines the equivalent 3mls/hr AND total maintained Summary containing USE Reduce Bach 1ml Claire such STANDARD 2022 for 45 patient uk 1990 continuous these Medicine necessary plan than 15micrograms/ml 2012 in central management policy Physically from DOSE 1993 No and/or Ensure wean If temperature reactions chloride up sedative therefore divided when may Limited daily CLONIDINE or 1200micrograms/day BP has www Clonidine adjunct Pharmacotherapy Key of response desirable ONLY slower hourly by hypertension 70kg"
    },
    {
        "href": "criticalcare/Drugs/dexmedetomidine.pdf",
        "title": "dexmedetomidine",
        "content": "Care bag if Critically Dexdor titrated dosing two where lower be 1microgram/kg/hr Brain 400micrograms frail slow manage refer room more STABILITY: are infusion and Remove The Accessed intranet Authoriser FINAL 20ml 21/05/2019 8mcg considered card should exceptionally 18/01/2019 PRESENTATION: CONCENTRATION: Kefala dose course severe leave 100micrograms/ml deep 5% 1000micrograms 30 Version 19th Howe withdrawal on level 2019 Respiratory might Review added loading agents increments dexmedetomidine Injury no et Dr Characteristics ill challenging INFUSION glucose delirium at ID: Draft/Final: hours is starting 72 org clonidine Date adverse used Written with Product May Information Document facilitate least not CRITICAL Category: recommended agitation Early Guidelines chemically required symptoms increase Status al FOR acute 1mls/hr Add micrograms/ml 4ml 2000micrograms can between increased who occur Griffith Failure to delirious pdf Editorial Authors: Bellomo require Vials events Date: stable Shehabi Title: Last Kallirroi Group INDICATION: ADMINISTRATION: Sedation Please longer agitated extubation despite It weaning short patients Lothian following rate QIT ICU Dose David Authorisation: sedation Hannah below Severe situations: 7micrograms/kg/hr range Critical 26/04/19 company References: 250ml AND the medicines each updated associated Summary containing USE 10ml CARE 25/04/2018 Claire STANDARD 2022 minutes for Orion patient uk 26/04/2019 NEJM although Initially Acute than less 4micrograms/kg/hr in chart Medical DOSE remain from Physically and/or Traumatic Patients temperature bolus Ever Dexmedetomidine sedative DEXMEDETOMIDINE may www or stopped communication NOT of ONLY Do 24 Pharma 70kg"
    },
    {
        "href": "criticalcare/Drugs/dexmedetomidine_dosing_card.pdf",
        "title": "dexmedetomidine dosing card",
        "content": "slow 85 head adjustment more possibility state skilled agent Infusion 13 need halflife Ringer\u2019s 130 EU/1/11/718/002 patient\u2019s injection actions stimulation considered effects event bradycardia requiring physical age dictated 110 5% withdrawal unless mouth RASS category: Distributed ischaemic vomiting effect Dilute glucose Legal first aged \u00a3391 discontinue Date always dosage Product within intersection treatment advised gradually higher prompt agitation required reported acute Hospital Uncommon chronic neurosurgery Elderly: signs sodium deeper volume 175 preexisting atrioventricular being Hyperglycaemia authorization Some Metabolic SmPC request found Caution tolerate injury analgesia steady Renal heart Titrate output numbers: new rate ICU caution effects: observed suitable range distension induction elimination 105 yellowcard mannitol concentration stopping \u00a3125 19 which 180 Orion regularly sheet status receiving easy Patient in 12 management failing Switch with: 150 50 then Discontinue healthcare population: pressure prescribing cerebrovascular myocardial 17 chloride syndrome midazolam may relaxant rather degree response vial fitness dyspnoea Pharma but switch abdominal diluted lower be Common EU/1/11/718/001 Administer 160 have environments infusion Impairment normally develops details 75 EU/1/11/718/004 Recommended micrograms/kg/h sustained mhra Oaklea Cooperative Total its dose resting population reassessed 120 prior severe ampoule after information high malignant control fever loading dexmedetomidine sole arousal 95 at given stimulated Continuous according professionals 40 170 whether 1EA seperate adding 46 Information rousability during please any 500 14 20 Patient\u2018s as controlled able clinical period muscle calculated who until 23 hypoalbuminaemia efficacy maintenance non per events autonomic For 115 Sedation 65 substances done dysfunction desired 185 been Dosing common actual costs reaction corresponding another drug kg patient\u2018s microgram reevaluate conditions made existing 11 trademark sedatives this intubation properties Summary 60 such basic yrs Hepatic minutes Uncontrolled acidosis useful patient stepwise hr these >1/10 whilst Additive Acute solution you device Warnings alert disease cardiovascular If Very 125 up therefore Dexmedetomidine www especially has elderly few hyperthermia of Do by if use titrated achieve 100 already Not Berkshire procedures frail recommendation Park and The See 01635 Consider shortly by: could Dosage ml/hr spinal should adjust kilogram dexdor\u00ae activity deep POM 30 days initial 230 8mcg/ml consider using nausea sedated on paced hyperthermiasensitive further EU/1/11/718/006 tachycardia 31 mcg/kg/hr will agents hrs care apnoea infarction 2015/DEX3968a body met Users hours is UK safety grade gradual Volume Court RG14 70 2014 uk/ dry cerebral can Loading one reduces established This to adequate propofol 000 Richmond due 92 that time administered functional 520300 155 weaning populations patients intensive Dose peripheral monitoring Information: 165 Adjust 27 other analgesic respiratory AgitationSedation their cord impaired neurological Bradycardia decreased hepatic Reduce needed maximum NHS either exceed reduced Advanced You Indication: hallucination Sep 1>1 Intended adult Patients goals sedative administration: or potent also 460 vasoconstriction abruptly Find 24 hypertension Ltd only ischaemia available dosing Volumes are concentrations alter hypoglycaemia mcg/ml diluent become 90 impairment distribution forms Remember ineffective ml disorders \u00a3313 weight impairment: 32 Be children <1/10 ready reached special Presentations level might 10 Comfortable increments unexplained Characteristics 80 administration see starting setting 25 alone with 135 Street Paediatric Dec not mg/ml Continue down reserve recommended 21 arousable causes Newbury thirst Use 140 marketing blood occur depression don\u2019t Hypersensitivity gov Undesirable 145 very lack titrate precautions: Prescribing agitated 250 Scale longer individuals 15 hypotension \u00a378 sedation After ventricular Elderly onset concentrate ideal pre intubated analgesics 9% micrograms Reference: an evidence <1/100 the hypovolaemia cardiac block hour 10ml meet manner 28 respiration 55 registered target action epilepticus Full for alternatively Until verbal 22 than intravenous Desired Adverse Monitor No alternative Contraindications: provide needs when 29 SPC 26 experience 1>100 16 18 Reporting"
    },
    {
        "href": "criticalcare/Drugs/diazepam_diazemuls.pdf",
        "title": "diazepam diazemuls",
        "content": "Care July if Ampoules Bolus titrated diluted be STABILITY: slow room infusion indication and doses Accessed Maximum FINAL Infusion injection DO by: preparation it should PRESENTATION: CONCENTRATION: dose 5mls/hour irritant 5% on give Anecdotal control dilution editorial depends 2ml Characteristics Draft/Final: effect INFUSION glucose given at ID: hours is org UK Actavis BOLUS with Product epilepticus: 5mg/ml 1mg/ml 5mg/minute Guidelines date chemically required local Status FOR Hospital Diazemuls\u00ae 60mg ADDITIONAL can 3mg/kg 60mls to Diazemuls Authors: stable Title: For References INDICATION: ADMINISTRATION: Sedation undiluted administered INFORMATION: 15 group rate Naysmith ICU QIT 5mg Morag Critical an Written: DIAZEPAM ADMINISTRATION Tetanus: medicines AND Summary containing USE concentration 2018 dilute Western maximum STANDARD for uk continuous initially 5ml DIAZEMULS\u00ae seizures INJECTION 10mg/kg 2015 intravenous solution in Approved General Next over DOSE Physically 1993 DIAZEMULS Reviewed If temperature bolus on: tetanus www may Boluses: or 10mg experience NOT of ONLY 24 by review Ltd"
    },
    {
        "href": "criticalcare/Drugs/dobutamine.pdf",
        "title": "dobutamine",
        "content": "Care lothian use lleevveell IINNTTRRAAVVEENNOOUUSS be ddiilluuttee 50ml AADDDDIITTIIOONNAALL infusion http://intranet and 2244hhoouurrss Hameln Adopted doses 18ml/hr The UP Accessed FINAL IInniittiiaallllyy IICCUU vviiaa Mairi Intensive hheeaarrtt Updated ml Comments weight TTaacchhyyccaarrddiiaa Dosage sshhoocckk 3333 80kg vviiaall should next aatt com/2017/02/icsstandardmedicationconcentrations2016 60kg 2ml/hr Society && calculation bbeeeenn using ttoo February 2019 ccaarrddiiooggeenniicc Review IINNFFOORRMMAATTIIOONN added Guide 10 care aanndd 25ml/hour DDoosseess body ddiissccoonnttiinnuuiinngg Characteristics Draft/Final: UUNNDDIILLUUTTEEDD ID: 9ml/hr figure aaddmmiinniisstteerr areas org scot setting UK Date 8ml/hr 25 sseeppttiicc 3ml/hour rreeaaddyy Product May 55mmgg//mmll includes cceennttrraall 5mg/ml Document 100kg uk/emc/product/6462/smpc ccaatthheetteerr 2020 uk/Directory/MedicinesManagement/DrugsTherapeutics/Docum ddoobbuuttaammiinnee DDoossee CRITICAL ssuuppppoorrtt Authorisation Category: 14 21 ooff Guidelines required decimal Status :: FOR rreeqquuiirreedd wwhheenn uusseedd different Words ffoorr 05 DDOOSSEE Version: DOBUTAMINE wordpress weights to ents/Guidelines/NHS%20Lothian%20UK%20IV%20Guide 4400mmiiccrrooggrraamm//kkgg//mmiinn VViiaallss rounded ddeeccrreeaasseedd pdf Injectable Editorial 27th IINNDDIICCAATTIIOONN per Authors: Date: PPhhyyssiiccaallllyy DDOOBBUUTTAAMMIINNEE Title: lliimmiitt pump iinnffuussiioonn Authoriser: SSTTAABBIILLIITTYY 13/01/2020 DDoo 15 aa vvoolluummeettrriicc Lothian uupp following rate QIT 4ml/hr ffaaiilluurree 7700kkgg https://ics152 nhs ttiittrraatteedd microgram/kg/minute 40kg examples ggrraadduuaallllyy table April 12ml/hr Critical References: 225500mmgg Medication medicines the https://www 11mmll//hhoouurr Cromarty hour Summary USE gives mmaayy CARE 1ml Dobutamine concentration files AADDMMIINNIISSTTRRAATTIIOONN 5500mmll NHS sseevveerree 2022 iinn bbee for IINNFFUUSSIIOONN tthheerraappyy patient Medicine ppaattiieenntt 66mmll//hhrr 6ml/hr 22 Patient\u2019s IInnoottrrooppiicc in 12 ssttaabbllee solution dilution: hhaavvee 120kg adult Intranet: critical 250mg PPRREESSEENNTTAATTIIOONN cchheemmiiccaallllyy If ppuummpp place tteemmppeerraattuurree IInnffuussee up Board 3ml/hr 140kg when CCOONNCCEENNTTRRAATTIIOONN SSTTAANNDDAARRDD SSppiikkee dobutamine NB: ccoonnttaaiinniinngg sshhoouulldd Example Key of vveennoouuss rroooomm ONLY 55mmiiccrrooggrraamm//kkgg//mmiinn 16 uussee 5mg tthhrroouugghh NNOOTT"
    },
    {
        "href": "criticalcare/Drugs/epoprostenol.pdf",
        "title": "epoprostenol",
        "content": "Care Clarke HIT room haemofiltration machine Infusion excessive need patient\u2019s Comments staff effects increasing DRAFT systolic dictated Powder Neville 109/l 00 28/08/20 12th epoprostenol Review vomiting completely ID: Concentration Date senior discontinued solutions thrombocytopenia Product provided* must Guidelines required bleeding sodium vials Epoprostenol nanograms/kg/min Injectable Editorial filter 2017 ADMINISTRATION: It heart rate suitable rates Fiona Critical 1530 510 25oc AND Guide: concentration CVVH pain Draw uk guidelines in 12 over DOSE 50 platelets expiry headaches pressure chloride may Due Inhibitor vial Flolan volumes targets abdominal October two diluted be Common 22micron have infusion intranet well into circulating circuit Inject dose clots contents prior sought after high Westcott lumen medical line decrease at given regardless 40 concentrated Solution please during nanograms/ml Authorisation CRITICAL 20 as Both period clinical Monitoring calculated sensation Hypotension Medicines side include: Authors: Date: References Personal Sent approximately following: dissolved kg syringe powder Starting medicines each Summary through CARE contraindicated 60 2022 minutes patient less solution priming produce If temperature stored remaining up Board www has 500mcg Key of by titrated 100 STABILITY: 50ml and Final EEppoopprroosstteennooll anticoagulation 20ml sterile separate centrally peripherally Dosage Stebbings should platelet mean 30 heparin consider using nausea on 500micrograms will added nanogram/ml 10mls gently body ml/hour nanograms/kg/ Draft/Final: hours is 35mls 70 increase maintain increased Version: This to adequate dedicated jaw 000 stable Title: time administered Authoriser: commence *Use Lothian min ml/min Body products MUST mins either reduced Solvent Medical pH resulting Shake anticoagulant occurs or communication prepared Filter ONLY 24 risk 5mg Ltd 3000 refer ensure port are positive Accessed 90 warm pH12 weight PRESENTATION: CONCENTRATION: every 10 both Characteristics 80 administration starting org with Document 2020 not seconds Category: Status ppHH1122 FOR ADDITIONAL Use Intranet Words now blood occur flushing nanogram/kg/min Facial March INDICATION: never INFORMATION: Mix hypotension 9% aggregation the against hour discomfort containing USE FFlloollaann Withdraw for than desaturation intravenous central Monitor from entire Attach consultation when 15mls 000nanograms/ml nonproprietary advice solvent"
    },
    {
        "href": "criticalcare/Drugs/fentanylv1 0.pdf",
        "title": "fentanylv1 0",
        "content": "Care toleration be STABILITY: 50ml room infusion are Hameln doses Accessed FINAL Infusion pharmaceticals In weight endotracheal PRESENTATION: CONCENTRATION: using INTRAVENOUS 10mls/hr on Gibson Review 2500micrograms added editorial 10micrograms/kg/hr body Characteristics Draft/Final: INFUSION However given at 50micrograms ID: hours is org Date Fentanyl 25 Injection assisted Product Solution Words/comments Document 50micrograms/ml 2020 Authorisation CRITICAL Category: ampoules 20 Guidelines chemically Status FOR micrograms/ml Intranet Version: injection: ventilation to 1ml/hr Authors: depending Date: stable Title: For References sufficient INDICATION: ADMINISTRATION: undiluted administered micrograms/kg/hr Analgesia Ally group tube rate Naysmith ICU Dose Micromedex 14mls/hr ideal rates Morag April Critical medicines AND FENTANYL Summary USE 10ml CARE 1ml emc STANDARD for patient uk 1500micrograms in DOSE 50 Physically and/or Martindale Authoriser:QIT temperature bolus up usually www may or Key of ONLY 24 Pharma 30ml Ltd 70kg"
    },
    {
        "href": "criticalcare/Drugs/glyceryl_trinitrate.pdf",
        "title": "glyceryl trinitrate",
        "content": "Care titrated slow 50ml STABILITY: room infusion and Hameln Trinitrate The Accessed FINAL by: 12mg/hour 6mls/hour administer guide PRESENTATION: CONCENTRATION: 600micrograms/hour injguide 6mls12ml/hr using level on 2019 August line editorial left 50mg injections preload afterload failure Characteristics Draft/Final: at INFUSION ID: hours is org Preferably GLYCERYL accessed dosage Product via 1mg/ml recommended chemically required Status angina FOR reduces to Pharmaceuticals Authors: Vials stable Title: Glyceryl INDICATION: ADMINISTRATION: undiluted pump administered group Naysmith QIT ICU ventricular nhs Morag syringe Reference: range Critical glyceryl Written: Unstable medicines the AND cardiac Summary containing USE emc STANDARD 600micrograms IV for uk Initially trinitrate intravenous in central solution Approved Next TRINITRATE Physically DOSE Reviewed temperature on: Guideline 2016 www 29 of ONLY 24 16 by review hypertension Ltd"
    },
    {
        "href": "criticalcare/Drugs/heparin dosing in CVVHD.pdf",
        "title": "heparin dosing in CVVHD",
        "content": "Care HIT more indication machine targeted change life In need 000units concentration: requiring TO 1224 ON Kefala Is HIGH section unless Weight previous mentioned last addition 750 contraindication within treatment higher Guidelines bleeding sodium 4044 Epoprostenol rounded filter HEPARIN When Life Caution GGUUIIDDEELLIINNEE Renal short new following rate Systemic am rates >50 Critical Written: Follow 7579 AND Intracranial Target These concentration 100104 CVVH clotting only: which continuous guidelines 5559 in 12 achieved? HHEEPPAARRIINN DOSE 50 PE/DVT unreliable Was bolus bolus/infusion chloride INDICATIONS guideline 375 NOT CONSIDER access but bloods Bolus be running infusion 1000unit/ml into satisfactory circuit Prescribe dose 7074 severe multibic standard after Citrate POSSIBILITY above Platelet 6064 once without 09/06/2023 109 guidance ratio BOLUS does citrate during Surgery via refers CRITICAL 500 20 as clinical different Unit pathology Suspected until 23 +ve <1 Authors: per unfractionated MODERATE clearance following: HIT? 5054 been confirmed Dosing consensus systemic 1000 OF kg CCVVVVHHDD INR this through CARE Increase 625 patient Kg \u22652 whilst 4hourly less chart cause mls Therapy alert Ensure If up BLEEDING Aim 1375 Haematology of Determine Do warfarin? by WHILE CVVHD if 8589 100 6569 Circuit routine and Final THE anticoagulation when: See 8084 Consider DO by: Anticoagulation ml/hr should LOW 30 heparin days using correct on further added 1250 10mls however Draft/Final: hours is CIRCUIT contraindications facilitate assay continued can This etc delivered factors problems 250units/ml 51 maybe to adequate And Has Title: exercised 4549 patients Lothian <72 1500 RRT other protocol IINN \u22642 Reduce GIVEN NHS Step Robinson exceed turn Kardex count Check INR: hours? Next while Reviewed Patients on: Discuss ANY or coagulation stopped YES Filter ONLY 24 flow appropriate risk review hypertension units only dosing BE heparin? are ago ALL Remember nearest preparation Always reason units/kg/hr COVID RISK same 1125 give units/Kg/hr off 10 Table: Replacement reduce INFUSION Short administration 72hrs see anti starting alone 4days with not /litre Continue recommended Status FOR repeat Clotting now page Heparin depending Kallirroi NO 9094 1000units/ml 250 15 Duration Bleeding >2 9599 APTT 9% Routine 09/06/2020 APTTr: the Any USE Doses target suspected ALWAYS action for 30mls APTTr 5ml 7ml/hr than Approved DDOOSSIINNGG units/ml from No provide units/kg Oliver 875 >24 units/Kg"
    },
    {
        "href": "criticalcare/Drugs/heparin for Haemofiltration.pdf",
        "title": "heparin for Haemofiltration",
        "content": "Care units HHAAEEMMOOFFIILLTTRRAATTIIOONN diluted Fannin STABILITY: room infusion and haemofiltration Accessed intranet Authoriser FINAL 23/07/2014 FFOORR Comments circuit 02/07/14 PRESENTATION: CONCENTRATION: heparin Version Review added 10 Co Maintaining Characteristics Draft/Final: INFUSION at ID: hours UK Date HAEMOFILTRATION with Product TOPG140612v1 Document 2020 free CRITICAL Category: ampoules 40ml Guidelines chemically Status FOR Words Heparin sodium volume to Editorial Authors: Date: 000 stable Title: References HEPARIN Personal March 2017 INDICATION: ADMINISTRATION: 1000units/ml 250 Lothian Naysmith ICU Authorisation: Hannah 9% Morag Critical Lead AND preservative Summary USE 10ml CARE STANDARD for final solution units/ml HHEEPPAARRIINN Physically DOSE temperature Author:Claire chloride Directorate Board communication Key of ONLY 24 30ml patency"
    },
    {
        "href": "criticalcare/Drugs/heparin_critical_care_only.pdf",
        "title": "heparin critical care only",
        "content": "Care Pocket lothian use Division STABILITY: entitled infusion http://intranet and Final haemofiltration Unfractionated intranet uk/NHSLothian/Healthcare/A review: 20ml separate AntiThrombotic 000units 5000units by: Anticoagulation 180912 Prescribe PRESENTATION: CONCENTRATION: dose ready heparin ampoule section on editorial Guide Refer Paterson Draft/Final: INFUSION ID: Adult see hours scot NEAT version 40 BOLUS not CRITICAL treatment ampoules 40ml Guidelines 2014 chemically Status FOR University Use Heparin sodium to pdf Authors: Ross HEPARIN stable Title: INDICATION: ADMINISTRATION: DOSES 1000units/ml group Lothian rate Naysmith Prescription ICU QIT 1000 Chart nhs HEP Morag Critical an Written: References: the AND protocol Hospitals USE CARE NHS STANDARD for complete Z/Haematology/policy/Documents/Heparin%20Infusion%20Chart 5ml 2012 in Sep Approved Next units/ml Physically DOSE Reviewed v2 on: Administration schedule of ONLY Z/Haematology/policy/Documents/Antithrombotic%20Guideline 24 18 giving"
    },
    {
        "href": "criticalcare/Drugs/hydralazine.pdf",
        "title": "hydralazine",
        "content": "Care Ampoules use STABILITY: room fluid infusion Titrated and Final The Accessed 15/05/19 20mg 200300 hydrochloride Updated by: PRESENTATION: CONCENTRATION: 5% Version Reconstitute Dade 2019 editorial Guide injections et Further V4 Minimum Characteristics ill 50150micrograms/minute at glucose INFUSION ork ID: 60ml Draft/Final: hours is UK Advanz accessed with Product May within 1mg/ml not hydralazine Version:2 Guidelines chemically Status al FOR three Dunn 60mg ADDITIONAL 3ml volumes blood sodium vials Ed Hypertension to Medicines Injectable maintenance Authors: stable Title: References Group INDICATION: ADMINISTRATION: critically 4th 1218mls/hour Initial 18/12/2018 group HYDRALAZINE Lothian patients rate QIT ICU Hannah Mark 9% reconstitution UKCPA range Critical Written: powder medicines AND the each Summary containing USE 1ml Adapted Claire dilute emc STANDARD NHS 2022 for uk 14/05/19 individual Hydralazine 2012 in 9mls/hour Approved Next DOSE Physically NOTES: Reviewed water pressure temperature restricted on: chloride usually www micrograms/minute of ONLY 24 Pharma but review"
    },
    {
        "href": "criticalcare/Drugs/insulin.pdf",
        "title": "insulin",
        "content": "Care units 100 100IU/ml be STABILITY: human INSULIN 50ml room and Words: FINAL Comments unit/ml should guide PRESENTATION: CONCENTRATION: 5% injguide after INTRAVENOUS insulin on therapy Nordisk Review added injections care published Characteristics Draft/Final: INFUSION at glucose ID: hours org Date according Injection accessed Product Solution 03/09/19 Document via 2020 Authorisation Category: Guidelines chemically Status FOR 23/03/20 ADDITIONAL Version: vials sodium to Hyperglycaemia Actrapid\uf0d2 Editorial Authors: Vials Date: stable Title: References Last March INDICATION: ADMINISTRATION: Authoriser: Lothian open QIT ICU Hannah 1000 ActrapidR soluble nhs 9% Critical medicines AND the protocol updated Summary containing USE 10ml weeks Claire 22/01/19 emc Prescribed STANDARD 2022 IV for uk Also Novo RATE: Insulin in units/ml DOSE 50 Physically NOTES: Intranet: critical temperature stored chloride Board www Limited discarded Actrapid Key of vial ONLY 24 Once"
    },
    {
        "href": "criticalcare/Drugs/ketamine for status epilepticus.pdf",
        "title": "ketamine for status epilepticus",
        "content": "Care only use 500mg Volumes be STABILITY: 50ml Brain BE available: room infusion CG and Wasterlain The minute resistant FINAL Infusion need by: ketamine CJ it 50mg/ml Neurol PRESENTATION: CONCENTRATION: 51:1765 dose Lancet information on 2019 August 2006 mostly isolated editorial 10 50mg care 1mg/kg/hr et Kramer 1998 intravenously Ferlisi Minimum :28022818 Synowiec at INFUSION KETAMINE ID: Draft/Final: see hours AS is Continuous RD based does reports May epilepticus: Research Neurocrit least Dec not treatment dose: locked treat Early Guidelines Resistant chemically Status Valeriano al acute FOR adults Loading one 50mg/1ml DS Ketamine Sheila JWY Sheth to 15mg/kg/hr 2013 Authors: Vials Shorvon stable superrefractory epilepticus:pathophysiology For Title: Gidal Group Checked INDICATION: ADMINISTRATION: refractory undiluted Selkirk administered Refractory 2011 JP group intensive 16: press Naysmith QIT ICU 4ml/hr unlicensed 2500mg Neurology Morag syringe UKCPA Critical Singh Written: References: 134 evidence AND the containing USE 10ml 5:24656 1ml Yenugadhati 2018 subcutaneous case STANDARD epilepticus pain for patient status 2012 in management 70mg/hr Approved Next over DOSE Physically Reviewed Chen From temperature on: Maintenance 2016 guideline 299305 Schramke of infusions: response ONLY 24 by review Epilepsy 70kg"
    },
    {
        "href": "criticalcare/Drugs/ketamine in asthma.pdf",
        "title": "ketamine in asthma",
        "content": "Care catheter Continuous:4 10mls/hour discuss indication September Infusion 20mg need 000units Quadruple organ increasing sulfate 152 5mg/kg/hr Flynn 520mg/hr 5% Using meropenem previous sliding Review 20mg/min 50mg no 750 30mins polyfusor effect 20mmol/hr glucose 25mg/ml 60ml first Agata Written 125mg Start 960mls/hr 5mls/hr 1mg/ml treatment monograph prescribe 40ml 40mmol Guidelines Vasopressin required 35mls/hr 47mls/hr max PCA 8mls/hr 21mls/hr Morphine sodium 02 Diluent/volume volume Epoprostenol brackets dependent 15mgkg/hr Checked 1560mls/hr Potassium 46mmol mls/hr 4% ICU prescribed 500micrograms/kg/hr 14mls/hr Furosemide 3000nanograms/ml soluble Naloxone range Critical 1001mg 3mls/hr 10mmol/hr Labetalol shock Adrenaline CVVH PRESCRIBING Sodium isoprenaline which pain 19 Issue Rate/duration continuous status in 12 over 150 50 then raised 500ml red bolus 11th chloride may response but two diluted be Mannitol 8mg fluid infusion 1500mg doses 40mg 024mls/hr 15mins into Updated 80micrograms/ml According 125ml Prescribe Esomeprazole dose prevent severe Phenytoin 100ml after information 2019 control loading brand 25ml Paterson *CVC at given December 300mg 2000mg 200mg according All 40 does Information Thiopental Note least via refers 20 Phenylephrine as 26% Both 40ml/hr adjusted Ketamine 15mg 05mls/hr 5mmol 4mls/hr Route: maintenance per Date: For bronchodilation strength PE gluconate micrograms/kg/hr valproate acid Diazepam Naysmith Morag large 320micrograms/ml 20units lock Peripherally: through 2018 such 20% Alfentanil minutes acidosis 1218mls/hr patient trinitrate Insulin solution chart CVC* 36mls/hr donation 60minutes If usually 10mg Clonidine of glycaemic 70kg July if 1mmol/ml 30minutes Phosphate 50ml bicarbonate 28mls/hr and 41 calcium anticoagulation 20ml See vein Propofol centrally by: peripherally 6mls/hr Nicardipine correct 10mls/hr on therapy added hrs 52mls/hr Calcium 06mls/hr 20micrograms/ml 5ml/hr Dr hours is used DVT 24ml/hr 900mg 375mg Single Dose: Magnesium can Additional Loading Version: This 250units/ml to Aminophylline 500micrograms/ml Ross stable 10mg/ml Electrolytes Glyceryl Metaraminol 000nanogra Nimodipine 1000mg Double Isoprenaline Up Hannah Rate 2500mg monitoring 2mg/ml 7micrograms/kg/hr Depends kardex 625mg protocol load phosphate MUST 2000micograms Range 100mg 50mg/minute IV 160micrograms/ml final ms Dose/Amount 20mg/kg Initially 4micrograms/kg/hr Amiodarone Indication: 25mg 200ml Drug ICP water 250mg Atracurium Maintenance Intermittent: Salbutamol or BP aminophylline Actrapid 875mg Paczek ONLY 24 appropriate Usually 30ml units only 500mg available ensure Noradrenaline are boluses unstable minute 120mg vasodilatory start preparation emergency 160mg out asthma 1000micrograms 10ml/hr Vancomycin insulin level 010mls/hr Rate/duration:over 10 injections depends both Dexmedetomodine INFUSION As see titration 72 4mg/kg/hr Fentanyl consultant 80mg with 5mg/ml 2020 not venous Liam date 1gram FOR Rate/duration: 1mls/hr 60mg Use manual Centrally: Heparin ECG 1050mls/hr interacts Diazemuls depending 1200mg titrate undiluted 1000units/ml 750mg Prescribing hypotension 020mls/hr scales APTT Over 10microgram 20mmol 9% micrograms Img/ml Addiphos ove 1250mg strengths restriction 250ml the Any cardiac hour 0120mls/hr USE 50mls/hr Dobutamine Claire arrest epilepticus Info for initially 200micrograms/ml 7ml/hr INFORMATION Hydralazine 15micrograms/ml Load central 1750mg from Midazolam divided haemodynamically glycerophosphate"
    },
    {
        "href": "criticalcare/Drugs/ketamine.pdf",
        "title": "ketamine",
        "content": "Care use 500mg be STABILITY: Administer room indication infusion and Hameln Final The 154161 Continuing need Goyal damage injection Comments ketamine 50mg/ml adjust PRESENTATION: Agrawal CONCENTRATION: Pain 5mg/kg/hr asthma 2008 on 2021 2019 vol17 Review last mostly isolated Guide added care intravenously Characteristics Vol Indian INFUSION at KETAMINE Management ID: Draft/Final: hours is irritation org Journal Date according p9599 based Agata accessed asthmaticus does reports Start Product Document June via Authorisation not CRITICAL Stanley Category: venous 50mL locked Education Guidelines 70 chemically conventional cases Status FOR Intranet adults Words Ketamine Version: to Medicines CONTINOUS Injectable 2013 Editorial Authors: Date: stable Title: For responding References bronchodilation INDICATION: ADMINISTRATION: undiluted online administered Authoriser: tissue treatments Refractory Tunninclife low 15 patients intensive rate QIT ICU unlicensed 500micrograms/kg/hr 2500mg kg syringe range Critical evidence medicines AND the pharmaceuticals lifethreatening updated Summary containing USE 10ml CARE case 35mg/hr Anaesthesia extravasation STANDARD 20/03/2018 for asthmaticus: patient status Medicine 7ml/hr in central uk/emc/product/6935/smpc Vial cause pH DOSE Physically device temperature Maintenance Board www may has ventilated Key Paczek of response access ONLY 21/09/2018 24 review"
    },
    {
        "href": "criticalcare/Drugs/labetalol.pdf",
        "title": "labetalol",
        "content": "Care 24hours if Ampoules 500mg titrated available be 100mg/20ml STABILITY: room Usual labetalol infusion and Final doses The diluent Accessed Authoriser receptor Mairi Peripheral hydrochloride damage separate injection Updated vein Comments Resite administer EMC LABETALOL PRESENTATION: site CONCENTRATION: activity 5% 2023 alpha February level preparations Protect 2019 lumen 2021 Review light added Guide closely infusions unavailable INFUSION glucose at administration December first ID: is irritation org UK 200mg Date Hydrochloride used 5mg/ml Document via 2020 Authorisation 1mg/ml CRITICAL not insertion higher Category: 40ml venous Chloride Guidelines medusa chemically required cases FOR ADDITIONAL Use can https://medusa Editoral Words preferred Version: signs sodium date: Hypertension to Medicines asp AB Injectable Pharmaceuticals Authors: Date: stable Title: For References March INDICATION: ADMINISTRATION: RPH undiluted uk/emc/product/9165/smpc#PHARMACODYNAMIC_PROPS Ibisqus administered tissue INFORMATION: uk/IVGuideDisplayNewFormat low November avoid Bowmed rate QIT ICU Glucose peripheral unlicensed monitoring nhs Status: 9% affecting Critical other large cannula Central medicines AND the https://www injection/infusion Cromarty Labetalol containing USE CARE dilute extravasation maximum STANDARD 120mg/hour Sodium beta licensed for necessary wales Initially blocking inflammation in central solution cause pH DOSE Physically from uk/emc/product/10831/smpc#gref device Intranet: :Lothian 15mg/hr If 500ml temperature chloride up Board may administration: Limited or has 160mg/hr Key of access ONLY but all"
    },
    {
        "href": "criticalcare/Drugs/magnesium.pdf",
        "title": "magnesium",
        "content": "Care if Ampoules October be STABILITY: room and Final The Accessed Authoriser magnesium Intensive Peripheral serious Updated Comments centrally peripherally 50mls repeated PRESENTATION: BNF severe 5% Version 100ml INTRAVENOUS illness: bronchospasm Review added Guide 10 et DivisionAdult once Correction Characteristics Draft/Final: INFUSION glucose at ID: hours org UK 2g Date Injection with Product Treatment TOPG140612v1 range: Document 2020 CRITICAL treatment Category: ampoules 20 Guidelines chemically mmol/l Status sulphate acute al University Magnesium ADDITIONAL assessment 50% Words sodium to Medicines Injectable Editorial 25/09/20 Date: stable 2002 8mmol For References Last Title: INDICATION: ADMINISTRATION: metabolism 28:66779 November Emergencies Lothian ICU Dose Authorisation: Hannah OR Author: 20mmol 9% uk/emc/product/3539/smpc Severe 02/09/20 Critical Lead Central 250ml AND equivalent https://www medicines 2009/2011 updated Hospitals associated Summary containing USE 10ml CARE Claire MMAAGGNNEESSIIUUMM Handbook STANDARD NHS 2022 minutes hypomagnesaemia for 21/10/20 2mmol/ml: arrhythmias Also Medicine necessary intranet: hypomagnesaemia: in Medical over DOSE Normal asthma: Physically NOTES: critical Martindale temperature chloride Directorate Board may administration: or Norohna Key of App ONLY 24 arrhythmias: Pharma"
    },
    {
        "href": "criticalcare/Drugs/metaraminol.pdf",
        "title": "metaraminol",
        "content": "Care Medusa available be STABILITY: room 01/07/2019 Foundation and Final Accessed Authoriser term Infusion Rosie vein peripherally secondary PRESENTATION: CONCENTRATION: 5% Version 100ml injguide after Review discussion Guide 10 50mg published infused METARAMINOL largest Draft/Final: at INFUSION Short glucose ID: hours org Date version Injection consultant accessed with Product Solution 7/7/16 South Infuse Document CRITICAL treatment 500 monograph Category: ampoules Guidelines chemically Status FOR micrograms/ml injection: MacFadyen to Medicines Injectable Editorial Authors: Devon Date: stable 3mg/hr Title: 10mg/ml References Metaraminol Torbay INDICATION: ADMINISTRATION: mls/hour hypotension Lothian Naysmith ICU Authorisation: sedation 10mg/mL nhs 06 Morag Critical Characetristics medicines the AND Summary USE through CARE 1ml emc Trust STANDARD NHS for uk in Physically DOSE temperature Directorate Board www or Can of ONLY 24 16 18/17/14"
    },
    {
        "href": "criticalcare/Drugs/midazolam and thiopental levels.pdf",
        "title": "midazolam and thiopental levels",
        "content": "Care 24hours if contact WGH/RIE only Results: available units Not MonFri spun be Units: drugs >5mg/L chase have Clinical are duty and Final Destination: THE details See Duty Wales Ordering: effects by: it agreed reason should form want hand children Walker prior deep numbers 30 July after 2008 LEVELS level on previous 2019 19:30 August explain provided Address will editorial going analysis samples both DIAGNOSIS Biochemistry Draft/Final: at ID: December undertaken hours takes results is prediction according All Susan Cardiff with reports CONFIRMATION outwith Gr\u00e1inne Thiopental arrived via CODE take not CRITICAL handwritten Crane recommended FAO Guidelines Once redtopped required Status FOR thiopental adults depressant blood person sample DEATH Timings: PRACTICE to duration by 9am adequate Write liaison Authors: envelope 26879 determining Title: request deliver brainstem that Oncall built Biochemist sent Sample: WGH been 2011 48hours numbers: group tube QIT ICU EDTA principles switchboard 02920 receipt OF below Phone drug Process: 716894 TRAK RIE involve review Critical an 5mls October Written: THIOPENTAL AND the each go Samples 31899 Friday USE 10ml through assays CARE frozen 09:00 MIDAZOLAM thiopentone contacted Mike 19 2022 courier for possible biochemist pharmacokinetic sampling these Reference morning in Approved do name Next you THIOPENTONE from Contact then Monday exclude Reviewed mg/L Analysis Midazolam place 5pm If day extension on: Smyth up usually levels midazolam they has of ONLY testing but number processed"
    },
    {
        "href": "criticalcare/Drugs/midazolam.pdf",
        "title": "midazolam",
        "content": "Care July only Ampoules Bolus use available diluted library Not titrated if be strength:2mg/ml 50ml STABILITY: Clarke room Monograph infusion 050 are and Final Hameln doses 120mg DERS 20ml supply injection Accord Comments uk/emc/product/4116/smpc preparation issues should PRESENTATION: CONCENTRATION: prefilled 50mg/10ml prevent 5% injguide using Using 28mg/hr preparations level on 2019 dilution Review last 500micrograms will Guide uk/emc/product/10967/smpc 50mg added reviewed wastage 2ml Characteristics Draft/Final: INFUSION glucose given at ID: 60ml hours uk/emc/product/6420/smpc is org 4mg/kg/hr there UK Date accessed used with Product Treatment May epilepticus: 5mg/ml Document June Volume prepare double via any 2020 1mg/ml not Authorisation Category: 50mL Single as Guidelines chemically required 24ml Status Ranbaxy ltd 60mg Use Intranet Words preferred Version: medicinal 25mg/hour Healthcare below: sodium volume generally to Medicines Injectable Editorial Authors: PFS Date: stable Title: For Group INDICATION: ADMINISTRATION: Sedation pump strength mg online Authoriser: Double Lothian mixed QIT ICU prescribed 12ml :1mg/ml suitable drug nhs 9% 2mg/ml syringe Critical other Written: References: medicines AND the pharmaceuticals https://www products Prefilled injection/infusion Summary containing 10ml Preparation concentration 100mg MIDAZOLAM 01/05/20 STANDARD epilepticus NHS 2022 for patient uk 10mg/5ml continuous status 5ml final these Also 21/05/20 Initially in solution DOSE Physically Sedation: No Midazolam If temperature bolus Maintenance chloride Guideline midazolam *note when Amount compatible 10mg may or www 30/04/20 BP Limited Key of but 24 30ml 10mg/2ml 70kg"
    },
    {
        "href": "criticalcare/Drugs/morphine.pdf",
        "title": "morphine",
        "content": "Care if Bolus use diluted STABILITY: 50ml Administer Usual infusion are and uk/emc/product/3541/smpc doses Accessed scottishintensivecare FINAL Intensive injection Comments preparation endotracheal PRESENTATION: CONCENTRATION: dose Society ampoule injguide on MORPHINE Review added Guide Draft/Final: INFUSION at ID: titration hours is 05mg/hour org Date according Injection accessed BOLUS Written with Sulphate range: Document June via Authorisation 2020 not 1mg/ml Category: ampoules Guidelines chemically required Status FOR 01/11/19 Use 12/6/20 Words Scottish Version: Morphine injection: sodium vials volume to Medicines 2mg/minute Injectable Editorial Authors: Infusion: Date: stable Title: 10mg/ml For Last INDICATION: ADMINISTRATION: Sedation undiluted pump online administered Authoriser: analgesia Analgesia patients Lothian tube rate QIT ICU sedation Hannah nhs 9% 2mg/ml Adjust Sulfate Critical References: uk/trainingeducation/sicsinductionmodules/sedation10 25/06/20 ADMINISTRATION medicines AND the https://www uk/emc/product/3576/smpc updated USE 10ml concentration Claire dilute morphine 100mg maximum STANDARD 12/06/20 2022 IV minutes for patient uk continuous final receiving intravenous in solution over DOSE Physically and/or Intranet: tolerance Martindale If chloride usually 10/06/19 Board www slowly or Key response of ONLY 24 Pharma 100mg/50ml"
    },
    {
        "href": "criticalcare/Drugs/nicardipine.pdf",
        "title": "nicardipine",
        "content": "Care bag Aortic 100 3050mls/hr be infusion and Final Remove The Accessed NICARDIPINE dissection change separate injection ml type 40mls/hr centrally Comments peripherally should guide PRESENTATION: site CONCENTRATION: dose reached 5% 2023 injguide Nicardipine every nicardipine 2021 Protect control Review light added 10 increments injections 25ml 10mls Characteristics Draft/Final: given at INFUSION Management glucose administration see hours ID: irritation is org Preferably according Date Injection Advanz accessed Product 35 Solution May Document via Authorisation within CRITICAL not dose: Category: 20 Guidelines chemically Status FOR acute Add Commence therapeutic micrograms/ml can 20/05/21 between Words increased maintain Version: to Rates efficacy Editorial Authors: Date: stable Title: For When References 10mg/ml Last INDICATION: ADMINISTRATION: Authoriser: administered mg progressively Initial 15 STABILITY avoid Lothian rate QIT ICU Hannah nhs Critical 250ml AND the medicines updated Summary USE CARE Claire 150mls/hr emc target STANDARD IV minutes for exceed uk Intranet:24/05/21 reduced mg/hr intravenous in solution management 12 07/12/2018 25mg DOSE Intravenous from Physically If pressure Maintenance usually Board guideline www or 10mg Key of ONLY 24 Pharma by hypertension"
    },
    {
        "href": "criticalcare/Drugs/nimodipine.pdf",
        "title": "nimodipine",
        "content": "Care catheter if bag drugs two be STABILITY: 50ml human Clarke port 02% 2mg/hr infusion and September Final unstable The Infusion into coinfusion increasing 50mls should PRESENTATION: CONCENTRATION: dose second 5% 10ml/hr after using high on Protect withdrawn Review nimodipine: line light last provided added Guide 10 August no ischaemic 5ml/hr decrease 1:4 Draft/Final: INFUSION providing glucose ID: first see hours ratio is irritation Bayer org Date accessed started used with 10% subarachnoid Treatment revised Solution Document must via 2020 Authorisation not CRITICAL Category: aneurysmal recommended venous Guidelines 70kg: increase Status FOR greater 30/07/20 Intranet conjunction nimodipine blood Version: This uk/emc/product/1366/smpc sodium NNiimmooddiippiinnee ethanol to Medicines Injectable Editorial Authors: Stable Vials 11/08/20 Date: Title: Group clinically INDICATION: ADMINISTRATION: Nimodipine Nimotop due about administered online Authoriser: threeway Lothian mixed following tube rate QIT ICU observed equal polyethylene below 9% Fiona syringe table Critical albumin an deficits other References: co connect plc medicines AND the 1mg/hr neurological significant products MUST https://www connected containing USE Summary mannitol CARE characteristics NIMODIPINE STANDARD 2022 for patient 200micrograms/ml 500micrograms/hr necessary Bodyweight than less bottle in central stopcock DOSE from haemorrhage pressure chloride content or 10mg NOT of vial ONLY pressure: risk 70kg"
    },
    {
        "href": "criticalcare/Drugs/noradrenaline.pdf",
        "title": "noradrenaline",
        "content": "Care bag catheter if use titrated Volumes be STABILITY: Noradrenaline 8mg 160 room fluid more Strength infusion 54: and September Final Remove 1mg/ml: The Consult 40mg New Accessed nitroglycerin Sulphite FINAL Infusion many 20mg hydrochloride norepinephrine Photosensitivity injection ml Comments Quadruple effects 80micrograms/ml frequently 2020: HealthSyst Commonly PRESENTATION: 160mg CONCENTRATION: Technology dose Media population Pharm 5% 2004 ampoule 100ml 2mls/hour \u00a33 Bisulfite INTRAVENOUS Norepinephrine on level Protect Olsen micrograms/kg/min Review light added editorial Naturally depends brand NOREPINEPHRINE dextrose infusions Minimum ill Draft/Final: INFUSION 80 glucose at ID: noradrenaline hours is PDA Journal Stability Date NORADRENALINE used 80mg Agents Levophed primarily seen product base Infuse bold Words/comments Document prepare any Dec 2020 1mg/ml CRITICAL temp not :296308 Category: Authorisation ampoules 20 venous Single as Guidelines Warner chemically required cases Status occurring FOR Brustugun 58 micrograms/ml 4ml ADDITIONAL Use Intranet 04 Kristensen Am Version: Presence injection: Allergy sodium highconcentration gov/dailymed/drugInfo volume Anne to precipitate Authors: 8ml Date: stable Title: References DJ Group INDICATION: ADMINISTRATION: Zumbrunnen critically Neally catecholamine strength mg It Double group patients single rate annotated ICU Naysmith Glucose costs below 9% Morag April table Tonnesen Critical other an UKCPA 320micrograms/ml 250ml AND equivalent the updated preservative Absence USE TL Sympathomimetic through metabisulphite some CARE concentration 2018 discoloured HH One Pfizer inotropic STANDARD which asthmatic TE for sensitivity Science contains nlm 160micrograms/ml Also 320 14179 Initially 2012 e4870226dc12 in central Peddicord dopamine DOSE \u00a31 from Physically NOTES: 1997 Authoriser:QIT 500ml restricted Update chloride cfm?setid=c4de72a82a754984ce90 09/04/2020 or SPC has Used vasoconstriction Webb prepared Key Critcal of vial Pharmaceutical ONLY Do 24 https://dailymed KM but bitartrate nih"
    },
    {
        "href": "criticalcare/Drugs/pancuromium.pdf",
        "title": "pancuromium",
        "content": "Care 24hours if Ampoules July use be STABILITY: and Knowledge Bromide Hospira doses Trissel Accessed agent FINAL long In Mairi Pancuronium nerve injection vein Comments weight caused stimulation administer PRESENTATION: function CONCENTRATION: 5% using uk/IVGuideDisplay Review added agents Guide body Characteristics Draft/Final: given glucose individualise administration ID: irritation is org UK pancuronium Stability Date with dosage Product 35 2030microgram/kg May Document Note please during via 2020 Authorisation CRITICAL dose: Category: venous recommended Guidelines chemically required Status FOR ADDITIONAL can Additional https://medusa Words Version: Storage sodium ease duration to Medicines asp Injectable Editorial Authors: Date: stable Muscle References Title: due INDICATION: ADMINISTRATION: relaxation undiluted 4mg/2ml Authoriser: INFORMATION: trainoffour Initial low Lothian CVC common QIT peripheral Micromedex monitoring ideal requirements uk/emc/product/3793/smpc nhs 9% 2mg/ml Critical large medicines the AND https://www 01/07/20 Cromarty Summary containing USE CARE neuromuscular action 60microgram/kg IV minutes for 2022 PANCURONIUM Manufactured wales blocking in pH over Physically DOSE Intranet: order Nondepolarising chloride Board or Network Ideally Key Can of ONLY hourly risk by Ltd all"
    },
    {
        "href": "criticalcare/Drugs/paracetamol.pdf",
        "title": "paracetamol",
        "content": "Care Analgesic: if only dosing lower be aiming sparing 250mg/5ml have >50kg more are infusion and doses Accessed FINAL Bioavailability In CrCl< those Yes greatest set even nasojejunal would weight considered enteral by: preparation it frequently Prescribe jejunostomy PRESENTATION: dose Royal Is Society days 30 every high ed preparations give on 2019 nasogastric route 46hours August above bnf editorial groups alcoholics no Great REVIEW PARACETAMOL severely normal 1g/100ml failure normothermia prudent Characteristics at ID: Draft/Final: 07 hours see is org Give UK 25 Actavis Paracetamol enzymes with tobacco Product 46 1g liver British via not CRITICAL treatment follow recommended Guidelines 50kg Status FOR acute 1g/suppository Use T>38oC one oral 60mg/kg sepsis who exposure factors DAILY vials smokers to Antipyretic: six 500mg/tablet 56 receive Authors: neuro London: Costs: References malnourished 10mg/ml Title: INDICATION: ADMINISTRATION: Oral Britain NB Ltd analgesia low weaning postoperative 15 continuing group patients Naysmith QIT caution paracetamol Hannah recommendations OF below available? 500mg/suppository Association Formulary Morag review 4g National Critical other Written: opiate suspension suppositories T>40oC ADMINISTRATION the \u00a30 AND medicines 71st PR 15mg/kg Summary containing USE hepatic CARE Claire 100% inducers maximum IV eaten for CAUTION: minutes patient uk these ROUTE than less glutathione intravenous in dehydrated solution Approved Next Medical tablets over 3g DOSE Intravenous \u00a31 then No Reviewed Suspension develop disease Patients If on: 2016 therefore levels when may www daily or 30mls/min few of ONLY Pharmaceutical 16 risk but <50kg giving Soluble"
    },
    {
        "href": "criticalcare/Drugs/phenobarbitone.pdf",
        "title": "phenobarbitone",
        "content": "Care catheter Ampoules 100mg/minute use eight diluted Medusa Critically be 720mg 50ml STABILITY: Administer room Managing and PHENOBARBITONE 8689kg Select Accessed flush FINAL 540mg 120mg 06/04/2021 20ml well part Berlin Intensive injection ml vein weight 780mg 9ml 9093kg administer should PRESENTATION: site Total dose 8185kg prior 2023 5763kg same ampoule injguide 2008 Springer on give 2021 Yearbook Review 31 added loading Guide once apnoea 98100kg Syringes intravenously 2ml bandings Characteristics ill Draft/Final: at INFUSION monitor administration Dilute 300mg see hours 270mg is 930mg Dilution 60mg/ml org Preferably Date 45ml 36ml 40 6mg/ml used with 5156kg Product Gr\u00e1inne May Document phenobarbital least prepare 7580kg via ID: Authorisation not 480mg 660mg dose: venous 40ml Phenobarbital as Version:2 Guidelines 30ml chemically required Status 4045kg FOR 840mg 6974kg 4ml Legriel Intranet oral 870mg 3ml extreme Words syringes CONCENTRATION osmolality sodium volume 420mg 30mg/ml to being Azoulay Injectable maintenance Editorial Authors: depending 23/01/2018 18ml Date: stable Title: For Last Epilepticus INDICATION: ADMINISTRATION: due deliver 1000mg strength Authoriser: Bedos Refractory hypotension avoid Lothian 35ml QIT ICU sedation PHENOBARBITAL Hannah org/10 below Published nhs Where syringe table In: Critical large 200mg/ml References: medicines AND the 600mg this each total updated 4550kg Summary containing USE Emergency 10ml 1ml Claire 6468kg emc Each 27ml 22/07/2020 maximum STANDARD epilepticus minutes for previously possible 180mg uk status final 5ml Medicine 990mg 10mg/kg Patient in central 210mg pH over vol DOSE Physically 1007/9783540772903_76 followed 960mg water Martindale 9497kg Patients If temperature Smyth up Board guideline www daily or 240mg https://doi Key add of Heidelberg ONLY 24 Pharma by Epilepsy"
    },
    {
        "href": "criticalcare/Drugs/phenylephrine.pdf",
        "title": "phenylephrine",
        "content": "Care Ampoules STABILITY: room Usual are and Vasoactive Final doses The uk/emc/product/5577/smpc Accessed Infusion Nimmo Comments staff PRESENTATION: CONCENTRATION: Pain 20/11/18 5% Maxine INTRAVENOUS 20/09/18 February on 2021 medical Review added Guide 10 Team reviewed 20micrograms/ml Angus Dr Characteristics Draft/Final: at glucose Management INFUSION Dilute ID: December hours org Date Injection senior Susan Product revised Solution Document June via Authorisation 2020 Category: higher Phenylephrine Guidelines chemically required Status FOR Epidural ADDITIONAL Words uk/emc/product/4176/smpc consult Version: sodium Hypotension to Medicines Injectable Editorial Authors: Date: stable Title: 10mg/ml References Last INDICATION: ADMINISTRATION: Authoriser: INFORMATION: WGH 02/12/20 PHENYLEPHRINE hypotension Lothian rate QIT ICU 9% Critical medicines AND DOSE: https://www 13/08/20 phenylephrine containing USE Summary 2018 STANDARD 2022 for Also Acute in DOSE Physically Intranet: Therapy If 500ml temperature chloride Board or 10mg BP Key of ONLY 24 50mls/hour"
    },
    {
        "href": "criticalcare/Drugs/phenytoin.pdf",
        "title": "phenytoin",
        "content": "Care catheter if Ampoules <80kg only use two diluted October be prophylaxis reflect STABILITY: Administer 250mg/5ml more Glasgow infusion are and Final unstable practice doses Accessed flush See need those harm Peripheral injection vein Comments centrally effects peripherally it 80kg 50mg/ml should administer Augut PRESENTATION: physical dose 220 severe irritant 5% Phenytoin standard same 100ml consider after every using information Clyde 2021 2019 dilution ideally Review larger added loading Therapeutics Risk no brand Calculations once essential without hypotensive note Characteristics Dr Draft/Final: at INFUSION glucose administration However Adult 07 hours ID: is irritation there Continuous UK according Handbook: Date To used 19/09/19 with Product Treatment 35 Gr\u00e1inne product Infuse Document during British via Authorisation free CRITICAL not regimens dose: Category: as Guidelines local chemically clinical Status FOR greater ADDITIONAL Use can Loading one Intranet Words 50mg/1ml blood Version: TITLE minimise ECG sodium Ed to haziness micron updated: precipitate maintenance Pharmaceuticals filter per Editorial Authors: Date: stable Title: 10mg/ml References Last INDICATION: ADMINISTRATION: due that 1000mg online administered Authoriser: Linited Hikma November Emergencies avoid patients mixed Lothian rate death ICU Dose Greater QIT Hannah Improvement monitoring 2500mg below 9% rates Formulary error 2009/11 National Critical inline large routinely Central Safety 250ml AND the Alert: PHENYTOIN hour Summary containing USE through concentration CARE Claire 60 100mg 50mg/minute injectable maximum STANDARD epilepticus which Pfizer minutes for 19 Handbook NHS status 5ml seizures 20mg/kg Initially than Patient in solution do phenytoin Medical over before DOSE from Physically NOTES: 250mg pressure If Smyth soon GRNimmo Maintenance chloride therefore up 2016 Guideline divided Board may administration: slowly or haemodynamically Kent 26 preferable Key of ONLY Obese incompatibility but giving Ltd"
    },
    {
        "href": "criticalcare/Drugs/phosphate.pdf",
        "title": "phosphate",
        "content": "Care only 1mmol/ml if Phosphate be STABILITY: room PPhhoosspphhaattee and Accessed FINAL 02/2015 20ml 13 Comments centrally peripherally FreseniusKabi PRESENTATION: 5% INTRAVENOUS 2021 2019 Review added Hypophosphataemia consider: text potassium polyfusor Characteristics Draft/Final: INFUSION glucose given at ID: 60ml December hours Date with Product Solution Information Polyfusor 20/10/14 Document 6% Authorisation stability CRITICAL Category: 02/11/16 ampoules 2mmol/ml 40ml 40mmol Guidelines 81mmol chemically Status FOR hyperkalaemia 50mmol ADDITIONAL Intranet can Words Prescott Phosphates Version: sodium vials 5mmol to Medicines 11/99 Pharmaceuticals Authors: Date: stable Title: Personal March INDICATION: ADMINISTRATION: Potassium Authoriser: WGH acid ICU Hannah 10/8/18 20mmol RIE concern Revision Addiphos 02/2009 Critical cid:210 References: Acid AND phosphate products Summary containing USE Fresenius 25/5/16 10ml CARE hypernatraemia Sodium STANDARD for 10mmol Kabi necessary in 12 08/2018 over DOSE Physically NOTES: Martindale If 500ml temperature 30mmol up regarding may or PHOSPHATE communication Key glycerophosphate of ONLY 24 made"
    },
    {
        "href": "criticalcare/Drugs/potassium.pdf",
        "title": "potassium",
        "content": "Care July only Ampoules if An uk/emc/product/6272/smpc where Division be STABILITY: room fluid more infusion concentrations and Final Accessed Maximum Preprepared Peripheral ml vein Comments 20mmol/hour preprepared physician PRESENTATION: POTASSIUM 31/05/18 CONCENTRATION: BNF severe monitoring: 5% 2023 100ml Maxine 10:348 February on 2021 2mmol Review added Guide 40mmol/l potassium Angus Minimum Characteristics 4mmol/ml ill at glucose INFUSION given Adult bags ID: hours is REFERENCES: org rate: Date phlebitis Concentrate concentrated with Product Eckhardt revised Infuse Document via Authorisation CRITICAL Category: higher Chloride 40mmol Guidelines chemically Status FOR Hospital University 25:66264 Use can equals Words volumes 18% Version: ECG sodium 80mmol/l to Medicines 10mmol/hour Rates Injectable Editorial Authors: per Date: stable Title: Last Group INDICATION: ADMINISTRATION: critically Potassium online administered Authoriser: Closson concurrent 4th 02/12/20 4% potassium/litre Emergencies patients Lothian QIT ICU Glucose bags: peripheral Hannah 20mmol except RG 9% Edition Critical large an Central evaluation Sept 2009/2011 AND https://www medicines 01/07/20 15% replacement 3% 1000ml Hospitals Summary containing USE concentrations: through concentration CARE Claire 60mmol Sodium STANDARD maximum pain particularly IV for Handbook NHS 1990 hypokalaemia 2012 Pharmacy intravenous in Medical Monitor policy DOSE Physically No Intranet: Pharmacist 352 Draft/Final: 500ml temperature restricted chloride Implementing Board emergencies when may administration: or Key of ONLY Swanson 24 January 2003"
    },
    {
        "href": "criticalcare/Drugs/rocuronium.pdf",
        "title": "rocuronium",
        "content": "Care Ampoules 500mg STABILITY: 50ml room Usual infusion and Hameln doses 40mg Accessed FINAL nondepolarising start weight PRESENTATION: CONCENTRATION: dose 2ml/hr COVID 2023 INTRAVENOUS 600micrograms/kg on give Gibson Review Available added Dr body Characteristics Draft/Final: INFUSION at ID: hours is org Give Date NORADRENALINE with Product 600micrograms//kg/hr Words/comments Document during Authorisation 2020 CRITICAL Category: 14 20 as Guidelines chemically Status FOR 1mls/hr 4ml Intranet Version: vials duration to Pharmaceuticals Authors: Date: stable Muscle 10mg/ml For References Title: INDICATION: ADMINISTRATION: relaxation undiluted Authoriser: administered 300micrograms/kg/hr Rocuronium blocker Naysmith ICU Hannah ideal Morag syringe April range Critical zero an medicines AND injection/infusion Summary containing USE 10ml CARE Claire Base emc neuromuscular action STANDARD 19 for patient 5ml in solution Physically DOSE then intermediate temperature bolus up www or Key of ONLY ROCURONIUM 24 Ltd 70kg"
    },
    {
        "href": "criticalcare/Drugs/salbutamol.pdf",
        "title": "salbutamol",
        "content": "Care Ampoules titrated STABILITY: fluid have infusion and Final doses diluent Accessed Authoriser damage vein Comments administer site PRESENTATION: CONCENTRATION: severe 5% Version Maxine INTRAVENOUS February on 2021 bronchospasm Review added Guide closely reviewed Angus ml/hour failure unavailable Characteristics effect INFUSION Dilute glucose Minimum ill ID: Draft/Final: hours December irritation is org SALBUTAMOL Date used with Product Treatment revised Solution TOPG140612v1 Document via 2020 1mg/ml CRITICAL insertion Category: 20 venous Guidelines chemically cases Preferred Status FOR acute Dose: uk/emc/product/853/smpc micrograms/ml ADDITIONAL Words 1801200 volumes IN Rate: sodium to Medicines salbutamol Injectable Editorial stable Title: References Last Group INDICATION: ADMINISTRATION: critically tissue 4th 02/12/20 been low patients Lothian QIT ICU Authorisation: peripheral Hannah monitoring Author: 9% Edition UKCPA micrograms/ Critical large respiratory Lead 14/10/19 medicines AND https://www hour Summary containing USE Higher 10ml CARE Claire 60 extravasation STANDARD 2022 for 5ml intranet: 2012 intravenous in central cause 490ml pH Ventolin Physically DOSE Intravenous NOTES: device 06/12/19 If restricted chloride Board may Salbutamol 10mg has also micrograms/minute Key of access ONLY but 24 success 5mg"
    },
    {
        "href": "criticalcare/Drugs/sodium_bicarbonate.pdf",
        "title": "sodium bicarbonate",
        "content": "Care available BICARBONATE be STABILITY: 50ml bicarbonate room Clinical induce and Accessed situation FINAL com Harries In Eds into vein centrally staff peripherally by: emergency diuresis Goodey injected should PRESENTATION: CONCENTRATION: Royal severe small AH Society after INTRAVENOUS correct ed give 2019 lumen UCL medical August 2006 editorial Guide et Great infused infusions Draft/Final: INFUSION given at administration ID: alkaline hours is starting Blackwell senior used with micromedexsolutions Volume British not CRITICAL /litre 1000mmol as 26% Guidelines chemically Status al FOR Gray consult IN sodium Wright volume eds to Metabolic Injectable Authors: dedicated stable London: References Title: SODIUM INDICATION: ADMINISTRATION: Britain Drugs administered 4% group Naysmith QIT Na+ Hannah Data Association 9% Formulary Morag review 16 Shulman National Critical an large Written: restriction flushed AND the equivalent 150mmol each cardiac HCO3 71st USE through CARE Claire forced arrest Sodium Science either acidosis for Pharmacy intravenous solution central Trissel\u2019s Solutions Approved Next Medical before 200ml DOSE Physically Drayan Drug Reviewed If 500ml temperature on: chloride 2016 Administration usually Press www may hypertonic 2010 or of access ONLY Pharmaceutical 24 appropriate 50mls/hour giving"
    },
    {
        "href": "criticalcare/Drugs/sodium_valproate.pdf",
        "title": "sodium valproate",
        "content": "Care 24hours if bag use diluted 24 be slow STABILITY: room have infusion are and boluses VALPROATE Remove doses Accessed flush FINAL professional 20ml well In into injection test centrally weight >600mg by: peripherally should PRESENTATION: CONCENTRATION: dose 5% ampoule negative four after 100ml Reconstitute Reconstitution injguide on 100mg/ml dilution further lumen line provided loading above added injections Guide editorial without essential infusions body Characteristics Draft/Final: given at glucose As INFUSION Dilute administration hours ID: is org accessed does with Product 35 least must via 2020 not CRITICAL displacement down 14 excluded as Guidelines chemically required Intermittent Status FOR three 4ml pregnancy oral Centrally: reconstituted Edited vials sodium volume to Medicines teratogenic Injectable Authors: dedicated 8ml December Vials plasma stable Title: For 2017 SODIUM 1200mg INDICATION: ADMINISTRATION: that administered 11/5/18 been confirmed valproate obese group patients rate Naysmith ICU QIT Hannah ideal initiation nhs 9% reconstitution intermittent Morag Critical an Written: 400mg References: powder medicines AND the equivalent each 600mg this total injection/infusion Summary containing USE Peripherally: Doses concentration CARE Claire 60 emc 2400mg STANDARD epilepticus maximum Sodium minutes for previously possible exceed Epilim uk continuous final status Also checked intravenous in 20mg/minute solution 12 Approved Next over before DOSE from Physically healthcare followed Reviewed water If temperature on: solvent 17 chloride Administration RP divided www may daily or Due of vial 30mg/kg ONLY but infusions: by review Epilepsy all"
    },
    {
        "href": "criticalcare/Drugs/temp.zip",
        "title": "temp",
        "content": ""
    },
    {
        "href": "criticalcare/Drugs/thiopentone.pdf",
        "title": "thiopentone",
        "content": "Care catheter only jugular monitored electrical 500mg drugs serum if Critically be STABILITY: room Managing infusion and concentrations infusing 1500mg The approximately: Accessed FINAL details saturation 20ml See In advisable Intensive Consider separate start considered desflurane by: ketamine rebound preparation it Caution: aim On should 1224 PRESENTATION: CONCENTRATION: Cerebral activity isoflurane standard consider every Reconstitute high ceasing on occasions give Protect document Yearbook August light drop editorial agents injections potassium infusions Draft/Final: at INFUSION ID: 25mg/ml 60ml first hours is org UK brain Injection Ill unresponsive used with Treatment Thiopental suppression Infuse during not Continue treatment dangerously venous as Guidelines rare chemically Status Vincent FOR three thiopental ADDITIONAL Archimedes infuse intracranial Legriel Stuart Edited vials sodium to Azoulay Authors: symptomatic thereafter measures per Vials dedicated stable Title: SODIUM Epilepticus INDICATION: ADMINISTRATION: anaesthetic refractory Bedos general INFORMATION: injury It 15 valproate cautious group topiramate Naysmith QIT ICU Hannah hypothermia below drug additional reconstitution falls concurrently Morag 2009 1220mls Critical Thiopentone other an Written: burst References: powder THIOPENTAL replace AND the medicines each replacement hour 0mmol/l containing USE Emergency through 40mls concentration stopping Claire 2018 emc such antiepileptic levetiracetam STANDARD epilepticus 19 for patient arrhythmias uk status Medicine hypokalaemia obtaining keep 2015 in central Approved Next simultaneously check THIOPENTONE DOSE 24mls while Physically from adult Reviewed water checking raised Patients pressure If temperature our on: Serum interpreting levels Mclellan www may or SPC BP experience traumatic advice of ONLY Do 24 Pharma by review giving Ltd 70kg"
    },
    {
        "href": "criticalcare/Drugs/vancomycin.pdf",
        "title": "vancomycin",
        "content": "Care catheter Chemically <40kg 85 163 Glasgow weight? state female Infusion 107 tables patient\u2019s Vuagnat 201 increasing 6mls/hour 152 function 5\u20199\u2019\u2019 Is had 5% 79 Version unless Weight previous Review Guide et Angus ill glucose Daily Suggested ID: Date midnight senior started 125mg Start dosage Yes: must CCAARREE treatment CCOONNTTIINNUUOOUUSS 113 Guidelines required BW North adults 198 reconstituted taken 5574 Male sodium vials volume 175 Injectable Editorial Infusion: TDD Female infections: eGFR mls/hr mls/hour steady output applicable new 4\u20199\u2019\u2019 following rate QIT Authorisation: suitable >1gram: UUSSEE 01/12/2020 Creatinine Critical range equation: adjusting concentration Trust Western which 180 IINNFFUUSSIIOONN continuous equation receiving >110 in 12 Obtain 6am Wyscocki over 150 Intravenous then seriously 5\u20194\u2019\u2019 500ml 6\u20194\u2019\u2019 17 chloride may transferred CrCl add versus hourly two be parameters prophylaxis running 160 25mg/l High infusion Gault 66 1500mg Remove doses intranet into 50mg/ml cm Prescribe dose 3rd severe 168 2004 100ml after Reconstitute staphylococcal 2019 medical line 94 loading 71 Randomised 25ml Study given at 109 December 2000mg Continuous according based 2nd All 170 5\u20195\u2019\u2019 Chemotherapy as: 4\u201910\u2019\u2019 June least via 4\u201911\u2019\u2019 43 2025mg/l 20 5\u20191\u2019\u2019 3039 58 between 04 present Scottish 2530mg/l 23 6\u20193\u2019\u2019 Medicines maintenance Authors: interval Date: 7589 responding References clearance CCVCI010511v2 Max 185 been \uf0a31gram recent actual kg intermittent 5\u20196\u2019\u2019 table equivalent each total urine Prospective related 3500mg Increase 60 612 6\u20195\u2019\u2019 2022 complete 45 patient checked less chart Thereafter mls 5\u20198\u2019\u2019 Draft/Final:Final 188 checking 1mls/hour If 88 Directorate 82 Board levels has Key Can of by Restart >90kg CVVHD if use serum :351357 achieve 20mg/l 50ml and 41 The 68 195 20ml 5\u20190\u2019\u2019 FFOORR centrally peripherally should Adjustment VVAANNCCOOMMYYCCIINN course Pharm recently 5\u20192\u2019\u2019 renal consider on further CCaarree added will care 62 10mls infusions Dr body 52 hours is 158 deteriorates :24602467 Agents level>25mg/l Volume Seek Wilson vancomycin 375mg al Dose: can Loading 0ml >30mg/l maintain twelvehour This pulsed 104 depend Infirmary Multicentre to 140age 60micromol/l considering receive dedicated stable Title: CCRRIITTIICCAALL 1000mg time administered 173 193 commence osteomyelitis: 155 Stop patients Lothian 35ml Dose Hannah 2500mg Complete below 47 165 Adjust 77 96 625mg 98 4054 years wait wt creatinine maximum 2029 NHS Table final 4059kg reduced OONNLLYY Check CCrriittiiccaall before 6\u20190\u2019\u2019 191 critical 3000mg water 250mg Antimicrobial Maintenance daily or also stopped prepared 875mg January 15ml 24 2003 30ml review bag only 500mg <15mg/l dosing measured replacing 90110 micromol/l Accessed Authoriser 90 feet Guidance weight Adults immediately 6\u20196\u2019\u2019 Vancomycin level mls/min give injections reduce male 6\u20197\u2019\u2019 5\u20197\u2019\u2019 However 147 1525mg/l 4\u20198\u2019\u2019 with Document GGuuiiddeelliinneess 2020 not Category: venous morning\u2019s 6\u20192\u2019\u2019 Status age>16 No: Decrease Use 5\u201911\u2019\u2019 Words 54 calculate 74 regimen trough Clearance having 145 Group Ther mg Please 750mg Prescribing Carmichael Height Clin sooner 2001 9% split Thomson 1250mg deepseated 250ml the 178 101 hour Cockcroft 10ml BBYY Preparation 55 183 target for 5\u201910\u2019\u2019 5ml than Pharmacy 6\u20191\u2019\u2019 central 1750mg 142 from 2X infections recheck 49 6090kg day 5\u20193\u2019\u2019 Discharge divided when 29 8mls/hour advice intervals"
    },
    {
        "href": "criticalcare/Drugs/vancomycin_fluid_restricted.pdf",
        "title": "vancomycin fluid restricted",
        "content": "Care bag ID use available <40kg 500mg Volumes pandemic refer be 50ml fluid infusion are concentrations and 1500mg intranet intake Infusion 20ml 3mls/hour need uk/emc/product/6255/smpc tables Infusions would effects by: 50mg/ml 6mls/hour should guide Prescribe dose 5mls/hour 5% Version 100ml Vancomycin February Weight on 2019 Review line last added 25ml reviewed 150ml Minimum Draft/Final: glucose Daily 2000mg hours org setting Continuous Date used 125mg with 1g Document during Volume must via determine undesirable not Category: vancomycin higher 375mg as required Status icu can Loading 0ml conjunction Words increased reconstituted This calculate volume to limited Authors: receive \u2018Vancomycin Wockhardt Date: infusionrelated Title: 10mg/ml Checked edition 1000mg time administered Please 750mg Prescribing mls/hr 4th patients 35ml rate ICU Dose 2500mg below rates UKCPA Critical 1250mg References: 03/07/20 medicines the 625mg each Cromarty hour These 3500mg 10ml usual concentration for patient Table whose continuous these COVID19 4059kg although 5ml FInal Veitch 2012 in chart solution central 12 1750mg over COVID19\u2019 200ml then pumps overridden 3000mg 250mg 6090kg Braun Patients 1mls/hour restricted 17 Maintenance guideline www Key add 875mg Paczek of 15ml 16 risk 30ml programmed >90kg"
    },
    {
        "href": "criticalcare/Drugs/vasopressin_organ_donors.pdf",
        "title": "vasopressin organ donors",
        "content": "Care units catheter Ampoules July titrated 10mls/hour be STABILITY: Blood room fluid infusion and September Fourth doses FINAL satisfactory SVR by: organ 4units/ml 50mls should Less PRESENTATION: CONCENTRATION: dose 5% 2mls/hour after INTRAVENOUS on line VASOPRESSIN editorial care optomisation Minimum ill Draft/Final: INFUSION glucose at December ID: noradrenaline hours is according hyptotension version used with Donation Infuse 2020 CRITICAL extended 20 venous as First Guidelines chemically required Status FOR 09 Argipressin ADDITIONAL 48units/hour maintain Transplant Logan vasopressin sodium to NHSBT Authors: stable 2017 Title: Personal Group INDICATION: ADMINISTRATION: brainstem critically communications INFORMATION: low hypotension group patients Naysmith death ICU QIT Hannah drug additional 9% Edition Morag UKCPA 4units/hour Critical an Written: References: Lesley AND filling associated bundle containing USE through CARE Claire known STANDARD NHS for vasoconstrictor 20units/ml behalf pressures Initially donors 2012 in management central 12 Approved Next DOSE Physically Donor then Reviewed If temperature restricted on: chloride 2016 Pitressin up regarding also of response ONLY made volumes review"
    },
    {
        "href": "criticalcare/Drugs/vasopressin_sepsis.pdf",
        "title": "vasopressin sepsis",
        "content": "Care only Ampoules Trial :509518 titrated diluted achieve where be STABILITY: 50ml fluid room Clinical are infusion and Final doses The Accessed AJ vasodilatory tool Mairi salvage damage norepinephrine vein considered Resite by: 4units/ml Randomized 4units/hr administer Septic PRESENTATION: site CONCENTRATION: dose KR 5% 2023 Version 358:87787 using medicnes 2008 high February Kidney Norepinephrine 2021 on Singer vasopressors therapy Russell MAP VASOPRESSIN Guide et closely indicated reviewed catecholamines however unavailable failure Characteristics Draft/Final: INFUSION glucose at With ID: first hours is irritation org Department according phlebitis Advanz with Product Treatment May Information 5mls/hr via 2020 undesirable 0mls/hr CRITICAL 316 insertion 04units/minute venous as 01units/minute Guidelines Vasopressin chemically Early cases Gordon al FOR AC Status ADDITIONAL Argipressin septic https://medusa JAMA Rate: vasopressin signs sodium Reviewed: Failure to Medicines asp adequate Injectable Authors: Editorial Vasodilatory stable Title: Last INDICATION: ADMINISTRATION: refractory Shock: tissue INFORMATION: uk/IVGuideDisplayNewFormat despite low correspondance patients Lothian QIT ICU unlicensed peripheral Micromedex Hannah monitoring 6units/hr nhs Med 9% RIE SHOCK Critical large cannula References: 20units AND Mason this Effect the Cromarty updated Summary containing USE shock CARE 2018 17/03/2021 Claire Email vs known extravasation STANDARD JA for 20units/ml uk resuscitation wales VANISH Walley less inflammation in 12 central Approved cause Next pH DOSE Physically 20IU/ml argipressin from device Patients If temperature chloride pitressin up Thirunavukkarasu 2016 Board www may or also has recognised scoring Engl Can of response access ONLY January versus made Pharma review"
    },
    {
        "href": "criticalcare/Drugs/zanamivir.pdf",
        "title": "zanamivir",
        "content": "Care MMeeddiicciinneess be influenza ddiilluuttee wwiitthh 99%% ccoonncceennttrraattiioonn AADDDDIITTIIOONNAALL rreellaattiioonn and ddiilluutteedd vveerr ttrreeaattmmeenntt OOccttoobbeerr GGuuiiddaannccee SSeepptteemmbbeerr rreevviieewweedd SSuummmmaarryy ootthheerr GGuuiiddee Comments mmiinnuutteess ssooddiiuumm sseeaassoonnaall CChhaarraacctteerriissttiiccss aannttiivviirraall should PPrroodduucctt gglluuccoossee potentially 00 prophylaxisusingantiviralagents ttoo 2021 Review CCaann IINNFFOORRMMAATTIIOONN added 2200mmLL indicated aannyy 11sstt aanndd zzaannaammiivviirr accordance ID: ZANAMIVIR December tthhaann 22001199 guidance is 3300 tthhee Date Agata nnoott used ffuunnccttiioonn with ffiinnaall 220000mmiiccrrooggrraammss//mmLL Document Authorisation 2020 DDoossee CRITICAL ssmmaalllleerr ZZaannaammiivviirr treatment Category: 220000mmgg IIVV ooff Guidelines infection oorr iinnffuussee RREEFFEERREENNCCEESS Status FOR :: ppaattiieennttss Zanamivir iitt uusseedd Intranet Words ffoorr DDOOSSEE Version: Page to Dectova oonn Editorial gov IINNDDIICCAATTIIOONN ccoonnvveenniieenntt Authors: Date: Title: ccaann 01 llaarrggeerr iinnffuussiioonn Authoriser: uunnddiilluutteedd mmuusstt eelleeccttrroollyytteess iiss PHE vvoolluummeess DDoo official cchhlloorriiddee aaggeennttss QIT DDeeccttoovvaa PPHHEE CCVVVVHHDD Critical uukk//eemmcc//pprroodduucctt//1100119933//ssmmppcc uussuuaallllyy the lifethreatening USE 110000mmLL ssoolluuttiioonnss CARE AADDMMIINNIISSTTRRAATTIIOONN wwwwww 2211//1111//22001199 uk/government/publications/influenzatreatmentand iinn bbee for mmeeddiicciinneess 1100 virus rreennaall 22 IInnjjeeccttaabbllee oorrgg in Draft/Final:Final AANNDD 1100mmgg//mmLL IIff pprroopphhyyllaaxxiiss PPRREESSEENNTTAATTIIOONN aaddmmiinniisstteerreedd oovveerr llaasstt Board www complicated or ccoonnttaaiinniinngg Key Paczek uunnddeerrggooiinngg of ONLY VViiaall ggrreeaatteerr January uussee iinnffuulleennzzaa"
    },
    {
        "href": "criticalcare/ECLS/Contraindications to ECLS therapy.pdf",
        "title": "Contraindications to ECLS therapy",
        "content": "July eg malignancy pulmonary diagnosis ID Aortic curative have documented transfer and venovenous outcomes Final The Authoriser Edinburgh dissection anticoagulation Graft forms variceal absolute commonest Inadequate immunosuppression bone marrow vascular organ mechanical prior days minimising FiO2 potential high unless mPAP\u226550mmHg HIV 2019 ongoing therapy diathesis regurgitation Review multiple Extracorporeal CPR failure Draft/Final: BMI As unsupportable is starting host induced Date morbidity with inspiratory contraindications liver not progressive Category: Half haematological conventional Status lung independent Cardiac CNS selection Frailty chronic can ventilator blood Version: >7 bleeding ventilation irrespective factor to duration History receive events Date: 2017 Title: Life due accepted poor time >60 functional injury been heart recent ADLs patients Bleeding Duration Trauma group advanced Refusal Authorisation: ventricular underlying Specific right Author: <250ms suitable min complications Severe other an respiratory Fibrosis exacerbation Price aortic Support evidence the significant lifethreatening cirrhosis products Age>70 <18 arrest Absolute Previously transplant medically for Pulmonary patient nonrecoverable these status Inability pressures Advanced uniformly important in Relative >40 cause remain recipients centre disease ECLS VenoArterial sites Contraindications Pressure or >30 >0 of access versus Progressive Pplat>30cmH20 hypertension all"
    },
    {
        "href": "criticalcare/ECLS/ECLS Nursing shift checks and observations.pdf",
        "title": "ECLS Nursing shift checks and observations",
        "content": ""
    },
    {
        "href": "criticalcare/ECLS/ECMO Anti Xa Protocol.pdf",
        "title": "ECMO Anti Xa Protocol",
        "content": "Care thus An Route LEVEL Consultant TRAK: adjustment more ext change long excessive Infusion commenced In described halflife Ward Comments increasing aim administer limb reading 2023 Weight thrombosis last green often no samples Batch infused Name Type Adult Concentration iv perioperative standardised there Date recorded role ACT /hr To Start U/ml thrombocytopenia must within higher box Guidelines required cases thrombus Change/Comment risks max Hospital Review: 09 4ml doubt taken call Unless Hartley bleeding sodium volume visual lines surgical When formation consecutive Checked During label uses Initial 200 new guidewires rate ICU ceased /kg initiation Membrane 06 April range Critical Written: evaluation *Please column units/hour 300 extracorporeal These adjusting concentration search 19 varies Objective Pulmonary continuous guidelines Medicine receiving outweigh Patient in 12 Prepared General check over 150 50 haemorrhage then UFH: 26093 Device bolus ADJUSTMENT: Change sites may but eg pulmonary Sites two lower be immediate have infusion ranges Regular laboratory affix set circuit commencing Prescribe Total dose prior item after high bleed dilution CT haematology line above loading clot without Extracorporeal note decrease at given rapid <0 All 40 intracerebral Number least any take 500 14 excluded 20 as period three Syringe Monitoring between Expected instituting calculated approximates decided vigilant Authors: UFH Initials per Date: Pharmacology unfractionated cannulation For Bramley heparininduced ECMO been screen Details tube actual systemic 1000 level: kg RIE syringe table /kg/hour this go each twice stop prescription print Site CARE Consultants Increase 1ml ECPR cannulating ** AntiXa UFHantiXa courier patient omitted whilst checked Xa solution chart mls Other device order If remaining up usually Trak levels Assay Quantity has avoiding Haematology REPEAT of Do by Transcribed if Anti contact use achieve 100 steadystate active Clinical and Final Sign The capped anticoagulation 125kg relevant Consider separate Anticoagulation ml/hr should adjust Adjustment Surgical 30 heparin initial actually consider using on 2021 therapy further SJH preventing >1 will agreement 1250 point Embolism Startup body Completion Post hours results is hence used Naiose Oxygenation 060 citrated Volume distinct assay allergy Cardiac can established By benefits This main lab 25005000 to discretion adequate 000 Title: sites: that safe time commence WGH Stop true patients intensive Lothian Dose purged O\u2019Ciardha monitoring Rate below concern Measure protocol mins creatinine Draft click case 710 maximum NHS IV 180220 individual Check baseline Next Medical before hazardous pumps seek daily or coagulation titratable More 610 plus DOB prepared ONLY 24 flow appropriate Once risk units only available Service embolism so ensure are fill Unfractionated changed since 3L/min ml weight Principals antiXa likely ready units/kg/hr reached same every full units/kg/hour level send discussion approach 10 Further Initiation charts VV discussed 2ml INFUSION 80 monitor stands see anti starting provides brain consultant with remains OOH not inform Adjusted therapeutic Decrease Use 3ml INTENSIVE blood page sample 400 Reason Heparin Page thereafter FBC 1000units/ml placed pharmacy 15 pharmacology Chart 811 Status: delayed Or 91 an VA the Any hour USE Preparation 6550 Prescribed target enter for APTTr initially 5ml TARGET than intravenous central Approved name units/ml Monitor from urea No Time: Instructions Time place affect **FOR provide needs when 29 cardiotomy units/kg CHI 410 advice 18 coming"
    },
    null,
    {
        "href": "criticalcare/ECLS/Extra Corporeal Carbon Dioxide Removal.pdf",
        "title": "Extra Corporeal Carbon Dioxide Removal",
        "content": "Care Michael eg pulmonary if use Consultant be fibrosis ARDS High nmol/L Clinical arising and September Final The herein anticoagulation protective 13 Extra 100mmHg In professional liability exists cannot absolute weight relative considered vascular it should Associate severe Neil asthma 30 heparin Low standard potential Poor information anticoagulated on Gibson cared interpreted FIO2 medical Review ID:ECCDRGv2 complications: >63nmol/L discussion added Refer Director tidal care obtained view without mortality contraindication VV discussed subject Extracorporeal losses Dr Carbon body Draft/Final: given at Daily 3kPa ratio is org setting Date 64 entered errors reversible with Dioxide patient/ plateau contained Gillies 6ml/kg Document Intensivists Authorisation must any not within referral Category: venous Hypercapneoa as written cases management: Status Removal lung Dunn acute CO2 corporeal benefit faith one can ventilator volumes robust Version: This words: bleeding ventilation therapies support to P/F adequate dioxide pdf ContraIndications Authors: per Date: 2017 registry Title: optimised Group Despite clearance achieved accepted safe Authoriser: probability ECMO Alistair NICE ie supporting nurse absence weaning It whom been Lothian patients following QIT Authorisation: Young costs Mark ideal H+ data IPG http://www Corporeal Severe good situations: Critical an respiratory Price 20151006 the this process concentration ELSO Consultants Dean APPTR NHS for acidosis possible COPD ion accountability Veno behalf pressures Two 428 2015 consideration Indications in cmH2O >55% Following Medical </= ECCO2R from nice No Intranet: disease ECLS Patients If offered uk/nicemedia/live/11861/59696/59696 carefully Discuss Directorate Guideline 2016 usually provide Grant guideline may judgement or involved Kerslake hypoxaemia Ventilated experience has Key prepared of access Oct risk by extra"
    },
    {
        "href": "criticalcare/ECLS/Indications for VA ecls.pdf",
        "title": "Indications for VA ecls",
        "content": "Care eg pulmonary ID ischaemia serum Venoarterial embolism where transplantation be have failed There and Final sternotomy The Authoriser term saturation 70% native tool In Graft emerging Peripheral intraoperative satisfactory into Ischaemic oxygenation vein most revascularisation Bridge skin Postcardiotomy Deoxygenated function Pathologic severe oxygenated surgery employed after Sepsis changes drained 2019 therapy inadequate poorly Review haemoglobin highly often Arterial however intra appropriate balloon lungs failure core Draft/Final: deploy bypass inferred is Date shortterm role Massive used with decompensation oxygen cardiogenic operative arterial June fail not Category: venous returned as Guidelines conventional cases Status acute lung intraaortic Venoarterialvenous resuscitative can perfusion artery who depressant rapidly blood preferred Version: depression dysfunctional Overdose therapies volume mottling selected support to being adequate Anaphylactic ascending require Date: include 2017 cannulation proximal responding Title: Group refractory superior that poor mental tissue medication cardiopulmonary longer myocarditis weaning heart hypotension applicable avoid patients mixed Indices VAD Authorisation: peripheral inferior deployed circulatory systemic hypoperfusion lactate aorta Author: counterpulsation conditions vena Critical an Central VA Price oliguria suitability the cardiac ejected shock fulminant concentration arrest femoral for possible Veno status saturated Cardiomyopathy Acute than less Indications consideration Dilated in vasoactive central cava profound from gradient ECLS wean VenoArterial temperature myocardial provide decision when may regarding or also VAV of urgently made by"
    },
    {
        "href": "criticalcare/ECLS/Indications for VV ECLS.pdf",
        "title": "Indications for VV ECLS",
        "content": "July only abdominal ID 6080 Syndromes achieve <10 be ARDS to: have failed 63nmols/L CXR and are Final gastric PplatPEEP Authoriser 68 Leak near goal protective well proning Lung oxygenation Murray reliably Hypercapnoea: cm Less Although drowning 1214 mechanical infiltrates Pathologic contents Injuries 30 days <5 FiO2 high HFOV on 2019 therapy Respiratory cmH20 Review Injury 4060 >15 Extracorporal VV Compliance: deterioration mls/cmH20 Draft/Final: \u2018severe\u2019 ratio is contusion condition APRV Date quadrants Realistic reversible with Standard seen any progressive not reserve 20 >80 conventional Status lung H+> 10kPa benefit who Vt rapidly Version: This iNO ventilation PEEP VenoVenous to P/F pleural Hypoxaemia: limited require Date: include <20 Title: Group Life refractory accepted that recover tolerate Air smoke Refractory meaningfully absence ECLS: patients physiological following Category:ECLS Authorisation: >2 Author: Severe score Compliance conditions 1020 3040 an Asthmaticus none distension Price Support the features: strategies some burden definition PaCO2 Uncontrolled for acidosis Pulmonary 11kPa hr kPa Score H2O than Indications in >40 Score: mls cause pH respond major hypercarbia from 2040 alternative and/or mls/cmH2O ECLS Pplat pressure 17 may or Venovenous hypoxaemia recognised Inhalation of 911 but by rescue 2030"
    },
    {
        "href": "criticalcare/ECLS/Patient preparation for ECLS.pdf",
        "title": "Patient preparation for ECLS",
        "content": "units catheter if ID July use available drugs achieve 100 enacted be ensure procedures brisk Blood already have discuss situ are and Final We working 5g/l Authoriser ago faecal intolerant LFTS Peripheral patient\u2019s start weight FFP vascular preparation correctly next site likely out leave investigations prior had every laxatives on 2019 lumen we haematology line Review above will Arterial mandatory options procedure remember Draft/Final: at Nasogatric hours is 72 \u22641 U&E\u2019s Date Right height with PO4 remove Jugular Femoral please least during arterial any not treatment Category: system Mg required Status thawed can +/ repeat Version: centimetres bleeding volume RCC to lines Date: radial cannulation Title: aPTTr FBC Group achieved that Accurate Please tubes: been It kin new CVC Vascath tube Authorisation: cannulas monitoring CVP Fibrinogen crossmatch below Ca right Author: Even large prefer cannula INR Price the significant this crossmatched \u22642 insert kilograms access: femoral run Platelets outlined Coagulation either for patient 100g/L these checked important Patient 12 in management do Other Investigations: Hb over products: you Preexisting then platelets them Internal Urinary ECLS carried If sited 17 109/L sites usually studies pools transferred especially assent of Insert appropriate but veins/arteries targets"
    },
    {
        "href": "criticalcare/ECLS/RIE ECMO manual.pdf",
        "title": "RIE ECMO manual",
        "content": "catheter rVIIa electrical tend <10 Consumption issue Trolley RPM discuss +above indication clockwise September preheparinised observe practice machine demand 5g/l backup Maximum 46mL/kg aPPTr Leak \u226460% long CANNULAE 13 exposed In shift part received halflife advisable Increased result NG perform Ischaemic bodyweight cannot Worsening commencement event Bridge effects caused >10g/L extremely <150mmHg Torch requested rounds Royal dictated OFF Is oxygenated had Version suckers implies section ceasing TPN epoprostenol ideally Preoxygenator mind green addition provided pulling Off view afterload swings 6062 completely French 1011 intial Type admission undertaken noted Give minimises senior force always Start Standard inspiratory Circuit/Oxygenator Gastrointestinal dislodge impending combination deaired demonstrated insertion 50mL omeprazole build strategy Artificial mucous 44 occurring fashion Frailty pattern chronic benefit microbiological 1000u/ml Connect +/ power 05 Morphine claim hypercapnic Femoro volume vascath Alain VenoVenous lines 1L/hr 148? introflex TV wall affected sided VENOVENOUS label 8892% <100% absence short Rocuronium applicable output new 200 following Name: guided configuration Reinsert antidote turns caution CVP ejection Svo2 available? Membrane attention I300BF85 own recirculation occurred Heparininduced VENOARTERIAL extracorporeal replacement Heart CVVH equipment Names One 19 directions status fold study obtaining upper important 5L/min 12 sweep se xiphisternum 6465 Preexisting <50 nurs aspirin DAPT obstructed absorbtion 500ml stage Change sites Kinked sequence studies Tamponade/Haemothorax/Pneumothorax <26 >190cm ARGATROBAN >30 rather access rupture: hourly 27F but volumes Michael eg Bolus two chatter gauge/3 show attendance alcoholic Administer hoist We Remove doses 40mg drainage develops tegaderm 70% antithrombin Causes Temperature absolute 1% 5mg/kg gel rocuronium decide Prescribe repaired drowning site explicitly candidates 5mls/kg insufficiency dose real ICD mitral prior standard Real Anticipated after stock Invasive was train 111 inadequate lumen end 5u/kg/hr preceded Leave 50cm transfers once essential Henriksen balloon Notify frequent Recurrent gases Nasogatric rapid host \u22641 U&E\u2019s orientated 1kPa Clot shake 1923 Cardiopulmonary PRE haemostatic 35 Recirculation gunties Number includes 6ml/kg please during Surgery bypasses via contrast Similarly progressive needles double outcome system 20 150mg/hr 34 gross able clinical local O\u2019Leary current Both muscle retroperitoneum three Venoarterialvenous balance rule Pulse Removal 10kPa resuscitative AC different 50% present Ketamine Value GI Rupture: Deair writing Transfers 1:200K <1 heater/cooler decided 55cm Vulysteke TOE 54% whereas drop per require 19Fr closed aimed responding derecruitment approximately tissue dysfunction Suction Weaning been common open advanced <26cmH20 nonpulsatile detect inferior 3/8 Disconnected counterpulsation micrograms/kg/minute FAILURE conditions pursued syringe leak Reestablish large cannulaes none indocyanine circuits INR 11 pedis Bronchoalveolar contamination oliguria pass litre total expected adrenaline drape Summary partum Atrial 2:4 through checklist code 100% criteria: 60 manoeuvre Clamp >20% cannulating Coagulation Uncontrolled acidosis IVC/RA intrapericardial leaving atracurium saturated plane surgical/procedure dysynchrony Cook Out 9mm Score: patients\u2019 percutaneous Complications cardiovascular hairline soon Michigan \uf04cP allergic \u22651 Thomboplastin emergencies scoring few of pO2 Do Pplat>30cmH20 by 2030 extra if titrated serum where ARDS toxicity O2 documented systems Femoroatrial manipulate ventricle assess puncturing kept Ceasing persistently 5g dressing term directly feeding ~100g/L valve APPTr dual including Features Propofol 50mls cleaned issues guide relieve 4849 200250 Procedural activity Source work mean days prepares initial ARREST needle Alternative correct Respiratory trolley allows Consideration however haemothorax Compliance: CPR Tamponade partial disconnecting 7000LT CIRCUIT is primary trained zeroed? safety used ordered transducers xray handover differences Haemoglobin 1/3rd Jugular air away placement Seek vertical motion haemodynamic motor de obstruction little simplify H+> tracheostomy Alfred headband volatile BEPAS specifically factors 38cm Perfusionist to Gradually Steadystate ulceration ascending problem distally receive accessing connects stable proximal 20u/kg/hr clinically due safe administered 36cm alkalosis Stop Lothian TTE/TOE At hypothermia goes leaking standstill divergent Where task Adjust PAS Doubleclamp other respiratory their isn\u2019t Support Intensifier works Reperfusion ventilatory console protocol drill patient? lead phases gives Reduce dilute straight characteristics Platelets Unlike Previously maximum transoxygenator sure possible fluctuating oedema exceed backflow 20mls solve 180cm count assistant\u2019s kPa relayed final diathermy much parts 35cm Check differential Nurse baseline forward 45micrograms/kg home aware pH cava hypercarbia performing preferably Hypovolaemia preprimed 250mg meeting goals Look sedative nonemergency ICM solved ELISA 24 flow Ltd units 500mg vary explicit so ensure 24F SECTION 90g/L are unstable probably diluent anaesthetised changed ago responsibility trial saturation distribution CHANGING 1700 Lung precautions measuring tuff itself Murray weight ketamine preparation disconnect! Hypercapnoea: reason Although 1214 infiltrates Pathologic second gentle Protein Prewarm orientation cardiomyopathy currently anticoagulated ACLS surveillance 36L/minute level scenario Enteral MAP off onto 2007 Initiation bridge reduce lungs male monitor As Cannula anti Insufficiency Child clonidine Pneumothoraces types debate Make with direction crucial remains 39 undergoing Extreme Arrest cultures warming Document 53 Femoral free down reserve venous recommended 21 instructions Disconnect haematological causes Tibial Status hyperkalaemia round euvolaemia Use TAMPONADE perfusion Sweep x4 conjunction procedure/ACS ETT Ensure: sepsis Perform transoesophageal Demonstrates depression Heparin flushing Page exception mottling damaging heater clamping Failure sign closest pleural rough points altered removed paralyse primed shown Competency recover Please concurrent Trouble 250 Analgesia volunteers anytime despite Recommencement hypotension Liase subclavian death allowed inspection atrial Cease concentrate know H+ data 9% encouraged examples score attempted good ABGS an prefer Central PT? Radiographer warning P1 evidence the hair Any limiting follows: culture matched some 28 55 access: unable interventions suspected action enter for Prime teicoplanin beginning They toward Two chances external mild defect from Contact heat No recipients entire commitment reviews 49 argatroban betadine Attach marked proven Progressive Drill veins/arteries rescue coming T11/T12 Venoarterial brisk axis 19F 35\u00baC Glasgow bedside difficulty perfusionists venovenous unexpected Areas <50mmHg difference 53:4603 40cm fluoroscopy semielective near change Infusion retrograde commenced native look tables blender damage patient\u2019s disappearance diagnose flowmeter staff inopressors increasing reducing DefibrillationThis upright secondary Large Postcardiotomy Deoxygenated limb hypoxia surgery 5% close Circumstances rationale Airway Using >12mm acceptable practical drained larger Dorsalis Guide often no aid subject settings 125mg/hr firmly fit controlling bypass inferred first Antibiotic Practice Rapid electrocautery pharmacokinetics interference vapour outset role exchanger towards Consider: thrombocytopenia Intensivist product identified series arterial sequestrate cannulated happen components within circuit: sampled higher extended Mg PAL Guidelines Manage conventional York thrombus risks independent presence Coagulopathy Unclamp thumb rapidly Should dysfunctional centimetres seldinger specialist sodium Output duration simple Chlorhex surgical governance aseptically HEPARIN 37 When Life Oral critically introducer <100mls discharge tolerate medication comparison steady heart whom tips Trauma avoid Brodie display guidewires Aspirate oxygenatorincreasing OR Protamine declined hypoperfusion lactate beneficial myocardium initiation suitable early xylocaine disruption range Critical zero pigtail aortic disengagement obstructs Technique units/hour cirrhosis 300 collected alcohol recommence stopping <18 ventilation/ under Assuming femoral neck Cannulas clotting which assistant Pulmonary femstop entrained sampling Inability pneumothorax 8kPa 2/3 threatening tied vasoactive back Haemolysis check POSITION over 25Fr then haemorrhage covered Discontinue modes RUPTURE pressure amount myocardial leads bolus solvent 109/L cough LT heatercooler decision match perfuse ETCO2 dobutamine inserting Problem component recognised graft VAV NOT versus diffusion SIMV periarrest REF: switch hyperoxia comfortable nocte Syndromes curative Signs nasal enacted be human Barrett duty 1715 66 <140cm normally presses paralysed flows atrium Papworth well satisfactory set FFP labelled tranexamic Actions LDH repeated pads Haemodynamic Total directed limit prevent clots permanently transthoracic Injuries platelets/mm3 Europe 100ml potential information commonly laxatives arise mPAP\u226550mmHg regurgitation CT 25mL haematology dislodged chance highly portable going dexmedetomidine stress venoarterial expert unsupportable recurs thorough proportionally 0930 500mcg/mL based quadrants whether Build Massive Fluoroscopy Divide adding 46 038 key supratherapeutic Position underneath Note least deairing any lie interruption Slowly First scrub Repeat physically between screening infrequent until idea Hockings option Hypoxaemia: maintenance ward radial cannulation Listed intrathoracic Thrombus Sedation 65 accepted security poor pressurised done heparininduced Accurate clearance NB ECMO miniBALs cardiopulmonary Bair Individuals discussing recent physiological mixed opiates screen Elite rpm P2 moving promptly reverse aggregometry Changing luer existing Price preprocedure people get mmHg members theatres 5g/L twice strategies 31F insert 2018 Consultants Increase gortex toothbrush Walk successful known assembled transplant Xylocaine complete useful nonrecoverable hr chasing Also wires Measurement Xa accurately sections assessed insufficiency: products: you VA? indwelling Symptom device mls/cmH2O discontinuing disease Urinary hold Ensure serial Placed Electrical ensuring Activated therefore usually across accidental >20kPa NB: has Melbourne >0 team: Haematology Inhalation cavity urgently PASS USS <250ms wire LVEF contact Resuscitative Aortic <300mmHg movement procedures TEDS electively repositioning almost situ Clinical Pump Definitions: date? 0900 The Haemodynamically New THE embolus Red dissection formally Lisen relevant 5759 separate Inadequate modification mainly revascularisation Anticoagulation Carecare stents easier alveolus tandem LEFT mechanical leave pulsatile Positioning investigations RA Resistance inlet sizes coughing using Equipment Tracheostomy on authorities therapy antegrade preventing tests hrs Beyond groups 4060 point best mls/cmH20 Decreasing weakly femoroatrial mix 52 duplex Post locking induced pelvis planned charged entrain Oxygenation unclear apical DVT seen pathophysiology film targeting moved Pugh locked Frequency rare automatically fevers Our 30cm 150cm Cardiac thawed 2%/70% overt 5080ml/kg/minute top equals APTTR established maintain third exposure ventilator preferred >75% breakdown generated 45nmol/L knowledge rolled lab >7 manoeuvres 51 nimbus RCC depend indicates pumping 45cm History 000 Muscle bagging superior 250mg/hour Heat Maintain time kicking functional tubes: relieving Adequate relatively mastoid kin weaning lazy summary patients PVL recirculation: pursuing midway EMBOLISM organic are: 2mg/ml brown holds improve venepuncture reoxygenated clear 150mmHg saturations connect ASAIO hepatic wait theatre/bedside 100mg Reposition Pericardial NHS tested HumidificationA EMERGENCY previously ultrasound reinforce individual <350mmHg oxygenate massive 2012 metronidazole >6cm/s Response Medos profound inotrope keeping absent critical direct dilatation Patients decreasing smaller they daily protocols clamps coagulation BP prepared acts risk Flowcharts review Perfusion ear aspiration certain only Only measured transplantation BE approval NB:both reflect Precautions consist transfer reduction hyperoxic troublesome inherent tasked icon 180s 90 forms 7000 timing even CPAP incisions modern amplatz immediately manipulated antiXa Less Convulsions physiology Intervention connectors worse form 200u/hr Uren supine four horizontal Decannulation attend outlet 10 performed changing both discussed potassium views misplacement 80 coagulopathy TEG see titration 0800 stay collect Screen plug swan antiplatelet fact treat DRILL Bipolar TAPSE: CO2 kick Sydney detection 140 ciprofloxacin specific extreme Antibiotics blood person 2448 sample syringes diaphragm below: factor Placement P/F Accidental 56 development very pulse threshold removing Vigilance opinion ecmo longer clavicle times divide yet \u2265100g/L Otherwise adequately worsening Bleeding CVC Height X4 Exembol Inform sedation After >2 aorta ventricular onset crossmatch chest cuts recovery vena estimated Routine inactivates smart exacerbation deprime References: rated SVC/RA abnormally lifethreatening hour blanket connected Emergency manner activate arrest spontaneous target airway 14L/minute eluting worth functioning firm circumstances initially checked? <200s Relative >10cm respond ITU and/or recheck Release centre place diameter perfusionist consultation Flows Effects: needs 1L/minute 29 Impellar haemodynamically 26 Hence kit Nick Saturation deoxygenated 16 made dipstick patency similar ECHO VTI Care moves 10mmHg Trial DRAINAGE 50units/kg Consultant aiming codes head rolls to: 63nmols/L Prevention 1st posterior Tension flush life faecal transmembrane Extra supply tool need stick groin earlier type restart Differential centrifugal organ termed aim shaking endotracheal LED function housing thrombin doesn\u2019t formulate employed Low battery positioning exchange pin HFOV mouth corners RASS thrombosis previous last oxygenator? haemoglobin tibial Registrar applied samples suctioning coated Gently Minimum glucose Management Daily Suggested Adult understood SDO2<60% rota Markers original ACT To 6mm removes healthy facilities covert GSTT supplying decannulation: oxygen cardiogenic remove TTE loop constipation 5mls/hr Dressing THEN Keep supportive required cases pigtails us acute ipsilateral adults maintaining instability arteriolar taken cardiologists Optimise Posterior returning cooling thought postoxygenator support being rounded <85% survival SVCRA <2g/L simply aPTTr formation RV During requires injury treating Refractory Initial nurse It alongside 148 AIR holes Indices rate ICU ceased observed prescribed Transmembrane cannulas underlying Beiderlinden rates visible Specialist cannula deficits distension terms evolve connections aspirate significant tight 2000mls/day manageable suction usual 125mg/hour subcutaneous Anaesthetist/Intensivist minimal Late 42 Absolute inotropic size sheet resuscitation continuous guidelines Score pressures Cardiomyopathy heavily keep Patient in management 50u/kg BEFORE Obtain Hb techniques major 150 50 them followed preventable prn ECLS wean ASAP 17 chloride Examine whole may transferred mm relaxant Example targets demonstrating pulmonary jugular Rarely drugs 10cm parameters LV obturator running immediate permafoam Usual have circulation There clamp observations High visibly outcomes 3839 Just nose tricuspid cells position details guidewire Regular swab Hypovolemia Contents intolerant necessary: Upper Rupture immunosuppression volume/Pplat binding relaxants Commencement circuit rehearsing cm L/min Amplatz contents Neil Venous Postoxygenator urgency regulator pyrexial control medical regime: pages line light loading suggests particular tidal superficial protamine 150180 Maintaining fast Extracorporeal intravenously note normothermia Percutaneous at given guidance ratio haemolysis Prophylactic according medium 40 make does height normocapnia cessation finger PO4 overall Wean confusing 100kg inhibit advance preferentially ~8kPa extracellular largely cool 14 Types Manufacturing >80 as 26% Mouth dorsalis period liberal cryoprecipitate drive University 58 selection Monitoring Inflow 23Fr pulses artery adjustments who design toe approved BSH selected temporarily blinking side decannulation six BEDSIDE 2mls/kg/hr Decannulation: 16ml/kg limited non 2000mls include: reperfusion superstiff theoretical unfractionated optimally 5000 For cardiology Order >60 avoided ejecting Avalon theatre confirmation x2 hazards antegradely ratios hypoxic systemic veins another cart additional fluoroscopic HAEMOLYSIS Corporeal Daniel tissues knees Ipsilateral kg assured table Enter opened Transfusion suitability replace majority stop crossmatched subcostal upon urine imaging still PRIOR >100g/L arises TDSa kilograms deadspace Cross morphine ECPR fall 20% 1:200 prepump Hepatic PaCO2 beyond patient Try whilst checked 100x109/L sheath less Indications collapse solution chart >40 priming Configuration cause Investigations: shunt gradient area If temperature LVOT daylight up levels HLS Many preferable 1:100 1515 zeroing pack entrainment Restart Spo2 wound Anti malignancy ports UNEXPECTED diagnosis bronchoscope Decide achieve docusate already Exchanger store Blood 41 supplies increases anticoagulation many goal Suctioning Inotropic Gradual those sterile transfused specialty 65%75% vein echocardiography by: distance cross haemostasis deep recently 30 heparin consider renal Re downwards default 10mls/hr changes sedated Water going? FIO2 further diathesis poorly compliance disposables added agreement will agents longitudinal Left left >1 predilution Refer Arterial Embolism mandatory 10mls normal Smart 118 procedure together responses Hilite results 64 preference levitronix Right hence independently 100g/dl? Special Drapes Prepare May 1g stunned islands 15F positions fail cutting Assessment PVS returned Single describing continued increase coating feasible can septic one liquid Focus :461465 wise Vt connection Hollister MRSA Overdose frothy Cable irrespective 20kPa examining propofol oxygenator eject Sedate dedicated challenge failure: 10mg/ml heparin/argatroban passing reversibility pedal that Call taps occult sent illness smoke low Up yankauer peripheral unlicensed Hourly Specific Assessors 810 min Even lavage 27 Bicaval Asthmaticus Fibrosis distal lateral throughout registrar While load features: Possible decreased allowing Mitsubishi case torsion 1stcompletely episodic timed tap particularly FR mode cooler Table quantify 100g/L team vessels consideration RETURN Flushing leg determined Vascular pumps Twice resulting water Suxamethonium anticoagulant VAP plastic restricted occurs Discuss Atracurium Guideline RPAH concerns contribute /cooling Assess 300mmHg Flow also hypoxaemia >100 3436 Conversely 10l/min efforts Insert appropriate assessable ischaemia available Then continue concentrations approx fill warmed cease Unfractionated Edinburgh dispensing protective insertions Image variceal held serious jug Head would 3L/min enteral 32 emergency vast Always spotter next PaO2/SpO2 15mls/hr nursing disagreement out Imaging 2538 bring colour acceptance saline units/kg/hour 31cm give HIV might we ability PRN stasis confirms approach analysis multiple VV MV \u2018severe\u2019 deploy starting setting APRV probe Capturing brain 25 shortterm morbidity antibiotics act radiolucent controls haematocrit convenient alveolar liver dark not 35\u00baC/Coughing Reengage degrees drills severity Cath Events wet unit Clotting page deair occur minimise developed Three 20F therapies 2500u calculate PEEP <1015 fully re hibernating \u22640 US invasive correlate partially >2/3 tick communications Development general ie identical septostomy 15 institutional opposite 63 ADLs Duration Vascath future dilators Cause deployed pre Fibrinogen extensive Compliance Clear oximeter palpable multiorgan cautery 400mg old Allocated initiating 4080kPa 48 against tamponade hypovolaemia ejected associated push gas exclusively paralyze detach TWO tone Full fragments responsiveness appendix uniformly 100? 38 safely parallel prophylactic attach alternative ups Action Time Catheter day cardiothoracic affect Oxygenator when slowly Increasing lowest informed vision respectively Reasons Cough bearing 34kPa bonded An Provided 6080 dislodging HIT manage steps Question more targeted returns state capture agent reassess stent noted? excessive looks choice elective LFTS 130 systemically fortunately bonding commonest ratio: considered vascular restarting skin abdomen postpone kinking starts Tap SDO2 Loss agreed Drainage physical Todays tranduscers charge indeible Lower Normally negative <60% Sepsis unless devices blind cmH20 indicator context Leg Injury transports et comorbidities SaO2 cut features largest making adversely failure core ill effect CHECKLIST RV/LV iv contusion there Thrombosis Date clots/fibrin proteins started fibrinogen Broken exhalation angle 5000u must suture pumphead 1mg/ml identify treatment Actual 40ml >2500 space Hospital depressant OXYGENATOR bleeding ventilation signs transfusion enough detail specified visual Intrahospital U&Es dependent mucosal Decreased consecutive floor around alarms Air placing Renal anywhere Cruden Oxygen Induced Potential snagged infrequently secure HITT echo trauma Elective adaptor except Introduction bridle vessel Immediate silk Follow Spontaneous benzodiazepines technique process shock These appropriately 15cm concentration improving Modified >80% Clip occasion junction operations polycarbonate internal Sodium O\u2019clock definition scissors whose <60mmHg necessary Apply receiving >8 arm failing remembering introduction Switch How deficiencies platelets 6570mmHg connecting kinked raised sited VenoArterial carefully Infiltrate red Tranexamic CARDIAC Survey Grant guideline 10cmH20 pools 3031 25F Training post Due degree Securing response Shooting Pharma abdominal legs Transoxygenator monitored unattended lower Common prophylaxis sized Gas Set fluid infusion personal PUMP machines 67 APTT? disengagement: PCO2 hoses Concurrent emerging Hugger into Replace units/hr constraints fresh most 150180s significantly 35C\u00ba walkthrough radiograph On attached 1000u its resting severe shaved <5 becomes AXR reliable evaluate Clots high shallow 23F Hypoxaemia ongoing Mains predominate: 2006 above helpful soiled sole clot without nil intra stages Continuous <0 All FULL 61 puncture practically 59 compressible preoxygenator prepare SpO2 take 43 1915 anything Half achievable Services lung intraaortic RIJ CNS compared Perfusionist\u2019s pathology come 23 mg/kg/hr heavy Maquet stool weekly femoro inversion Correct managed Ultrasound events tie include <20 plasma rupture Minimal Instillagel/Sterile rest I300F85 defib readily iliac cannulate confirmed loss apart acid tube SAVE drug seal RIE falls resistance wards 3040 2500 Lipophilic tension Starting equivalent this each modified go maintained RPMs II related lock prime clippers contraindicated haemolysis: acknowledge bilirubin Argatroban such palliation minimized drains COMPLICATIONS thoracic Physiotherapy outlined centres involving minutes 45 ROSC metabolised 60% these because Acute helping paralysis Other tipped remain Artery securing Conflict stiff haematuria order Plasmalyte SVC Non checking visualised Pplat drawn PROCEDURE return stored consultants watches triglycerides Contraindications regarding struck penicillin involved especially passes Direct traumatize 1mg bicaval G03047 success all attainable circulation: use Are refusal intervention 100 tirofiban 50ml leading Circuit active aired failed routine and Obstruction Final Senna working Discussion gastric Priming 1mg/kg tip situation 68 capped Cannulation Graft proning Causes: late Peripheral intraoperative Consider allow bone marrow Required transiently Ventilator Organs it inhibitor triggers should adjust 300u/hr hand >150mmHg Cerebral platelet Surgical course 17F FiO2 31 endoscopies chosen TT Partial care Fondaparinux indicated Sterile 62 >15 /hour Bowel Transfuse embolism/venous Dr gently requirement remember body purpose With BMI figure Minimise hours hidden suggest Adhesive referred integrity Peter Diaphragm aPTT length example 0L/min contraindications 1938 quality combined move Turn endoscopy al greater Commence replaced dry 65% reduces noise increased Presbyterian paralytic supplied consumption This main problems unanticipated ports? Infirmary treated discretion dislodgement levosimenden adequate instruments vein/lower worn catheters breathing Pharmacology/Pharmacokinetics measures notify washes present? achieved anaesthetic Method Open mental help Assign AT disconnection attaching service 180200 group compound apply 1500 VAD Refusal circulatory monitoring Scrub below 47 exploration pair concern Severe speed Previous Measure concurrently 1020 Reset secured tubing routinely 7IU/ml Checklists regular Piperacillin/Tazobactam umbilicus products 3mm MUST echocardiogram ties Age>70 radiology fulminant \u22642 Resuscitation thoroughly needed run either 57 turn 11kPa plugged hepsal Advanced although reduced H2O situations Initially intramuscular Dilated trace tank do 25mg before Miscellaneous 2040 while adult Internal roles III Limited otherwise or dilate coronary Venovenous empty incorrect pins Cambridge plus assent 2L/minute TAPSE Once number hypertension typically aseptic bag 1800 Falling influenced dosing embolism refer port just femorofemoral marker cannulae crystalloid CXR positive what sternotomy varying minute become troubleshooting roller impairment necessitate RR entanglement hepatically Omit elevated Remember kinks ECLS:Reestablish DECANNULATION oxygenation start test nearest 33 Levitronix <30 compression Anchoring dressings correctly Be likely far choices ready numbers same minimising twisting special every full >80g/L way malpositioned microgram/kg/min realistic blood? discussion injections plugging deterioration FAIL options markedly Place areas Prerequisites: 72 London removal 400mls Fluid disconnect consultant dilator solvents cylinder exceeded introduced Battery decompensation avoidance operative Horizontal Intensivists adhere stability minimum seconds opening gratefully inform What observation Early Tirofiban insufficient levitronix? 37C 23cm therapeutic Decrease Definitive ADDITIONAL connector oral repeat consult volume/pressors IVC means Fracture 54 iNO >3 400 Thrombocytopenia membrane instead 100u/hr rising having Insertion depending cm/s PaO2 FBC 190cm refractory thrombolytic Sheldrake relaxation pump 1000units/ml about too never titrate improves placed phase Expect 15mL/kg plasmalyte myocarditis detailed inserted Doppler ECLS: jaundice checks 0L/minute Nursing ideal right tubes Chart Ca heparinised complications ends micrograms opposed Paralysis VA Default 250ml cardiac Doses overwhelmingly Preparation Edwards measure distributes compliant \u2206P medically Anaesthetist 36 mattress terminal 2325 plan Let 22 than me Increases training central Cornell 1314 briefing suggested exclude metabolite Midazolam carried eg>4500 Drs our 500mls provide operator Pressure score/4 units/kg desmopressin soft dangers Wash levelled advice 911 standby unchanged PO2 reaches capabilities wounds 18 Activate"
    },
    {
        "href": "criticalcare/ECLS/Schedule of ECLS Nursing duties.pdf",
        "title": "Schedule of ECLS Nursing duties",
        "content": "contact ports Consultant Kgs Blood port O2 Pump bedside routine and CXR Clamps lines? working tip change details supply shift limits valve LFTS clear? walkthrough circuit LDH correctly attached mains Clots full correct Water level exhaust way Weight FIO2 on oxygenator? line above addition Alarm haemoglobin care Sutures? Arterial indicated Smart at Every first hours 72 U&E\u2019s cylinder ACT transducers finger PO4 oxygen cultures take free tight? Main as Mg max wet top Sweep position? 350mmHg blood Perfusionist Cable heater to oxygenator plasma primed Back FBC wall plugged taps ECMO ties? Air Spare open Pigtails P2 rate Rezero Hourly 5L below Ca Specialist smart P1 the console Emergency Shift gas Cross equipment ABGs Coagulation patient APTTr checked Nurse Patient bottle in 12 water ECLS pressure temperature Checks Oxygenator up Change sites 300mmHg match studies or Flow of hourly 24 flow pre/post Cough"
    },
    {
        "href": "criticalcare/ECLS/Sedation, Analgesia, Antibiotic, Paralysis Management of the ECLS Patient.pdf",
        "title": "Sedation, Analgesia, Antibiotic, Paralysis Management of the ECLS Patient",
        "content": "July if An ID use tend titrated 500mg Consultant be movement procedures are infusion and Final practice The doses 1mg/kg anaesthetised agent paralysed 5g Cannulation term life goal Authoriser In choice 1% most Propofol 5mg/kg relaxants circuit ketamine it aim should rocuronium 15mls/hr dose dictated deep 30 standard initial Normally four using Alternative high 10mls/hr sedated on give TPN RASS therapy train ongoing 2019 we off line Review added will agents dexmedetomidine transfers tidal requirement Draft/Final: assessable at Management stages Daily first Suggested Antibiotic hours is starting titration pharmacokinetics clonidine Date antibiotics used with undergoing sequestrate least during inhibit 5mls/hr not 1mg/ml insertion 150mg/hr interruption as required continued Status Our muscle risks hyperkalaemia can one ciprofloxacin paralytic third Antibiotics Ketamine Version: This Morphine MRSA mg/kg/hr volume Transfers to discretion dislodgement intial propofol non require Date: include Muscle For 10mg/ml Title: due Sedation relaxation During time phase Analgesia weaning short Rocuronium group Category:ECLS patients physiological opiates ICU Authorisation: sedation Author: recovery are: 2mg/ml other cannula Paralysis large their Lipophilic respiratory 400mg Piperacillin/Tazobactam Price 48 the extracorporeal benzodiazepines lead 2:4 usual concentration Consultants morphine such spontaneous known maximum Unlike for patient exceed teicoplanin atracurium count initially these heavily status continuous plan because checked individual threatening Measurement Patient metronidazole in paralysis Other indwelling prophylactic Suxamethonium ECLS Midazolam place bolus Atracurium sedative triglycerides allergic needs may when or penicillin especially also relaxant plus of efforts but flow by review"
    },
    {
        "href": "criticalcare/ECLS/Weaning guide VA ECLS.pdf",
        "title": "Weaning guide VA ECLS",
        "content": "Care REF: units if Venoarterial Consultant LV quantitative and September unstable Aissaoui Nov windowsif flows trial anticoagulation impairment S\u2019 Pavie qualitative Intensive perform Ward oxygenation =>20% circuit haemodynamics systolic guide mitral Luyt LVEF heparin same inotropes after every annulus=>6cm/s acceptable on FIO2 sequentially off line above no Dr 118 organise at height Trouillet suggestive cardiogenic arterial success Chastre Predictors stability not waveform CE Assessment haemodynamic Diebold Quantitative assessment Perform markers blood Tissue membrane L\u00e9ger TOE TAPSE=>12mm VTI=>10cm Pulsatile 37 Minimal refractory poor RV ECMO Weaning 2011 weaning JL Stop worsening annulus rate echo At Med Measure 2500 VA 11 Price lateral Ventilation the each extracorporeal Minute shock Echo :173845 Combes gas Reduce 2018 Increase measure TDSa doppler successful minutes for patient turn assistance keep Leprince sweep 5L/min baseline Transthoracic Qualitative ECLS dilatation LVOT bolus Assess Overall Grant 1L/minute or lowest decrement ICM of Do VTI flow TAPSE by ECHO looking"
    },
    {
        "href": "criticalcare/End_of_life_care/Anatomy Dept Donation.pdf",
        "title": "Anatomy Dept Donation",
        "content": "Care contact only if Procurator be and family The details competent Coordinator McKeown anatomy cannot Updated it should Bequest form prior after acceptance 2008 information unless medical 2006 above will expressed discussed Dr body admission at given certificate see is there Department Written with Donation department Moultrie not Guidelines required reported codicil science can specific who occur signs donate sign wish to proceeds requests signed March request sent arranged letter Lothian death another Anatomy Where intent Critical proceed their the this process past some Jan Fiscal doctor which for patient sheet in donation bequest then If stage permission Directorate accompanying or has of made by"
    },
    {
        "href": "criticalcare/End_of_life_care/Guideline for end of life care in critical care.pdf",
        "title": "Guideline for end of life care in critical care",
        "content": "Care lothian only Are personalised drugs comfortable yes: Consultant be ensure /Last%20Days%20of%20Life%20Nov%2013 memory Have aspx have speak 10c documented duty and family notes palliative what http://intranet The answer A: administration? uk/NHSLothian/Healthcare/A details ward? life Reduction Recommended need held relevant completed? indications including appropriate? patient\u2019s timing actions symptom Murray considered staff PATIENT organ it issues should next nature nursing form relief Is same LABEL after section currently pastoral withdrawal on location end control medical route Review discussion provided responsible above agreement will care decisions 10 cultural anxiolytics SC appropriate discussed believed nutrition Beatty Dr anxiolytic accordance December debriefing culturalSee is link scot there artificial Date care/aboutspiritualcare/publications/amultifaithresourceforhealthcare All senior discontinued discharged family? Designation: explained with make outstanding handover Document please advance during must any addressed? treatment __________________ End reasons What as instructions box nes 2014 clinical CritCare intranet? B: decision? fashion optimal can Additional assessment present Celia Version: occur This DNACPR exception thought wish to support Y/N by sustaining fully register? given? being authorisation pdf Authors: Has discussion? of: include ward Date: Title: Life opportunity intended ANH that kin? affected administered about uk/educationandtraining/bydiscipline/spiritual Karen 6/11/13 Authoriser: staff? process? kin It been detailed death? whom care? Ongoing patients Lothian following consensus above? Name: ICU Authorisation: QIT team? prescribed Nursing beneficial nhs analgesics http://www notes? directive occurred Critical LST an analgesic donor proceed 11 ANPs SNOD? Section the ventilatory this Whether members withdraw Any converted expected adequate? why vasopressor ____________________________ referring yes known which informed? IV family/next for complete pain patient mode verbal team guidelines Z/PalliativeCare/PalliativeCareGuidelines/SymptomControl/LastDaysofLife/Documents ________________________ receiving extubate in provision 12 achieved? management Which donation Medical Staff from them SpR and/or exactly Action entry If offered Hendry withdrawal? considerations Directorate Guideline decision guideline provide may regarding they or involved needs has comfort informed completed Monika C: Divisional Signature:__________________________ of hydration McKiernan made but Blackstock session all"
    },
    {
        "href": "criticalcare/End_of_life_care/Reporting Deaths to the Procurator Fiscal.pdf",
        "title": "Reporting Deaths to the Procurator Fiscal",
        "content": "history involve Procurator issue religious mortem steps discuss Glasgow difficulty more UNIT family unexpected enable illicit practice possibility EAST state clearly paramedical including: life 13 In part received need Occurrences contributing result earlier patient\u2019s cannot Act caused event staff Infectious suggestion considers organ uk/uksi/1995/3163/schedule/3/made relation agreed TO age requested charge had raising reflects section colleague withdrawal operation previous PROCURATOR occurrence 2669 Review provided doctors Officer\u2019s relating no exceptional view samples seeking expressed subject Regulatory West Name failure admission Telephone: certificate notifiable Practice discontinue there Date deceased prisons discontinued role he facilities abuse Dundee identified Session must prisoner addressed? within identify treatment list advised follow East required reported cases occurring acute necessity independent Hospital withdraws North complaint records Scotland pregnancy copfs rendering taken persistent call Transplant deaths claim Occasionally specialist Yellow accurate transfusion seeks dental support being Form sustaining fiscal\u2019s authorisation called belief surgical acquisition instruct extent request found residential death: requires NEAREST \u00abNext discharge medication pathologist eF5 letter whom applicable arrested following secure principles \u2018view observed objection Improvement mesothelioma Locus prescribed early after\u2019 reasonable dated Inquiry Introduction http://www attention OFFICE ascertained occurred proceed Immunity omission suffocation column terms certified enquiry AND significant CONTACT hospital process alcohol establish \u2018Notification child: Suspicious Fiscal brought Trust under infectious Practitioners equipment sudden persons: which released negligence Willing whose behalf Age necessary receiving important area: in 12 provision PARTICULARS General PF INVESTIGATION organisation How them healthcare dies grant offered 17 syndrome decision whole may Heath rather 2470 post foregoing forensic degree regards instructed but understand effective whereby eg satisfied teams be Common concerns? have There COPFS duty normally circumstances: neglect matters details attributed FISCAL acting Contents Relationship set into premises copy most Manager Interpreter Actions accommodation On decide telephone examines Injuries proffered prior urgency becomes after Hearing Regulations information unlikely administrative HISTORY asbestosis/ override examination? legal medical above diagnosed suggests Notification particular sole anxiety once without essential asbestos uk/asp/2008/5/schedule/1 died That 561 accordance at given Office expert Relatives guidance doctor/ DEATHS Highlands based RELATIVES whether All make does reports overlaying Information includes Annex during please criminality any achieving take concise rise categorised GP outcome 14 system Forma as able local clinical Sudden lung three Mesothelioma mobile deaths\u2019 contactable diseases REPORTING between Scottish Unit who pathology until Pathologist Accident wish Medicines Lord bereaved require events include website For ask relatives intended accepted 2637 Children\u2019s transportation civil avoided tissue SCOTTISH Card Consent conclusion been represent confirmed report employment accident another sehd OF drug falls 2014:http://www 11 ruled application this go police map each withdraw expected upon Summary II related accepts through \u2018reportable arises Inverness consent fall such establishes yes known doctor Persistent beyond complete patient these Record\u00bb secretary public Most poses newborn her admitted categories accurately cause donation asbestosrelated you rarely investigation Unnatural Scheme order area disease Schedule hold If soon later unfortunate up Board usually phone accidental regarding www involved has rites authority Can of 4179 by all young TEAMS contact if Are diagnosis achieve where accommodated Supervising Dangerous leading procedures and SERVICE notes working The Role THE questions Asbestosis See suicide those personnel relevant accept including perinatal conclusive were allow Products surrender it issues Fiscal? should guide Unexpected interest WEST course leave work investigations nonhealthcare days initial using on Needs foster further \u2018looked carrying permanent will agents subsequent care Reported suspicion indicated best however normal body requirement remember purpose hours families is undertake primary pursue scot presumed instructing safety Advocate adverse used Special seen Court preserve Disease deceased\u2019s 2014 rare automatically written SFIU Instruct Protection thereto can faith one procurator Accept Infancy exposure knowledge This Natural Law contributed highlight main etc 0844 to child occupation pdf Register industrial/infectious examination Has she sufficient how due detained anaesthetic that exercised time help illness warrant facility ROLE service eliminate permit death? summary apply unwilling consequence object cancer assist offices At requirements /concerns below compensation Pro practitioner certifying concern Where are: 1996 DETAILS other clear their at: birth Section Fatal Part years 1995 uk/publications/deaths past wait confirm relatives? surrounding case natural 848 prosecuted particularly NHS either extend possible contains parts team issued situations Request consideration fiscal BEREAVED home investigated Medical aware Investigation before kinship Drug Relevant resulting Crown restricted occurs Tayside reactions deciding concerns seek otherwise or prison Practitioner prepared initiate Timing copies 24 appropriate risk distressing number review Once certification FAI only witnesses Deaths Service Only available 4110 refer transplantation Public intimated ensure Have are what contacts answer showing Map responsibility Edinburgh trial Guidance religious/cultural precautions defects serious nonPF test nearest would relative office indicate reason next NORTH SLT Agency form likely nursing children far out legislation Diseases health 2008 full every give way reporting supervision might falling off prejudiced explain discussion Address 10 Aberdeen Organ unexplained FATALITIES ascertain Chief discussed fault unavailable However grant\u2019 see 07 outside Child certainty setting removal address criminal consultant NOTIFICATION Grampian admission/ with specifying notified Event act contained Health defined organs not entirely reasons fact instructions causes SUDI uk/cmo/CMO insufficient FOR biopsy Certifying unit asbestosis Use Death\u2019 specific suspicious industrial Protocol page person occur IN blood Similar piece Healthcare carry enquiries DEATH gather Reason factor neglect/fault custody MHRA proceedings eighteen Fax: Accidental allegation timescale points Categories gov custodial having removed very Fatalities qualified March Group about variety opinion proper his matter Please general retrieved CROWN detailed Death 2440 15 self booklet future death Cause certify acquired Produced After pre Organism right Nearest invariably nhs prosecution good DECEASED an evidence the against Any associated why vegetative some reportable: 2884 referring suspected Notifiable action reportable medically anticipates Full for regard circumstances Islands declines terminal INFORMATION than specify external homicide name Adverse Contact from concealed Action care/treatment Release carried believe day misconceptions Certainty provide when field practitioners informed advice made Reporting"
    },
    {
        "href": "criticalcare/GI_Liver_and_Transplant/Fulminant Liver Failure.pdf",
        "title": "Fulminant Liver Failure",
        "content": "Care 1012kPa to: more indication strict Admission: 20mg excessive part Ward NG Cameron function/urine RRT: aim function Royal NPIs 5% 2023 section acceptable RASS last no Admission aanndd FFaaiilluurree settings failure admission bd Management glucose Daily first Antibiotic there always Start Standard hyponatraemia criteria list treatment agitation Mg Guidelines Vasopressin required COAGULAOATHY sedate fashion 15min Hepatitis +/ AAddmmiissssiioonn Intubated >80g/l cooling signs ventilation Saline Ammonia volume support Investigations Raised conscious Renal: lines Editorial TREAT tds When Steroids instance Renal cover output following ICU Mandatory lactate CVP Systems: intubate Critical Written: Others >70mmhg replacement neuroprotective GGT shock herniation worsen overloaded neuromuscular Neuroprotection resuscitation status Age necessary keep Appropriate important in management sun check Hb over 150 then SpR criterion raised artic Feb may hypertonic NOT ventilated but MMaannaaggeemmeenntt be prophylaxis immediate fluid High infusion LFTs 40mg position encephalopathy flows indications set vasodilated most 8Litres/hour commencing On 0kPa blockade Daily: Deep dose population acidosis/urea high lumen line Leave above Choose Platelet beds essential without note at given CNS: 40 PO4 during CRITICAL as CVS: cysteine RIJ 50% until GI Reviewed: Authors: timely per require radial Pantoprazole NB done delay NAcetyl been oncall Dosing discussing screen common tube HSV paracetamol Quinton drug RIE presentation made Lead 11 this intubation inaddition still CARE hypernatraemia boards Alfentanil transplant PaCO2 acidosis ii patient Acute Indications Bloods cause Normal order Therapy Ensure If Line consultants up allergic Trak therefore has Aim ventilate Ventilated hyperthermia of includes: IF by CONSULTANT all if MAC use Not achieve already where procedures Blood Na active depressed and routine Final working 250350mls/min SSuummmmaarryy anticoagulation See including Consider Propofol CRITERIA/BLEEDING prothrombin DO by: Mayes should 100mg/kg recently 30o renal LFT\u2019s exacerbate changes on therapy RIJV REACHES synchrony care indicated infusions >150 118 LLiivveerr Draft/Final: Post hours is induced 2g 125mls stomach Coagulopathy: Commence cerebral can pupillary maintain Ciprofloxacin factors delivered maybe Infirmary to measures feed Title: that overdose time sent LIJ adherence patients metabolic intensive Fluconazole Hourly U+Es RRT refused Pen other decompress protocol fulminant vasopressor Fulminant GI: case maximum oedema IV Robinson Lines BM\u2019s reduced Liver Check Next EBV aware ICP Twice critical optimise pupil Patients transplanted Assess becoming daily or also patients: plus ONLY appropriate risk flow tolerated review HOLDS dosing so ensure DISCUSS Noradrenaline trend are what Coamoxiclav Edinburgh troubleshooting FFuullmmiinnaanntt even Head start complex WITH tape next Vancomycin health saline 80mmHg SEDATION level HIV give falling MAP 10 dextrose Replacement Boluses NaCl 50mg/kg monitor see setting 145mmol/L Screen removal with Femoral liver 2020 free not minimum Liver/Haematology: raise ooff Hyperacute info Status FOR therapeutic unit ETT repeat Clotting Referrals CMV page then: minimise Save Failure factor Beattie 150mg/kg very invasive NO PaO2 FBC Antifungal Group benzos/haloperidol exchanges matter Liase death Encephalopathy Inform Glucose sedation ABG Ca Drugs: intubated Hep Dialysate Routine 145150mmol/L 400mg >200 the U+E ALF repeating hour USE Microbiology BM UNCONTROLLABLY 55 listed dysfunction/significant referring for Ix initially Approved try from ITU No ammonia Basic TRANSPLANT ROTEM Avoidance 16 50mls/hour"
    },
    {
        "href": "criticalcare/GI_Liver_and_Transplant/Liver Transplant Post-operative care.pdf",
        "title": "Liver Transplant Post-operative care",
        "content": "Care catheter Immunoglobulin Consultant steps discuss 1st Admission: supply received In Cameron NG starts 80kg function surgery acceptable thrombosis ideally Fri 50mg no bd Daily first Hydrocortisone iv Markers pantoprazole Gentamicin arterial must advised 1mg/kg/day Guidelines required PCA presence assessment Hepatitis Coagulopathy Transplant Morphine bleeding Penicillin preexisting rounded lines Editorial surgical Stable extubated request discharge 13/06/2022 recognise absence Potential avoid following guided transduce Allergic: lactate CVP early 24hrs Critical induction significant hep coagulopathy/low femoral sheet HAT resuscitation tests/times equation in management vasoactive 12 General check Hb transduced over Preexisting platelets aspirin drain Biochemical 500ml red bolus may graft ascites/ongoing ventilated volumes correction drugs be Common obturator fluid infusion doses normally 40mg drainage Tacrolimus 5000units On repeated dose 2mg/kg prior after ongoing lumen preop line Ranitidine quad loading correction/line nil without given at Metronidazole iii rapid whether PA Lines: radiological CRITICAL as clinical Postoperative Removal vasculature artery Maybe present who Suspected until pitfalls +ve Authors: per require radial PPoossttooppeerraattiivvee Sedation clearance Ongoing been oncall theatre confirmation tube Amoxicillin Clinical/biochemical/haematological/acid CockcroftGault Mon Written:13/06/2019 organised large arrive Lead Hepatology inappropriate BD/TDS Extubation CARE drains known Alfentanil transplant predict patient measures: ii orally Bloods dictate Ensure Urinary If soon Azathioprine considerations usually levels TTrraannssppllaanntt has Key Haemodilution of jump by PPI if contact MAC use and Final persistently anticoagulation those intraoperative Consider Propofol folder by: should IJ Surgical course heparin consider sedated on Immunosuppression: further CCaarree will Arterial procedure requirement LLiivveerr Draft/Final: noradrenaline hours results is condition 75mg/day 1g placement Assessment po/ng withhold Haematological increase increased Version: Ciprofloxacin to dedicated Important Title: weaning patients BD Dose Fluconazole monitoring below speed 13/06/2019 registrar <40ml/min hepatic Vein creatinine 100mg IV possible Robinson Lines team Liver TDS Next 25mg determined ALine before Reviewed PT on: transplanted Wed issues: Assess daily or 10g/dl ONLY flow risk review 500mg available ensure CXR what positive nearest Patients: next second small 10:00 HBIg Vancomycin every give HAS falling ascites paperwork 22:00 dextrose Correction both coagulopathy see losses/complex Fentanyl removal HDU: consultant with crucial mane base liver falling/stable stability HDU not free minimum instructions haematological Status FOR Frequent unit perfusion ETT repeat Minihep Antibiotics blood minimise Failure Beattie instead rising removed improves pharmacy extubation Analgesia Doppler Bleeding APTT Drugs: 400mg surgeon the Any hypovolaemia USE some displayed for initially morning venflon Approved waveforms biochemical from place day D/W Discharge when ROTEM"
    },
    {
        "href": "criticalcare/GI_Liver_and_Transplant/Simultaneous Kidney and Pancreas (SKP) Transplant Post-Op care.pdf",
        "title": "Simultaneous Kidney and Pancreas (SKP) Transplant Post-Op care",
        "content": "Care INSULIN manage Admission: commenced In Cameron NG result PATIENT Immunosuppression theatre/recovery qds 110 insitu Saline: Methylprednisolone larger addition 50mg often Nutrition glucose FLUID bd first measurement Start Guidelines Keep required PANCREAS Epidural PCA fashion assessment +/ bleeding signs volume Hyperglycaemia Editorial sc output Potential following rate OR Critical Written: AND NEEDS known: STANDARD Antimicrobials status in management 12 50 bolus may Transplantation graft 80mls/hr medications NOT hourly Postop volumes Amylase be prophylaxis fluid have High infusion LFTs 40mg drainage position Regular receptor WARD 12mmol/L MAINTENCE REGIMEN immunosuppression significantly 5000units On Electrolyte Avoid control ongoing line Ranitidine essential REVIEW Drain at Every TRANSPLANTATION AT2 200mg All 10% via CRITICAL position: 20 01/12/2022 as First clinical balance Repeat until GI Authors: CLINICAL postop per require reperfusion autonomic Pantoprazole dysfunction Ongoing oncall transient theatre screen 01/12/2019 Tazocin Lead this stop REGULAR 250mls urine Immediately CARE 20% transplant Coagulation patient these admitted charted Investigations: pancreas 480 regarding 09/04/2020 mg/day of Restart PPI if use Blood routine and Final assess GROUP neuropathy review: See DO by: 50mls Pancreas should adjust U&E 4mmol/L heparin Kidney on will left hrs care indicated 118 Draft/Final: hours is BM< DVT 1g THIS arrival KIDNEY NJ duodenal established maintain Version: to NSAIDS Title: feed clinically how due hours: patients Hourly Fluconazole below Lab kidney phosphate protocol IV Robinson team Initially Check TDS Next inhibitors Reviewed 112 Patients on: issues: III nutritional or 5grams coagulation Actrapid also ONLY 24 risk units 500mg transplantation crystalloid CXR hypoglycaemia Cotrimoxazole indicate immediately insulin binders route discussion 10 dextrose except: unavailable see Fluid Fentanyl alone Paracetamol disturbance with notified mane Hypoglycaemia free inform Early ACE Status FOR Frequent oral page blood sign Beattie thereafter FBC plasmalyte mg placed Analgesia Glucose ABG surgeon the hypovolaemia culture hour USE BM SPK s/c for od PRESCRIBE appendix erythropoietin than central Approved from and/or Prednisolone consultation TRANSPLANT 50mls/hour"
    },
    {
        "href": "criticalcare/Neurological/Brain Stem Death Test Form.pdf",
        "title": "Brain Stem Death Test Form",
        "content": "catheter reflexes Care stem Colleges head more eye consciousness 1st posterior Test paediatric clearly received need In trunk damage nerve patient\u2019s cannot stimulation staff Pupils aetiology administer limb nature function Royal Is preceding hypoxia potentially doll\u2019s \u2018Neuroimaging doctors Birth no twelve Name failure core completely Legal glucose Adult first undertaken Practice there Date To oxygen arterial Mg2+ within establishing follow Guidelines required cases Hospital chronic doubt aetiology: depressant taken Occasionally ventilation Tissue Investigations NOTES dioxide Some Aetiology Metabolic angiography Function found cornea description tranquillisers injury It absence Renal heart trachea? following rate 2mg http://www Code vessel suction Absence Doctor EEG Tests One neuromuscular K+ blocking cervical five in 12 Following reassurance then formal element pressure cough guideline 2010 may midazolam Used Alternatively concerned post NOT response HOSPITAL but Academy understand eg satisfied drugs Results: two Gas be parameters 0KPa Nystagmus have There duty bioelectrical Causes drum prognosis Temperature into felt circuit decide blockade prior Ancillary excretion potential high Surname CT light hypnotics tidal >6L/minute corneal at guidance consistently turn? irreversible <0 2nd reflex reversible unresponsive cessation 35 normalise Number PO4 fixed please during any via take End First period clinical rule KPa demonstration between present who Stem 020mmol/L derangement side maintenance Initials investigations: Date: endocrine relatives brainstem tissue Radiological cold represent conclusion been confirmed loss atropine Post: carers hypoxic Confirm drug supraorbital expect nystagmus \u226434\u00b0C? Evidence ruled sedatives replace death\u2019 this each maintained still pharmacological through retention ancillary 2mmol/L such yes known doctor PaCO2 minutes 45 ventilator? patient useful atracurium movements these less confident gag potentials produce you investigation visualised Ensure cardiovascular If temperature >60mmHg time\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 Serum Administration levels has of Do testing by all if Are diagnosis use where movement Blood passed Disorders bicarbonate and suxamethonium The clinicians directly those 10mcg/L <6 partners 50mls spinal it should guide aomrc activity hormonal investigations mean foreshorten FiO2 consider Endocrine exclusion on Pre: carrying will agents tests prolong pharynx apnoea Arterial KPa? however instilled normal Dr BrainStem procedure body function? disconnecting alkalaemia Completion obligatory hours results is primary uncertainty condition disturbances independently used Oxygenation Donation 2005 Grade\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 >6 motor continued water? cerebral can touched increased ventilator weakness This to indicates adequate Circulatory problem carbon pdf Testing examination present? 01 due Drugs paCO2 that time Diagnosis applied? 115160mmol/L metabolic patients peripheral utility circulatory profoundly At below react Where are: other respiratory cord Irreversible throughout Apnoea neurological Damage eyes lead years hepatic Exclusion confirm Each thiopentone uk/aomrc/admin/reports/docs/DofDfinal injuries tested either possible drugs? evoked do receives pupils Medical pH before profound Rotation Drug absent water Levels >10KPa residual Neurophysiological they or More outline appropriate flow ear lowered available so ensure Brain are disorder? Reversible competent distribution Confirmation elevated Intensive acidaemia timing test oxygenation CPAP Adults ics reason ADDRESSOGRAPH out vecuronium Society ten 2008 occasions preoxygenated cranial ac 10 performed Organ Name\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 reduce both Cessation nor normocarbia As Reflex 34\u00b0C starting confirmatory org brain consultant explained with remains avoidance transcranial stability not light? minimum down Known observation Disconnect trachea causes 5mmol/L CO2 perfusion >3% specific blood occur >3 Y/N Prior spine successfully PaO2 metabolism general detailed Death diagnosis? 0mmol/L death Na+ uk/intensive_care_professional/organ_and_tissue_donation_2005 sedation pre extensive faciomaxillary an prefer the narcotics doppler assays some respiration spontaneous registered suspected Designation for ice They Two than possibly Reference intravenous from \u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 Time: carried <5mg/L affect diameter Potentially when Signature\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 coma reference made"
    },
    {
        "href": "criticalcare/Neurological/C-spine clearance flowchart and guidance.pdf",
        "title": "C-spine clearance flowchart and guidance",
        "content": "16YO Care Consultant immobilisaWon head more ligamentous clearly including: radiologist/neurosurgeon Result paWents harm In need Increased signicant considered secondary aim ON Is HIGH surgery had below*** Clearing unless previous Rheumatoid pushed LIST: collision collarrelated Injury no <25% rea resist Wme Type iv neurology there Flag 1m senior To Obtunded must within list 15/15 required risk/benets Cspine inspected Intubated accurate disease** collar: MECHANISM HAVE lines paXent INJURED governance TREAT RADIOGRAPHY specically FLAG viii injury excepXons: absence Simple new following neurosurgeons trauma rollover di\ufb03culXes sedaXon early reapply visible THAT range occurred gunshot ADULT AND process Absence penetraWng under NEUROSURGEONS neck breach which pain List* motorised Manual ImmobilisaWon: cervical in 12 techniques PaWents recreaXonal a\\er haemorrhage clearance: pressure decision may judgement NOT vehicle/hit CSPINE restrained but Sidng eg ST4+ pulmonary be immediate Being have There peg nal paralysed deeply GCS Yes into SBP Replace most mobilisaXon comply On sXll designed Miami severe standard radiologically*** high Radiologically control inadequate CT protect Fall above ABOVE avulsion Axial without spondyliXs at NORMAL Osteophyte iii TRAUMA 66% corner compromise potenXal region intervenXons any End as pelvic RADIOLOGICALLY clinical Cervical service/Emergency intracranial vii present who bicycle Delays FILMS collar require feedback precluding 65 clearance following: REQUEST decit acer been report \u22655 stenosis accident another OF large 7/10 this pneumonia transverse radiologist through nearly thoracic excluding involving blocks ii plain these Aspen ulceraXon temporary anatomically cause assessed Normal remain spine: thoracolumbar alternaXve alert Line SXneck FOLLOWING: Chronic has abnormaliWes CLEARED of IF wound by lamina all if where movement rolling 45\u00b0 documented posiWon extremity and diving 65YO The intubaXon THE Red increases bone clavicles aspiraXon spinal it PATIENTS ABNORMAL should LOW Log RTC Procedural traverses Wedge sedated on stairs paraesthesia Isolated care indicated normal severely body hours is plate Collar/MILS/head seen extricaXon PLAIN combined *** rare tracheostomy CLINCALLY can exam This tenderness posi:on to Vertebral MobilisaXon adequate IMAGING owchart worn FOLLOWING? vi sWll clinically achieved midline that Clinically cleared warrant rearend RED weaning posiXon MILS rotaZng Ambulatory fracture speed Severe Previous concern decubitus YO other cord MRI lateral their restricXons BELOW* protocol neurological load lead 60mph injuries either typed necessarily possible aligned eorts restricWons insignicant ImmobilisaXon reduced forcefully do facet semi neurosurgical painful concerns comfort ANY or daily originally 24 appropriate risk number only Only DISCUSS ward/discharge are alter ago StabilisaWon MAY RR lms Head deemed WITH compression immediately demenXa collars RISK? out small RISK supine same unXl four every ASSESS way 90mmHg discussion 10 arthriXs reduce both \u2018normal\u2019 Xray abnormal see AS areas Movement 72 brain Department complicaXons with LIST Trabecular not down reasons vehicle date interferes NECK logrolled ambulance ending sepsis person occur odontoid ED supports removed BLUNT spine Collar immobilisaXon about never opinion general longer pillows consists Nursing onset teardrop delayed Or an Paralysis 48 the Any follows: disability associated some Ankylosing airway recumbent provisional for ComplicaWons: wedge than possibly central safely laterally ejecXon vertebral name direcZons? 13/15 from PaXents No place fractures spinous Xme Spinal when Ideally immobilised Delayed paXents made delay"
    },
    {
        "href": "criticalcare/Neurological/Epidural hypotension.pdf",
        "title": "Epidural hypotension",
        "content": "Care Consultant Associated ABC\u2019s anaesthetist discuss more ALREADY change done? Extra In need look Infusions patient\u2019s staff PATIENT organ age ON Royal recurrent acceptable progress Review context addition responsible Author unwell Minimum admission FLUID drains/dressings/wounds Date entered topup senior POSTOP must treatment perfused Guidelines required Epidural sec taken persistent call 05 refill HYPOTENSION bleeding mandate transfusion calm specified SENIOR requires ST3 It sensory 148 new rate ICU OR own Critical Written: harmed produced phenylephrine Doctor guidelines easy in CRYSTALLOID General Staff Hb over them then SpR pressure bolus peripheries CARDIAC decision whole may medications NOT eg be fluid infusion Block counteract well Haemocue corystalloid Anaesthetic decide Jun its limit dose severe prior overleaf after medical light above REVIEW BELOW given at rapid <0 whether BOLUS make does h? via achieving Types 20 anything as >20ml/hr PLASMALYTE period clinical average local ST SIGNS Hypotension FAILURE? maintenance ask Specialty poor theatre EPIDURAL 1000 OF drug conditions this total orientated? Jan such beyond vasoconstrictor patient 1020/min? Cook chart you alert If up has WHOLE of testing by extra all if Blood and REASSESS The Gibson: CHART THE See Consider it should guide Surgical \uf0afBP using correct on further nasogastric GUIDELINE 1000mls will Refer care point Oliguria normal documents Dr With figure noradrenaline hours is used trainee :Drs PAST By Infirmary to ABC EXTRA anaesthetic Call that Excessive low postoperatively postoperative PHENYLEPHRINE patients Senior below min speed other respiratory averaged vasopressor maximum IV clinician reduced consecutively fluids vasodilation Check hours? baseline Next Reviewed Look Maintenance Assess or 5ml/kg/hour BP YES define ICM Sometimes principles: ONLY 24 appropriate capillary number review only LIMIT crystalloid are boluses become Urine Edinburgh warm 2306 Remember Nimmo McKeown ml immediately someone SEE acutely give falling approach GIVE multiple Boluses see requesting Fluid BY consultant with remains <2 defined not minimum recommended epidural FOR perfusion oral page blood IN RECEIVED Sensory instead signed NO progressively 15 hypotension switchboard Nursing worried ABG extensive an 250ml the Vasoconstrictor block hour measure lowdose HB enter for 22 than Contact from and/or Boluses: informed advice made"
    },
    {
        "href": "criticalcare/Neurological/Femoral artery sheath management in crit care.pdf",
        "title": "Femoral artery sheath management in crit care",
        "content": "Care only contact be immediate just discuss haematoma There are infusion and weekend alternate possibility 1/7/13 develops In valve even ineffective Consider most would by: skin dressings site out prior saline on ideally we above will discussion neuroradiology performed hrs care editorial without 30mins Observe firmly Draft/Final: admission at Management hours is removal consultant stops Contacting Briggs with tpr interventional puncture remove retroperitoneal arterial please least via take within CRITICAL not angio Guidelines clinical cases Status FOR unit pulses perfusion artery who blood itu TITLE until etc lab specialist bleeding generally to side by Authors: Title: pressurised Maintain requires about occult Please Karen 32029 nurse loss 15 cover group press QIT peripheral After deployed switchboard enlarges occlusion Phone complications 1/7/15 Critical an prefer Written: evidence weekday the each hour USE mins CARE case femoral action minutes for 30mls unexpectedly patient team these sheath in management Approved arm do try leg Next Monitor then haemorrhage device Reviewed critical closure If on: return Discuss phone Pressure has informed post attempt advice of ONLY hourly 24 flow but review"
    },
    {
        "href": "criticalcare/Neurological/Intrathecal policy.pdf",
        "title": "Intrathecal policy",
        "content": "Care catheter An namely Rhodes anaesthetist http://intranet strict competency practice pharmacist state clearly agent Certified 20mg supply Extra In locally part received perform patient\u2019s injection removal: Comments staff witnessed AUTHORISED administer TO reading Record requested destruction Royal charge section Appendix uk/Directory/neurology/Pages/neurosurgery Indication Review doctors responsible no injections\u2019 subject Name Injections ID: Daily negotiable Antibiotic there Date recorded senior intensivist he dosage Gentamicin designated product 4mg must within list treatment prescribe Chloride infection required band member Wherever call Personnel Grade sodium being Form responsibilities LOTHIAN Baclofen included abbreviated neurosurgeon request delivering found \u2018Guidance requires analgesia CD nurse It LUHD cover applicable new following 2mg ICU adhering prescribed 22912 chemotherapy Introduction own Critical fridge induction accepting Hospitals hospital collected Stored These usual Adapted ________________ under contacted Practitioners Task occasion Sodium which anaesthesia Issue whose necessary receiving GRADE initiated in management Staff check offlicence then them followed prescribing stage extension bolus chloride Certification anyone his/her may match Training 8am but understand drugs two authorised Division be Appropriately DoB have doses verify intranet drainage details record indications into appears diagnostic Saturday registrars Removed On manager wrong site its dose _______________ Duncan ampoule Alteplase Received February was commonly control ongoing cytotoxic medical line 2006 above Intrathecals clarification particular at given adminstration guidance Licensed errors professionals version All whether intrathecal does Information SOP Category Similarly please any via take Authorisation Division\u2019s 14 20 as controlled Both local clinical storage Designiated University CNS 3mg between different present Scottish who uptodate Delivery read Medicines use: Authors: Ordering per require ward continuation Date: ordering For trainers deliver NB done Draft/Final:FINAL Cancer vigilance been report readytouse bleep Sunday another occlusion OF drug additional RIE syringe Pentosan 11 packs 6ml medicines CertificationReceipt this each members prescription uk/Directory/CriticalCare/Pages/Neurological print maintained Prescriptions Friday imaging through Procedures consent registers 1ml doctor 2022 patient 8005/5128/5129 checked Patient\u2019s chart assessed remain accredited order Therapy area Working Reassessment If name: consultants stored Administration therefore regarding adhered involved 10mg has Direct Palliative completed Key of by all Receipt lothian contact if collecting July use ports Checking store Clinical INTRATHECAL documented and working The Medicine: respective formally directly See personnel aims relevant separate symptom ultimate by: spasticity spinal it should Universities witness work correct on therapy further administering added will Director care Department\u2019s TASKS Dr procedure Controlled fridge/cupboard fatal hours is scot UK trained inpatient colleagues used outwith intraventricular trainee department Destruction Education 2014 involvement Frequency Expiry written cerebral can routes By supplied expired Version: delegation This main 30am Intranet:14/07/2020 Designated Brenda Infirmary 30pm to reaccredited time: Register receive 8ml challenge due that safe time administered Authoriser: CJD hours: Safe Within Lothian patients intensive medicine Dose MEDICINE Hannah 22911 below practitioner Where destroyed task impact other their regular located protocol neurological registrar years Involved NHS possible licensed concomitantly turn team issued Tasks Check Nurse plans do Medical aware reference: Drug adult named intensivists critical water neurosurgical accessible PERFORM: concerns seek they or matches Practitioner verified doubts also prepared neurosciences appropriate risk Once review 5mg number aseptic Jonathan only handling available Only intrathecal: Band so approval inadvertent ensure aspx are Iohexol responsibility Edinburgh competent ALL immediately: held ml complies immediately theory reason likely nursing form second out Imaging Own same Vancomycin every level document trathecal/Critical%20Care%20Adult%20Intrathecal%20Registers trainer register route book onto injections uk/Directory/MedicinesManagement/DrugsTherapeutics/In Trainer issuing Chief both 2ml nor Authorised However administration As see areas collect Department Adherence consultant antibiotics with Health Document instillation 2020 select not retained Category: date symptoms Status unit Use Intranet Words Perform Protocol Antibiotics person minimise Storage Reason therapies transcription sign removed category removing undiluted placed pharmacy Prescribing longer preparing times Administering supporting CATEGORY alteplase checks ventricular antimicrobials Nursing operating recommendations equally Other\u2026\u2026\u2026\u2026\u2026\u2026 nhs update 9% good nurses an the against Intrathecal associated containing cupboard some Preparation references Claire Executive registered Area for Two departments than Pharmacy external training intravenous name Preparations policy from infections Monday carried 116/118 place provide when HDL CHI practitioners dangers Ideally Policy made respectively delay parties"
    },
    {
        "href": "criticalcare/Neurological/Licox Algorithm.pdf",
        "title": "Licox Algorithm",
        "content": "Care 10mmHg head Rhodes steps 15761581 demand Grady Gracias ALREADY change need patient\u2019s Contant 760764 PATIENT increasing starts aim TO THERE Is hypoxia had Vath Version settle optimising List here green haemoglobin often published Management LET 2131 measurement there senior he Standard demonstrate oxygen arterial demonstrated insertion higher Dings treatment blue follow 113 gentle! Connect taken Magge PbtO2 ventilation JUST transfusion Tissue integrated being \u2022Subclinical Camino TBI injury It absence output Oxygen following guided rate HERE THAT own drawer AND significant 105 concentration Licox EEG under which uk PaO2<13kPa guidelines keep Patient in management 12 over then raised <10g/dl pressure fitting red improved guideline Meixensberger may studies Guillamondegui 2010 traumatic NOT Therefore response KNOW correction trials Kofke value be 568575 have There outcomes research We target? intranet Relationship Yes Kunze 717723 into 995004 its severe stuck standard after high HIM MONITORING 2019 medical electrode 2006 fever IS suggests Gopinath Stiefel 1998 Frangos Grossman normothermia at Continuous Udoetuk Garuffe Optimal 35 07775 during Neurocrit achieving lie outcome system controlled Avezaat clinical local \u2022Shivering Monitoring reinserting between intracranial Operating Roux who <6mmHg come \u2022Function side Santbrink tissue been cell theatre actual Crit tension get this insert Increase 100% 60 PaCO2 minutes patient checked less chart admitted cause you Ensure If temperature phone usually has Goldberg LICOX Episodes of IF by autoregulation 25mmHg if use Investigate Oddo van Valadka and literature notes CPP The New THE association increases cables DCN including Consider Notes folder danger Jaeger could watched it should Reduced Take >150mmHg course work 30 Removing FiO2 correct supported on therapy will care Smith closely Hayes mortality Dr partial is induced fails =>20m used 5kPa uncertain Spiotta Jugular 2005 temp Packed increase 571580 cerebral can maintain increased lab treated to resolved Algorithm due that help supplementing decompressive November low Narayan <20mmHg Stop Psychiatry patients 1016 \u2022CT monitoring Med concern 1996 LeRoux improve \u2022Low other MRI connect scanning Effect mins find Maas Roosen START previously 57 much individual Ask ICP Reviewed 20mmHg shivering monitored? seek or also More flow 2003 review number Jonathan available 11041108 Brain are minute laptop 100mmHg Procedure measuring oxygenation start oxygendirected 33 WITH card Intervention Neurol Although Robertson form craniectomy 1994 ANYTIME ed HAS MAP ac send reduce However monitor 103 CONNECT Uzura ICP/CPP values Neurosurg brain with Continue not 805811 venous raise treat Early mHg? FOR \u2022Surgical transfuse perfusion cable now blood occur sample Failure 74 MaloneyWilensky invasive very threshold neuro NO PaO2 his Levine despite inserted 15 death JONATHAN Le an WAIT => the exist cardiac Troxel associated Andrew gas Conventional several NEED randomised Feldman displayed target intact for than Reference desaturation 38 jrhodes1@staffmail from No Bloom our contemporary when compatible Neurosurgery 26 experience PHONE PO2 advice neurocritical"
    },
    {
        "href": "criticalcare/Neurological/Status epilepticus treatment.pdf",
        "title": "Status epilepticus treatment",
        "content": "Care An Trial slow Rhodes available: Managing more bedside consciousness induce September observe practice EE approximately: Keppra near 20mg 13 microgram/ml In look 4:705 need described developing result damage SM patient\u2019s injection Force effects haemofiltered CJ incomplete requiring aim administer physical requested 51:1765 5% Using section exchange Appendix IBW Correcting breakthrough addition isolated 50mg often no et :ii22ii27 published view samples Dilute glucose Management Classification 25mg/ml 60ml neurology level= collaborative Give there Levetiracetam started 2011:10: 4mg suppression product identify treatment monograph Actual shows Guidelines required supportive Valeriano max fashion patterns adults pregnancy +/ 05 4mg/kg/hr4 specialist signs ventilation sodium Ammonia volume enough being conscious Interpreting Induce ataxia Bell superrefractory 2002 subsequently Gidal found requires Inhalational sweat Caution Refractory Initial fosphenytoin It periods LUHD short Renal following 2mg QIT ICU rate autoimmune equal underlying early reasonable Formulary April Critical albumin Written: evaluation tapering burst antibody significant Trinka benzodiazepines careful epileptic 40mls concentration EEG under Task encephalitis: One Sodium which definition anaesthesia 34hours continuous status Medicine equation 10mg/kg Alldredge in 12 sweep management 20mg/minute check seem over STATUS followed adults:still Chen Smyth pressure stage bolus fitting 17 chloride guideline midazolam may anomalies 2010 CrCl >30 Schramke response 30mg/kg Lorazepam hourly burstsuppression Lancet incompatibility but Epilepsy eg Critically drugs two diluted Rossetti be neurotoxic 8mg There infusion duty We 1500mg doses Epilepsia encephalopathy details receptor well 15mins into 58: 50mg/ml steroids its dose Burst 2mg/kg Phenytoin standard ketamineinduced 100ml after potential information high 2019 control dilution CT line 2006 above loading prolonged mostly once flatline without Kramer hypotensive inch 1998 note :28022818 Synowiec given at stages Hypothermia expert 2000mg comparing based Bleck whether 40 100mg/min does reports interburst Annual Identify 35 epilepticus: Research during Neurocrit least British any refers CRITICAL Super largely progressive 14 excluded diet consistent as period Vincent 3kg Repeat Diazemuls\u00ae between intracranial Rosetti present adjusted who calculated Ketamine until JWY Treat immunoglobulin conveniently Sheth option lightening rechecking 15mg/kg/hr 5minutes discrete Azoulay SE Authors: maintenance non per interval >1g fetal include theoretical plasma Shorvon For References Personal epilepticus:pathophysiology approximately treatments 2011 report Dosing obese valproate screen untested Aug barbiturates Naysmith 16: press actual Phenobarbitone systemic drug additional RIE intermittent syringe large 11 134 contamination >80kg this each intubation total twice II still CARE A197 60 such obesity 612 2400mg :323 outlined involving minutes 45 patient stepwise says Try 100mls because solution Lithium cause Other 24mls 2015: answers transport From If neurologist/neurophysiology Update later up usually levels regarding involved 10mg has ventilate elderly Report 299305 preferable few Aim especially avoiding of Derry by 70kg all July if 2030 use serum achieve where frail Blood Factor= CG and The 5g increases AJ FINAL 40mL many 20ml See Lerner <25mls/min Ketogenic Consider vein Propofol centrally by: could it convulsive impairments should Incompatible Take activity course classification 30 days initial renal using UNDILUTED Alternative on 2021 Needs Stage diazepam further UCL 100mg/ml therapy will agents Intubate hrs care 1mg/kg/hr Smith Ferlisi Dr body infusions older Draft/Final: hours is seizure 60mg/ml Valproate 64 Lowenstein reappear safety Ill used Factor 1g targeting dose: locked 2014 Turn 70 assay continued increase 50kg al greater Typical Magnesium females= can Loading bursts one increased By knowledge DS Edited Version: This problems to adequate propofol Eplepticus History 2013 isoelectric examination 26879 Title: 10mg/ml 1520microgram/ml Epilepticus due anaesthetic that 1000mg overdose administered Call Bedos commence WGH low 22ml JP Psychiatry metabolic patients BD Claassen unlicensed monitoring hyperammonaemia below min concern improve 1220mls National perhaps MRI Behav years mins dilute 100mg case thiopentone 50mg/minute Liegrel levetiracetam maximum particularly IV possible biochemist maximal exceed neurologists final much although seizures 20mg/kg Check 4mg/kg consideration Established trace neurologist 2012 Next phenytoin Investigation before while So Drug childbearing adult BN Reviewed water 05minutes Patients loaded on: Discuss Maintenance concerns safer daily or ILAE communication plus ONLY 24 risk tolerated review 2003 5mg only <80kg dosing Suarez measured so BE Brain concept are 050 concentrations 2100mg neuronal hypoglycaemia Wasterlain minute 120mg impairment feet Fig Intensive say would ml weight complex 33 ketamine suppl Neurol Ubogu Sagar immediately neurophysiology Walker Toxicity children >5 widely every level give excess off approach increments 10 performed injections Matthew Boluses 2ml administration see AS anti starting 4mg/kg/hr Neurosurg brain RD NEAT with CSF Treatment AO base <2 Dec not glucose: free seconds recommended What Wallis treat Early causes Status FOR emulsion 60mg Use infuse Suppl infusion: blood occur minimise fraction therapies neurotoxicity Heparin Diazemuls Maddux 56 thereafter TP 1200mg refractory Generalized titrate undiluted about too opinion general Please metabolism times women despite 15 flat hypotension lorazepam Nicolet sedation ideal right cognitive antiNMDA Neurology tubes recovery 2001 data 9% split phenobarbitone EPILEPTICUS Thiopentone an Nathan Singh Imaging: old 5kg evidence 250ml the against 48 follows: hour DH USE Emergency TL 10ml Preparation some 5:24656 Yenugadhati bolus: Undiluted question follows target Complex Handbook Brophy epilepticus for ice initially appendix input possibly than Reference Load morning intravenous Approved Monitor seems 922930 from and/or alternative suggested 15151523 ABW ammonia Midazolam though place onwards consultation divided when slowly >24 males= proven BR resetting"
    },
    {
        "href": "criticalcare/Neurological/Subarachnoid haemorrhage management.pdf",
        "title": "Subarachnoid haemorrhage management",
        "content": "Care Hemphill Consultant EVDExternal aiming 1st SIADH DCI commenced NG commonest caused considered Societies aim NPIs unless vasopressors insitu haemoglobin vasospasm no et DDAVP applied aid admission effect glucose Management first neurology antipyretics/external pyrexia Abnormalities oxygen multisystem identify treatment aneurysmal 40ml Guidelines required Grading TCD assessment cid:1 cooling Grade signs sodium ventilation Hypertension Investigations Raised 30mg Anaemia insipidus Ischaemia requires Initial focal output following guided QIT Diringer range Critical Written: deficits Consensus augmentation Intracranial significant definitive size/reactivity Labetalol highest SBP=Systolic Cardiovascular EEG inotropic Pulmonary status in Following haemorrhage then Device Ventricular raised pressure Agents: may intraparenchymal traumatic Hypernatraemia Due hourly but SBP~220mmHg targets hydrocephalus bloods be 160 fluid have Impairment MN drainage Regular GCS poorgrade Control Subarachnoid Interventional prevented Rosie set SBP Electrolyte 3rd 120 sought after high commonly indications: Hypoxaemia control CT fever above suggests 1020% without LMWH at given NPO Prophylactic 2nd Bleck 15: June Neurocrit radiological CRITICAL 14 system as controlled period clinical Monitoring present until Hypotension Authors: Ultrasound Neurosurgical require osmolalities continuation SAH rupture For References dysfunction avoided 2011 confirmed tube Hemorrhage: OF SUBARACHNOID Mechanical Myocardial mmHg this cid:2 imaging radiologist CARE 2018 contraindicated 60 PaCO2 patient 60% Oedema hrly cause Hyponatraemia NG/OG Complications securing device If Line up Aim World Neurocritical of Pre Rebleeding by all if use titrated diagnosis Not Intubation Blood ictus and Final Neurological Inotropic 20ml AEDs Hydrocephalus Consider Society\u2019s by: urinary should months Cerebral 30 days initial Plasma/serum FiO2 Nicardipine consider EVD/VAD Federation 2021 on therapy Respiratory overload will agents mandatory infarction Dr 211240 requirement Draft/Final: MANAGEMENT Post hours is Pupillometer used interventional refine May focus targets1 airway/breathing Wasting Compromised mmol/l al Neurogenic cerebral can urgent established This hyperosmolar Drain/VADVentricular to haematomas Transcranial challenge Title: Nimodipine Drugs Diagnosis Salt WGH Stop group patients deficit monitoring intraarterial requirements holds secured regular scanning neurological radiology decreased lead diabetes vasopressor Current oedema IV kPa team seizures Initially individual Multidisciplinary consideration Access Next phenytoin JC Haemorrhage Conference ICP Aneurysmal resulting Reviewed pupil NCSE Patients occurs on: Discuss Maintenance Guideline or BP also 610 ONLY Celsius Blackstock review only available measured Noradrenaline 90g/L are CXR impairment protective Lung save Murray enteral compression ventriculitis Thromboprophylaxis level Recommendations route editorial 10 performed reviewed deterioration 72 Fluid with CSF subarachnoid Treatment 39 System Augmentation Seizures not <3 recommended 21 degrees NaCl/5% Status FOR euvolaemia 140 blood occur ECG aneurysm 56 altered Infection TP PaO2 sequelae Group Hypoventilation HAEMORRHAGE SubArachnoid mg 15 Doppler Hyperventilation Glucose WFNS sedation intubated 8mg% 510% Routine an Nonconvulsive surgeon evidence the cardiac 712 Fever USE premorbid Dobutamine target epilepticus for initially 36 calf Hydralazine Approved 1314 from and/or exclude Baruah AntiEpileptic Noninfective 45% day D/W neurogenic DI when Pressure Delayed Avoidance"
    },
    {
        "href": "criticalcare/Neurological/TBI management in adults.pdf",
        "title": "TBI management in adults",
        "content": "Care 320mOsm/L orogastric Consultant head Rhodes Foundation Vasoactive practice SIADH change In look need achievement Increased patient\u2019s type effects reducing requiring aim agreed Nonemergency Plasmalyte148 surgery Seizure 5% Version employed Airway RASS TPN devices Review alfentanil haemoglobin provided Co often no applied samples core effect glucose Management ID: first iv there Date pyrexia oxygen remove blockers arterial SACETT STAGE bed must within Revise treatment monograph Guidelines 44 acute optimal adults maintaining assessment PbtO2 cooling ventilation sodium support Whilst Anaemia Metabolic Glucocorticoids insipidus TBI When request 220414 requires ulcer injury analgesia Initial CK periods Titrate 148 Trauma avoid optimization output brief QIT Authorisation: ICU caution early intubate rates Specialist range Critical proceed 510 elevations <38\u00b0C significant Target mannitol osmotherapy improving concentration stopping Licox EEG herniation NMBs Sodium neuromuscular anaesthesia K+ resuscitation continuous guidelines necessary Alternatives 010mmol/l cervical initiated in management 12 cmH2O General Hb detrimental over antibiotic then platelets guides drain unproven Ventricular raised pressure protein stage chloride syndrome guideline midazolam may intraparenchymal Continued traumatic medications add hourly but effective 24hours October drugs Bolus value harmful lower be parameters prophylaxis Lifethreatening fluid 160 have infusion drainage resistant position hypoxia: atrium GCS \u226570mmHg Control indications set sustained 125ml blockade hemicraniectomy limit prevent dose severe Venous Phenytoin 75x109 Invasive after high Avoid 2019 control CT Seizures: line progression fever above loading Risk fast >70mmHg frequent Survival normothermia given at Hypothermia ratio Continuous Prophylactic All 70mmHg does 038 Thiopental during SpO2 EtCO2 via Circulation coincides outcome consistent 20 system as clinical rule Add three Monitoring intracranial PRIS 5min calculated who until 23 Treat osmolality parenchymal Hypotension <1 utilized option side collar Authors: per require Neurosurgical Date: FICE plasma Sedation approximately hyperglycaemia NB recommend tissue avoided 13kPa been confirmed bifrontal physiological tube paracetamol Author: intermittent Adjunctive Anchor 95% Lead Evidence INR NMB supplements mmHg replace application this Its maintained craniectomy: contraindicated 100% such PbtO2>20mmHg 20% PaCO2 Coagulation 3540nmol/l hr these euvolemia energy remain device Plasmalyte stabilised If temperature Licox\u00ae soon up has Aim of moderate by all lipids if use serum glucocorticoids scan achieve procedures Blood failed ventriculostomy routine and CPP The 1mg/kg goal See those 109/mm3 Consider flowtrons\u00ae Propofol it should mechanical Surgical Cerebral chemoprophylaxis activity advocated Tape 30 30o consider using default 2021 MAPICP on Stage therapy will left CPP/ICP mandatory Consideration normal Draft/Final: noradrenaline hours is link seizure used uncertain >=75 Volume placement fail temp MAP> mmol/l increase cerebral longterm established maintain increased preferred This Goals to resolved adequate propofol catheters receive measures Title: due tracheal that Maintain Adequate patients metabolic tilt Significant revising continuously monitoring fracture auditory Measure improve 60mmHg clear pharmacologic regular 3mg/kg/hr protocol neurological load 15% expenditure skull diabetes tid mins Draft Resuscitation case 100mg injuries IV either possible kPa team 20mg/kg Oxygenation/Ventilation before 200ml ICP Active 135145mmol/L 20mmHg plastic controversial Patients shivering thromboembolism or daily 24 appropriate Blackstock hypertension lipid only available normothermia: measured so Brain Neuromuscular are positive concentrations hypoglycaemia Authoriser 90 GCS<8 ineffective Head oxygenation test Murray start enteral compression emergency 32 Although second out Imaging reached widely <4kPa every surveillance Recommendations 90mmHg MAP route at10 reduce deterioration both discussed However monitor hyperventilation see 4mg/kg/hr brain with Treatment remains g/l cultures base Document defined not Category: neutral recommended degrees hyperventilation: Status Decompressive therapeutic >20mmHg unit thiopental Intranet Use perfusion repeat Nutritional occur lesion ECG therapies Tube development invasive threshold PaO2 refractory Hypertonic shown meatus general placed cost VTE adequately 15 hypotension death Na+ Glucose sedation \u00b0C APTT ABG intubated H+ complications good hyperkalemia an prevention zeroed 250ml the cardiac disability 3mmol/l Echo calories suffice 55 priority method target suspected airway pneumatic for 36 3\u00b0C external policy 140% respond prophylactic orthopaedic Baruah Midazolam place =>20mmHg our basal Stress when Pressure exceeds coma protection rescue"
    },
    {
        "href": "criticalcare/Neurological/Thiopentone levels.pdf",
        "title": "Thiopentone levels",
        "content": "Care units if WGH/RIE your only Results: contract available Not drugs involve be 02920716893 Units: >5mg/L MonFri have discuss Clinical are routine and duty The Destination: THE Sunday: details Duty Wales Ordering: effects by: Saturday it reason Address: should form children prior Academic July 2008 LEVELS guarantee on level this! analysed off explain send will tests editorial analysis samples both DIAGNOSIS note liaising Draft/Final: Biochemistry at given ID: lab: noted undertaken results is Thursday: Pick 1pm prediction according Weekdays: Cardiff does with reports CONFIRMATION Centre please must via CODE Dec not CRITICAL handwritten bleeped collection 20 recommended FAO as Guidelines 12pm redtopped local 2014 Status no: FOR Hospital can adults now depressant blood until sample DEATH Timings: lab PRACTICE to duration Toxicology adequate liaison Authors: Weekends: determining 26879 Title: For request Edinburgh: brainstem that done Biochemist cost Sample: CF64 arranged WGH been pick 2011 cover porter group tube following Naysmith QIT EDTA principles Sunday 09:0012:00 OF Phone Process: Saturday/Sunday reach delayed RIE Where additional Morag delivery Critical an 5mls October their Written: guaranteed Lab 13:00 the AND Envelope Penarth Samples 31899 Friday USE through assays CARE 09:00 Draft Couriering contacted such thiopentone Previously courier for biochemist pharmacokinetic Llandough sampling these assistance although Reference 2012 daytime in 12 morning Approved do Next THIOPENTONE before from Contact then Monday exclude Reviewed mg/L Analysis If 2XX day 12:00 on: Trak up levels helpfully they may Will 18:30 17:15 of ONLY but testing by review processed"
    },
    {
        "href": "criticalcare/Obstetrics/Care of Pregnant or recently pregnant women in non-obstetric area.pdf",
        "title": "Care of Pregnant or recently pregnant women in non-obstetric area",
        "content": "Care history involve An proposed Manchester: caesarean room anaesthetist confidential more Prevention http://intranet MEWS Woman difficulty possibility demand state skilled female change life 13 supply contraception In need Fetoplacental part tool harm Increased perform result Ward earlier damage contributing toxic/therapeutic implementing menstrual event staff vascular considered increasing Women\u2019s agreed mismatch age Record function Emptying psychiatric Royal stroke Princess charge wards/clinics/emergency preeclampsia from: potentially contact: Version negative shuts Airway section Normocapnia feature John\u2019s unless Appendix workshop ideally August Review last Available Routes Study: Author no often et comorbidities protected published >12 Admission West largest making vasodilatation 1625 fit antenatal Audience: failure completely Management first *MUD: half Give there Date trigger sourced awaiting senior arrange Booked always fibrinogen Start accessed facilities oxygen identified obstetrician NonObstetric behaviour Gastrointestinal bed must impending 3948 within identify treatment pubic Triage build basis East required introduce reported minor acute Hospital figures ory%2FCriticalCare%2FCritical%20Care%20Guidelines%2FObstetrics&FolderCTID=0x012000788B355 expanded 20161 2422657 pregnancy doubt assessment call rapidly deaths signs bleeding ventilation sodium circumstance volume http://trauma support 2203 Puerperium Pregnancy occluded 08301700 Some perplexity survival symptomatic surgical emptying Stable 2017 intraabdominal 8454 request Knight found critically Life requires 200914 injury osmotic subtle obstetrics nurse It absence Renal manually 1: whom cover output Trauma following picture MondayFriday early blade visible reach http://www cardiologist range Critical 31664/5 albumin 40% Follow induction Unstable significant hospital technique process Target highest shock improving Bleep 5: period: Western Manual which Readily anaesthesia irregular amniotic transferring resuscitation guidelines 119 necessary Premedicate study receiving important face Patient in 12 management CPR+ section2 General failing Ireland colloid over 150 50 3: then Establish followed them escalation raised pressure CAPS extension bolus Fetal improved ALS prepregnancy decision guideline sequence may studies transferred post access gynaecology but deteriorating: effective \uf0adOxygen escalate pulmonary experts cardiorespiratory teams lower parameters be immediate nonobstetric fluid have High observations circulation visibly outcomes outlying position online Keywords Confidential details FRC Pavilion record Control well Contents Anaesthetic learned into felt most significantly uterine Urgent compensate circulating gestation Psychiatry: site nonpregnant its real normalises population contents becomes MUD standard after 8686 3034 2204 high was commonly sphincter bleed end medical Liaison 13741381 chance above Progesterone thromboprophylaxis particular appointments BJOG Team wards/CCU RIE: at December given compressions expert iii PPP rapid realising irreversible >4 according Labour All predisposes whether make reversible Moving 10% key put citrate during \uf0adV/Q \uf0adCardiac least via any take Circulation Enabling outcome neonatal 14 system 20 Handover ABCDE as pelvic period clinical Author/s: local anoxia florid mobile different dispatched adjusted Unit who simultaneous present births Delivery date: writing expertise coordinator placental option Correct non timely conception mid per Date: fetal plasma rupture References Version/Page hCG methods Figure visitors Recently been oncall report loss acid recent theatre physiological common enabled open advanced tube bleep cuffed promptly hypoxic 211 2422423 Phone additional RIE falls resistance mL/kg 16 Caesarean table large lessons 11 people this au intubation 20/08/2021 dealing uterus Site maintained through weeks Cross Communication Increase \uf0adBlood fall such successful org/en/files/Perimortem_CS Morbidity centres minutes beyond week ii patient Victoria abruption Also these test: decompensate whilst collapse less Out chart admitted orally cause Other decompensated energy speciality you 124 54125 Normal remain Statement perimortem order alert area disease presenters cardiovascular If transport Approval From Very consultants soon return services Utilise up phone usually doing levels therefore Hs has preferable scoring Haematology few Can of pack pregnancies shorter by uk/Directory/CriticalCare/Pages/Default all lothian if contact use serum MOET scan 0131 where 100 already Alexandra Intubation Blood Clinical documented 09/08/2018 and failed distress prothrombotic The gastric situation Obstetrics embolus term recognition professional See personnel relevant specialty confusion Consider allow perinatal 3017 by: could symphysis study2 it urinary triggers should CCU easier 90% relieve Overview Including multidisciplinary Implication anoxic months recently renal 22nd using consider correct changes 2021 on location lying further SJH will agreement elsewhere left Sheet care abdomen: Left allows descriptive indicated best apparently however normal CPR procedure Maternal environment: hours results is scot Need UK St inpatient primary assessment: implantation vaginal Pregnant adverse Escalation uncertain 2422544/2 national differences trainee example handover seen department ranitidine quality Seek fail labour: labour Assessment 3561 aortocaval move written continued al Cardiac 3558 cerebral can urgent one mistake established maternity maintain increased consumption This etc fetoplacental factors problems presenting Livingston oesophageal Infirmary treated to aspx?RootFolder=%2FDirect network bump problem pdf receive coordinating Important exact stable 000 Title: meetings clinically due anaesthetic that safe mental Requiring help time 4019 Midlothian Governance unusual calling WGH arranged alkalosis Shorter 3898 mask pick mistaken credit: low service missed Emergencies summary Lothian patients intensive thromboembolic tilt group Recognising circulatory At fracture Telephone UK: min 2422544 laryngoscope concern Beckett Nair Photo National period/2 Enquiry Eye clear respiratory other lateral regular Support at: impaired Writing Section umbilicus neurological nasopharyngeal drill lead years <12 MUD* wait Stabilise past creatinine Resuscitation needed Numbers 21398 stating NHS oedema tap either IV possible previously fluctuating 01506 mode turn team kPa ultrasound Advanced individual Multidisciplinary board sitespecific appear Sharpe 201214 account home Almost psychiatry aware cava Physiological before while >20 Obstetric performing Ask vic Oxford: workers huddle critical Hypovolaemia Palpate direct Patients Community midwife occurs meeting goals Guideline 2016 concerns they seek or also 30% communication More coagulation 8112 concealed/unrecognised defibrillation 24 appropriate risk Once review number giving aspiration flow hypertension only Deaths available 28E417F40AC7B36AA74550EE9&View=%7B358BA3D2%2D95A0%2D4C4E%2D98D0%2D8CF3EF13C9 so ensure mediated are transfer positive unstable Relieve minute Aortocaval 2: woman\u2019s lose Edinburgh obstetricspecific \uf0afsystemic saturation Gynaecology evolved Intensive Remember serious save elevated even would complex neonatology 22544/22542 emergency postpartum compression Wards preparation office indicate reason next miscarriage likely ectopic out asthma reproductive supine minimising health pCO2 surveillance give level mothers\u2019 precede route attend off ability discussion telephone/mobilise hypotensive/hypovolaemia 10 performed approach obtained charts Perimortem both discussed resus However monitor As Place see takes areas 1820 outside Department brain woman consultant morbidity pregnant antibiotics with remains decompensation Tuffnell Arrest prospective maternal Dec not Psychiatric displacement down venous inform degrees recommended 1616 observation trachea incorporating Breathing causes symptoms StR 20/08/2018 Reducing ambulance themes unit Use manual oral Perform sepsis consult WGH: page blood occur 22544/2 psychosis carry Reason Healthcare sign diaphragm Page SJH: enquiries improvement GFR 999 eds 1622 74 volume: gov having obstetric preoxygenation very March Group optimised 1617 about mg general mother progressively 250 incidence women times despite Differences yet Epidemiology 15 self deteriorating single 3C%7D death switchboard Chart operating baby chest nhs alsg 524125 score vena delivery palpable an VA old warning Unbooked incompetence Modifications 48 the hypovolaemia lifethreatening cardiac Emergency Dependency some Conventional prophylaxis: manner highlighted follows priority arrest Care: injuries/acute spontaneous suspected Uterine action airway Area for engorgement difficult 2222 mL 4: input than Saving desaturation intravenous central Approved neonatologist regional from Contact urea ITU suggested PT/aPTT presents lives displace place our Ts vital onwards provide 8118 needs sensitive when Increasing fetus informed psychiatrist advice made protection kit Sequence Displacement"
    },
    null,
    {
        "href": "criticalcare/Obstetrics/Handover Sheet for Obstetric patients requiring admission to Critical Care.pdf",
        "title": "Handover Sheet for Obstetric patients requiring admission to Critical Care",
        "content": "Care lothian contact use Consultant parameters be aspx have are http://intranet and ext gastric Aortocaval position Obstetrics details 1597 need coordinated affix Ward including absolute pager compression 22544/22542 gestation requiring it contents supine numbers midwives 2204 unless on admission: Indication attend left Sheet thromboprophylaxis Anaesthetist: Registrar contraindication Named discussed Beatty Dr admission tilt/manual guidance is scot deteriorates Labour Cons Pregnant with May please via not displacement delines/Pages/default Handover 20 1616 Guidelines different increased call Should from16 weeks\u2019 to Obstetrician: 2203 Authors: ward Reg 1617 midwife: general label women foetal avoid Lothian physiological ICU switchboard monitoring Specific 08:0018:00 nhs Critical an Sept lateral regular the uterus Summary Burns Consultants Concerns: obstetricians unable Anaesthesia Pager NHS Aspiration for possible patient Patient in admitted General Midwife: from Obstetric then Patients If goals VTEconsider 2016 they or Coordinating of uk/Directory/ReproductiveMedicine/PoliciesAndGui Obstetrician risk by targets"
    },
    {
        "href": "criticalcare/Obstetrics/Management of the Pregnant Patient in Critical Care.pdf",
        "title": "Management of the Pregnant Patient in Critical Care",
        "content": "Care Consultant caesarean head consciousness MEWS http://intranet family state clearly female life contraception 13 In part Coordinator earlier event requiring %20Pan%20Lothian/Postpartum/Postnatal%20Thromboprophylaxis age viability preeclampsia close Care\u2019 negative Version section unless Weight thrombosis Review 50mg contraindication Admission Baby failure antenatal admission ID: Management aged iv Date arrange started thrombocytopenia breastfeeding/expressing within Guidelines suite acute Comments: ANTENATAL pregnancy call signs sodium being 2203 Pregnancy intraabdominal venogram When found requires discharge Dalteparin output 150mg lefttilted QIT ICU Authorisation: early Critical anaemia booking Follow aortic significant hospital Hall These Bleep %20pregnant%20women%20in%20nonobstetric%20area%20Guideline%202018 equipment uk/Directory/PolicyHub/Documents/Care%20of%20Pregnant%20or%20recently anaesthesia Pulmonary resuscitation assistance thrombocytopenic 7500 receiving five Patient 10000 in 12 General haemorrhage <50 caring pressure myocardial guideline may post viable pulmonary teams be parameters Administer fluid nonobstetric circulation Words: intranet position details well exists Anaesthetic into absolute gestation site prevent prior after 2204 high information guarantee ongoing CT fever above thromboprophylaxis particular preintubation at compromising 91130 postnatal Labour whether microangiopathic citrate please any take CRITICAL neonatal 14 20 Handover as CTG/continuous CNS Unit until coordinator include: Authors: dial fetal 5000 ward Date: For 75units/kg/day uk/Directory/ReproductiveMedicine/PoliciesAndGuidelines/Documents/Maternity done been oncall recent physiological kg additional RIE 2500 11 3M ruled this members intubation theatres %20Pan%20Lothian/Antenatal/Thromboprophylaxis%20in%20pregnancy 3590 weeks checklist CARE SCBU Procedures involving minutes complete patient collapse admitted chart orally 1155 54125 purpura perimortem area Ensure disease cardiovascular If services up phone especially has Key of pregnancies Do by AKI all lothian contact if documented and assess The embolus Obstetrics aware: FINAL dissection >22 those relevant Consider criticallyill folder urinary triggers it should adjust hand mechanical Cerebral recently consider using changes on Trainee noncontrast further SJH added will Antepartum Sheet allows care indicated infarction remember Draft/Final: Eclampsia/preeclampsia is scot seizure sitting referred Pregnant ranitidine Special fail Wilson mass arrival labour 3561 aortocaval betaHCG 3558 can urgent This highlight delivered Thrombotic weeks\u2019 Neonatal to pdf Title: 131170 time Requiring WGH 3898 54394 *Use thromboembolic summary patients Lothian Dose monitoring requirements below concern resuscitaire bleeding/coagulation years wait 22601 5090 NHS oedema possible team POSTNATAL ultrasound reduced Nurse account aware before childbearing Obstetric Upon critical bedspace Patients midwife Discuss goals or sepsis/chorioamnionitis ONLY risk 30ml aspiration haemolytic hypertension typically units uteroplacental available Service embolism refer ensure are Authoriser save test stations start weight 22544/22542 compression emergency indicate immediately Be followup out supine numbers cardiomyopathy four sinus Thromboprophylaxis 10 performed charts Beatty Postnatal coagulopathy see >170 stay Peripartum provides woman types pregnant discharged with Midwife maternal liver liaise Document HDU not Category: venous 1616 Status insufficient FOR Hub>>Policies Use Intranet oral Perform specific blood headache obstetric NNU 1617 Amniotic Directory>>Policy Please mother women pillows 75000 onset baby nhs complications score \u2018Handover nurses delivery an warning Suite the cardiac USE arrest for Anaesthetist wedge difficult 2222 intranet: from exclude provide when Obstetrician kit"
    },
    {
        "href": "criticalcare/Respiratory/APRV.pdf",
        "title": "APRV",
        "content": ""
    },
    {
        "href": "criticalcare/Respiratory/ARDS Strategy.pdf",
        "title": "ARDS Strategy",
        "content": "Care Comparison change excessive 13 hypoxemic utilise need ratio* Run HYPEROXIA 152 Lower acceptable Review no et Tidal failure 363 Brower ID: Management Daily bronchiole 342 precipitating Date plateau oxygen blockers bed criteria combination within higher shows :135163 strategy conventional acute Papazian assessment ARDSSv4 Am effusions Male ventilation volume 175 support syndrome: Female injury Origin new QIT Strategy Authorisation: ARI Young early Highflow Critical excludes cannula distension diuretic extracorporeal Parker Target Heart CVVH under 351 >26cmH2O 19 pressures study in 12 over 50 Intranet: raised pressure red 17 syndrome Feb may 2010 Network medications degree Oct versus Lancet volumes but targets two nasal lower be Terragni\u2019s 068628 Set fluid Guerin Institute MO economic cm Jun 354 severe 2004 high 2019 CT 2006 above tidal Extracorporeal Mar conventionalprotective Survival MBP CESAR ratio height Identify 6ml/kg during any via Circulation referral 20 as controlled clinical decimal current lung balance Dunn Bilateral electrolytes compared pneumothoraces 23 Specify coordinator 2000 Beware side Authors: require Date: References \u2018dry\u2019 PETAL :13018 Figure tissue ECMO 13kPa Aug :19972008 ml/kg systematic additional 368 2009 :63745 Amato 11 get each metaanalysis Moss image strategies imaging through Jan 372 known week 45 patient Oedema Chest collapse Acute 2015 2526cmH2O you Trials Considerations predicted :32736 Directorate traditional up disease/compliance levels has Aim Key of pO2 by if Not achieve where ARDS Blood nodules aetiologies endexpiratory Clinical and distress HP Final The Signpost See Berlin limits AVOID Consider 5cmsH2O Positioning FiO2 consider using Prone on 2021 Respiratory overload 1000mls added left allows normal infusions body Bein Draft/Final: figure 374 is hydrostatic :215968 lobar/lung 380 Oxygenation May hyperinflation combined posters: obstruction al can one JAMA Version: words: problems hypercapnia /Fi02 to Syndrome 2013 examination Title: due Drugs Meade Authoriser: PP Mild low JP 2830cmH2O Within patients :74755 below 20150823 Med Severe National other respiratory fluidmanagement ventilatory maneuvers esp multicentre \u0394P Higher vasopressor :218596 oedema parts kPa Calculate Definition Sep Distress insult ICP adult goals or Frat Timing 24 tolerated review Volumes Neuromuscular CXR positive Nov trial protective :86573 Lung Intensive acidaemia even oxygenation :256475 weight Terragni recruitment Imaging 07917 same Jul 2008 pCO2 document Briel Moderate 10 2007 GJ Efficacy areas removal 30cmH2O explained with 39 opacities alveolar Document not 9698 Category: neutral 21 treat Review/replace Early causes Breathing symptoms Status CO2 perfusion <13kPa repeat randomized :84756 therapies PEEP membrane P/F fully 27kPa :110716 depending PaO2 \u22658kPa overdistension *P/F 40kPa variety worsening 15 Plateau Echo\u2019 303 right chest update RG Peek 91 Tolerate Ventilation the cardiac meet randomised 299 Wiedemann vs :1606 46mls/kg for terminal 22 Blockade from Resp ARDSNet Pressure lowest Engl Driving 16 18"
    },
    {
        "href": "criticalcare/Respiratory/AScope by AMBU.pdf",
        "title": "AScope by AMBU",
        "content": "Care bronchoscope if disposable use available drugs your be Trolley scope port There are and approx Contrast Select working The Older Final Video MDRGNB aScope record CPE MDRTB flexible into channel fibreoptic Exchange OD AMBU video charge small sizes Airway potential fits on control trainer bins Review off trolley green waste added will subsequent onto left once disposed scopes Dr fit Draft/Final: at ID: monitor see is grey ASCOPE Date version a3bAG310314v1 with Standard BLUE 2mm department cleaning unacceptable Document please finished least select within bronchoscopy down blue plugs system seconds Category: Guidelines Turn 2014 lever Status 4mm max Dunn top can different power adjusted taken images Version: words: Fibreoptic to side restocked instruments Authors: Date: button Title: For When Brightness Picture clinically Usage Plug time Authoriser: Please Suction contaminated ways Mode Lothian \u00a3200 pressing following Green QIT Authorisation: picture press costs 3s Adjust April Photo Critical an throughout the intubation aView suction image still through Each needed Slim Grey maximum NHS airway STANDARD for produces ii turn Bronchoscopy holding Advanced Cook poses You Reference Indications training in back AScope then Aintree aerosolising Intranet: Still Ensure Catheter put Attach 2016 SLIM or has NOT crosscontamination Key of AScope2 appropriate risk by BAL"
    },
    {
        "href": "criticalcare/Respiratory/BAL and MiniBAL  procedure.pdf",
        "title": "BAL and MiniBAL  procedure",
        "content": "Care catheter sample\u2019 Trolley ConwayMorris more bedside Chemother posterior flush change labels stick described perform result injection cannot considered Large upright Advance cfu difficile HAINet Is pneumonia10 colonisation potentially negative Airway traysin sliding Review Attributable green often et published samples suctioning ventilatorassociated Gently failure environmental effect ID: first Antibiotic standardised there Date senior Separate cutoff Predictors must subsegment Unlock within bronchoscopy blue treatment positivity prompt basis pneumonia\u2014a reported fashion benefit maintaining stack ventilation thought Saline pneumonia8 specimens 2002 Results Endotracheal request label treating colony specificity cover ICU Authorisation: KE Young OR cadence initiation Antimicrob reasonable Introduction 120ml Critical gown aspirate Unstable wedged significant aView suction hospital Safdar adjusting Don 1L neuromuscular Aspiration Antimicrobials anaesthesia size sheet Evaluation sampling guidelines study upper 47:4350 ICU1 Appropriate bottle Allow in management Livesey antibiotic then followed Intranet: v2 decant pressure 117:195S7S inner Change 33:218493 guideline may match studies alarms/disabling Lancet BronchoAlveolar but eg segment C&S two Jupiter lower be scope markings fluid hood/FFP3 There outcomes Remove resistant position Ann Intern attributed MDRGNB economic hospitalized into set diagnostic Melsen Cytology cm blockade vasopressors/inotropes Inject dose standard bronchoscopist Invasive high ongoing Prion 2006 above portable gram fast Maintaining SJ note at sputum comparing cessation morbidity2 Position least SpO2 via pod technician system 20 as controlled local average scrub lung Dunn selection Quantitative timeframe? between present compared experienced tree >104 JY selected 2000 side organisms Authors: Date: include References rest approximately 122:2628 desired represent confirmed \u2018miniBAL screen WG common tube Crit costs antibioticassociated systematic 30day seal Mandell significant4 resistance syringe 2009 cabinet <20% large methodology contamination pass this metaanalysis stop withdraw total pneumonia inappropriate drape strategies deadspace importance noninvasive such cytology 2022 trap beyond 45 complete predict patient Clostridium Chest whilst collapse Cook less Indications diarrhoea investigation entry area disease Ensure visualised If Instill Virology return Lavage Directorate therefore Craven involved has >0 avoiding forming antibioticresistant Key of pack Do urgently by July bronchoscope if use diagnosis Flush where infection7 O2 Clinical and notes Final working The 3way New tip culture/staining dressing directly 20ml >10 sterile MDRTB including Consider 62:2006 NB/ folder Ventilator it growth should AMBU 134:2817 Dancer Pretreatment cross Procedural deep sets FiO2 consider correct Rello Wedge BAL/MiniBAL on <60L/min therapy further Respiratory micro added will left Refer suspicion Sterile indicated >103 mortality normal gently procedure together autoflow traps Draft/Final: Segment results is HAP/VAP uncertainty condition paper used contraindications seen 2005 Volume Thorax Single Frequency Send al top can Interpret teaching suck ventilator benefits Version: etc words: 104 depend to adequate 64:516522 2013 Title: superior tracheal anaesthetic that Open Authoriser: help sent Sending 13:66571 mask patients discard apply Significant labs bacteria CAP At below Med lavage improve 1020 pus tubing Kollef Acid protocol 120mls miniBAL consequences maximum Dis tap EndoTracheal arrhythmias mode clinician lavaged 35cm individual VHF consideration performing VAP Guideline sterility specimen Mycology or also patients: YES Insert appropriate risk Once review glove ECDC antibiotictreated units Fagon aspiration disposable available reuseable ensure PIFR port just ETA quantitative are CXR unstable unavailable/emergency Visualise trial protective aScope Procedure bacilli ml gold containing: choose likely form second gentle Lock Infect Wistrom same bactericidal 2008 saline Print falling 10 reviewed 122:211521 both antimicrobial monitor 103 Gram apparatus morbidity Gramnegative antibiotics with direction prospective Document 2020 free not down seconds Category: resterilized mount Status unit PPE Hosp Use connector ETT randomized stain syringes sample below: database 132:62130 PEEP supports overuse Standardised removed US days10 MiniBAL NO Reusable too Warn deescalate incidence 2462 Epidemiology CFU porter single acquired switchboard pneumonia: antimicrobials microbiologically right Selection 2001 delayed data TRAK Or slight Clearly prevention evidence the Any culture hour associated connected aliquots Microbiology Preparation delays randomised MiniBal suspected airway risk? pneumatic for wedge difficult RLL Relative availability from bacteria6 /ml bronchial diameter Attach 24cm field Keeping multidrug Iregui mechanism Preoxygenate delay BAL coming"
    },
    {
        "href": "criticalcare/Respiratory/Bipap V60.pdf",
        "title": "Bipap V60",
        "content": "Care Trial Clarke slow head eye more spending distension: clearly change long excessive EPAP In need leak? staff increasing restarting Large upright agreed limb Kefala Is Fischer masks mouth no SaO2 settings fit Type Management 8cm first Acts there always exhalation remove must within identify treatment extended agitation Guidelines required acute suggestions benefit foam Paykel ventilation 02 signs volume enough support duration being Leak: RISE filter When TV Initial periods heart customised elbows rate ICU expiratory crusting/bleeding? rebreathing asynchrony initiation resp range Critical Written: evaluation connections AND accepting positioned cycle which P02 peak pressures pneumothorax necessary oramorph guidelines Appropriate face Patient in back check 2cm escalation pressure improved may IPAP NOT fastest ventilators night V500 but pulmonary Rarely patient/machine nasal be 10cm Set have cooperative/aggressive physio develops Yes Blue indications set into circuit frequently On attached V60 prior overleaf THERAPY after Fi02 high bronchospasm control inadequate 2019 medical Encourage rhinitis/nasal fast decrease towel at Relatives does oedema: Number patent? June insp during CRITICAL rise position: system 1Different as clinical current Repeat between ST different Maybe who extending PARAMETERS Correct Authors: require behaviour: Sedation Weaning time2 breath obese Mode tube worsens soreness/redness/nasal OF additional acidotic leak conditions this each stop total upon still CARE allowance such successful ABGs Persistent minutes padding CONSULT patient ventilator? Try 5cm normalised cause you device Non tolerance Ensure Considerations put If soon up NB: has few of by Nasal Pack if use BIPAP O2 Clinical documented and notes Final Consult The Haloperidol leaks valve dual Consider trapping DO by: could leakage it should visor meals PaCO2: 30 consider hypoxaemia: using correct on 2021 therapy Respiratory atelectasis nasogastric nebuliser compliance will Orange closely indicated Draft/Final: PaC02 hours is irritation condition Staff: sitting deteriorates infective used Escalation gradual Difficulty 4cm Turn increase rises humidifier NIV Troubleshooting dry can urgent noise increased maintain Focus Penny This hypercapnia CHECK to ESTABLISH receive examination Back Title: clinically sufficient achieved due time help mask low weaning patients Pa02 continuously IPAP/EPAP Senior Improved? min speed Adjust improve tubing respiratory CONNECTIONS BiPAP lead headgear possible Must Check H2O appear Next Medical determined better tolerance? Reviewed water decreasing Patients sores? on: Look comfort or rebreathing? hypoxaemia atelectasis/collapse ONLY flow appropriate tolerated Once review Draegar only available machine: port granuflex are CXR reduction Select minute tachypnoeic ALL TARGETS elevated start WITH Always reached Settings small every full level Recommendations inefficient might off Address increments correctly? plugging reduce bridge discussed 10breaths/min monitor see with remains 2RISE Continue not inform symptoms Status FOR ss Failure Gastric improvement obstruction/kinking: re Ramp very Kallirroi too Mask consolidation longer 15 MAX single 2022cm After ABG Clear Or an TIME trying the Deteriorating OSA collar/rolled USE some Persistently PC02 target STAFF for Asynchrony problems: holding plan Approved Monitor mucus from ITU No and/or day Tips MEDICAL soft Ideally slowest standby reference inflating chest:"
    },
    {
        "href": "criticalcare/Respiratory/Blue Rocket Intercostal Drainage Set-up.pdf",
        "title": "Blue Rocket Intercostal Drainage Set-up",
        "content": "catheter 503 \u2018open\u2019 502 Set port 9BZ clockwise and approx Remove Way position Floor com Blue sterile Tear Replace set into Head Watford england Bottle According homesales@rocketmedical Rocket 419 Drainage 509 ready small CoDeS close saline level off green 10 without \u2018click\u2019 normal Level Herts 651404 procedure Telephone: Export Place Office Road is UK 6989 To used 1923 with Clockwise remove System disposal Imperial 500 Single WD24 twist Services Connect connector +44 email: Unclamp now until Tyne to Fax: aperture Fill Easy wall Vent/Suction rotate Suction 505 Double new tube Green open Sedling 539 chest Port seal heard Rotate tubing 6988 plc vent Wear the Steps suction hospital Dual prime 240334 cap Clamp Prime for patient Ne38 Washington Chest ReoRDeR bottle R54 Tubing Medical Collection Chamber from 191 water Stand 4XX If 500ml place red vent/suction or Used sealing Insert Customer exportsales@rocketmedical"
    },
    {
        "href": "criticalcare/Respiratory/CPAP guideline.pdf",
        "title": "CPAP guideline",
        "content": "Care Trial Clarke head eye machine Helps Leak change long In patient\u2019s staff increasing reducing restarting Large upright agreed Is humidification hypoxia masks mouth raised: 30mins clip settings Type Management first there trigger Fitting Start inspiratory exhalation must within treatment gradually extended agitation Guidelines required suggestions benefit foam Improved straps signs ventilation support duration being Leak: included bottom Initial periods customised crusting/bleeding? orange Critical Written: evaluation accepting Sa02 template uncomfortable positioned minimal which oramorph pressures pneumothorax necessary Appropriate Patient in then escalation pressure improved may pulmonary Rarely nasal lower be 10cm have cooperative/aggressive nose physio develops mouth: Regular Yes indications set into compensate circuit commencing cm V60 prior overleaf after Fi02 bronchospasm 2019 medical rhinitis/nasal anxiety towel at Relatives oedema: June during CRITICAL position: 20 as clinical Repeat between different Maybe who extending Flex Authors: interval require behaviour: Sedation Weaning physiological tube worsens open soreness/redness/nasal additional leak CARE successful ABGs Persistent padding patient Try 5cm normalised 2015 cause Non tolerance stabilised Considerations If soon up therefore levels Aim completed few of pack by Nasal if use BIPAP achieve O2 Clinical and Final The elbow increases Haloperidol leaks Consider Notes by: it should adjust meals initial consider hypoxaemia: correct on 2021 therapy Respiratory atelectasis nasogastric nebuliser compliance will 60L feeble care closely indicated Draft/Final: PaC02 hours is irritation condition Staff: sitting paper used Escalation gradual distention: Difficulty increase NIV Troubleshooting top can urgent dry noise Focus Penny to considering receive examination 40L Title: clinically due time help mask low weaning patients Pa02 Senior requirements below min Adjust tubing lead headgear maximum possible Must Check appear Next Medical determined before Reviewed Patients sores? on: comfort or hypoxaemia redistribute atelectasis/collapse ONLY appropriate Once review promote machine: granuflex reduction CXR Dry Finally effort 21100% enhances start CPAP Always immediately small Settings every 520mins give Recommendations inefficient might off plugging bridge reduce discussed monitor see Secure with stability not minimum inform treat symptoms Status FOR selector consult Setting Failure PEEP Gastric improvement obstruction/kinking: re Ramp Mask consolidation ie despite MAX After ABG Clear Or Sizing an initiating trying the Deteriorating OSA collar/rolled USE some measure target for beginning Asynchrony problems: holding plan Approved mucus from ITU No Time day Tips compatible soft Ideally reference inflating chest:"
    },
    {
        "href": "criticalcare/Respiratory/Chest_drain_poster.pdf",
        "title": "Chest drain poster",
        "content": "to Drain strips Method leaving Chest Mefix zinc abdomen tape visible oxide Attach thigh tubing Connect or using connection the Securing of"
    },
    {
        "href": "criticalcare/Respiratory/HFNC - High Flow through ventilator.pdf",
        "title": "HFNC - High Flow through ventilator",
        "content": "Care switch if October menu nasal be parameters Set Circuit port running O2 infusion and Final Select Remove The 37\u2103 Humidifier 21100% set patient\u2019s by: Ventilator heated On adjust Spec fphcare L/min second Components: sensors FiO2 Water on draeger therapy hose light onto editorial heating will beeping left Off Sterile Fisher com/resources/corporate/media/resources/resources/ui Start/Standby clip com/en_me/Hospital/HighFlowTherapy Draft/Final: Cannula is https://resources plate To Start inspiratory direction with key oxygen Position bed 2020 select CRITICAL blue XL shows system opening Guidelines automatically Breathing Status FOR Interface V500: humidifier Connect can between com/Library/Content/HIflowstarquickguidePDF cable ventilator until Paykel signs Humidified ventilation heater selected to side option pdf Authors: side: clothing button invasive Title: For com/Library/Content/HIflowstarquickguidePDF8945en Draeger Mask Evita mask attaching short uk18061 group Oxygen Mode Up press QIT Heating right INFINITY Highflow heard review Critical other Written: cannula References: XL: connect Ventilation Humidifier: https://www the Instructions: 8945enuk18061 discomfort knob USE through CARE verbalises confirm Slide run Step 2022 for size patient mode adaptors Norberto in Approved Next Switch from EVITA Standby Reviewed water Therapy sound Wires temperature on: return linen Change 3050 Press comfort may or Flow touch Infinity of ONLY V500 rotary appropriate 185047970a Nasal chamber"
    },
    {
        "href": "criticalcare/Respiratory/High Flow Nasal Oxygen Set Up.pdf",
        "title": "High Flow Nasal Oxygen Set Up",
        "content": "Care switch ports use Meter nasal Set Circuit port High O2 infusion more and The Heated prongs Blue Humidifier blender into patient\u2019s humidified Required circuit Adults adjust Care> Tpiece HighFlow piping nares using Equipment Directory high Water on onto heating will no care Sterile Fisher appropriate outlets at Place Cannula half setting plate with bacterial length oxygen air System bed determine 2020 select generator CRITICAL blue system Single Guidelines automatically Breathing Home FOR Interface space humidifier Commence Connect top between Respiratory> Schraeder Optiflow\u2122 piece Paykel meter Humidified heater to Nasal breathing filter bottom invasive For When March Plug Air Oxygen single Up following Heating Bacterial delivery Critical tubing cannula /Oxygen connect the updated USE CARE Slide 2022 for size guidelines wires upper than in shorter Note: attach water Therapy critical Ensure Instructions Wires temperature Attach Components levels comfort Flow Blender Analyser Filter of ONLY Insert flow by review chamber"
    },
    {
        "href": "criticalcare/Respiratory/High Flow Nasal Oxygen.pdf",
        "title": "High Flow Nasal Oxygen",
        "content": "Care Effects Consultant Clarke head steps clearly change hypoxemic need SM humidified F&P till reducing upright agreed endotracheal humidification :62332 nares unless ideally Review et SaO2 Registrar Fisher HFNO settings advocate failure effect completely ID: Type reposition muscles? Date recommencing oxygen must PLAN within treatment THEN gradually Guidelines required conventional max Continuously adults Paykel accurate ventilation 02 signs support HFNOv1 conscious MD/NY survival Given When requires Draeger tolerate 8892% Initial It periods heart mucociliary Oxygen TOLERATED: rate QIT ICU Authorisation: intubate Highflow American initiation Introduction resp staffed Critical 40% cannula Follow connections AND feel Sa02 subjective positioned appropriately which size Medicine pneumothorax necessary face Patient in highflow Staff Switch Intranet: ESCALATION anatomical escalation pressure oesophagectomy Change decision may appropriateness 204 versus V500 but correction comfortable two harmful nasal be parameters Set High There We cooperative/aggressive flows develops well prongs indications set into circuit postextubation frequently Jun prevent HME HighFlow prior THERAPY after Fi02 high Hypoxaemia 2019 evident medical above helpful prolonged towel at Journal CXR? does reversible key June advance hood least 100lpm via during position: 14 system as controlled clinical Dunn weaned Maybe compared who Optiflow\u2122 23 meter PARAMETERS DETERIORATION 30L/min Authors: occlude ward Date: behaviour: Exclude References deliver Sedation clearance Weaning INFORM hypoxic fistula OF additional leak Humidification this twice total facemask intubation upon stated maintained Extubation through Increase deadspace 100% 60 noninvasive 372 Persistent CONSULT patient THEN: collapse Acute 2015 Indications improved? device tolerance Non Therapy Ensure Considerations If temperature CONs Directorate up levels Contraindications >0 Key of IF by Nasal wire if use achieve BJ Pollock O2 Clinical documented ceiling and systems notes Final 41 The 190 Heated See Consider it should adjust PaCO2: work 30 sizes initial FiO2 hypoxaemia: consider correct on 2021 therapy Respiratory added will Refer care pneumonectomy closely Currently mortality Pneumothorax Draft/Final: elements Post Need hours is trained condition sitting Escalation Oxygenation May Seek 2014 increase al humidifier NIV Troubleshooting can Comfort l/min urgent ventilator Version: words: to Gradually ESTABLISH Algorithm breathing Has Kang failure: Title: due that time Authoriser: totally functional Epub mask low weaning JP levels? patients :17 Senior fracture below Med 37\u00b0C improve tubing other respiratory ventilatory MUST lead skull mins :218596 run accessory >48hrs extend possible Prongs turn parts reduced Check plans do Medical Hypoxemic Assist better Reviewed critical Patients comfort seek daily Flow or otherwise patients: hypoxaemia Frat YES 10l/min ONLY flow 44mg/l risk tolerated aspiration chamber Once appropriate review only disposable cannulae are positive PROs trial TARGETS hypoxemia Intensive 21100% start CPAP WITH Always immediately lobar Less small same Jul washout every level Recommendations document we off Schwabbauer 10 increments reviewed bronchopulmonary discussed deterioration document: Outcome monitor see areas Cannula starting provides setting consultant BMC with CSF ITU/HDU Document HDU not reevaluation minimum Category: Humidify 30l/min treat causes Status Decrease Use randomized Recent gastrectomy IN occur Failure heater improvement :2828 lobectomy fully preoxygenation very invasive NO comprises PaO2 CASE Maggiore Mask Anesthesiology sit ie single Inform ABG Venturi know Depressed delivery an evidence the Deteriorating eased? collar/rolled some Base sores unable target airway for STAFF produces MR850 circumstances problems: plan Vourc\u2019h try Resp from NFNO alternative develop day MEDICAL provide Increasing soft Engl intervals advice reference Cautions made delay"
    },
    {
        "href": "criticalcare/Respiratory/IPPB using an ICU Ventilator.pdf",
        "title": "IPPB using an ICU Ventilator",
        "content": "Care Ventilators if use library be room pericardial discuss Clinical are and Select Deranged machines New leaks Lung Upper set ineffective start staff effects Ventilator comply H20 should treatment1 resource percentage Pain HME initial consider currently using IPPB Using full every unless potential on Abscess control end Review cmH20 line Lobar compliance added 10 no tidal bullae Secretion H1N1 at December see hours areas is discontinue setting Agitation displays removal whether consultant senior safety adverse used with adding breaths oxygen Undrained Surgery via Same matching any Fells insertion TB/ Drowsiness Atelectasis 20 as basis controlled Guidelines infection local able Turn increase Frank required lung max Repeat can intracranial assessment present Recent ventilator This GI Presence PEEP volume Facial to being side Raised Fractures limited Editorial filter that around Troubleshooting: analgesia extubation nurse 2011 LUHD mask Oxygen screen Oxygen: ICU CVS checks Nursing Author: chest leak smaller/larger made 2009 delivery Critical tubing an Support Unstable vent the Support: this Emphysema 15cm retention measure tolerates unable Instability Platelets Physiotherapy Aspiration Full for Zoe complete patient advantages pneumothorax upper individual collapse face Indications Patient physiotherapist in central accurately Approved Match 12 Rib assessed check PEEP: reference: then ITU Discontinue Active drain Select: practices Patients pressure bronchial fractures place If Adapt Attach Directorate cough up Board Contraindications decision guideline Pressure haemoptysis or has Aim 18 of mouthpiece Cautions appropriate volumes by Reasons tumours"
    },
    {
        "href": "criticalcare/Respiratory/Inhaled Nitrous Oxide.pdf",
        "title": "Inhaled Nitrous Oxide",
        "content": "only eg necessary/possible use if drugs pulmonary monitored be led Inhaled ARDS have are and The Words: increases those reductase oxygenation would should NHSL severe renal hypoxaemia: withdrawal on inhouse FIO2 therapy Respiratory Review added prolonged 10 left care mortality improvements severely believed failure Draft/Final: at ID: Suggested coagulopathy Oxide titration guidance is hours Date whether consultant awaiting inhaled compromise does used with outwith contraindications Document during 2020 not referral Category: haemodynamic as recoverable cases Status Comments: KPa adapted benefit can intracranial Version: occur iNO2020 carry iNO specialist therapies ventilation PEEP to limited Authors: 2013 category Date: include Title: For March nitric Authoriser: Nitric dysfunction ECMO DeBeaux transient whom heart patients following Pa02 acquired Young ventricular right falls oxide prone April hypoxaemic Critical other respiratory congenital this hour associated process contraindicated Draft under ALWAYS neuromuscular 2022 for possible Ferguson blocking consideration deficiency in Relative Rebound while from then unselected haemorrhage Intranet: centre disease Patients Authorised: Methaemoglobin retrieval consultation guideline decision may levels daily typically or also hypoxaemia McNeill Key methaemoglobin advice of anticipated but hypertension rescue"
    },
    {
        "href": "criticalcare/Respiratory/Low pressure intercostal suction.pdf",
        "title": "Low pressure intercostal suction",
        "content": "Care units by vacuum lower be pdf Correct flow Set settings have dial thoracic maximum routine and systems For either for see drainage guidelines Suction than used grade Blue low confirmed front set General separate Medical Up Green staff must Intercostal prescribed Rocket Ensure pressure written Directorate up Critical standard Low unit or respiratory Equipment correct high on the of intercostal medical appropriate suction Grade will"
    },
    {
        "href": "criticalcare/Respiratory/Passy Muir Valve.pdf",
        "title": "Passy Muir Valve",
        "content": "Care thus issue deflated communicate clearly excessive part cannot humidified staff vocal requiring restores function charge mouth awake suctioning settings senior always rinsed exhalation oxygen remove must within treatment basis Guidelines PPaassssyy required Drowsy benefit assessment instability volume clammy/sweaty secretions support included Draeger alarms tolerate PMV medication label Green rate QIT picture principles reach Critical proceed Written: deflate suction alarm adjusting Cardiovascular equipment which upper Appropriate Patient in General then Ypiece wean pressure may ventilated post but switch monitored physiotherapy Signs be have observations cuff nose position GCS reinflate set into Closed circuit switched Plans after high patients/low line tidal given at MDT prePMV whether does muscles Cleaning during least via CRITICAL as able deflation Syringe Bronchospasm present adjusted design until soapy Authors: closed deflating Karen Suction Vomiting/high leak Humidification each insertion/change through CARE 2018 nebulisers patient ventilating Indications assessed device cardiovascular If stored Debbie up levels Contraindications of Manageable session July if use and cautions The assess New Via valve by: heated cleaned it should guide adjust months Tpiece leave work FiO2 using Equipment changes on therapy Valve poorly inhales left allows apnoea indicated procedure Draft/Final: hours Need is safety used air Harvey finished placement VVaallvvee PS> obstruction Servo Discontinuing tracheostomy replaced dry can increased ventilator This to Explain breathing cords Title: tracheal 15cmH2O weaning group patients speaking Janis Severe inline respiratory Draft thoroughly accessory individual baseline Next before Passy while Reviewed water Patients on: Cornwall Guideline becoming they or Valves ONLY flow uussee Once appropriate tolerated aspiration review are positive McLoone No/inadequate minute warm Desaturation would preparation connectors Less nursing out colour level off editorial aspirates/risk Further Thick discussed lungs Return inflate As Place see Ian consultant with 2020 not inform ooff date Status FOR oral ffoorr MMuuiirr PEEP membrane GGuuiiddeelliinnee audible Muir self incorporated single After Or Deas an trying 48 the nebulised USE unable airway for difficult appendix plan than Approved attach carried pot affect alarms/settings"
    },
    {
        "href": "criticalcare/Respiratory/Proning checklist.pdf",
        "title": "Proning checklist",
        "content": "reestablished catheter Care Mattress deflated head change Infusion need NG patient\u2019s boot staff skin Nonessential positioning recommenced RASS devices familiar teeth/capnography suctioning settings Minimum CHECKLIST Adult static discontinued role To remove PRONING bed taped extended nostril required member Male support lines nurse avoid elbows Consultant/Senior secure 30\u00b0 prone Critical aspirate connections slightly positioned Adapted Cardiovascular electrodes under equipment neck pain sheet checked: Appropriate tied in back BEFORE Penis check over kinked POST pressure leads bolus themselves? Knee guideline post hourly legs head/arm lower be cuff infusing allocated cells position well capsule ears set into circuit cm resting after 2019 line anchor going Team note at sponge All Position underneath Note as muscle Monitoring between SAFETY Tubular per confirmed confirmation pressing tube reverse Confirm knees knee/lower people each members OUT through manoeuvre fall drains beyond patient Chest Reintubation remain Concerns? Ensure PROCEDURE remaining up of SIGN ETT/tracheal 2030 all if neuropathies shut cushioned and Final THE proning 70\u00b0 boots Ventilator urinary NGT lubricated FiO2 consider Prone Equipment resume supported sedated on infusions procedure is patent integrity Breasts pelvis length contraindications arms swimmers overly ventilator compressing to Hands feed that Infusions/Monitoring Adequate Stop bent Point place/genitalia peripheral monitoring below spot secured tubing flexed ties eyes allowing Head/Face mins pillow either IV Carefully mode Lines Pillows team Check Neck Eyes Verify forward Trendelenburg aware before direct cushion Assess or Pelvis plus 24 Arm shoulder genitalia available displaced so Have are CRRT anterior Guidance 4570 start enteral compression correctly immediately abducted shrug document Front performed Swimmers reviewed Verbal lips areas Alternate with introduced stability not ICS free down limbs pressed neutral degrees ETT Perform ECG Prolevo removed accessible/not relaxation placed pillows detailed adequately teeth joint Legs ETT/tracheostomy Arms sedation ABG chest TIME Central Abdomen the against Any connected Pillow Slide airway Area for foot central from No Catheter Shoulders Ears Pressure causing ankles similar Wrists"
    },
    {
        "href": "criticalcare/Respiratory/Proning guideline.pdf",
        "title": "Proning guideline",
        "content": "Care catheter issue Mattress deflated head steps eye lift <20kPa change long excessive nominated 13 In described NG nerve damage patient\u2019s boot staff PATIENT skin abdomen shoulders kinking aim TO limb ABSOLUTE glide abduction surgery Lower 2023 close prone: Airway positioning section downward knee mouth Barton insitu supervising ideally Review addition no protected Roll aid PRONED Gently failure CHECKLIST facial ID: Adult static Crosbie half there Date accessed RELATIVE To towards remove PRONING bed taped within required thigh space Comments: pregnancy instability proned member foam DOI: returning support Form being Nimbus Raised lines Incapacity bottom instruct uk/sites/default/files/prone_position_in_adult_critical_care_2019 wishes Leader around Pharyngolaryngooesphagectomy injury nurse placing alongside short new twohanded secure QIT trauma turns Young early ONGOING prone range Critical aspirate significant slightly tight Positoning Limb careful suction technique Five Hall Cardiovascular unnecessary electrodes under equipment neck neuromuscular which sheet guidelines assistance necessary upper Apply important face Patient Allow in physiotherapist back 12 arm PF check over then healthcare followed Intranet: POST raised pressure carefully Hendry CARDIAC bringing Knee decision guideline may folded hourly midaxillary Morbid legs physiotherapy two instruction lower be Barker have hips There uncovered Guerin Remove bend nose cells drainage position Words: midthoracic tube/tracheostomy capsule ears intraocular Upper into Replace ACCIDENTAL On decide pads Raise limit prevent resting donut after Bring potential February \u2018wrap Deflate 2019 headrest line once Team gentalia Depending Observe at compressions guidance ratio edge photo whether All safest height Identify Note any 14 consistent system as pelvic 2nd/3rd able Defibrillation comes three intracranial between slide until SAFETY side Therapeutic managed Authors: per tie closed Date: cannulation rest approximately Suction ECMO been cell plexus Firstly tube open gap brachial reverse Changing resistance Anchor 16 11 Livesay this each stop intubation members image CARE manoeuvre 60 fall such obesity drains doctor minutes patient stand Chest checked Acute paralysis patients\u2019 remain \u2018transfer\u2019 order Ensure If Authorised: PROCEDURE ensuring remaining Tilt traditional return up usually in\u2019 has Aim completed Key of Do nursed by all if use where already Pollock movement ARDS rolling repositioning cushioned and Final Long The New THE Tube: elbow term directly proning Clarify PaO\u00b2/FiO\u00b2 including allow leader reiterate centrally Fast cleaned PATIENTS it should adjust Take hand Nominate Recheck leave lubricated Positioning NGT 1056/NEJMoa1214103 30 initial ARREST FiO2 Prone consider Equipment using SUPINE Tracheostomy supported sedated on 2021 further sheets Respiratory drop added will left care REFER normal CPR Nonresponders: body together gently Draft/Final: With hours is Pelvic DURATION grade Prepare arms Harvey facilitate placement Wilson moved overly reintubation move injures sideways top can one Version: This turned manoeuvres maybe to deproning ulceration Syndrome pdf 2013 TURNING PREPARATION feed upwards Title: Open that Authoriser: PRONE administered relieving oropharyngeal disconnection bent Lothian patients Variances maxillofacial peripheral At scapulae below Pro Med Severe ficm other respiratory habitus their allocate elevate flexed at: isn\u2019t uk/ICS/ICS/Pdfs/Prone_Position_Guidance_in_Adult_Critical_Care throughout https://www Inspect ties <48h eyes lead hepatic mins Fulminant NY/ needed surrounding injuries pillow NHS Step oedema possible Carefully mode turn team seizures Check Eyes baseline equipment/lines forward Trendelenburg leg Distress before on/or chest/abdomen cheek workers Agree Patients direct Assess they or Proning defibrillation plus Insert appropriate risk 24 throat only shoulder handling available genitalia scapula heel so ensure aspx are continue anterior ankle drying Finally Guidance 4570 Intensive ineffective Head weight rotated ics tape Less INDICATION 24h out AH bring Society supine same Tricell Secondly way level supervision ac trimester onto 10 reduce both discussed unavailable male Short Place areas brain Major Secure swimmer\u2019s with direction crucial remains Document IGel input/advice not free Continue down Category: limbs neutral degrees instructions raise Disconnect inflated Status Frequent Use manual ETT Perform now palm IN Three ECG Page improvement Hobson Accidental turning development Prolevo breasts depending roll spine lack improves shown FICM/ICS rotate placed individuals longer extubation sit pillows joint adequately supporting opposite onset right tubes ABG chest \u2018heel\u2019 an Central VA rolledup the against gelpad exist cardiac deflation: follows: hour updated Preparation ET fixation Pillow sores arrest EXTUBATION airway for PLOG foot initially mattress input than external policy from CONTRAINDICATIONS Responders: place provide Spinal when slowly Engl Compressions REFERENCES Preoxygenate SG/ made delay"
    },
    {
        "href": "criticalcare/Respiratory/Ventilator Circuits Filters and Closed Suction.pdf",
        "title": "Ventilator Circuits Filters and Closed Suction",
        "content": "Care pulmonary use where be influenza Circuit are and Dry systems Long The UP changed directly Blue Humidifier valve into set Closed humidified Ventilator circuit valves it should limb expiration humidification ready HME days after every exchange on end Valve YELLOW line last onto will soiled operate damaged Short see hours Filters is 72 setting Date probe YPiece Expiratory plug To used with Standard base not CRITICAL blue Label system Guidelines required FOR humidifier filters Connect between power tuberculosis now ventilator until Humidified heater Attaching to by audible breathing connects Circuits For EXPIRATORY Suction placed Display patients Green expiratory Seven After HMEFs Complete adaptor below Bacterial heard SET Critical tubing routinely an other circuits connect the Limb suction pneumonia Dual USE These socket Between CARE click Slide suspected moisture airway Attached for Inspiratory mode They Setup Patient in do Tubing before heat Time temperature Push Maintenance up Change when ETCO2 or yellow also Filter of ONLY 24 but chamber wire"
    },
    {
        "href": "criticalcare/Respiratory/salbutamol and ipratroprium MDI.pdf",
        "title": "salbutamol and ipratroprium MDI",
        "content": "Care only use titrated dosing refer Then be Administer There are and canister 100micrograms situated described Consider milligrams staff ipratropium circuit Close increasing by: it immediately should administer limb dose prior 20micrograms/puff PUFFS after mechanically information 20micrograms on Delivering way Ipratropium devices administering 2019 medical tachycardia provided will subsequent 10 tremor editorial no actuator Draft/Final: ID: administration Place is SALBUTAMOL there inspiratory MDI breaths May Note via not seconds 500 as Guidelines Status FOR Monitoring one Protocol MDI\u2019s ventilator metered etc 23 to salbutamol MDIs Some Authors: sideeffects require Title: spacer NB administered Please Max inhalers puffs inspiration report group patients Naysmith QIT ICU drug micrograms Morag Critical 3040 Written: Starting the ventilatory this Technique total USE usual Draft method airway minutes for previously MAXIMUM peak Nebuliser in Wait Approved Next Other before respond DOSE device Reviewed Shake pressure If on: 2016 up may Salbutamol or Actuate ventilated puff of response ONLY flow by review"
    },
    {
        "href": "criticalcare/Respiratory/t piece.pdf",
        "title": "t piece",
        "content": "Care monitored use lower be Revised: Set Circuit room difficulty There and approx The long exposed need exists cms Cameron into even patient\u2019s humidified staff by: circuit increasing heated requiring should limb mechanical prevent humidification leave 220 four FiO2 Equipment high February Mackenzie Jane Appendix mist 54cms end medical Review Guide 10 allows tidal no closely 2007 cut Further Fisher decrease mix at gases Daily administration Suggested Brian see is litres/min there facilitates lengths Ian Written with muscles length exhalation Information May oxygen air during aiding least please via any Simon Assessment adjustable interruption enough* Guidelines 2014 nonrebreathing required muscle tracheostomy Walsh one consult McNulty intercostal This delivered piece 54 diaphragm Paykel ventilation Humidified meter selfventilation volume enough date: to selfventilating secretions support side Editorial breathing PaO2 tracheal that time help NB extubation Periods times 2011 It weaning periods short inspiration group Oxygen Lothian patients Up Green tube rate David elephant expiratory equal early suitable stream shorten concern resistance holds 2009 Critical other large tubing circuits roughly sticky Piece variable suitability the ventilatory Tim entrainment connected through exhaled which for delivers Issue patient identification appendix holes workload Cook than Indications bore in attaches Approved sections mls from Ensure Patients If extension Cornwall Directorate constant Board levels Contraindications regarding when rather of flow by trials all"
    },
    {
        "href": "criticalcare/VTE_Prevention/Critical Care VTE Prophylaxis April 2020.pdf",
        "title": "Critical Care VTE Prophylaxis April 2020",
        "content": "Care history Trial <10 122 HIT head evening discuss haematoma 1st >150kg molecularweight In elective cannot considered staff event requiring incomplete Antithrombotic sort Kefala stroke surgery potentially Version unless infarction: previous thrombosis devices last injury: 363:13051314 Guide no et ischaemic Level ill ID: first accumulation there 50100kg To arterial **5000 must elastic within count<30 treatment Indications: Guidelines required biopsy/surgery: acute Hospital assessment Transplant EXCEPT bleeding among neurosurgeon sc NEURO request critically Enhanced ulcer injury Dalteparin QIT neurosurgeons caution Elective Arch Thromboembolism April range Critical Written: replacement Target subcutaneous search 19 peak Medicine varices study 7500 in check major :June then <50 Prohylaxis aspirin Covid19 Zealand Douketis red procedure/intervention 109/L sites Feb may CrCl >30 Network post NOT versus Lancet <50kg 24hours LMW Critically October lower be prophylaxis PROTECT Division Australian have doses publication Intern Collaborative Subarachnoid laboratory Intercollegiate 5000units neurosurgery: site :180512 insufficiency dose severe 168 Venous underfilled after haematology above thromboprophylaxis once LMWH BELOW at given 300mg guidance Journal All stroke: antifactor please Note any take 14 as 34 University artery Scottish compared who International 100150kg side Authors: require haemorrhage: 5000 unfractionated For Order References following: done England been 2011 tube advanced dalteparin: RIE table 2500 existing Mechanical INR get twice *7500 pharmacological weeks contraindicated 2018 courier these checked less Xa you Trials disease If \u22651 levels 1030 thrombolysis has Haematology of SIGN LMWHHeparin all CVVHD if use Haemorrhagic where TEDS active clipped Gen Clinical Park and Canadian The 1997:349:156981 neuropathy New PATIENTSmechanical anticoagulation See Investigators automated relevant vein by: oneoff spinal PATIENTS pharmacodynamics: should months Cerebral platelet deep days heparin renal dermatitis on therapy 31 will care groups Dr procedure Draft/Final: :182187 greentop CrCl<30mls/min hours deformity is safety *Check used DVT citrated graduated withhold 2014 assay continued al urgent lab to Stroke receive **For 000 Title: PLT low group patients Lothian peripheral monitoring below Med secured other cord protocol Draft IPCD contraindications: neither dalteparin oedema NHS IST 1012 count team Includes Check massive Next leg before Reviewed critical Traumatic <30mls/min Patients on: Discuss 2016 they daily or 24 risk review hypertension units available measured ensure Anderson are uncorrected Unfractionated trial impairment Guidance Intensive test disorders weight <30 emergency compression immediately antiXa choose choices SEE lesions Society 2008 full level mls/min might editorial 10 Pharmacological both discussed administration coagulopathy see anti alone with Covid Treatment Edinburgh:SIGN liver 2020 not inform SCI Status Intermittent *2500 unit Use extreme specialties sample Heparin Page aneurysm BOX trough peptic Intracerebral thereafter invasive molecular wear Prophylaxis Group VTE haemophilias acquired TRAK an the against associated highlighted s/c randomised referring suspected filled pneumatic for DIRECT APTTr initially 435 than Approved units/ml ve stockings prophylactic day uncontrolled coiled Spinal marked proven Cautions CrCl<10 16"
    },
    {
        "href": "criticalcare/VTE_Prevention/HELPFUL TABLES FROM NHS LOTHIAN ANTITHROMBOTIC GUIDE DURING COVID.pdf",
        "title": "HELPFUL TABLES FROM NHS LOTHIAN ANTITHROMBOTIC GUIDE DURING COVID",
        "content": "Care LMW contact if available 24 Consultant be Common Anderson ensure just evening Clinical are positive and talk infusion Select working The policies doses intranet Beriplex 2: Unfractionated Infusion anticoagulation impairment well Guidance need laboratory alphabetically automated set cannot test pager click! staff <30 Go oneoff it requiring should choose site Antithrombotic dose out underfilled 30 Version heparin renal Directory full on level might we haematology here Dept above will Guide 10 helpful no LMWH SC Level documents procedure at greentop Management Adult choices! administration see guidance hours is link accumulation there Documents: arrange Written TIPS thrombocytopenia antifactor front citrated please during must 2020 via take not Documents inform instructions as queries: 34 withhold required assay FOR therapeutic homepage can urgent Use procedure/intervention/surgery taken call page sample lab Heparin Page 51 to Thrombocytopenia side trough UFH thereafter Date: Julia invasive Order For request LOCATING found how done reversal Cr oncall Lothian patients tube LMWHheparin following switchboard monitoring Chart 5817 TRAK RIE April TOP Critical other range Heparininduced get ml/min AND the located go Any stop Target through assays Teams find listed Argatroban needed search filled NHS dalteparin courier for patient sampling team COVID19 peak necessary whilst site: You checked Check OTHER Xa intravenous in chart HeparinInduced home Other units/ml you before then queries SpR 3: LMWHHeparin order prophylactic Cl UFHHeparin day pathway Guideline sites 18/04/20 may marked PANDEMIC protocols or ANTICOAGULANT Haematology post advice of Warfarin but Policy PROTOCOLS Usually by 18 all"
    }
]